255

FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45
Page 2: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:2

FRIDAY,SEPTEMBER21,2018-

ORALABSTRACTS:ADVANCEDFFR-GUIDEDDECISIONMAKING

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room23B-C,UpperLevel

1:00PM-2:00PM

AdvancedFFR-GuidedDecisionMaking

Moderators:AllenJeremias

Discussants:JosedeRibamarCostaJr,StephenP.Hoole,GiampaoloNiccoli,ExpeditoEustáquioRibeiro

1:00_PM TCT9:CoronaryPressureandFlowinPatientsWithSevereAorticStenosisandCoronaryArteryDiseaseUndergoingTAVI:ImplicationsforClinicalIndicesof

CoronaryStenosisSeverity Lecturers:YousifAhmad,MD

1:10_PM RoundtableDiscussionWithAudienceQA

1:15_PM TCT10:PhysiologicalVersusAngiographicGuidanceforMyocardialRevascularizationinPatientsUndergoingTranscatheterAorticValveImplantation Lecturers:GabrielePesarini

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM TCT11:AssessmentoftheAdenosineDependentHyperemicResponseDuringtheSubacutePhaseofaMyocardialInfarction:InsightsforFFRGuided

CoronaryRevascularizationinNonInfarctedRelatedArteries Lecturers:HernanMejia-Renteria

1:40_PM RoundtableDiscussionWithAudienceQA

1:45_PM TCT12:ElevatedFFRValuesattheAcuteMomentinNonCulpritVesselsofSTEMIPatientsduetoDecreasedAdenosineResponsiveness:AComparisonwith

theAdenosineFreeiFR Lecturers:NinaVanderHoeven

1:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:AMIOUTCOMES

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room26A-B,UpperLevel

1:00PM-2:00PM

AMIOutcomes

Moderators:RajeshM.Dave

Discussants:AngelesAlonsoGarcia,RobertoBotelho,WarrenJ.Cantor,JayaChandrasekhar,RobertoDiletti

1:00_PM TCT21:PrognosticImpactofSYNTAXIIScoreinPatientsWithSTElevationMyocardialInfarctionUndergoingPrimaryPercutaneousCoronaryIntervention:

Analysisofan8yearAllComersRegistry Lecturers:AnaBelenCidAlvarez

1:10_PM RoundtableDiscussionwithAudienceQA

1:15_PM TCT22:TheResidualSYNTAXScorePredictsPrognosisinSTElevationMyocardialInfarctioninBothSingleVesselandMultivesselDisease Lecturers:SonyaBurgess

1:25_PM RoundtableDiscussionwithAudienceQA

1:30_PM TCT23:DerivationandValidationofTemperatureRecoveryTimeasanInvasivePredictorofMicrovascularObstructionandPrognosisAfterSTSegment

ElevationMyocardialInfarction Lecturers:AnnetteMaznyczka

1:40_PM RoundtableDiscussionwithAudienceQA

1:45_PM TCT24:ImpactofBleedingonOutcomeandPredictiveValueofBleedingScoresinPatientsWithCardiogenicShockaSubstudyoftheCULPRITSHOCKtrial Lecturers:AnneFreund

1:55_PM RoundtableDiscussionwithAudienceQA

ORALABSTRACTS:COMPLEXANDHIGHERRISKPROCEDURESFORINDICATEDPATIENTS(CHIP)

Page 3: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:3

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room31B-C,UpperLevel

1:00PM-2:00PM

ComplexandHigherRiskProceduresforIndicatedPatients(CHIP)

Moderators:JeffreyW.Moses

Discussants:ToddJ.Brinton,JensFlenstedLassen,RobertT.Pyo,WilliamMSuh,GeorgeW.Vetrovec

1:00_PM TCT25:RadialArteryAccessAndOutcomesForLeftMainStemPCI:AnAnalysisof19482CasesFromtheBritishCardiovascularInterventionSociety

NationalDatabase Lecturers:TimKinnaird

1:10_PM RoundtableDiscussionwithAudienceQA

1:15_PM TCT26:RecanalizationofChronicTotalOcclusionsinPatientsWithvsWithoutChronicKidneyDisease:theImpactofContrastInducedAcuteKidneyInjury Lecturers:LorenzoAzzalini

1:25_PM RoundtableDiscussionwithAudienceQA

1:30_PM TCT27:LeftVentricularFunctionFollowingHigherRiskPercutaneousCoronaryInterventionPerformedWithHemodynamicSupport Lecturers:JuanRusso

1:40_PM RoundtableDiscussionwithAudienceQA

1:45_PM TCT28:RepeatChronicTotalOcclusionAngioplastyFollowinganUnsuccessfulCTOPCIAttempt:PredictorsofSuccessandAssociationofSuccesswith

AnginaSymptoms Lecturers:AdamC.Salisbury

1:55_PM RoundtableDiscussionwithAudienceQA

ORALABSTRACTS:EXCELTRIALSUBSTUDIES

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room33B-C,UpperLevel

1:00PM-2:00PM

EXCELTrialSubstudies

Moderators:NicholasJ.Lembo,Marie-ClaudeMorice

Discussants:AnibalA.Damonte,FaustoFeres,DietmarH.Glogar,ThomasC.McAndrew,TanveerRab

1:00_PM TCT33:MortalityAfterRepeatRevascularizationFollowingPCIorCABGforLeftMainCoronaryArteryDisease:TheEXCELTrial Lecturers:GennaroGiustino

1:10_PM RoundtableDiscussionWithAudienceQA

1:15_PM TCT34:EffectofBaselineAnemiaonOutcomesAfterPCIandCABGinPatientsWithLeftMainDisease:TheEXCELTrial Lecturers:PrakritiGaba

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM TCT35:ImpactofCardiovascularRehospitalizationsFollowingPCIvsCABGforLeftMainCoronaryArteryDisease:ASexSpecificAnalysisFromtheEXCEL

Trial Lecturers:IoannaKosmidou

1:40_PM RoundtableDiscussionWithAudienceQA

1:45_PM TCT36:TheImpactofGuidelineDirectedMedicalTherapyafterRevascularizationinPatientsWithLeftMainCoronaryArteryDisease:AnalysisFromthe

EXCELTrial Lecturers:R.JayWidmer

1:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:HYPERTENSIONANDRENALDENERVATION

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room27A-B,UpperLevel

Page 4: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:4

1:00PM-2:00PM

HypertensionandRenalDenervation

Moderators:IvoPetrov

Discussants:RichardR.Heuser,PiotrJankowski,KonstantinosP.Tsioufis

1:00_PM TCT29:ProceduralandAnatomicPredictorsofResponseinRADIANCEHTNSOLO:AMulticenterRandomizedShamControlledTrialOfEndovascular

UltrasoundRenalDenervation Lecturers:AjayJ.Kirtane

1:10_PM RoundtableDiscussionWithAudienceQA

1:15_PM TCT30:RenalDenervationImprovesCardiacFunctioninaSwineModelofHeartFailure Lecturers:TraciGoodchild

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM TCT31:ComparisonofStandardRenalDenervationProcedureversusNovelDistalandBranchVesselProcedurewithBrachialArterialAccess Lecturers:IvoPetrov

1:40_PM RoundtableDiscussionWithAudienceQA

1:45_PM TCT32:ConfidenHTTMSystemDiagnosticElectricalMappingofRenalNervesforOptimizingRenalDenervationProcedures Lecturers:KonstantinosP.Tsioufis

1:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:NOVELSTRUCTURALHEARTDISEASETHERAPIES

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room32A-B,UpperLevel

1:00PM-2:00PM

NovelStructuralHeartDiseaseTherapies

Moderators:EricEeckhout,GlennVanLangenhove

Discussants:StevenL.Almany,IgorF.Palacios,LarsSondergaard,BrianK.Whisenant

1:00_PM TCT17:TricuspidValveRegurgitationReductionFollowingConcomitantSubvalvularandAnnulusLevelTreatmentExVivoStudy Lecturers:MichalJaworek

1:10_PM RoundtableDiscussionWithAudienceQA

1:15_PM TCT18:NovelConceptOfCatheterBasedTreatmentForTricuspidRegurgitationCerclageTRBlock:APreliminaryAnimalExperimentinaSwineModel Lecturers:Min-KuChon

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM TCT19:PredictingTMVRRelatedLVOTObstruction:ConceptofFluidMechanicsModeling Lecturers:KeshavKohli

1:40_PM RoundtableDiscussionWithAudienceQA

1:45_PM TCT20:LeftVentricularFluidDynamicsSimulationforTranscatheterMitralValveReplacement Lecturers:JamesOtton

1:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:TAVRPIVOTALTRIALS

FRIDAY,SEPTEMBER21,2018

1:00PM-2:00PM

Room28D-E,UpperLevel

1:00PM-2:00PM

TAVRPivotalTrials

Moderators:CharlesJ.Davidson

Discussants:DanielJ.Blackman,JeffreyJ.Popma,MichaelJ.Reardon,AlanZajarias

1:00_PM TCT13:5YearOutcomesFromtheRandomizedCorevalveUSPivotalHighRiskTrial:FinalResults Lecturers:ThomasGleason

1:10_PM RoundtableDiscussionWithAudienceQA

Page 5: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:5

1:15_PM TCT14:Final5YearOutcomesOfTheREPRISEIIStudy:LongTermOutcomesWiththeFullyRepositionableandRetrievableLotusTranscatheterAorticValve Lecturers:NicolasDumontiel

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM TCT15:TwoYearOutcomesAfterTranscatheterAorticValveReplacementWithMechanicallyversusSelfExpandableValves:ResultsFromTheREPRISEIII

RandomizedTrial Lecturers:MichaelJ.Reardon

1:40_PM RoundtableDiscussionWithAudienceQA

1:45_PM TCT16:IncidenceOutcomesAndMicrobiologicProfileOfProstheticValveEndocarditisAfterTAVRAndSAVR:InsightsFromPARTNER Lecturers:MatthewSummers

1:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:BIORESORBABLEVASCULARSCAFFOLDS

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room33B-C,UpperLevel

2:00PM-3:00PM

BioresorbableVascularScaffolds

Moderators:AntonioL.Bartorelli

Discussants:SalvatoreBrugaletta,BernardoCortese,StephenG.Ellis,DavidG.Rizik

2:00_PM TCT62:FiveYearClinicalOutcomesWithEverolimusElutingBioresorbableScaffolds:ResultsFromtheRandomizedABSORBIITrial Lecturers:PatrickW.Serruys

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT61:ClinicalOutcomesFollowingCompleteBioresorptionoftheAbsorbEverolimusElutingBioresorbableScaffold:FouryearResultsfromtheABSORBIII

Trial Lecturers:DeanJ.Kereiakes

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT63:SafetyandClinicalPerformanceoftheDrugElutingAbsorbableMetalScaffoldintheTreatmentofSubjectswithdeNovoLesionsinNativeCoronary

Arteriesat24monthfollowupBIOSOLVEIIandBIOSOLVEIII Lecturers:MichaelHaude

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT64:TwoYearClinicalandImagingOutcomesofThinStrutSirolimusElutingBioresorbableVascularScaffoldsinDeNovoCoronaryArteryLesions:The

MeRes1Trial Lecturers:RicardoA.Costa

2:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:CORONARYARTERYSURGERY

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room26A-B,UpperLevel

2:00PM-3:00PM

CoronaryArterySurgery

Moderators:JohnD.Puskas

Discussants:StuartJ.Head,EricE.Roselli,AlfredoTrento,RashmiYadav

2:00_PM TCT105:NonPeriproceduralMyocardialInfarctionAfterCABGinPatientsWithLeftMainDisease:AnalysisFromtheEXCELTrial Lecturers:BjornRedfors

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT107:PatientCenteredDecisionMakingofRevascularizationStrategyforLeftMainorMultiVesselCoronaryArteryDiseaseinRealWorldPractice Lecturers:ChoongkiKim

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT108:LongtermSurvivalAfterHybridCoronaryRevascularizationforTripleVesselDisease:HowDoesitComparetoCoronaryArteryBypassSurgeryor

MultiVesselPercutaneousIntervention Lecturers:CraigBasman

Page 6: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:6

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT106:AreOutcomesFollowingCABGforLeftMainDiseaseImprovingOvertheLastDecadeAPropensityMatchedAnalysisFromtheEXCELandSYNTAX

RandomizedTrials Lecturers:PatrickW.Serruys

2:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:CT-FFR,QFR,ANDOCT-FFR

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room23B-C,UpperLevel

2:00PM-3:00PM

CT-FFR.QFR,andOCT-FFR

Moderators:JavierEscaned,TimP.VandeHoef

Discussants:YaronAlmagor,NielsR.Holm,SreenivasArramrajuKumar,CarmeloPanetta,NealG.Uren,BoXu

2:00_PM TCT37:DiagnosticPerformanceofOnSiteCTDerivedFFR.ComparisonWithFusionMyocardialPerfusionandInvasiveFFR Lecturers:RyotaFukuoka

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT38:ImpactofFFRCTonDecisionMakingandOutcomesinStableCoronaryArteryDiseaseinNorthAmerica:ResultsoftheInternationalADVANCE

Registry Lecturers:KoenNieman

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT39:FunctionalAssessmentofInstentRestenosisWithQuantitativeFlowRatioQFR.AComparisonWithDeNovoCoronaryStenoses Lecturers:CatherineLiontou

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT40:DiagnosticAccuracyofIntracoronaryOpticalCoherenceTomographybasedQuantitativeFlowRatioforAssessmentofCoronaryStenosis Lecturers:ShengxianTu

2:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:MITRACLIPSTUDIES

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room28D-E,UpperLevel

2:00PM-3:00PM

MitralClipStudies

Moderators:EricA.Cohen,BrijMaini

Discussants:BruceBowers,JohnD.Carroll,NeilJ.Weissman

2:00_PM TCT45:QualityofLifeOutcomesafterTranscatheterMitralValveRepairinanUnselectedPopulation.AReportfromtheSTSACCTVTRegistryTM Lecturers:SuzanneV.Arnold

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT46:MitralValveGradientHeartFailureAdmissionsandOneYearMortalityFollowingMitraClipRepairin5378Patients:ResultsfromtheACCSTSTVT

Registry Lecturers:LowieVanAssche

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT47:LongitudinalAdaptionOfHighRiskPatientsSurvivingFiveYearsAfterSuccessfulMitraClipImplantation Lecturers:EikeTigges

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT48:PredictorsofProceduralandClinicalOutcomesinPatientswithSymptomaticTricuspidRegurgitationUndergoingTranscatheterEdgetoEdgeRepair Lecturers:PhilippLurz

ORALABSTRACTS:NEWTAVRDEVICES

Page 7: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:7

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room32A-B,UpperLevel

2:00PM-3:00PM

NewTAVRDevices

Moderators:MartinB.Leon

Discussants:HaimDanenberg,DavidHildick-Smith,SamirR.Kapadia,BernardPrendergast,GerhardC.Schuler

2:00_PM TCT41:AcuteandSixmonthOutcomesofaNovelSelfExpandingTranscatheterHeartValve Lecturers:UlrichSchäfer

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT42:AnEarlyFeasibilityStudytoAssessSafetyandEffectivenessoftheTransfemoralJenaValvePericardialTAVRSystemintheTreatmentofPatients

WithSymptomaticSevereAorticStenosisAS Lecturers:HendrikTreede

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT43:FirstInHumanExperienceofaNovelTransradialDeviceforEmbolicDeflectionDuringTranscatheterAorticValveReplacement Lecturers:DarrenMylotte

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT44:ComparativeEffectivenessandSafetyofFiveLeadingNewGenerationTAVIDevices:12MonthResultsfromTheRISPEVAStudy Lecturers:GiuseppeBiondi-Zoccai

2:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:PULMONARYARTERYINTERVENTION

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room27A-B,UpperLevel

2:00PM-3:00PM

PulmonaryArteryIntervention

Moderators:Shao-LiangChen

Discussants:AndrewJ.Klein,PeterP.Monteleone,AlexM.K.Rothman,AmitSegev,AkhileshK.Sista,MitchellWeinberg

2:00_PM TCT57:HemodynamicandFunctionalImprovementFollowingBalloonPulmonaryAngioplastyforChronicThromboembolicPulmonaryHypertension:Initial

ExperienceataHighVolumePulmonaryThromboendarterectomyCenter Lecturers:EhtishamMahmud

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT58:CryoablationmethodforPulmonaryArterySympatheticDenervationinPatientswithChronicHeartFailureandPulmonaryHypertension Lecturers:BorisRudenko

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT59:OutcomesofCatheterDirectedThrombolysisversusStandardMedicalTherapyinPatientsAdmittedtoIntensiveCareUnitswithSubmassive

PulmonaryEmbolism Lecturers:StephenD'Auria

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT60:StentTreatmentofBranchPulmonaryArteryStenosisinChildrenWithCongenitalHeartDiseaseAfterCardiacSurgery Lecturers:SauleKadirova

2:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:VULNERABLEPLAQUESANDVULNERABLEPATIENTS

FRIDAY,SEPTEMBER21,2018

2:00PM-3:00PM

Room31B-C,UpperLevel

2:00PM-3:00PM

Page 8: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:8

VulnerablePlaquesandVulnerablePatients

Moderators:JohnA.Ambrose,FaroucAJaffer

Discussants:KalpaDeSilva,UzomaIbebuogu,JohnA.McPherson,NickE.J.West

2:00_PM TCT53:RoleofSingleOCTMorphologicalVariableintheCLIMATrialRelationshipbetweenCoronarypLaquemorphologyoftheleftanterIordescending

arteryandlongterMclinicAloutcome Lecturers:EnricoRomagnoli

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM TCT54:TheDistributionofHighRiskPlaqueswithRespecttoArteryStenosisinNonCulpritNonIschemicNativeCoronaryLesionsofDiabeticPatientsdata

fromCOMBINEOCTFFRstudy Lecturers:TomaszRoleder

2:25_PM RoundtableDiscussionWithAudienceQA

2:30_PM TCT55:ClinicalPredictorsofObstructiveCoronaryArteryDiseaseinIndividualswithSuspectedCoronaryArteryDisease Lecturers:SubhiAl'Aref

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM TCT56:HighResolutionIntravascularOCTNIRFMolecularImagingforInVivoAssessmentofInflammationinAtherosclerosisandVascularInjury Lecturers:ZhongliePiao

2:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:CARDIOGENICSHOCKANDHEMODYNAMICSUPPORT

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room31B-C,UpperLevel

3:00PM-4:00PM

CardiogenicShockandHemodynamicSupport

Moderators:SimonRedwood

Discussants:BiswajitKar,MaurizioMenichelli,VincentJ.Pompili,FayazShawl

3:00_PM TCT81:TheComparativeEffectivenessandSafetyofImpellaVersusIntraAorticBalloonPumpinPatientswhoUnderwentPercutaneousCoronary

Intervention:InsightsfromtheBlueCrossBlueShieldofMichiganCardiovascularConsortiumBMC2 Lecturers:DevrajSukul

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM TCT82:RacebasedDisparitiesintheManagementandOutcomesofCardiogenicShockComplicatingAcuteMyocardialInfarction:A15YearNationalStudy Lecturers:SaraschandraVallabhajosyula

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT83:LactateandCardiacPowerOutputMeasurementsat1224HoursReliablyPredictOutcomesinCardiogenicShock:InsightsfromtheNational

CardiogenicShockInitiative Lecturers:MirBasir

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT84:PercuatenousExtracorporealMembraneOxygenationECMOUtilizationinRealWorldAllComersPopulationwithRefractoryCardiacArrest Lecturers:SachinKumar

ORALABSTRACTS:CEREBRALVASCULAREVENTSINTAVRPATIENTS

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room26A-B,UpperLevel

3:00PM-4:00PM

CerebralVascularEventsinTAVRPatients

Moderators:AlexChebl,AlexandraJ.Lansky

Discussants:JanKovac,AxelLinke,ReginaldI.Low,MichaelJ.Rinaldi

3:00_PM TCT69:TranscatheterAorticHeartValves:HistologicalAnalysisProvidingInsighttoLeafletThickeningandStructuralValveDegeneration Lecturers:StephanieSellars

3:10_PM RoundtableDiscussionWithAudienceQA

Page 9: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:9

3:15_PM TCT70:IncidenceTrendsandRiskFactorsforEarlyStrokeafterTranscatheterAorticValveReplacementintheFirst5yearsofUSClinicalPractice:Reportof

theSTSACCTVTRegistry. Lecturers:ChetanHuded

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT71:PredictorsIncidenceandOutcomesofPatientsUndergoingTranscatheterAorticValveImplantationComplicatedbyStrokeFromtheCENTER

Collaboration Lecturers:WienekeVlastra

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT72:AProspectiveEvaluationforHypoattenuatedLeafletThickeningFollowingTranscatheterAorticValveReplacement Lecturers:LiangTang

3:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:CTOINTERVENTION

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room28D-E,UpperLevel

3:00PM-4:00PM

CTOIntervention

Moderators:DimitriKarmpaliotis

Discussants:KevinJ.Croce,DavidF.Kong,ElmirOmerovic,DmitryStolyarov

3:00_PM TCT77:ProceduralSuccessandOutcomesWithIncreasingUseofEnablingStrategiesforChronicTotalOcclusionIntervention:AnAnalysisof28050Cases

FromtheBritishCardiovascularInterventionSocietyDatabase Lecturers:TimKinnaird

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM TCT78:ImpactofCollateralChannelTypeontheOutcomesofChronicTotalOcclusionPercutaneousCoronaryIntervention Lecturers:JuditKaracsonyi

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT79:QualityofLifeinPatientsWithRefractoryAnginaAfterChronicTotalOcclusionAngioplasty Lecturers:TaishiHirai

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT80:NaturalChangeoftheDistalBedFollowingPercutaneousCoronaryInterventionWithDrugElutingStentsforChronicTotalOcclusionLesions Lecturers:OsungKwon

3:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:INTERVENTIONALTREATMENTOFDISEASESOFTHEAORTA

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room27A-B,UpperLevel

3:00PM-4:00PM

InterventionalTreatmentofDiseasesoftheAorta

Moderators:JacquesBusquet

Discussants:CostantinoDelGiudice,PhilipGreen,KendraJ.Grubb,ZazaKavteladze,HugoF.Londero,VirendraIPatel,KazuoShimamura

3:00_PM TCT85:EndovascularRepairofPenetratingAtheroscleroticUlcersWiththeCardiatisMultilayerFlowModulatorImplantasanAlternativetoCovered

EndograftstoPreserveBranchVesselPatency Lecturers:DanielaTirziu

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM TCT86:3yearsFollowUpofSuccesfulEndovascularInterventionsinTakayasuArteritisinvolvingAortaandAorticArchVessels Lecturers:AjayaPaudel

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT87:ThirtyDayReadmissionRateEtiologiesafterEndovascularRepairofAbdominalAorticAneurysm:ANationwideAnalysis Lecturers:VarunsiriAtti

Page 10: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:10

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT88:OptimalCerebralProtectioninCardiacandAorticInterventions:VascularFiltersvs.BalloonOcclusion Lecturers:MichaelZhadkevich

3:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:INTRAVASCULARIMAGING

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room23B-C,UpperLevel

3:00PM-4:00PM

IntravascularImaging

Moderators:GuillermoTearney

Discussants:AdrianoCaixeta,R.StefanKiesz,MassimoNapodano,FrancescoPrati

3:00_PM TCT68:ClinicalImpactOfPostStentOpticalCoherenceTomographyFindings:TwoYearFollowUpFromASingleCenterRegistry Lecturers:YuqiFan

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM TCT65:HighDefinitionMicroOpticalCoherenceTomographyforEndothelialCellVisualizationintheCoronaryArteries Lecturers:KensukeNishimiya

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT66:TheEffectsofStentPostDilatationDuringPrimaryPercutaneousCoronaryInterventionPPCIforSTelevationMyocardialInfarctionSTEMI:Insights

fromOpticalCoherenceTomographyOCTandCoronaryPhysiology Lecturers:GrigorisKaramasis

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT67:PostStentOCTvsIVUSPredictorsof2YearOutcomes Lecturers:XiaoWang

3:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:STENTVSSTENTSTUDIES

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room33B-C,UpperLevel

3:00PM-4:00PM

StentvsStentStudies

Moderators:AlexandreAbizaid,DidierCarrié

Discussants:GiuseppeDeLuca,UpendraKaul,ManelSabate,SigmundSilber,GiulioStefanini,ClemensvonBirgelen

3:00_PM TCT197:EarlyVascularHealingAfterImplantationofaBiolimusCoatedBioFreedomStentoraSirolimusElutingOrsiroStentinPatientswithSTsegment

ElevationMyocardialInfarction Lecturers:KirstineHansen

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM TCT90:ClinicalOutcomesThreeYearAfterRevascularizationWithaBiodegradablePolymerUltrathinStrutSirolimusElutingStentandaBiodegradable

PolymerBiolimuselutingStent.FromtheSORTOUTVIITrial Lecturers:JuliaEllert

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT91:UltrathinBioresorbablePolymerSirolimusElutingStentsversusThinDurablePolymerEverolimusElutingStentsinPatientsUndergoingCoronary

RevascularizationBIOFLOWV:AcuteCoronarySyndromeSubgroupAnalysis Lecturers:ArielRoguin

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT92:RandomizedComparisonofRidaforolimusandZotarolimusElutingCoronaryStents:2YearClinicalOutcomesofthePooledBIONICSandNIREUS

Trials Lecturers:DavidE.Kandzari

3:55_PM RoundtableDiscussionWithAudienceQA

Page 11: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:11

ORALABSTRACTS:TRICUSPIDVALVEINTERVENTION

FRIDAY,SEPTEMBER21,2018

3:00PM-4:00PM

Room32A-B,UpperLevel

3:00PM-4:00PM

TricuspidValveIntervention

Moderators:RebeccaT.Hahn,JoseLuisNavia

Discussants:ChristopherU.Meduri,FabienPraz,MaurizioTaramasso,YanTopilsky,BernardVasseur

3:00_PM TCT73:TreatmentofSevereTRIcuspidRegurgitationinPatientswithAdvancedHeartFailurewithCAvalVeinImplantationoftheEdwardsSapienXTVALve

TRICAVAL:acontrolledprospectiverandomizedtrial Lecturers:HenrykDreger

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM TCT74:SCOUTStudy:Trialignresultsat30daysfromcombinedUSandEUcohortforthetreatmentoffunctionalTR Lecturers:ChristopherU.Meduri

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM TCT75:PhysiologicalandClinicalConsequencesofReliefofRightVentricularVolumeOverloadAfterTranscathetherRepairoftheTricuspidValveInsights

fromCardiacMagneticResonance Lecturers:PhilippLurz

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM TCT76:LongTermOutcomesFollowingTranscatheterTricuspidValveRepairWiththeFORMASystem Lecturers:LuisAsmarats

3:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:COMPLEXTAVRPROCEDURES

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room26A-B,UpperLevel

4:00PM-5:00PM

ComplexTAVRProcedures

Moderators:AlainG.Cribier,HeleneEltchaninoff

Discussants:AndreasBaumbach,AdamB.Greenbaum,RajMakkar,MollySzerlip,WilsonY.Szeto

4:00_PM TCT97:PreservingCoronaryAccessAfterValveinTAVI:AGlimpseIntotheFuture Lecturers:NicolaBuzzatti

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT98:EarlyClinicalImpactofCerebralEmbolicProtectionWithTranscatheterAorticValveReplacementaMulticenterStudyintheNetherlands Lecturers:HerbertKroon

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT99:DoesValveinValveTAVRCarryaHigherRiskforDiffusionWeightedMRIBrainLesionsComparedtoNativeValveTAVI Lecturers:ChristinaBrinkmann

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT100:EmergencyTAVRforCardiogenicShockRightHeartFunctionandEarlyMechanicalCirculatorySupportImproveOutcomes Lecturers:HansHuang

4:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:DESCLINICALOUTOMES

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room33B-C,UpperLevel

Page 12: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:12

4:00PM-5:00PM

DESClinicalOutomes

Moderators:MichaelA.Kutcher,TullioPalmerini

Discussants:SripalBangalore,AdrianoCaixeta,SalvatoreCassese

4:00_PM TCT117:TheBurdenofRestenosisafterCoronaryStentImplantationintheUnitedStates:TemporalTrendsClinicalPresentationTreatmentStrategiesand

InHospitalOutcomes Lecturers:IssamD.Moussa

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT118:TheImpactofBifurcationStentingTechniquesontheClinicalEvents:theStratifiedAnalysisof2510BifurcatedLesionsAccordingtoMADS

ClassificationintheGlobalLEADERSTrial Lecturers:NorihiroKogame

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT119:ImpactofClinicalSyndromeonOutcomesAfterPCI:AnalysisFromaLargePooledRandomizedTrialDataset Lecturers:MasaruIshida

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT120:LongtermOutcomesinWomenandMenFollowingPercutaneousCoronaryIntervention:AnIndividualPatientDataPooledAnalysisfrom21

RandomizedTrials Lecturers:IoannaKosmidou

4:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:LEFTATRIALAPPENDAGEEXCLUSION

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room27A-B,UpperLevel

4:00PM-5:00PM

LeftAtrialAppendageExclusion

Discussants:SameerGafoor,DavidR.HolmesJr.,JamesE.Muller

4:00_PM TCT101:ComparisonofTransesophagealEchocardiographyAndCardiacCTforDetectionofDeviceRelatedThrombosisFollowingLeftAtrialAppendage

Occlusion Lecturers:KasperKorsholm

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT102:IncidencePredictorsandOutcomesofDeviceRelatedThrombusAfterLeftAtrialAppendageClosureWithTheWATCHMANDevice.InsightsFrom

theEWOLUTIONRealWorldRegistry Lecturers:AlexanderSedaghat

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT103:UltrasealLeftAtrialAppendageOccluder:InitialMulticenterExperience Lecturers:LluisAsmarats

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT104:ComparativeDataontheUseofIntracardiacandTransesophagealEchocardiographyforLeftAtrialAppendageOcclusionintheAmulet

ObservationalStudy Lecturers:JensErikNielsen-Kudsk

4:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:LOWEREXTREMITYINTERVENTION

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room32A-B,UpperLevel

4:00PM-5:00PM

LowerExtremityIntervention

Moderators:TonyDas

Discussants:HansErikBotker,KeiIchihashi,NattawutWongpraparut

Page 13: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:13

4:00_PM TCT113:EffectivenessofAtherectomyvsBalloonAngioplastyforLimbSalvageinOcclusiveTibioperonealArterialDisease Lecturers:PayalSharma

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT114:ComparingEffectivenessofDifferentAtherectomyDeviceSystemsinOcclusiveLowerExtremityPeripheralArteryDisease:AnalysisofaLarge

NationalDatabase Lecturers:TongaNfor

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT115:LongTermFollowupofthePADITrial:PercutaneousTransluminalAngioplastyVersusDrugElutingStentsforInfrapoplitealLesionsinCriticalLimb

Ischemia Lecturers:ThijsWakkie

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT116:SpotStentingversusFullCoverageStentingAfterEndovascularTherapyforFemoropoplitealArteryLesions Lecturers:YusukeTomoi

4:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:NEWINTRACORONARYPHYSIOLOGYTECHNIQUESANDSTUDIES

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room23B-C,UpperLevel

4:00PM-5:00PM

NewIntracoronaryPhysiologyTechniquesandStudies

Moderators:ZiadA.Ali,JustinE.Davies

Discussants:JoostDaemen,ThomasEngstrøm,JuanLuisGutierrez-Chico,MichalHawranek,JanJ.Piek

4:00_PM TCT93:ThePhysiologicalPatternofDiseaseAssessedbyPressureWirePullbackhasanInfluenceonFractionalFlowReserveInstantaneousWaveFreeRatio

Discordance:InsightFromMulticenterAJIPRegistry Lecturers:TakayukiWarisawa

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT94:ContinuousInfusionofSalineforAssessmentofAbsoluteHyperemicFlowandMinimalMicrovascularResistance:ValidationinHumansUsing

15OH2OPET Lecturers:HenkEveraars

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT95:ASimplifiedFormulatoCalculateFractionalFlowReserveinSequentialLesionsCircumventingtheMeasurementofCoronaryWedgePressure

DuringBalloonInflation:theAPISSpilotstudy Lecturers:CarlosCortes

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT96:PredictingAnginaLimitedExerciseCapacityUsingCoronaryPhysiology Lecturers:ChristopherCook

4:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:PHARMACOTHERAPYINPATIENTSUNDERGOINGPCI

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room31B-C,UpperLevel

4:00PM-5:00PM

PharmacotherapyinPatientsUndergoingPCI

Discussants:GeorgeD.Dangas,GermanoDiSciascio,YalingHan,MichelleO'Donoghue,GeorgiosJ.Vlachojannis

4:00_PM TCT109:IntraCoronaryAdministrationofTacrolimusImprovesReperfusionofMicrovasculatureandLeftVentricularFunctioninPatientswithSTSegment

ElevationMyocardialInfarctionCOATSTEMIUndergoingPrimaryPercutaneousCoronaryIntervention Lecturers:Pei-HsunSung

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT110:IncidencepredictorsandoutcomesofDAPTdisruptionduetononcomplianceversusbleedingafterPCI:insightsfromthePARISRegistry Lecturers:KamiliaMoalem

Page 14: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:14

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT111:EfficacyandSafetyofGlycoproteinIIbIIIaInhibitorsonTopofaPotentP2Y12InhibitorinSTEMI:APreSpecifiedSubAnalysisoftheATLANTICTrial Lecturers:AnneTavenier

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT112:PatientOrientedClinicalOutcomesandNetAdverseCardiovascularEventintheGlobalLeadersTrial Lecturers:PatrickW.Serruys

4:55_PM RoundtableDiscussionWithAudienceQA

ORALABSTRACTS:PRIMARYPCISTRATEGIESINTHEAMIPATIENT

FRIDAY,SEPTEMBER21,2018

4:00PM-5:00PM

Room28D-E,UpperLevel

4:00PM-5:00PM

PrimaryPCIStrategiesinAMIPatient

Moderators:DavidA.Cox,DariuszDudek

Discussants:LarryS.Dean,DmitriyN.Feldman,JorgeGaspar,TimothyD.Henry,Jean-FrançoisTanguay

4:00_PM TCT49:TransformationalPathwaysforAMIManagementinDevelopingCountriesRolling600000RemotePatientEncounterstoD2BInterventions Lecturers:SameerMehta

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM TCT50:FiscalImpactofAvoidingUnnecessaryTransfersandHospitalizationinSTEMIInterventionsResultsfromLatinAmericaTelemedicineInfarct

NetworkLATIN Lecturers:SameerMehta

4:25_PM RoundtableDiscussionWithAudienceQA

4:30_PM TCT51:LongtermMortalityComparisonofPatientsWithAcuteMyocardialInfarctionandCardiogenicShockTreatedWithCulpritOnlyorMultivessel

PercutaneousCoronaryIntervention Lecturers:RubenVergara

4:40_PM RoundtableDiscussionWithAudienceQA

4:45_PM TCT52:IntravascularImagingguidedUrgentPercutaneousCoronaryInterventionforAcuteMyocardialInfarctionandLongterm3yearsPrognosis:ALand

MarkAnalysisofJMINUET Lecturers:HiroyukiOkura

4:55_PM RoundtableDiscussionWithAudienceQA

CARDIOVASCULARPROFESSIONALS(CVP)COURSE:27THANNUALCARDIOVASCULARNURSEANDTECHNOLOGISTSYMPOSIUM:RCISREVIEWWITH

HANDS-ON-HEARTS

FRIDAY,SEPTEMBER21,2018

8:00AM-1:00PM

Room28A-C,UpperLevel

8:00AM-9:55AM

SessionI.DeepDive-CardiacCatheterizationandPCI

Moderators:JeffDavis,ThomasH.Maloney

Discussants:MaryK.Egan,MarshaHolton,DavidP.Lee,GeorgeW.Vetrovec

8:00_AM CaseIntroduction:APatientwithAtypicalChestPainandShortnessofBreath Lecturers:GeorgeW.Vetrovec

8:10_AM AssessmentofthePatient Lecturers:MarshaHolton

8:20_AM RightHeartCatheterizationMatchedwithInteractiveCadaverHeartDissection Lecturers:RobertKutys,BrijMaini

8:35_AM MedicationsforDiagnosticCardiacCatherization Lecturers:MaryK.Egan

8:45_AM LeftHeartCatheterizationwithInteractiveCadaverHeartDissection Lecturers:RobertKutys,GeorgeW.Vetrovec

8:50_AM CoronaryAngiographywithInteractiveCadaverHeartDissection

Page 15: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:15

Lecturers:RobertKutys,GeorgeW.Vetrovec9:10_AM MedicationsforPCI

Lecturers:MaryK.Egan9:15_AM DevicesforPCIWiresBalloonsStentsFFRImaging

Lecturers:DavidP.Lee9:30_AM StentSelectionandTechnique

Lecturers:DavidP.Lee,GeorgeW.Vetrovec9:45_AM RoundtableDiscussionWithAudienceQA

9:55AM-11:45AM

SessionII.DeepDive-TheAorticValve

Moderators:JeffDavis,ThomasH.Maloney

Discussants:PhilippeGenereux,AzeemLatib,DmitryB.Levin,PaulD.Mahoney,ElizabethM.Perpetua

9:55_AM CaseIntroduction:SymptomsSuggestiveofAorticStenosis Lecturers:PaulD.Mahoney

10:05_AM FundamentalKnowledge:AorticValveAnatomywithInteractiveCadaverHeartDissection Lecturers:RobertKutys,DmitryB.Levin

10:15_AM HemodynamicsofAorticStenosisandValveCalculations Lecturers:JeffDavis

10:35_AM InterpretationofHemodynamicCTandEchoDataforTAVRClinicalDecisionMaking Lecturers:AzeemLatib

10:55_AM CaseDemonstration:TranscatheterAorticValveReplacement CasePresenter:PaulD.Mahoney

KeynoteAddress:ComplicationsCaseReviews

Lecturers:PhilippeGenereux

11:10_AM ComplicationsofTAVROverview Lecturers:PhilippeGenereux

11:20_AM RecognizingandTreatingAorticRegurgitation Lecturers:PhilippeGenereux

11:25_AM RecognizingandTreatingTamponade Lecturers:PhilippeGenereux

11:30_AM RhythmDisturbancesAfterTAVR Lecturers:PhilippeGenereux

11:35_AM RoundtableDiscussionwithAudienceQA

11:45AM-12:30PM

Hands-on-HeartsDemonstration

Lecturers:JeffDavis,MarshaHolton,MatthewKutyna,RobertKutys,MariaE.Romero,TorieSamuda,RenuVirmani

12:30PM-1:00PM

AfternoonBreakandRefreshments,SponsoredbyBostonScientificCorporation

CARDIOVASCULARPROFESSIONALS(CVP)COURSE:27THANNUALCARDIOVASCULARNURSEANDTECHNOLOGISTSYMPOSIUM:ANAFTERNOONIN

THECATHLAB

FRIDAY,SEPTEMBER21,2018

1:00PM-5:30PM

Room28A-C,UpperLevel

1:00PM-1:35PM

SessionI.CathLabEfficiencyandProductivity

Moderators:MarianC.Hawkey

Discussants:ReginaDeible,MaryK.Egan,JulieLogan,ThomasH.Maloney,MartinaKellySpeight

1:00_PM WelcomeandIntroduction Lecturers:MarianC.Hawkey

1:05_PM TBDLecture

Page 16: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:16

1:25_PM RoundtableDiscussionwithAudienceQA

1:35PM-2:20PM

SessionII:ComplexPCI

Moderators:ThomasH.Maloney

Discussants:RussellJ.D'Sa,ReginaDeible,ElizabethWillette

1:35_PM ComplexPCICaseIntroduction CasePresenter:ThomasH.Maloney

1:40_PM TheCHIPTeam Lecturers:ElizabethWillette

1:50_PM TheCHIPToolkitTechniquesImagingEquipmentTroubleshooting Lecturers:RussellJ.D'Sa

2:05_PM ComplexPCICaseConclusion CasePresenter:ThomasH.Maloney

2:10_PM RoundtableDiscussionwithAudienceQA

2:20PM-3:05PM

SessionIII:LeftAtrialAppendageClosurewiththeWatchmanDevice

Moderators:MartinaKellySpeight

Discussants:AsmaHussaini,DavidP.Lee,ElizabethM.Perpetua

2:20_PM CaseIntroduction:APatientWithNonValvularAtrialFibrillation CasePresenter:ElizabethM.Perpetua

2:25_PM AnatomicalConsiderationsforPatientSelection Lecturers:AsmaHussaini

2:35_PM OverviewoftheWatchmanProcedureandComplications Lecturers:DavidP.Lee

2:50_PM CaseConclusion Lecturers:ElizabethM.Perpetua

2:55_PM RoundtableDiscussionwithAudienceQA

3:05PM-3:50PM

SessionIV:TranscatheterAorticValveReplacement

Moderators:SarahClarke

Discussants:KimGuibone,MarianC.Hawkey,SandraLauck

3:05_PM CaseIntroduction:AorticStenosis CasePresenter:SarahClarke

3:10_PM CurrentIndicationsandGuidelinesforTAVR Lecturers:KimGuibone

3:20_PM IndividualizingthePatientCarePathway Lecturers:SandraLauck

3:35_PM CaseConclusion CasePresenter:SarahClarke

3:40_PM RoundtableDiscussionwithAudienceQA

3:50PM-4:35PM

SessionV:PeripheralIntervention

Moderators:MichelleMaier

Discussants:JulieLogan,SameerNagpal,SamitShah

3:50_PM CaseIntroduction:CriticalLimbIschemia CasePresenter:MichelleMaier

3:55_PM WhatIsCLIandHowDoWePreventIt Lecturers:SamitShah

4:05_PM WhataretheTreatmentsforCLI Lecturers:SameerNagpal

4:20_PM CaseConclusion CasePresenter:MichelleMaier

4:25_PM RoundtableDiscussionwithAudienceQA

Page 17: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:17

4:35PM-5:30PM

SessionVI:WhatElseisGoingoninTheCathLab?

Moderators:ReginaDeible

Discussants:KateDalton,AllenJeremias

4:35_PM UpdateoniFRandFFR Lecturers:JulieLogan

4:45_PM UpdateonCurrentImagingModalities:IVUSvsOCTvsNIRS Lecturers:AllenJeremias

4:55_PM UpdateonVascularAccessSelection:RadialvsFemoral Lecturers:MaryK.Egan

5:05_PM UpdateonClinicalResearchintheCathLab Lecturers:KateDalton

5:15_PM RoundtableDiscussionwithAudienceQA

5:25_PM Conclusion Lecturers:MarianC.Hawkey

REGIONALSNAPSHOTMEETINGS:THEBESTOFINTERVENTIONFROMEUROPE:FLASHDEBATES

FRIDAY,SEPTEMBER21,2018

9:00AM-11:00AM

Room24A-B,UpperLevel

9:00AM-10:00AM

SessionI.WhatisNewinCoronaryArteryDisease�FromDiagnosistoTreatment

Moderators:JeroenJ.Bax,StephanWindecker

Discussants:RobertA.Byrne,JavierEscaned,MichaelHaude,PatrickW.Serruys,HolgerThiele

9:00_AM CTAngiographyVersusIschemiaTestingforDetectionofCoronaryArteryDisease Lecturers:JeroenJ.Bax

9:06_AM BeyondORBITA:TheRoleofPCIinStableIschemicCAD Lecturers:AdrianP.Banning

9:12_AM NovelHemodynamicAssessmentParametersandIntracoronaryImagingtoOptimizePCIOutcomes Lecturers:JavierEscaned

9:18_AM TheNew2018ESCEACTSGuidelinesonMyocardialRevascularization:FocusonMultivesselandLeftMainDisease Lecturers:RobertA.Byrne

9:24_AM WhatistheFutureofBioresorbableScaffolds Lecturers:MichaelHaude

9:30_AM RevascularizationinCardiogenicShock:NewInsights Lecturers:HolgerThiele

9:36_AM AtrialFibrillationandACSPCI:TheEndofTripleTherapy Lecturers:StephanWindecker

9:42_AM DoesAspirinHaveaRoleintheManagementofPatientsUndergoingPCI Lecturers:PatrickW.Serruys

9:48_AM RoundtableDiscussionWithAudienceQA

10:00AM-11:00AM

SessionII.WhatisNewinStructuralHeartDisease

Moderators:JeroenJ.Bax,StephanWindecker

Discussants:JörgHausleiter,AxelLinke,FelixMahfoud,GeorgNickenig,ThomasPilgrim,LarsSondergaard

10:00_AM DurabilityofTranscatheterHeartValves Lecturers:BernardPrendergast

10:06_AM TAVR:NewIndicationsandUnmetNeeds Lecturers:ThomasPilgrim

10:12_AM StrokePreventionStrategiesinTAVR Lecturers:AxelLinke

10:18_AM AntithromboticTherapyinPatientsUndergoingTAVR Lecturers:StephanWindecker

10:24_AM TheFutureofTranscatheterMitralValveIntervention:RepairorReplace Lecturers:GeorgNickenig

10:30_AM HowtoSelectPatientsforTricuspidValveRepair

Page 18: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:18

Lecturers:JörgHausleiter10:36_AM PercutaneousPFOClosure:FinallyArrived

Lecturers:LarsSondergaard10:42_AM RenalDenervation:LightontheHorizon

Lecturers:FelixMahfoud10:48_AM RoundtableDiscussionWithAudienceQA

REGIONALSNAPSHOTMEETING:THEBESTOFINTERVENTIONFROMLATINAMERICA:SELECTEDTOPICSININTERVENTIONALCARDIOLOGY

FRIDAY,SEPTEMBER21,2018

11:00AM-1:00PM

Room24A-B,UpperLevel

11:00AM-1:00PM

TheBestofInterventionfromLatinAmerica:SelectedTopicsinInterventionalCardiology

Moderators:AlexandreAbizaid,JoseL.Leiva-Pons

Discussants:MarioAraya,RobertoBotelho,AnibalA.Damonte,EfrainGaxiola,AlfaroMarchena,HenriqueB.Ribeiro

REGIONALSNAPSHOTMEETING:THEBESTOFINTERVENTIONFROMCHINA

FRIDAY,SEPTEMBER21,2018

1:00PM-3:00PM

Room24A-B,UpperLevel

1:00PM-2:00PM

SessionI.InnovationsFromChina

Moderators:RunlinGao,MartinB.Leon

Discussants:OriBen-Yehuda,YunDaiChen,JuanF.Granada,AzeemLatib,JianLiu,SunilV.Rao

1:00_PM NewTAVRDevices:VitaFlowVenusAPlusandVenibri Lecturers:JunboGe

1:08_PM RoundtableDiscussionWithAudienceQA

1:10_PM UpdateoftheNeoVasBRSClinicalTrials Lecturers:YalingHan

1:18_PM RoundtableDiscussionWithAudienceQA

1:20_PM IronBasedBRS:DesignFeaturesExperimentalStudiesandFIMExperience Lecturers:KefeiDou

1:28_PM RoundtableDiscussionWithAudienceQA

1:30_PM PulmonaryArteryDenervation:UpdatesofExperimentalandClinicalStudies Lecturers:Shao-LiangChen

1:38_PM RoundtableDiscussionWithAudienceQA

1:40_PM IntelligentRecognitionofCoronaryAngiographyBasedonDeepLearningTechnology Lecturers:BoXu

1:48_PM RoundtableDiscussionWithAudienceQA

1:50_PM QuantitativeFlowRatioQFR:AValuableToolintheCathLab Lecturers:ShengxianTu

1:58_PM RoundtableDiscussionWithAudienceQA

2:00PM-3:00PM

SessionII.ComplexandHigh-RiskPCI:Case-BasedDiscussions

Moderators:AjayJ.Kirtane,YuejinYang

Discussants:ZiadA.Ali,GeorgeD.Dangas,LeiGe,J.AaronGrantham,NingGuo,GaryS.Mintz

2:00_PM Case1:FFRandIVUSGuidanceofLeftMainBifurcationPCI CasePresenter:JuyingQian

2:06_PM RoundtableDiscussionWithAudienceQA

2:10_PM Case2:AntegradeDissectionandReEntryCTO

Page 19: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:19

CasePresenter:ZeningJin2:16_PM RoundtableDiscussionWithAudienceQA

2:20_PM Case3:OCTGuidedPCIinaSeverelyCalcifiedLesion CasePresenter:JunjieZhang

2:26_PM RoundtableDiscussionWithAudienceQA

2:30_PM Case4:STEMIWithCardiogenicShock CasePresenter:KaiXu

2:36_PM RoundtableDiscussionWithAudienceQA

2:40_PM Case5:PostCABGPCI CasePresenter:QiZhang

2:46_PM RoundtableDiscussionWithAudienceQA

2:50_PM Case6:PCIinaPatientWithSevereLeftVentricularDysfunction CasePresenter:JunJiang

2:56_PM RoundtableDiscussionWithAudienceQA

REGIONALSNAPSHOTMEETING:THEBESTOFINTERVENTIONFROMJAPAN:ADVANCEDPCITECHNIQUESANDENDOVASCULARINTERVENTION

FRIDAY,SEPTEMBER21,2018

3:00PM-5:10PM

Room24A-B,UpperLevel

3:00PM-3:40PM

SessionI.AdvancedPCITechniques

Moderators:LeiGe,MasahikoOchiai

Discussants:AdrianP.Banning,EricEeckhout,ScottHarding,NicholasJ.Lembo,AshishPershad,SudhirRathore

3:00_PM TheLatestStrategiesforCTOinJapaneseFashion Lecturers:MakotoSekiguchi

3:12_PM RoleofDebulkingintheEraofDES Lecturers:HisayukiOkada

3:24_PM PPAPProximalPalmArteryPuncture:ShouldWeShifttoItfromRadialArtery Lecturers:ShingoKaneko

3:36_PM RoundtableDiscussionwithAudienceQA

3:40PM-4:30PM

SessionII.CoronaryImagingandPhysiologicAssessment

Moderators:AkikoMaehara,HitoshiMatsuo

Discussants:TakashiAkasaka,JavierEscaned,ShoichiKuramitsu,HidetakaNishina,ShigeruSaito

3:40_PM OCTGuidedPCIInDailyClinicalPractice:StrategyBasedonILUMIENIII Lecturers:ZiadA.Ali

3:47_PM RoundtableDiscussionWithAudienceQA

3:50_PM OCTGuidedBifurcationPCI Lecturers:TakashiKubo

4:00_PM RoundtableDiscussionWithAudienceQA

4:05_PM DiffuseandTandemLesionTreatmentbyPhysiologyGuidance Lecturers:HidetakaNishina

4:13_PM PhysiologyGuidedPCIOptimization:UseofPhysiologyDuringandAfterPCI Lecturers:HitoshiMatsuo

4:23_PM RoundtableDiscussionWithAudienceQA

4:30PM-5:10PM

SessionIII.EndovascularIntervention

Moderators:OsamuIida,ShigeruSaito

Discussants:MasahikoFujihara,DaizoKawasaki,MehdiH.Shishehbor,YoshimitsuSoga

4:30_PM IVUSGuidedRecanalizationfortheInfrainguinalChronicTotalOcclusions Lecturers:DaizoKawasaki

Page 20: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:20

4:37_PM RoundtableDiscussionWithAudienceQA

4:40_PM DrugSolutionsinPeripheralIntervention Lecturers:YoshimitsuSoga

4:47_PM RoundtableDiscussionWithAudienceQA

4:50_PM EvolutionofSFAInterventionintheLastDecade:TheRetrospectiveMulticenterMK3Study Lecturers:MasahikoFujihara

4:57_PM RoundtableDiscussionWithAudienceQA

5:00_PM ThreeyearOutcomesofSurgicalVs.EndovascularRevascularizationforCriticalLimbIschemia:TheSPINACHStudy Lecturers:OsamuIida

5:07_PM RoundtableDiscussionWithAudienceQA

ABCSOFINTERVENTIONALCARDIOLOGY

FRIDAY,SEPTEMBER21,2018

8:00AM-12:00PM

Room28D-E,UpperLevel

8:00AM-9:15AM

SessionI.BasicsofCardiacAnatomyandAngiography

Moderators:GeorgeD.Dangas,JohnM.Lasala

Discussants:RicardoA.Costa,HemalGada,AlexandraJ.Lansky,VergheseMathew,MiodragC.Ostojic,TanveerRab

8:00_AM OverviewofCardiacValvularandCoronaryAnatomy Lecturers:VijayKunadian

8:12_AM RoundtableDiscussionWithAudienceQA

8:15_AM VascularAccessRoutesComplicationsandVascularRescue Lecturers:JoseM.Wiley

8:27_AM RoundtableDiscussionWithAudienceQA

8:30_AM CoronaryAngiography:SetupViewsArtifactsandPitfalls Lecturers:VergheseMathew

8:42_AM RoundtableDiscussionWithAudienceQA

8:45_AM IntravascularImaging:CoreConceptsofIVUSOCTNIRSandMore Lecturers:GaryS.Mintz

8:57_AM RoundtableDiscussionWithAudienceQA

9:00_AM RightandLeftHeartHemodynamicSupportOptions Lecturers:JohnM.Lasala

9:12_AM RoundtableDiscussionWithAudienceQA

9:15AM-10:30AM

SessionII.OverviewofCardiovascularDiseaseandTreatment

Moderators:DavidA.Cox,HenningKelbæk

Discussants:VasimFarooq,AlokeV.Finn,GrzegorzL.Kaluza,ElvinKedhi,AfzalurRahman,EliasSanidas

9:15_AM CoronaryArteryDisease:PathologyandPathogenesis Lecturers:GrzegorzL.Kaluza

9:27_AM RoundtableDiscussionWithAudienceQA

9:30_AM CoronaryPhysiology:FFRandiFR Lecturers:AllenJeremias

9:42_AM RoundtableDiscussionWithAudienceQA

9:45_AM AcuteCoronarySyndromes:TreatmentofNSTEACSandSTEMI Lecturers:MichaelC.C.Kim

9:57_AM RoundtableDiscussionWithAudienceQA

10:00_AM LeftMainandBifurcationInterventions Lecturers:EhtishamMahmud

10:12_AM RoundtableDiscussionWithAudienceQA

10:15_AM InterventionalPharmacologyEssentialsforPCIandACS

Page 21: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:21

Lecturers:PieraCapranzano10:27_AM RoundtableDiscussionWithAudienceQA

10:30AM-12:00PM

SessionIII.IntroductiontoPCIandValveDiseaseInterventions

Moderators:JosephP.CarrozzaJr,JoseM.Wiley

Discussants:PeterBarlis,BimmerE.Claessen,GiuseppeDeLuca,RobertJ.Gil,HadleyWilson,ClemensvonBirgelen

10:30_AM CathLabRoomSetupandBasicEquipmentGuidingCathetersWiresandBalloons Lecturers:JasvindarSingh

10:42_AM RoundtableDiscussionWithAudienceQA

10:45_AM DrugElutingStentPlatformsandOutcomes2018 Lecturers:GennaroSardella

10:57_AM RoundtableDiscussionWithAudienceQA

11:00_AM DrugElutingStentThrombosisandRestenosis:MechanismsFrequencyandTreatment Lecturers:BinitaShah

11:12_AM RoundtableDiscussionWithAudienceQA

11:15_AM AtherotomyCuttingScoringLithotrispyAtherectomyRotationalOrbitalLaserandEmbolicProtection Lecturers:RobertT.Pyo

11:27_AM RoundtableDiscussionWithAudienceQA

11:30_AM AorticValvularHeartDisease:DiagnosisandTreatmentOptions2018 Lecturers:NicolaCorvaja

11:42_AM RoundtableDiscussionWithAudienceQA

11:45_AM MitralValvularHeartDisease:DiagnosisandTreatmentOptions2018 Lecturers:RamonQuesada

11:57_AM RoundtableDiscussionWithAudienceQA

SPECIALSESSION:CONSENSUSSUMMITONTRANSLATIONALPATHWAYSFORCARDIOVASCULARDEVICES(SPONSOREDBYINTERNATIONALSOCIETY

FORCARDIOVASCULARTRANSLATIONALRESEARCH)

FRIDAY,SEPTEMBER21,2018

8:00AM-5:00PM

Room30A-C,UpperLevel

8:00AM-8:20AM

Introduction

8:00_AM WelcomeStatement Lecturers:SpencerB.KingIII

8:05_AM ISCTRMissionandStatementofMeetingPurpose Lecturers:NabilDib

8:20AM-10:30AM

SessionI:RequirementsforCVDevicesApproval;Regulatory,Payers,andPracticeGuidelines

Moderators:SpencerB.KingIII,BramD.Zuckerman

8:20_AM RegulatoryRequirementforMarketingApprovalincludingtheParallelReviewNESTandBeyond Lecturers:BramD.Zuckerman

8:35_AM CMSRequirementforReimbursementforInnovation Lecturers:LoriAshby

8:50_AM PracticeGuidelineRequirementforNewTechnology Lecturers:AliceK.Jacobs

9:05_AM PreClinicalandClinicalTrialDesignandEndpointsforDeviceApproval Lecturers:ChrisMullin,RoseannMWhite

9:20_AM EarlyFeasibilityStudiesforDeviceEvaluation Lecturers:AndrewFarb

9:35_AM ThePatientsVoice Lecturers:MarkMercola

9:45_AM PanelDiscussion

Page 22: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:22

Discussants:PhilAdamson,LoriAshby,RobertO.Bonow,AndrewFarb,AliceK.Jacobs,LouisJacques,SpencerB.KingIII,MitchellW.Krucoff,ChrisMullin,David

Reuter,StanRowe,ChuckSimonton,RoseannMWhite10:15_AM Break

10:30AM-12:00PM

SessionII:ISCTRAwardPresentationandKeynoteAddress

Moderators:RobertO.Bonow,StanRowe

10:30_AM PresentationoftheGlenandMarilynNelsonAwardforInnovationandTranslationinCardiovascularMedicinetoAlainCribierandMartinLeonpresented

byStanRoweandRobertBonow10:40_AM VideoPresentationoftheGlenandMarilynNelsonAwardforInnovationandTranslationinCardiovascularMedicine

10:45_AM TheTAVRDevelopmentfromConcepttoFirstinMan Lecturers:AlainG.Cribier

11:05_AM TheTAVRDevelopmentfromFirstinMantoPhase3andBeyond Lecturers:MartinB.Leon

11:25_AM Lunch

12:00PM-12:50PM

SessionIII:TranslationalPathwayforTranscatheterAorticValveDevelopment

Moderators:JeroenJ.Bax,MartinB.Leon

12:00_PM TheMethodsforAorticValveDevelopment Lecturers:StanRowe

12:15_PM TheEndpointsforAorticValveDevelopment Lecturers:OriBen-Yehuda

12:30_PM PanelDiscussion Discussants:JeroenJ.Bax,RobertO.Bonow,IanMeredith,StanRowe,SusanStrong,BernardVasseur,BramD.Zuckerman

12:50PM-1:40PM

SessionIV:TheTranslationalPathwayforTranscatheterMitral/TricuspidValveDevelopment

Moderators:RobertO.Bonow,JohnCLaschinger

12:50_PM TheMethodsforTranslationalMitralTricuspidValveDevelopment Lecturers:MichaelJ.Mack

1:05_PM TheEndpointsforTranslationalMitralTricuspidValveDevelopment Lecturers:BlaseA.Carabello

1:20_PM PanelDiscussion Discussants:WadeAubry,BlaseA.Carabello,StevenL.Goldberg,MichaelJ.Mack,DavidReuter,SharonSaeger,GreggW.Stone,RobertThatcher,Patrick

Verta,ChangfuWu

1:40PM-2:45PM

SessionV:TheTranslationalPathwayforCoronaryStentDevelopment

Moderators:MitchellW.Krucoff,GreggW.Stone

1:40_PM TheMethodsforCoronaryStentDevelopment Lecturers:ChuckSimonton

1:55_PM TheMethodsforCoronaryStentDevelopment Lecturers:DonaldCutlip

2:10_PM PanelDiscussion Discussants:DonaldCutlip,JohnDominguez,NealFearnot,MichaelC.John,SpencerB.KingIII,IanMeredith,LauraPerkins,ChuckSimonton

2:30_PM Break

2:45PM-3:35PM

SessionVI:TheTranslationalPathwayforCatheterAblationDevelopment

Moderators:MarcoCannella,DouglasPacker

2:45_PM TheMethodsforCatheterAblationDevelopment Lecturers:DouglasPacker

3:00_PM TheEndpointsforCatheterAblationDevelopment Lecturers:MarcoCannella

3:15_PM PanelDiscussion Discussants:WadeAubry,JunDong,LarryHaffner,AnthonyHong,TimothyLaske,AmitShanker

Page 23: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:23

3:35PM-4:25PM

SessionVII:TheTranslationalPathwayforLeftVentricularAssistDeviceDevelopment

Moderators:IleanaL.Pina,MagdiYacoub

3:35_PM TheMethodsforLVADDevelopment Lecturers:FrancisPagani

3:50_PM TheEndpointsforLVADEvaluation Lecturers:KeithAaronson

4:05_PM PanelDiscussion Discussants:KeithAaronson,PhilAdamson,NeilArgo,RobinBostic,KevinBourque,MichaelMinogue,FrancisPagani,BernardVasseur,ChangfuWu

4:25PM-5:00PM

SessionVIII:ApplicationoftheConsensusDocument

Moderators:SpencerB.KingIII,BramD.Zuckerman

4:25_PM PanelDiscussion Lecturers:JeroenBax

Discussants:KeithAaronson,LoriAshby,JeroenJ.Bax,BlaseA.Carabello,AndrewFarb,AliceK.Jacobs,ChrisMullin,DouglasPacker,StanRowe,Chuck

Simonton,RoseannMWhite

SPECIALSESSION:TAVRFOUNDATIONSFORFELLOWS(SPONSOREDBYEDWARDSLIFESCIENCES)

FRIDAY,SEPTEMBER21,2018

8:00AM-6:00PM

Room30D-E,UpperLevel

8:00AM-5:30PM

TAVRFoundationsforFellows

Lecturers:M.AndrewMorse,MD,HeidiMyers

Faculty:RitaBirchard,RebeccaT.Hahn,MarianC.Hawkey,OmarK.Khalique,SusheelK.Kodali,TamimNazif,MarkJ.Russo,TorstenP.Vahl

8:00_AM WelcomeandIntroduction Lecturers:RitaBirchard

8:15_AM TAVREvolutionandPARTNERDataOverview Lecturers:SusheelK.Kodali

9:00_AM ValveClinicStructureandPatientScreening Lecturers:MarianC.Hawkey

9:30_AM Break

9:45_AM EchocardiographyforTAVR Lecturers:RebeccaT.Hahn

10:15_AM CTImagingforTAVR Lecturers:TorstenP.Vahl

10:45_AM TransfemoralProcedure:DeviceOverviewandCaseReview Lecturers:TamimNazif

11:45_AM BreakandBoxLunch

12:30_PM DontDismisstheImportanceofTAVREconomics Lecturers:HeidiMyers

1:00_PM CaseStudyPanel:ComplexCasesandComplicationsAlternativeAccessComplexCasesandChallengingAnatomyandComplicationManagement Lecturers:MarkJ.Russo

2:30_PM HandsonWorkshops:Room31ACTWorkstationEchoWorkstationProcedureSimulatorandHandsonDeviceDemonstration Lecturers:OmarK.Khalique,M.AndrewMorse,MD

4:00_PM AorticandMitralValveinValveProcedureandCaseReview

4:45_PM PanelDiscussion:TransitioningtoaTAVRCenter Lecturers:MarkJ.Russo

TCTENDOVASCULAR:CONTROVERSIESANDCOMPLEXDECISION-MAKINGINVASCULARDISEASE

FRIDAY,SEPTEMBER21,2018

8:00AM-5:10PM

Room25A-B,UpperLevel

Page 24: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:24

8:00AM-10:58AM

SessionI.SFAandPoplitealTherapies

Moderators:GaryM.Ansel,EhrinJ.Armstrong

Discussants:GeorgeSChrysant,EricJ.Dippel,OsamuIida,SahilA.Parikh,MehdiH.Shishehbor

8:00_AM CaseStudy:ALongSegmentSFACTO CasePresenter:MohammadMehdiAnsari

8:08_AM HowtoOptimizeIntraluminalAntegradeCrossingforSFACTOs:DedicatedWiresandCrossingDevices Lecturers:SteveHenao

8:16_AM WhenAntegradeFails:RetrogradeCrossingStrategiesforSFACTOs Lecturers:ArthurC.Lee

8:24_AM PercutaneousBypass:UpdateontheDETOURandDETOURIITrials Lecturers:EhrinJ.Armstrong

8:32_AM ReEntryRequired:WhentoPullWhichDevicetoGetBackIntotheTrueLumen Lecturers:BeauHawkins

8:40_AM AHybridAlgorithmforCrossingSFAandPoplitealCTOs Lecturers:SubhashBanerjee

8:48_AM RoundtableDiscussionCrossingSFACTOs

8:57_AM SevereCalcificationintheSFA:DefinitionsandAssociationsWithOutcomes Lecturers:JeffreyJ.Popma

9:05_AM RoundtableDiscussionTreatmentStrategiesforLongSegmentSFACTOs

9:15_AM HowtoTreatLongCalcifiedSFALesions Lecturers:SahilA.Parikh

9:23_AM WillAdjunctiveAtherectomyImprovetheOutcomesofDrugCoatedBalloonsinComplexSFALesions Lecturers:MehdiH.Shishehbor

9:31_AM RoundtableDiscussionCalcifiedSFALesions

9:40_AM Debate:StentsareStilltheBestEndovascularTreatmentforLongSegmentSFACTOs Lecturers:GaryM.Ansel

9:45_AM Debate:DrugCoatedBalloonsShouldbethePrimaryTreatmentStrategyforLongSegmentSFACTOs Lecturers:CarlosI.Mena-Hurtado

9:50_AM RoundtableDiscussionTreatmentStrategiesforLongSegmentsSFACTOs

9:59_AM AngiographicDissectionsAfterBalloonAngioplastyandTheirAssociationWithOutcomes Lecturers:OsamuIida

10:07_AM IsIntravascularImagingNecessarytoAccuratelyIdentifyandQuantifyDissectionsAfterBalloonAngioplasty Lecturers:NicolasWShammas

10:15_AM NewTreatmentApproachesforSFADisease:TacksShocksandAdventitialDrugDelivery Lecturers:EhrinJ.Armstrong

10:23_AM WhatistheOptimalEndovascularTreatmentforSFAInStentOcclusions Lecturers:CraigM.Walker

10:31_AM TreatmentStrategiestoOptimizeEndovascularOutcomesofTASCCDAortoiliacLesions Lecturers:PhilipGreen

10:39_AM Debate:CommonFemoralArteryLesionsCanbeTreatedwithEndovascularTechniques Lecturers:KennethRosenfield

10:44_AM Debate:CommonFemoralArteryDiseaseShouldbeTreatedSurgically Lecturers:VirendraIPatel

10:49_AM RoundtableDiscussionOptimalTreatmentofCommonFemoralArteryDisease

10:58AM-12:54PM

SessionII.Aortic/MesentericTherapies

Moderators:SahilA.Parikh,VirendraIPatel

Discussants:DanielleBajakian,RobertM.Bersin,RobertA.Lookstein,RahulS.Patel,KennethRosenfield,CraigM.Walker

10:58_AM RenalArteryInterventionsAfterASTRALandCORAL:WhoShouldWeTreat Lecturers:KennethRosenfield

11:06_AM OptimalRenalStentingTechnique Lecturers:SahilA.Parikh

11:14_AM ISRandComplexAnatomyinRenalStenting Lecturers:MarkC.Bates

11:22_AM RoundtableDiscussionTheUncertaininRenalArteryIntervention

Page 25: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:25

11:27_AM OpenEndovascularManagementofAcuteMesentericIschemia

11:35_AM PatientandProcedureSelectionforChronicMesentericIschemiatoOptimizeOutcomes Lecturers:BryanT.Fisher

11:43_AM RoundtableDiscussionOptimalPercutaneousTechniquesinMesentericIschemia

11:48_AM ConsensusGuidelinesforTimingandTreatmentofAbdominalAorticAneurysms Lecturers:S.JayMathews

11:56_AM ManagingChallengingAccesstoEnsureSuccessfulAorticEndografting Lecturers:S.JayMathews

12:04_PM NewDevicesandFutureTechnologiesforManagementofInfrarenalAbdominalAorticAneurysms Lecturers:RobertM.Bersin

12:12_PM Openvs.EndovascularAorticAneurysmRepair:ImportantFactorsinClinicalDecisionmaking Lecturers:VirendraIPatel

12:20_PM ManagementofEndoleaksandNewDataonLongtermDurabilityofAorticEndografts Lecturers:RahulS.Patel

12:28_PM CasePresentation:ComplexEndograftFEVAR CasePresenter:VirendraIPatel

12:36_PM CasePresentation:EndograftforAortoiliacOcclusiveandAneurysmalDisease CasePresenter:DarrenBSchneider

12:44_PM RoundtableDiscussionTrainingRequirementsforEVAR

12:54PM-2:32PM

SessionIII.VenousDiseaseTherapies

Moderators:RaghuKolluri,MahmoodK.Razavi

Discussants:TeresaL.Carman,AnthonyJ.Comerota,S.JayMathews,JohnMoriarty,RahulS.Patel,GregoryPiazza

12:54_PM AftertheATTRACTTrial:WhichPatientsWithAcuteDeepVeinThrombosisShouldReceiveEndovascularTherapy Lecturers:TeresaL.Carman

1:02_PM StatusofVenousStentstoTreatVenousObstruction Lecturers:MahmoodK.Razavi

1:10_PM ExistingandFutureTherapiesforChronicDeepVeinThrombosis Lecturers:RahulS.Patel

1:18_PM NovelTherapiesforSuperficialVenousInsufficiency:ThermalandNonthermalTechnologies Lecturers:RaghuKolluri

1:26_PM CasePresentation:WorstDVTEver CasePresenter:GregoryPiazza

1:34_PM CasePresentation:ReconstructionofComplexVenousOcclusion CasePresenter:JohnMoriarty

1:42_PM CatheterBasedTherapyforAcutePulmonaryEmbolism:WhatDoestheDataTellUs Lecturers:AkhileshK.Sista

1:50_PM EmergingTechnologiestoTreatAcutePulmonaryEmbolism Lecturers:MahmoodK.Razavi

1:58_PM CasePresentation:EndovascularTreatmentofaMassivePulmonaryEmbolism CasePresenter:JohnMoriarty

2:06_PM IndicationsforIVCFiltersin2018 Lecturers:IdoWeinberg

2:14_PM CasePresentation:ExtremeIVCFilterRemoval CasePresenter:JohnMoriarty

2:22_PM RoundtableDiscussionwithAudienceQA

2:32PM-4:10PM

SessionIV.AcuteandChronicCerebrovascularDiseaseTherapies

Moderators:AmanB.Patel,KennethRosenfield

Discussants:WilliamA.Gray,MatthewKoch,DemetriusLopes,CharlesMatouk,StephenR.Ramee,AdnanSiddiqui,ScottSilverman

2:32_PM CarotidArteryDiseaseAccess:FemoralRadialandDirectCarotidTechniques Lecturers:MohammadAliAziz-Sultan

2:40_PM CarotidArteryDiseaseAccess:WhenandHowShouldaDifficultArchbeNavigated Lecturers:AdnanSiddiqui

2:48_PM CarotidArteryDiseaseTechnicalConsiderations:EmbolicProtectionOptionsandSelection Lecturers:AlexanderA.Khalessi

2:56_PM CarotidArteryDiseasePatientSelection:ImpactofPlaqueMorphologyandAdvancedImagingOptions

Page 26: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:26

3:04_PM CarotidArteryStenting:SynthesizingtheCurrentRandomizedTrialEvidence Lecturers:HerbertD.Aronow

3:12_PM RoundtableDiscussionCarotidArteryDiseasePatientSelectionandTechnicalConsiderations

3:21_PM AcuteStrokeTreatments:RapidReviewoftheLatestData Lecturers:ScottSilverman

3:29_PM LogisticsofStrokeCare:RequirementsofanEffectiveCareSystem Lecturers:MohammadAliAziz-Sultan

3:37_PM RoleofArtificialIntelligenceinPatientSelection

3:45_PM ThrombectomyTechniques:Aspirationvs.StentRetriever Lecturers:AmanB.Patel

3:53_PM EdgesofPatientSelectionforStrokeThrombectomy:LowNIHSSandLargeCore Lecturers:DemetriusLopes

4:01_PM RoundtableDiscussionFutureofStrokeCare

4:10PM-5:10PM

SessionV.BestCasesoftheYear

Moderators:RobertA.Lookstein,SahilA.Parikh

Discussants:EhrinJ.Armstrong,DanielleBajakian,AmanB.Patel,VirendraIPatel

4:10_PM MyBestCaseLowerExtremityPADIntervention CasePresenter:DanielleBajakian

4:20_PM MyBestCaseDeepVenousDiseaseIntervention CasePresenter:RobertA.Lookstein

4:30_PM MyBestCaseCLIIntervention CasePresenter:EhrinJ.Armstrong

4:40_PM MyBestCaseNeuroIntervention CasePresenter:AmanB.Patel

4:50_PM MyBestCaseAorticIntervention CasePresenter:VirendraIPatel

5:00_PM MyBestCaseCombinedCoronaryandPeripheralIntervention CasePresenter:SahilA.Parikh

INTERVENTIONALINNOVATIONI

FRIDAY,SEPTEMBER21,2018

8:00AM-1:30PM

Room29A-B,UpperLevel

8:00AM-9:20AM

CoronaryInterventionsandTechnologies

Moderators:RobertS.Schwartz,GiuseppeTarantini

Discussants:FernandoAlfonso,AntonioColombo,FrancescoPrati,AsifQasim,EvelynRegar,CarlosE.Uribe

8:00_AM FeaturedLecture:InnovationinPercutaneousCoronaryIntervention:RemainingClinicalNeedsChallengesandOpportunities Lecturers:AntonioColombo

9:20AM-10:20AM

InnovationsinPeripheralVascularInterventions

Moderators:GeorgeLAdams,TonyDas

Discussants:MarkC.Bates,RobertM.Bersin,LuisMarianoPalena,KrishnaJ.Rocha-Singh,KennethRosenfield

9:20_AM FeaturedLecture:ReconcilingClinicalNeedsandFiscalResponsibilityinPeripheralVascularInterventions Lecturers:GeorgeLAdams

9:27_AM PeripheralCTOcrossingwiththeSoundBiteActiveWireSoundBite Lecturers:EricTherasse

9:34_AM FirstReportofthe12MonthOutcomesofSELUTIONTrial:ANovelSirolimusCoatedDCBTechnologyEvaluatedinSFAMedAlliance Lecturers:KlausBrechtel

9:41_AM ModeratedDiscussionwithQA

9:48_AM ClinicalOutcomesofSirolimusElutingBioresorbablePeripheralScaffoldSysteminSubjectswithCriticalLimbIschemiaDiseaseduetoDeNovoLesions

Meril Lecturers:GireeshWarwadekar

9:55_AM PercutaneousDeepVeinaRterializationfortheTreatmentofLateStageCriticalLiMbISchEmiaThePROMISETrial:EarlyFeasibilityInterimResultsLimFlow

Page 27: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:27

Lecturers:SteveHenao10:09_AM BlueLeaf:InitialExperiencewithaPercutaneousApproachtoDeepVeinReflux

Lecturers:RamonLVarcoe10:12_AM ModeratedDiscussionwithQA

10:20AM-11:30AM

InterventionalHeartFailure

Moderators:DanielBurkhoff,UlrichP.Jorde

Discussants:NavinK.Kapur,JohnM.Lasala,LiwenLiu,JeffreyW.Moses,IleanaL.Pina,BorisRudenko

10:20_AM FeaturedLecture:NewInterventionalOpportunitiesforDeviceDevelopmentintheHeartFailure Lecturers:UlrichP.Jorde

10:30_AM CryoablationMethodforPulmonaryArterySympatheticDenervationinPatientswithChronicHeartFailureandPulmonaryHypertensionFirstinManStudy Lecturers:BorisRudenko

10:38_AM NewTreatmentOptionforHOCMPercutaneousIntramyocardialRadiofrequencyAblation Lecturers:LiwenLiu

10:46_AM CardiacAutonomicNervesStimulationImprovesHemodynamics:APilotStudyinAdvancedHeartFailurePatients Lecturers:MichaelCuchiara

10:54_AM ModeratedDiscussionwithQA

11:04_AM OcclusionoftheSuperiorVenaCavatoReduceCardiacFillingPressuresisSafeandFeasibleinAcutelyDecompensatedHeartFailure:AFirstinManProofof

ConceptStudy Lecturers:NavinK.Kapur

11:12_AM SelectiveCRPApheresisasaNewTreatmentOptioninAcuteMyocardialInfarction:FirstResultsoftheCAMI1Study Lecturers:ChristophGarlichs

11:20_AM ModeratedDiscussionWithQA

11:30AM-1:30PM

FeaturedSessioninDigitalHealthCare

Moderators:SanjeevBhavnani,IssamD.Moussa

Lecturers:KenPersen,AsifQasim

Discussants:PeterJ.Fitzgerald,ChaimS.Lotan,LonnyReisman

11:30_AM FeaturedLecture1:DigitalHealthSolutionsinCardiology:TheHopetheHypeandtheFuture Lecturers:SanjeevBhavnani

INTERVENTIONALINNOVATIONII

FRIDAY,SEPTEMBER21,2018

1:30PM-5:30PM

Room29A-B,UpperLevel

1:30PM-2:50PM

TAVRInnovationandAncillaryTechnologies

Moderators:AxelLinke,ThomasModine

Discussants:HemalGada,IsaacGeorge,AdamB.Greenbaum,RanKornowski,GiuseppeTarantini

1:30_PM FeaturedLecture:FutureInnovationinTAVR:RemainingClinicalNeedsNovelTechnologiesandAncillaryDeviceStrategies Lecturers:MartinB.Leon

2:50PM-4:30PM

Trans-CatheterMitralValveIntervention

Moderators:VinayakBapat,JuanF.Granada

Discussants:StevenL.Almany,SamirR.Kapadia,IssamD.Moussa,DavidW.M.Muller,UlrichSchäfer,MathewWilliams

2:50_PM FeaturedLecture:TransCatheterMitralValveIntervention:TechnicalandClinicalLessonsLearnedfromEarlyHumanClinicalStudies Lecturers:VinayakBapat

4:30PM-5:30PM

Trans-catheterTricuspidValveIntervention

Moderators:AzeemLatib,GeorgNickenig

Discussants:CharlesJ.Davidson,PaoloDenti,RebeccaT.Hahn,ChristopherU.Meduri,IssamD.Moussa,MaurizioTaramasso

4:30_PM FeaturedLecture:CatheterBasedTricuspidIntervention:CurrentTechnicalChallengesandEarlyClinicalExperiences Lecturers:MaurizioTaramasso

Page 28: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|FRIDAY,SEPTEMBER21,2018

LastUpdated09/10/2018Page:28

4:38_PM SimplifyingTTVRwithaNovelCinchingSystemTricinch Lecturers:JanVanderHeyden

4:45_PM MinimallyInvasiveTricuspidValveAnnuloplastyRepairTechnologyMIATMMicroInterventionalDevices:EarlyClinicalExperience Lecturers:MathewWilliams

4:52_PM TranscatheterTricuspidValveRepair:ResultsFromTheMulticenterTrial6MonthOutcomes Lecturers:GeorgNickenig

4:59_PM ModeratedDiscussionWithQA

5:05_PM FirstinhumanTranscatheterTricuspidValveRepairbytheMistraldeviceMitralix Lecturers:HaimDanenberg

5:12_PM CompassionateUseofthePASCALSystemforTranscatheterTricuspidRepair:AMulticenterFirstinHumanExperienceEdwards Lecturers:RalphStephanvonBardeleben

5:19_PM ModeratedDiscussionWithQA

Page 29: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:29

SATURDAY,SEPTEMBER22,2018-

BREAKFASTPROGRAM:FUTUREPERSPECTIVESANDTECHNOLOGIESINBTKINTERVENTION(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,BOSTON

SCIENTIFICCORPORATION,ANDMEDTRONIC)

SATURDAY,SEPTEMBER22,2018

6:30AM-8:00AM

Room30D-E,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

FuturePerspectivesandTechnologiesinBTKIntervention

CoChairs:JuanF.Granada,SahilA.Parikh

Lecturers:WilliamA.Gray

Faculty:GeorgeLAdams,EhrinJ.Armstrong,LuisMarianoPalena,RamonLVarcoe

7:00_AM IntroductionandSessionObjectives Lecturers:SahilA.Parikh

7:02_AM CasePresentations:UnmetNeedsinCLI Lecturers:GeorgeLAdams

7:14_AM CrossingTechnologies:AvailableToolsandOutcomes Lecturers:EhrinJ.Armstrong

7:24_AM ModeratedDiscussion

7:26_AM DedicatedScaffoldsandStents Lecturers:RamonLVarcoe

7:36_AM ModeratedDiscussion

7:38_AM EmergentDrugsandLocalDrugDeliverySystems Lecturers:WilliamA.Gray

7:48_AM ModeratedDiscussion

7:50_AM PanelDiscussion:UnmetNeedsinBTKIntervention:WhereAreWeNowandWhereAreWeGoing

8:00_AM Adjourn

BREAKFASTPROGRAM:INTRA-AORTICBALLOONCOUNTERPULSATIONFORPERCUTANEOUSAORTICVALVEORCOMPLEXPCIPROCEDURES-AWARD

WINNINGCASEPRESENTATIONS(ORGANIZEDBYCRF,SPONSOREDBYGETINGE)

SATURDAY,SEPTEMBER22,2018

6:30AM-8:00AM

Room24A-B,UpperLevel

6:30AM-8:00AM

Intra-aorticBalloonCounterpulsationforPercutaneousAorticValveorComplexPCIProcedures-AwardWinningCasePresentations

Chairs:TayoA.Addo,GeorgeD.Dangas,JoseM.Wiley

Faculty:LampsonFan,TomaszGasior,StefanosVotsis

6:30_AM CheckinBreakfast

7:00_AM RocksandBalloons Lecturers:LampsonFan

7:15_AM QA

7:20_AM HowtoFixaBrokenHeartPercutaneousManagementofAcuteIschemicLeftVentricularFreeWallRupture Lecturers:TomaszGasior

7:35_AM QA

7:40_AM IntraaorticBalloonPumpUtilizationinaPatientWithCardiogenicShockFollowingCardiacArrestDuetoPartialLeftMainCoronaryArteryOcclusion

WhichWasCausedByValveannulusRemodelingofaBioprostheticAorticValve60DaysAfterTAVRProcedu Lecturers:StefanosVotsis

Page 30: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:30

7:55_AM QA

8:00_AM Adjourn

BREAKFASTPROGRAM:NEWTREATMENTSTRATEGIESFORCARDIOGENICSHOCK:IMPELLAEXPANDEDINDICATIONS(ORGANIZEDBYCRF,

SPONSOREDBYABIOMED,INC.)

SATURDAY,SEPTEMBER22,2018

6:30AM-8:00AM

Room23B-C,UpperLevel

6:30AM-7:00AM

Check-In&Breakast

7:00AM-8:00AM

NewTreatmentStrategiesforCardiogenicShock:ImpellaExpandedIndications

Chairs:WilliamW.O'Neill

Faculty:CindyL.Grines,NavinK.Kapur

7:00_AM AdvancesintheTreatmentofCardiovascularDiseaseinWomen:PCIMIShockMyocarditisSCADandPostpartumCardiomyopathy Lecturers:CindyL.Grines

7:15_AM Discussion

7:20_AM TheImpactofTheCardiogenicShockInitiativeNCSI:OneYearLater Lecturers:WilliamW.O'Neill

7:35_AM Discussion

7:40_AM UnderstandingtheImportanceofVentricularUnloadinginManagementofAMIandCardiogenicShock Lecturers:NavinK.Kapur

7:55_AM Discussion

8:00_AM Adjourn

BREAKFASTPROGRAM:PCICOMPLICATIONS:THEBESTOFTHEWORST(SPONSOREDBYCRF,SUPPORTEDBYMEDTRONIC)

SATURDAY,SEPTEMBER22,2018

6:30AM-8:00AM

Room28D-E,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

PCIComplications:TheBestoftheWorst

CoChairs:ManishA.Parikh,JasvindarSingh

Faculty:NiratBeohar,DavidA.Cox,JamesB.HermillerJr,DimitriKarmpaliotis

7:00_AM TheCoronaryPerforationNightmare Lecturers:DimitriKarmpaliotis

7:10_AM Discussion

7:15_AM TheCoronarythatSpiraledOutofControl Lecturers:JamesB.HermillerJr

7:25_AM Discussion

7:30_AM TheSlamDunkSTEMINoReflowandBeyond Lecturers:DavidA.Cox

7:40_AM Discussion

7:45_AM MyWorstVascularComplicationoftheYear Lecturers:NiratBeohar

7:55_AM Discussion

Page 31: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:31

8:00_AM Adjourn

BREAKFASTPROGRAM:RENALDENERVATION:TRIALDESIGNREALLYMATTERS(SPONSOREDBYCRF,SUPPORTEDBYMEDTRONIC)

SATURDAY,SEPTEMBER22,2018

6:30AM-8:00AM

Room26A-B,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

RenalDenervation:TrialDesignReallyMatters

Chairs:DavidE.Kandzari

Faculty:FelixMahfoud,AndrewSharp,MichaelA.Weber

7:00_AM Welcome Lecturers:DavidE.Kandzari

7:05_AM TheSPYRALOFFandONMEDSProgramandNextSteps Lecturers:AndrewSharp

7:17_AM RenalDenervationinClinicalPractice:RealWorldExperienceandLessonsLearned Lecturers:FelixMahfoud

7:29_AM WhatAdditionalEvidenceINeedorDonttoIncorporateRDNintoClinicalPractice Lecturers:MichaelA.Weber

7:41_AM Discussion

8:00_AM Adjourn

BREAKFASTPROGRAM:SIMPLIFYANDOPTIMIZEYOURPCIWITHENHANCEDIMAGINGANDADVANCEDPHYSIOLOGY(SPONSOREDBYACIST&

MEDTRONIC)

SATURDAY,SEPTEMBER22,2018

6:30AM-8:00AM

Room25A-B,UpperLevel

6:30AM-8:00AM

SimplifyandOptimizeYourPCIwithEnhancedImagingandAdvancedPhysiology

Chairs:ZiadA.Ali

Faculty:JoostDaemen,MortonJ.Kern,ArnoldSeto

6:30_AM CheckinBreakfast

7:00_AM Welcome Lecturers:ZiadA.Ali

7:05_AM CurrentPracticesandNewApproachesforBestOutcomes Lecturers:MortonJ.Kern

7:15_AM RestingIndicesforPhysiologicAssessmentAretheyallcreatedequally Lecturers:ArnoldSeto

7:25_AM UsingPhysiologyandImagingToolsforPostPCIAssessmentAreyoufinished Lecturers:JoostDaemen

7:40_AM ImagingandPhysiologyGuidedPCIWithoutContrastAdministrationIsthisthefuture Lecturers:ZiadA.Ali

7:55_AM WrapupandQA

8:00_AM Adjourn

MAINARENAI,SATURDAY,SEPT.22

SATURDAY,SEPTEMBER22,2018

Page 32: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:32

8:00AM-1:06PM

MainArena,HallF,GroundLevel

8:00AM-9:30AM

LiveCases#1

LiveCaseModerators:MartinB.Leon,RoxanaMehran

LiveCaseCoModerators:MichaelJ.Mack

LiveCaseDiscussants:AlexandreAbizaid,JohnK.Forrest,J.AaronGrantham,DavidHildick-Smith,DimitriKarmpaliotis,SusheelK.Kodali,AmirLerman,ManishA.Parikh,

MichaelJ.Reardon,CarlosE.Uribe,R.MichaelWyman

FactoidFaculty:ChristineJ.Chung,AmiraliMasoumi,MeghaPrasad,SabatoSorrentino,EisukeUsui

8:00_AM UniversityofWashingtonMedicalCenterRegionalHeartCenterSeattleWA LiveCaseOperators:RaviS.Hira,WilliamL.Lombardi,JamesM.McCabe

8:45_AM MayoClinicRochesterMN LiveCaseOperators:MackramF.Eleid,RobertFrantz,MayraGuerrero,ChetRihal,GurpreetS.Sandhu

9:30AM-9:36AM

TCT2018-30thAnniversary

9:30_AM 30thAnniversary Moderators:MartinB.Leon,GreggW.Stone

9:36AM-10:06AM

RapidFireCaseControversies:Coronary

Moderators:AntonioColombo,AjayJ.Kirtane

Discussants:ToddJ.Brinton,DidierCarrié,JunboGe,MichaelHaude,StuartJ.Head,AndrzejJ.Ochala,SimonRedwood,GennaroSardella

9:36_AM ComplexCoronaryArteryDisease:PCIvs.CABG CasePresenter:DavideCapodanno

9:46_AM STEMIWithMultivesselDisease:HowToProceed CasePresenter:PieterC.Smits

9:56_AM HighRiskElectivePCI:IsHemodynamicSupportNecessary CasePresenter:DavidG.Rizik

10:06AM-10:21AM

TCT2018GeoffreyO.HartzlerMasterOperatorAward

Moderators:MartinB.Leon,GreggW.Stone

AwardRecipients:JohnG.Webb

10:06_AM TCT2018GeoffreyO.HartzlerMasterOperatorAward Lecturers:MartinB.Leon

10:21AM-11:21AM

Late-BreakingTrials1,SponsoredbytheLancet

Moderators:GreggW.Stone

CoModerator:StuartSpencer

Discussants:GaryM.Ansel,RobertA.Byrne,DidierCarrié,MichaelR.Jaff,JensFlenstedLassen,TullioPalmerini,SahilA.Parikh,ThomasPilgrim,MahmoodK.Razavi,

ManelSabate

10:21_AM IMPERIAL:ARandomizedTrialofDrugElutingStentsforTreatmentofFemoropoplitealArteryLesions Lecturers:WilliamA.Gray

10:33_AM RoundtableDiscussion

10:41_AM BIONYX:ARandomizedTrialEvaluatingaThinCompositeWireStrutDurablePolymerBasedDESComparedwithanUltraThinStrutBioresorbable

PolymerBasedDESinanAllComersPatientPopulation Lecturers:ClemensvonBirgelen

10:53_AM RoundtableDiscussion

11:01_AM ReCre8:ARandomizedTrialEvaluatingaPolymerFreeCoronaryDrugElutingStentinanAllComersPatientPopulation Lecturers:PieterR.Stella

11:13_AM RoundtableDiscussion

11:21AM-12:06PM

LiveCases#2

LiveCaseModerators:AjayJ.Kirtane

LiveCaseCoModerators:IreneM.Lang

Page 33: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:33

LiveCaseDiscussants:RiyazBashir,StanleyJ.Chetcuti,AnthonyN.DeMaria,PhilipGreen,NickH.Kim,HiromiMatsubara,OscarA.Mendiz,IssamD.Moussa,Kenneth

Rosenfield,AlexM.K.Rothman

FactoidFaculty:ChristineJ.Chung,AmiraliMasoumi,MeghaPrasad,SabatoSorrentino,EisukeUsui

11:21_AM UniversityofCaliforniaSanDiegoSanDiegoCA LiveCaseOperators:AngLawrence,EhtishamMahmud,MitulPatel,RyanReeves

12:06PM-1:06PM

Late-BreakingTrials2,Co-SponsoredbyCirculation

Moderators:SunilV.Rao

CoModerator:RobGropler,DharamJ.Kumbhani,RoxanaMehran

Discussants:AndreasBaumbach,DonaldCutlip,DavidE.Kandzari,Marie-ClaudeMorice,FrancescoPrati,SigmundSilber,GiulioStefanini,PhilipM.Urban

12:06_PM LEADERSFREEII:EvaluationofaPolymerFreeCoronaryDrugElutingStentinHighBleedingRiskPatientsWithOneMonthDualAntiplateletTherapy Lecturers:MitchellW.Krucoff

12:18_PM RoundtableDiscussion

12:26_PM SORTOUTIX:ARandomizedTrialComparingaPolymerFreeCoronaryDrugElutingStentWithanUltraThinStrutBioresorbablePolymerBasedDrug

ElutingStentinanAllComersPatientPopulation Lecturers:LisetteOkkelsJensen

12:38_PM RoundtableDiscussion

12:46_PM TALENT:ARandomizedTrialEvaluatinganUltraThinStrutBioresorbablePolymerBasedCoronaryDrugElutingStentinanAllComersPatientPopulation Lecturers:PatrickW.Serruys

12:58_PM RoundtableDiscussion

KEYNOTEINTERVENTIONALSTUDIESI:ENDOVASCULARINTERVENTIONS

SATURDAY,SEPTEMBER22,2018

1:00PM-2:00PM

Ballroom6A,UpperLevel

1:00PM-2:00PM

KeynoteInterventionalStudiesI:EndovascularInterventions

Moderators:LindsayS.Machan,CraigM.Walker

Discussants:GeorgeLAdams,SubhashBanerjee,TonyDas,EricJ.Dippel,YosukeHata,KhusrowNiazi,MahmoodK.Razavi,EricASecemsky

1:00_PM IN.PACTDCB:PooledMultistudyAssessmentofDrugCoatedBalloonTreatmentforFemoropoplitealPeripheralArteryDisease Lecturers:MehdiH.Shishehbor

1:10_PM Discussion

1:15_PM EffPacRCT:ARandomizedTrialEvaluatingaDrugCoatedBallooninSuperficialFemoralandPoplitealArteries Lecturers:UlfTeichgräber

1:25_PM Discussion

1:30_PM DANCE:TwoYearOutcomesofAdventitialDexamethasoneDeliveryDuringFemoropoplitealRevascularization Lecturers:EhrinJ.Armstrong

1:40_PM Discussion

1:45_PM UseandOutcomesWithDrugCoatedBalloonsinPatientsWithLowerExtremityPeripheralArteryDisease Lecturers:SchuylerJones

1:55_PM Discussion

KEYNOTEINTERVENTIONALSTUDIESII:ACUTECORONARYSYNDROMES,CARDIOGENICSHOCK,ANDHEMODYNAMICSUPPORT

SATURDAY,SEPTEMBER22,2018

3:00PM-4:00PM

Ballroom6A,UpperLevel

3:00PM-4:00PM

KeynoteInterventionalStudiesII:AcuteCoronarySyndromes,CardiogenicShock,andHemodynamicSupport

Moderators:JonathanM.Hill,E.MagnusOhman

Discussants:ChristianW.Hamm,BiswajitKar,UpendraKaul,ZuzanaMotovska,GrahamNichol,DuaneS.Pinto,PieterC.Smits,WilliamMSuh

Page 34: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:34

3:00_PM AMICS:PredictorsofSurvivalinPatientsWithAcuteMyocardialInfarctionandCardiogenicShockSupportedWithaPercutaneousLeftVentricularAssist

Device Lecturers:WilliamW.O'Neill

3:10_PM Discussion

3:15_PM SHIELDII:AcuteOutcomesand90DayResultsinPatientsUndergoingHighRiskPCISupportedWithaPercutaneousLeftVentricularAssistDevice Lecturers:DavidE.Kandzari

3:25_PM Discussion

3:30_PM TROPICALACS:PlateletReactivityandClinicalOutcomesinAcuteCoronarySyndromePatientsTreatedWithPrasugrelandClopidogrel Lecturers:DánielAradi

3:40_PM Discussion

3:45_PM CvLPRIT:LongtermFollowupFromaRandomizedTrialofEarlyCompleteRevascularizationinPatientsWithAcuteMyocardialInfarctionandMultivessel

Disease Lecturers:AnthonyH.Gershlick

3:55_PM Discussion

KEYNOTEINTERVENTIONALSTUDIESIII:IMAGINGANDPHYSIOLOGY

SATURDAY,SEPTEMBER22,2018

4:00PM-5:00PM

Ballroom6A,UpperLevel

4:00PM-5:00PM

KeynoteInterventionalStudiesIII:ImagingandPhysiology

Moderators:NickCurzen,NilsJohnson

Discussants:CarloDiMario,HectorM.Garcia-Garcia,AmirLerman,FrancescoPrati,JenniferA.Tremmel,TimP.VandeHoef,GeraldS.Werner,NickE.J.West

4:00_PM DEFERRALMetaAnalysis:OutcomesafterFFRbasedDeferredRevascularizationofNonculpritStenosesinAcuteCoronarySyndromesvsStableCoronary

ArteryDisease Lecturers:JavierEscaned

4:10_PM Discussion

4:15_PM iFRSWEDEHEART:TwoYearFollowupFromaRandomizedTrialofInstantaneousWaveFreeRatiovsFractionalFlowReserveGuidedPCI Lecturers:OleFröbert

4:25_PM Discussion

4:30_PM IRISFFR:PrognosticPerformanceofFiveRestingPressureDerivedIndexesofCoronaryPhysiology Lecturers:Jung-MinAhn

4:40_PM Discussion

4:45_PM FORZA:ARandomizedTrialofFractionalFlowReservevsOpticalCoherenceTomographytoGuideRevascularizationofIntermediateCoronaryStenoses Lecturers:AntonioMariaLeone

4:55_PM Discussion

INTERVENTIONALINNOVATION:SHARKTANKINNOVATIONCOMPETITION

SATURDAY,SEPTEMBER22,2018

8:00AM-11:00AM

Ballroom6A,UpperLevel

8:00AM-11:00AM

SharkTankInnovationCompetition

Moderators:LouisA.Cannon,JuanF.Granada

Judge:DanielBurkhoff,TonyDas,PeterJ.Fitzgerald,StevenHochberg,FrankLitvack,ChaimS.Lotan,StantonJ.Rowe,RobertS.Schwartz

8:00_AM IntroductionandObjectives Lecturers:JuanF.Granada

8:05_AM AnnouncingtheJonDeHaanFoundationAwardforInterventionalInnovation Lecturers:RobertS.Schwartz

8:10_AM KeynoteLecture:CardiovascularInnovation:ReconcilingTodaysClinicalNeedsWiththeFutureofMedicalTechnologies Lecturers:SanjeevBhavnani

Page 35: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:35

8:20_AM RoundtableDiscussion

8:30_AM AVascularComplianceEnhancingDeviceforTreatmentofPulmonaryArterialHypertension:AriaCV Lecturers:JohnScandurra

8:40_AM QA

8:50_AM ABioinspiredTranscatheterMitralValveReplacementSystem:AValve Lecturers:MohammadSarraf

9:00_AM QA

9:10_AM IntelligentVoiceAssistantforHeartDiseasePatients:Cardiocube Lecturers:OskarKiwic

9:20_AM QA

9:30_AM NovelTransseptalNeochordalSystemforPreciseMitralValveRepair:Chordart Lecturers:AlbertoWeber

9:40_AM QA

9:50_AM ControlledFlowInfusion:ANewApproachtoMeasureDynamicMicrovascularResistanceandtoTreatMicrovascularObstructioninAcuteHeartAttack

PatientsintheCathLab:CorFlowTherapeuticsAG Lecturers:JonHoem

10:00_AM QA

10:10_AM NewSystemforMeasurementofPulmonaryandSystemicBloodFlowandIntracardiacShunts:InnovaMedical Lecturers:JosefStasek

10:20_AM QA

10:30_AM ComprehensiveSolutionforTricuspidRegurgitationandRVDysfunction:TrisolMedical Lecturers:GioraWeisz

10:40_AM QA

10:50_AM RoundtableDiscussion

DIDACTICSESSION:DRUG-ELUTINGSTENTS,BIORESORBABLESCAFFOLDS,ANDCORONARYDRUG-COATEDBALLOONS,PART1

SATURDAY,SEPTEMBER22,2018

8:00AM-12:15PM

Room2,UpperLevel

8:00AM-8:43AM

SessionI.MetallicDESProgressandFailures

Moderators:RenuVirmani,ClemensvonBirgelen

Discussants:SalvatoreCassese,AlokeV.Finn,NicolasFoin,JohnA.Ormiston,DineshShah,SigmundSilber

8:00_AM Keynote:WhyDoContemporaryDESFailEarlyandLateRestenosisandThrombosis Lecturers:MichaelJoner

8:15_AM CanContemporaryDESBeImprovedbyAlteringtheDrugPolymerAlloyorConstruction Lecturers:DavidE.Kandzari

8:25_AM UltraThinStrutDES:AMeaningfulAdvance Lecturers:SripalBangalore

8:33_AM RoundtableDiscussionWithAudienceQA

8:43AM-9:46AM

SessionII.DAPTDurationandTripleTherapy

Moderators:PhilipM.Urban,RobertW.Yeh

Discussants:MichaelA.Kutcher,MichelleO'Donoghue,ElmirOmerovic,ManelSabate,DanielI.Simon,GiuseppeTarantini

8:43_AM LatestThinkingonDAPTDuration:BalancingRiskvsBenefit Lecturers:TullioPalmerini

8:53_AM RoundtableDiscussionWithAudienceQA

8:56_AM AlgorithmicPharmacologyRecommendationsforthePCIPatientWithAtrialFibrillation Lecturers:C.MichaelGibson

9:06_AM RoundtableDiscussionWithAudienceQA

9:09_AM StentSelectionfor13MonthDAPT:CurrentEvidenceOngoingStudies Lecturers:StephanWindecker

Page 36: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:36

9:19_AM RoundtableDiscussionWithAudienceQA

9:22_AM DAPTDurationCasePresentation1:NSTEMIinaHighBleedingRiskPatientCaseIntroduction CasePresenter:ElvinKedhi

9:25_AM CasediscussionWithAudienceQA

9:31_AM CaseConclusion Lecturers:ElvinKedhi

9:34_AM DAPTDurationCasePresentation2:PCIinStableCADWithLMCADandMVDCaseIntroduction CasePresenter:AlaideChieffo

9:37_AM CaseDiscussionWithAudienceQA

9:43_AM CaseConclusion CasePresenter:AlaideChieffo

9:46AM-10:42AM

SessionIII.PCIandOMTforIschemiaandQOL

Moderators:DavidJ.Cohen,SunilV.Rao

Discussants:RashaAl-Lamee,JohnA.Bittl,DavidLFischman,RajivGulati,DharamJ.Kumbhani,MamasMamas

9:46_AM OptimalMedicalTherapyWithandWithoutCoronaryRevascularization:WhichDrugsMatterSymptomsIschemiaorPrognosisAndMagnitudeofImpact Lecturers:DavidJ.Maron

9:56_AM RoundtableDiscussionWithAudienceQA

10:01_AM IncreasingEmphasisonQOLOutcomes:FromPatientPreferencetoInstrumentValidation Lecturers:JohnA.Spertus

10:09_AM RoundtableDiscussionWithAudienceQA

10:12_AM PCIforIschemiaPartI:CriticalAnalysisoftheFAMETrialsandORBITA Lecturers:BernardJ.Gersh

10:22_AM RoundtableDiscussionWithAudienceQA

10:27_AM PCIforIschemiaPartII:WhytheISCHEMIATrialMightbePositive..orNegative Lecturers:AjayJ.Kirtane

10:37_AM RoundtableDiscussionWithAudienceQA

10:42AM-12:15PM

SessionIV.RevascularizationinComplexCAD

Moderators:AntonioColombo,JeffreyW.Moses

Discussants:EvaldH.Christiansen,CarlosCollet,AlfredoE.Rodriguez,EricE.Roselli,PieterC.Smits,WilsonY.Szeto

10:42_AM DefiningWhatConstitutesaClinicallyRelevantPeriProceduralMI:Analysisin17000Patients Lecturers:Jung-MinAhn

10:52_AM RoundtableDiscussionWithAudienceQA

10:57_AM MortalityandStrokeOutcomesofPCIvsCABGinMVDandLMDWithandWithoutDiabetes Lecturers:StuartJ.Head

11:07_AM RoundtableDiscussionWithAudienceQA

11:10_AM HowMuchHasPCIandCABGImprovedinMVDandLMD:InsightsFromSYNTAXIIandSYNTAXEXCELComparativeAnalyses Lecturers:PatrickW.Serruys

11:17_AM RoundtableDiscussionWithAudienceQA

11:20_AM PCIforMVD:IsCompleteRevascularizationtheMissingLinkAnatomicorFunctional Lecturers:WilliamF.Fearon

11:30_AM RoundtableDiscussionWithAudienceQA

11:33_AM HybridRevascularizationasanAlternativetoPCIorCABG Lecturers:JohnD.Puskas

11:40_AM RoundtableDiscussionWithAudienceQA

11:43_AM MVDCasePresentationWithHeartTeamDiscussionCaseIntroduction CasePresenter:AlanC.Yeung

11:46_AM CaseDiscussionWithAudienceQA

11:53_AM CaseConclusion CasePresenter:AlanC.Yeung

11:56_AM IsItTimetoMoveBeyondAngiographyforProceduralPlanningSYNTAXIII Lecturers:AntonioL.Bartorelli

Page 37: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:37

12:03_PM IsItTimetoMoveBeyondAngiographyforProceduralPlanningDECISION Lecturers:GreggW.Stone

12:10_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:INTERVENTIONALHEARTFAILUREANDHEMODYNAMICSUPPORT,PART1

SATURDAY,SEPTEMBER22,2018

8:00AM-12:15PM

Room6D,UpperLevel

8:00AM-9:34AM

SessionI.AcuteCardiogenicShock:WhatIstheRightTreatmentAlgorithm?

Moderators:CindyL.Grines,E.MagnusOhman

Discussants:EmmanouilS.Brilakis,MarisaCevasco,AnthonyH.Gershlick,NavinK.Kapur,AshishPershad

8:00_AM DefiningCardiogenicShock:UpdateFromtheSCAIHFSAWorkingGroup Lecturers:DavidABaran

8:08_AM AcuteCardiogenicShock:PathophysiologyandTreatmentGoals Lecturers:TimothyD.Henry

8:16_AM RoundtableDiscussionWithAudienceQA

8:21_AM MajorLearningsFromIABPShockIIandCULPRITShock Lecturers:HolgerThiele

8:31_AM IABPinCardiogenicShock:ReconcilingClinicalTrialResultsandGuidelinesWithRealWorldExperienceWithPracticaluseRecommendations Lecturers:RichardSmalling

8:39_AM RoundtableDiscussionWithAudienceQA

8:44_AM UseofImpellaCPandRPinCardiogenicShock:FromHemodynamicstoClinicalOutcomes Lecturers:WilliamW.O'Neill

8:59_AM RoundtableDiscussionWithAudienceQA

9:08_AM UseofECMOinCardiogenicShock:WhenandHowComplicationsandOutcomes Lecturers:A.ReshadGaran

9:16_AM UseofECMOduringCardiacArrest:WhenandHowComplicationsandOutcomes Lecturers:SachinKumar

9:24_AM RoundtableDiscussionWithAudienceQA

9:34AM-12:15PM

SessionII.InterventionalTherapiesforChronicHeartFailure

Moderators:JamesE.Udelson,ClydeW.Yancy

Discussants:AngelesAlonsoGarcia,ColinM.Barker,TimothyD.Henry,HowardC.Herrmann,BiswajitKar,GeorgeW.Vetrovec

9:34_AM StateoftheArt:MedicalTherapiesforCHFWithaFocusonDiabetes Lecturers:IleanaL.Pina

9:42_AM StateoftheArt:DevicebasedTherapiesforCHF Lecturers:UlrichP.Jorde

9:56_AM StateoftheArt:DeviceandDrugbasedStrategiestoReducetheIncidenceofHeartFailureFollowingAMI Lecturers:NavinK.Kapur

10:06_AM RoleofRightHeartFailureinPatientsWithChronicHeartFailureandPostLVAD Lecturers:NirUriel

10:16_AM RoundtableDiscussionWithAudienceQA

10:26_AM PCIandCABGforChronicHeartFailure Lecturers:DivakaPerera

10:36_AM PercutaneousMitralRepairforHeartFailure Lecturers:StefanAnker

10:46_AM TricuspidValveRepairforCHF Lecturers:RebeccaT.Hahn

10:56_AM TAVRinHeartFailure:UNLOAD Lecturers:OriBen-Yehuda

11:02_AM RoundtableDiscussionWithAudienceQA

11:12_AM InteratrialShuntsI:Corvia Lecturers:TedFeldman

Page 38: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:38

11:20_AM InteratrialShuntsII:Vwave Lecturers:JoAnnLindenfeld

11:28_AM CardiacContractilityModulationforHFrEFandHFmrEF Lecturers:WilliamT.Abraham

11:36_AM AorticArchNeuromodulationforChronicHeartFailure:EnoPace Lecturers:FelixMahfoud

11:44_AM PercutaneousVentricularReshapingoftheLVforChronicHeartFailure:Ancora Lecturers:DanielBurkhoff

11:52_AM TreatmentofLVAneurysms:Revivent Lecturers:HorstSievert

12:00_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:TRANSCATHETERAORTICVALVEINTERVENTIONS,PART1

SATURDAY,SEPTEMBER22,2018

8:00AM-12:00PM

Room5,UpperLevel

8:00AM-9:00AM

Session1.TreatmentofBicuspidAorticValves(BAV)

Moderators:JosephE.Bavaria,HorstSievert

Discussants:Jung-MinAhn,StanleyJ.Chetcuti,HeleneEltchaninoff,HasanJilaihawi,JohnCLaschinger,JonathonA.Leipsic,MathewWilliams

8:00_AM ASurgeonsPerspectiveonBAVTreatment:WhySurgeryisPreferredinManyMostBAVPatients Lecturers:JosephE.Bavaria

8:08_AM ACTImagingPerspectiveonBAVTreatment:WhichPatientsarePoorCandidatesforTAVR Lecturers:JonathonA.Leipsic

8:16_AM AStructuralInterventionalistPerspectiveonBAVTreatment:TheNextTAVRFrontierAlmostAllPatientsareTAVRCandidates Lecturers:MathewWilliams

8:24_AM TheVoiceofReason:WhyaRandomizedTrialisNecessarytoDecideifSurgeryorTAVRarePreferredinBAVPatients Lecturers:EricE.Roselli

8:29_AM DeviceSelectionandCTSizingforTAVRTreatmentofBAV Lecturers:LarsSondergaard

8:37_AM TAVROutcomesforBAVinAsianPatients Lecturers:Jung-MinAhn

8:45_AM CaseBasedDiscussiononBAVRapidFirePresentationof3BAVCases CasePresenter:HasanJilaihawi

9:00AM-10:00AM

Session2:StrokesandCerebralEmbolicProtectionDuringTAVR

Moderators:AlexandraJ.Lansky,AxelLinke

Discussants:SaifAnwaruddin,AlainG.Cribier,SammyElmariah,NicoleIbrahim,Jean-ClaudeLaborde,JoachimSchofer,JochenWöhrle

9:00_AM AStrokeafterTAVRPrimer:TimeCourseChangingIncidenceAscertainmentChallengesandComparisonvs.Surgery Lecturers:SamirR.Kapadia

9:10_AM Discussion

9:15_AM UlmUniversityGermany

Lecturers:JochenWöhrle9:20_AM ErasmusUniversityTheNetherlands

Lecturers:HerbertKroon9:25_AM CedarsSinaiMedicalCenterUSA

Lecturers:TarunChakravarty9:30_AM Discussion

9:15_AM UlmUniversityGermany

Lecturers:JochenWöhrle9:20_AM ErasmusUniversityTheNetherlands

Lecturers:HerbertKroon

Page 39: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:39

9:25_AM CedarsSinaiMedicalCenterUSA

Lecturers:TarunChakravarty9:35_AM KeystoneTRIGUARDCerebralEmbolicProtectionDuringTAVR:NewGenerationDevicesandtheStatusofOngoingClinicalTrials

Lecturers:TamimNazif9:15_AM UlmUniversityGermany

Lecturers:JochenWöhrle9:20_AM ErasmusUniversityTheNetherlands

Lecturers:HerbertKroon9:25_AM CedarsSinaiMedicalCenterUSA

Lecturers:TarunChakravarty9:45_AM Discussion

10:00AM-11:00AM

Session3:ExpandingClinicalIndicationsforTAVR

Moderators:AllanSchwartz,StephanWindecker

Discussants:NiratBeohar,PhilippeGenereux,RajivJauhar,PhilippePibarot,JeffreyJ.Popma,MichaelJ.Reardon,EricVanBelle

10:00_AM TheCaseforTAVRinLowRiskPatients:RationaleCurrentDataClinicalTrendsandUpdatesfromtheOngoingClinicalTrials Lecturers:JeffreyJ.Popma

10:08_AM MyCrystalBallPredictingtheRoleofSurgeryandSurgeonsintheTreatmentofAorticStenosisOncetheCycleofLowRiskStudiesisCompleted Lecturers:MichaelJ.Reardon

10:16_AM Discussion

10:20_AM RationaleforTreatingSASSandUpdateoftheEARLYTAVRTrial

Lecturers:AllanSchwartz10:28_AM WhoShouldbeTreatedTheRoleofImagingGuidanceinPatientSelection

Lecturers:PhilippePibarot10:33_AM WhoShouldbeTreatedTheRoleofBiomarkersinPatientSelectionandProcedureOptimization

Lecturers:EricVanBelle10:38_AM PuttingItAllTogether:AProposedNewStagingClassificationforPatientswithAorticStenosis

Lecturers:PhilippeGenereux10:46_AM Discussion

10:20_AM RationaleforTreatingSASSandUpdateoftheEARLYTAVRTrial

Lecturers:AllanSchwartz10:28_AM WhoShouldbeTreatedTheRoleofImagingGuidanceinPatientSelection

Lecturers:PhilippePibarot10:33_AM WhoShouldbeTreatedTheRoleofBiomarkersinPatientSelectionandProcedureOptimization

Lecturers:EricVanBelle10:38_AM PuttingItAllTogether:AProposedNewStagingClassificationforPatientswithAorticStenosis

Lecturers:PhilippeGenereux10:50_AM StatusUpdateoftheTAVRUNLOADTrialModerateASPatientswithReducedEjectionFractionandHeartFailure

Lecturers:JoostDaemen10:20_AM RationaleforTreatingSASSandUpdateoftheEARLYTAVRTrial

Lecturers:AllanSchwartz10:28_AM WhoShouldbeTreatedTheRoleofImagingGuidanceinPatientSelection

Lecturers:PhilippePibarot10:33_AM WhoShouldbeTreatedTheRoleofBiomarkersinPatientSelectionandProcedureOptimization

Lecturers:EricVanBelle10:38_AM PuttingItAllTogether:AProposedNewStagingClassificationforPatientswithAorticStenosis

Lecturers:PhilippeGenereux10:58_AM Discussion

11:00AM-12:00PM

Session4:BioprostheticAorticValveFailure:Valve-in-ValveTreatment,ValveLeafletThrombosis,andValveDurability

Moderators:MichaelJ.Mack,BernardPrendergast

Page 40: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:40

Discussants:VinayakBapat,DavideCapodanno,AdnanK.Chhatriwalla,AdamB.Greenbaum,RanKornowski,JohnCLaschinger,LarsSondergaard,JohnG.Webb

11:00_AM ClinicalLessonsfromtheGlobalAorticVIVIDRegistryOptimizingProceduralOutcomes Lecturers:JohnG.Webb

11:08_AM HowtoScreenforRiskofCoronaryObstructionRiskonCTPriortoAorticValveinValveProcedures Lecturers:PhilippBlanke

11:14_AM ToCrackorNottoCrack:TheRoleofFracturingBioprostheticValvesDuringViVProcedures Lecturers:AdnanK.Chhatriwalla

11:20_AM ToSplitorNottoSplit:TheRoleofBASILICAtoReducetheRiskofCoronaryObstructionDuringViVandotherTAVRProcedures Lecturers:AdamB.Greenbaum

11:26_AM Discussion

11:30_AM TheSpectrumofLeafletThrombosisinBioprostheticAorticValvesPrevalenceClinicalConsequencesandPracticalManagementStrategies Lecturers:LarsSondergaard

11:38_AM NewGuidelinesandClassificationofBioprostheticValveDysfunctionandFailure:ImplicationsandThoughtsonTAVRDurability Lecturers:DavideCapodanno

11:46_AM ShouldWeAnticoagulateAllBioprostheticAorticValvesRationaleOngoingStudiesandRecentTrends Lecturers:GeorgeD.Dangas

11:54_AM Discussion

DIDACTICSESSION:DRUG-ELUTINGSTENTS,BIORESORBABLESCAFFOLDS,ANDCORONARYDRUG-COATEDBALLOONS,PART2

SATURDAY,SEPTEMBER22,2018

2:00PM-6:02PM

Room2,UpperLevel

2:00PM-3:23PM

SessionV.StentThrombosis,Restenosis,andDrug-CoatedBalloons

Moderators:FernandoAlfonso,AzeemLatib

Discussants:HiramG.Bezerra,JosephP.CarrozzaJr,KevinJ.Croce,LisetteOkkelsJensen,AshishPershad,JoseM.delaTorreHernandez

2:00_PM IsThereaStandardWorkUpforStentThrombosisHematologyImagingandMore Lecturers:RobertA.Byrne

2:10_PM CaseStudy:MechanismandTreatmentofStentThrombosis CasePresenter:HectorM.Garcia-Garcia

2:17_PM RoundtableDiscussionWithAudienceQA

2:22_PM OptionsforStentUnderExpansionWithISR:LaserStentablationandMore Lecturers:AntonioColombo

2:30_PM POBADrugCoatedBalloonsDESandBRSforDESISR:AdvantagesDisadvantagesTheoryandEvidence Lecturers:FernandoAlfonso

2:40_PM AreDrugCoatedBalloonsAcceptableorPreferredforStentEligibleSmallCoronaryArteriesInsightsFromBASKETSMALL2andOtherExperiences Lecturers:BrunoScheller

2:50_PM NextGenerationDrugCoatedBalloons:LimusandBeyond Lecturers:JuanF.Granada

2:58_PM RoleofBrachytherapyforRefractoryISRin2018 Lecturers:RonWaksman

3:06_PM CaseStudy:MechanismandTreatmentofRefractoryISR CasePresenter:TayoA.Addo

3:13_PM RoundtableDiscussionWithAudienceQA

3:23PM-4:34PM

SessionVI.Long-TermABSORBDataandPerspectives

Moderators:BernardR.Chevalier,StephenG.Ellis

Discussants:SalvatoreBrugaletta,DanielChamie,StephenP.Hoole,GiulioStefanini,CorradoTamburino,Robert-JanvanGeuns

3:23_PM ABSORBBeyond3Years:ABSORBII5YearData Lecturers:PatrickW.Serruys

3:30_PM ABSORBBeyond3Years:ABSORBJapan4YearData Lecturers:KengoTanabe

3:37_PM ABSORBBeyond3Years:ABSORBChina4YearData Lecturers:RunlinGao

Page 41: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:41

3:44_PM ABSORBBeyond3Years:ABSORBIII4YearData Lecturers:DeanJ.Kereiakes

3:51_PM ABSORB4YearMetaAnalysis:IndividualPatientDataAnalysis Lecturers:GreggW.Stone

3:58_PM HowtoImproveBRSOutcomes:FocusontheDevice Lecturers:YoshinobuOnuma

4:06_PM HowtoImproveBRSOutcomes:FocusonImagingandTechnique Lecturers:ZiadA.Ali

4:14_PM FalconDevelopmentandStatus Lecturers:RichardJ.Rapoza

4:19_PM RoundtableDiscussionWithAudienceQA

4:34PM-6:02PM

SessionVII:ActiveBRSPrograms

Moderators:AlexandreAbizaid,RonWaksman

Discussants:BillD.Gogas,YasuhiroHonda,MatthiasLutz,ManelSabate,HuayCheemTan,BoXu

4:34_PM ProgressWithProgressivelyThinStrutUltraHighMolecularWeightPLLABasedPolymericBRS:FromAptitudetoMagnitude Lecturers:JuanF.Granada

4:44_PM OngoingActivitiesWithaRadiopaqueTyrosineCarbonateBasedPolymericBRS:Fantom Lecturers:UlfLandmesser

4:54_PM UpdateWithANovelThinStrutHybridCellDesignPLLABasedPolymericBRS:MeRes100 Lecturers:AshokSeth

5:04_PM LatestResultsandFutureDirectionsWiththeDESolveNXTPLLABasedBRSWithContouredStruts Lecturers:AlexandreAbizaid

5:14_PM EmergingPolymericandMetallicBRSfromChina Lecturers:YalingHan

5:24_PM ImagingandClinicalResultsWiththeLatestMagmarisMagnesiumBasedScaffold Lecturers:MichaelHaude

5:34_PM FlashDebate:PolymericBRSHavetheEdge Lecturers:PieterC.Smits

5:39_PM FlashDebate:MetallicBRSHavetheEdge Lecturers:RonWaksman

5:44_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:INTERVENTIONALHEARTFAILUREANDHEMODYNAMICSUPPORT,PART2

SATURDAY,SEPTEMBER22,2018

2:00PM-6:02PM

Room6D,UpperLevel

2:00PM-3:28PM

SessionI.ImplantedandNon-invasiveSensorsforMonitoring

Moderators:StefanAnker,IleanaL.Pina

Discussants:AngelesAlonsoGarcia,JozefBartunek,MarkGoldberger,AmitN.Patel,PascalVranckx

2:00_PM StateoftheArt:CongestionandPrognosisinHF Lecturers:PeterCarson

2:14_PM StateoftheArt:InvasiveandNoninvasiveTechnologiesforMonitoringCongestion Lecturers:WilliamT.Abraham

2:31_PM Cardiomems:UpdateandOngoingStudies Lecturers:JoAnnLindenfeld

2:45_PM Endotronix:DifferentiatingFeaturesandResults Lecturers:KatrinLeadley

2:59_PM NoninvasiveMonitoringWithSensibleMedicalforPreventingHeartFailureRehospitalizations Lecturers:DanielR.Bensimhon

3:13_PM RoundtableDiscussionWithAudienceQA

3:28PM-4:47PM

SessionII.DevicestoProtecttheKidneyandReduceCongestion

Page 42: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:42

Moderators:WilliamT.Abraham,JoAnnLindenfeld

Discussants:JeroenJ.Bax,PeterCarson,DarshanDoshi,HansR.Figulla,ChaimS.Lotan,PaulA.Sobotka

3:28_PM CongestionAProblemofCapacitanceShiftNotTotalSaltandWaterExcess Lecturers:PaulA.Sobotka

3:36_PM IntraaorticContinuousFlowPumpsforADHF Lecturers:NavinK.Kapur

3:50_PM RenalVeinPressureDecompressionforADHF:Magenta Lecturers:DavidDIsraeli

4:04_PM DirectLymphaticDecompressionforADHF:Whiteswell Lecturers:WilliamT.Abraham

4:18_PM VentricularandPulmonaryDecompressionbyIntravenousBalloonOcclusion:PreCardia Lecturers:NavinK.Kapur

4:32_PM RoundtableDiscussionWithAudienceQA

4:47PM-6:02PM

SessionIII.BridgingandChronicMechanicalCirculatorySupport

Moderators:NirUriel,HadleyWilson

Discussants:MarisaCevasco,VictoriaDelgado,RobertE.Michler,SundeepMishra,MarvinJ.Slepian,OsamaSoliman

4:47_PM StateoftheArt:LatestInnovationsinDurableLVADs Lecturers:UlrichP.Jorde

5:02_PM TheImpellaFamilyofDevices:UtilityofDifferentToolsforDifferentConditionsShorttermandLongtermUse Lecturers:JeffreyW.Moses

5:17_PM PercutaneousVentricularandPulmonarySupport:TandemLife Lecturers:BiswajitKar

5:27_PM NuPulse:ImplantableCounterpulsationforAdvancedCHF Lecturers:ValluvanJeevanandam

5:37_PM VentricularCounterpulsationforPercutaneousVentricularSupport:PulseCath Lecturers:JoostDaemen

5:47_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:PFOCLOSURE-EMERGINGEVIDENCE,INDICATIONS,ANDDEVICES

SATURDAY,SEPTEMBER22,2018

2:00PM-6:20PM

Room1,UpperLevel

2:00PM-2:58PM

SessionI.EvidenceforPFOClosureandGlobalPractices

Moderators:TeijiAkagi,JohnD.Carroll

Discussants:LeeN.Benson,StefanC.Bertog,CliffordJ.Kavinsky,FrancescoPelliccia,A.J.ConradC.Smith

2:00_PM Case1:ShouldThisPFOBeClosedinaPatientWithACryptogenicStroke CasePresenter:DominikM.Wiktor

2:08_PM UpdatedRCTDataforPFOClosureinAllComersandSubgroupsWithCryptogenicStroke:HowShouldtheGuidelinesBeUpdated Lecturers:KonstantinosDeanBoudoulas

2:20_PM EvolvingPFOClosurePracticeandChallengesinCanada Lecturers:EricHorlick

2:27_PM EvolvingPFOClosurePracticeandChallengesinAsia Lecturers:TeijiAkagi

2:34_PM EvolvingPFOClosurePracticeandChallengesinEurope Lecturers:LarsSondergaard

2:41_PM EvolvingPFOClosurePracticeandChallengesintheU.S. Lecturers:RichardSmalling

2:48_PM RoundtableDiscussionWithAudienceQA

2:58PM-4:02PM

SessionII.PatientSelectionforPFOClosure:Evidence-BasedandJudgment-Based

Moderators:MichaelJ.Mullen,DavidE.Thaler

Page 43: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:43

Discussants:JosephP.CarrozzaJr,TedFeldman,CraigEFleishman,DavidHildick-Smith,JacquelineSaw,JochenWöhrle

2:58_PM Case2:ShouldThisPFOBeClosedinaPatientWithaTIA CasePresenter:TedFeldman

3:06_PM OverviewofIndicationsandPatientSelectionforPFOClosure

3:16_PM PFOClosureinOlderPatients:ClinicalandTechnicalChallenges Lecturers:RobertJ.Sommer

3:28_PM PFOClosureforPrimaryPrevention Lecturers:BrianK.Whisenant

3:36_PM PFOClosureforMigraine:CurrentStatus Lecturers:RobertJ.Sommer

3:44_PM PFOClosureforHypoxemia Lecturers:JosephKay

3:52_PM RoundtableDiscussionWithAudienceQA

4:02PM-5:20PM

SessionIII.PFOClosureDevicesandTechniques

Moderators:WilliamA.Gray,HorstSievert

Discussants:StevenR.Bailey,NiratBeohar,BrianClapp,EricEeckhout,HenriJustino,LarsSondergaard

4:02_PM Case3:AComplexPFOClosureWithTechniqueChallenges CasePresenter:SameerGafoor

4:10_PM AssessmentofShunts:TCDvsEcho Lecturers:EustaquioMariaOnorato

4:18_PM ApproachtoChallengingPFOAnatomy Lecturers:ZahidAmin

4:26_PM TheLandscapeofDevicesforPFOClosure Lecturers:HorstSievert

4:36_PM PFOClosureWiththeCardioForm:DeviceDescriptionIdealandNonIdealAnatomyTechniqueandComplications

4:46_PM PFOClosureWiththeAmplatzerPFOOccluder:DeviceDescriptionIdealandNonIdealAnatomyTechniqueandComplications Lecturers:EricHorlick

4:56_PM ComplicationsofPFOClosure Lecturers:JacquelineSaw

5:04_PM RoundtableDiscussionWithAudienceQA

5:20PM-6:20PM

SessionIV.ProgramBuildingandHurdles

Moderators:RobertJ.Sommer,ChristianSpies

Discussants:SuzanneJ.Baron,RedaIbrahim,CareyD.Kimmelstiel,SrihariS.Naidu,ZoltanG.Turi,DominikM.Wiktor

5:20_PM Case4:ShouldThisPFObeClosedinaPatientWithaMigraine CasePresenter:DavidE.Thaler

5:28_PM NeurologyCardiologyPartnership CasePresenter:MohamadAdnanAlkhouli

5:36_PM PostProcedureCareIssues Lecturers:ChristianSpies

5:44_PM SCAIOperatorandInstitutionRequirements Lecturers:CliffordJ.Kavinsky

5:52_PM ToPFOCloseorNottoPFOClose:SharedDecisionMaking Lecturers:MeganCoylewright

6:00_PM CodingReimbursementforPFOClosure Lecturers:TedFeldman

6:08_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:PULMONARYHYPERTENSIONANDACUTECHRONICPULMONARYEMBOLITHERAPIES

SATURDAY,SEPTEMBER22,2018

2:00PM-6:00PM

Room25A-B,UpperLevel

Page 44: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:44

2:00PM-3:30PM

SessionI.GroupI-PulmonaryArterialHypertension

Moderators:OriBen-Yehuda,JayS.Giri

Discussants:TeresaL.Carman,Shao-LiangChen,Chung-HoHsu,IreneM.Lang,AlexM.K.Rothman,HarsimranSachdevaSingh

2:00_PM OverviewofGroupIPulmonaryHypertension Lecturers:OriBen-Yehuda

2:12_PM PulmonaryArteryDenervationI:ConceptsandPreClinicalData Lecturers:AlexM.K.Rothman

2:24_PM PulmonaryArteryDenervationII:RFAblationDeviceandLatestResults Lecturers:Shao-LiangChen

2:36_PM PulmonaryArteryDenervationIII:UltrasoundBasedTherapyandResults Lecturers:OriBen-Yehuda

2:48_PM RoundtableDiscussionWithAudienceQA

3:00_PM ImplantableDevicesforPulmonaryHypertension Lecturers:WilliamT.Abraham

3:12_PM Aria:ADeviceBasedApproachtoRVFailureandPulmonaryCompliance Lecturers:IreneM.Lang

3:24_PM RoundtableDiscussionWithAudienceQA

3:30PM-4:30PM

SessionII.AcutePulmonaryEmbolism

Moderators:KennethRosenfield,VictorF.Tapson

Discussants:RiyazBashir,MarkC.Bates,JayS.Giri,RahulS.Patel,GregoryPiazza,ThomasM.Tu

3:30_PM IncidenceandDiagnosis Lecturers:VictorF.Tapson

3:42_PM SystemicTherapyforAcutePE Lecturers:JayS.Giri

3:54_PM CatheterDirectedTherapyforAcutePE Lecturers:GregoryPiazza

4:06_PM PERT:TheTimeisNow Lecturers:KennethRosenfield

4:18_PM RoundtableDiscussionWithAudienceQA

4:30PM-6:00PM

SessionIII.GroupIVPulmonaryHypertension:CTEPH

Moderators:IreneM.Lang,EhtishamMahmud

Discussants:VikasAggarwal,WilliamR.Auger,MichaelM.Madani,HiromiMatsubara,FrancescoSaia,MehdiH.Shishehbor

4:30_PM IncidencePathophysiologyandDiagnosisofCTEPH Lecturers:WilliamR.Auger

4:40_PM PulmonaryThromboendartectomyistheDefinitiveTherapyforCTEPH Lecturers:MichaelM.Madani

4:50_PM BalloonPulmonaryAngioplastyforCTEPH:EvolutionofaNewTherapyforCTEPH Lecturers:EhtishamMahmud

5:00_PM BalloonPulmonaryAngioplastyforCTEPH:PatientSelectionforTherapy Lecturers:VikasAggarwal

5:10_PM BalloonPulmonaryAngioplastyforCTEPH:TheJapaneseExperience Lecturers:HiromiMatsubara

5:20_PM BalloonPulmonaryAngioplastyforCTEPH:TheEuropeanExperience Lecturers:IreneM.Lang

5:30_PM BalloonPulmonaryAngioplastyforCTEPH:TheSanDiegoExperience Lecturers:EhtishamMahmud

5:40_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:TRANSCATHETERAORTICVALVEINTERVENTIONS,PART2

SATURDAY,SEPTEMBER22,2018

2:00PM-6:00PM

Page 45: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:45

Room5,UpperLevel

2:00PM-3:00PM

Session5:PolicyControversiesonAorticValveReplacementTherapy�PatientAccess,VolumeThresholds,andParity

Moderators:RobertO.Bonow,MartinB.Leon

Discussants:JosephE.Bavaria,AaronHorne,Jr.,MichaelJ.Mack,PatrickT.O'Gara,MarkJ.Russo,SusanStrong,VinodH.Thourani,CarlL.Tommaso,LarryL.Wood

3:00PM-4:00PM

Session6:TAVRNewTechnologyForum

Moderators:JeffreyJ.Popma,HendrikTreede

Discussants:AlexandreAbizaid,GregoryP.Fontana,HowardC.Herrmann,SusheelK.Kodali,MichaelJ.Reardon,VinodH.Thourani,MathewWilliams

4:00PM-5:00PM

Session7.TAVRWorldCupatTCT-ClinicalCaseChallenges

Moderators:TamimNazif,TorstenP.Vahl

Discussants:SaifAnwaruddin,AnitaAsgar,VasilisBabaliaros,MarcoBarbanti,ColinM.Barker,JohnK.Forrest,KendraJ.Grubb,DavidA.Wood

5:00PM-6:00PM

Session8.TAVRWorldSeries�TheBestoftheRest!Moderators:SusheelK.Kodali,VinodH.Thourani

Discussants:DavidJ.Cohen,Jean-MichelParadis,RamonQuesada,RichardSmalling,GilbertH.L.Tang,HendrikTreede,AlanZajarias

5:00_PM MinimalistTAVRforEVERYONE:SafeEfficientandCostEffective

Lecturers:VasilisBabaliaros5:05_PM SelectiveMinimalistTAVRMakesMoreSenseandExtremeMinimalismisDangerous

Lecturers:SusheelK.Kodali5:10_PM Discussion

5:15_PM AGrowingConundrum:CoronaryAccessafterTAVRTechnicalTipsandTricks Lecturers:JamesB.HermillerJr

5:00_PM MinimalistTAVRforEVERYONE:SafeEfficientandCostEffective Lecturers:VasilisBabaliaros

5:05_PM SelectiveMinimalistTAVRMakesMoreSenseandExtremeMinimalismisDangerous Lecturers:SusheelK.Kodali

5:10_PM Discussion5:21_PM RationaleforCombiningTAVRandLAACinAFPatients:AnIntroductiontotheWATCHTAVRTrial

Lecturers:SamirR.Kapadia5:00_PM MinimalistTAVRforEVERYONE:SafeEfficientandCostEffective

Lecturers:VasilisBabaliaros5:05_PM SelectiveMinimalistTAVRMakesMoreSenseandExtremeMinimalismisDangerous

Lecturers:SusheelK.Kodali5:10_PM Discussion5:27_PM TheRapidEmergenceofTransCavalTAVR:TechniquesandClinicalOutcomes

Lecturers:AdamB.Greenbaum5:32_PM PercutaneousTransaxillaryTAVR:AStepbyStepTutorial

Lecturers:AmirKaki5:37_PM InnovationGoneWild:ThePiCardiaLeaflexAorticValveRemodelingSystem

Lecturers:PhilippeGenereux5:00_PM MinimalistTAVRforEVERYONE:SafeEfficientandCostEffective

Lecturers:VasilisBabaliaros5:05_PM SelectiveMinimalistTAVRMakesMoreSenseandExtremeMinimalismisDangerous

Lecturers:SusheelK.Kodali5:10_PM Discussion5:27_PM TheRapidEmergenceofTransCavalTAVR:TechniquesandClinicalOutcomes

Lecturers:AdamB.Greenbaum5:32_PM PercutaneousTransaxillaryTAVR:AStepbyStepTutorial

Lecturers:AmirKaki5:43_PM TAVRtoTreatPureAorticRegurgitation:TheTVTRegistryExperience

Lecturers:SaifAnwaruddin5:00_PM MinimalistTAVRforEVERYONE:SafeEfficientandCostEffective

Page 46: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:46

Lecturers:VasilisBabaliaros5:05_PM SelectiveMinimalistTAVRMakesMoreSenseandExtremeMinimalismisDangerous

Lecturers:SusheelK.Kodali5:10_PM Discussion5:27_PM TheRapidEmergenceofTransCavalTAVR:TechniquesandClinicalOutcomes

Lecturers:AdamB.Greenbaum5:32_PM PercutaneousTransaxillaryTAVR:AStepbyStepTutorial

Lecturers:AmirKaki5:49_PM AClinicalAlgorithmforDiagnosingandManagingPatientswithLowFlowLowGradientAorticStenosis

Lecturers:PhilippePibarot5:00_PM MinimalistTAVRforEVERYONE:SafeEfficientandCostEffective

Lecturers:VasilisBabaliaros5:05_PM SelectiveMinimalistTAVRMakesMoreSenseandExtremeMinimalismisDangerous

Lecturers:SusheelK.Kodali5:10_PM Discussion5:27_PM TheRapidEmergenceofTransCavalTAVR:TechniquesandClinicalOutcomes

Lecturers:AdamB.Greenbaum5:32_PM PercutaneousTransaxillaryTAVR:AStepbyStepTutorial

Lecturers:AmirKaki5:55_PM Discussion

TCTENDOVASCULAR:FELLOWSCOURSE

SATURDAY,SEPTEMBER22,2018

8:00AM-11:00AM

Room33B-C,UpperLevel

8:00AM-8:50AM

SessionI.VascularDiseasePast,Present,andFuture

Moderators:JayS.Giri,SahilA.Parikh

Discussants:GaryM.Ansel,DouglasE.Drachman,AndrewJ.Klein,CraigM.Walker,MitchellWeinberg

8:00_AM TraininginEndovascularIntervention Lecturers:SahilA.Parikh

8:10_AM RoundtableDiscussionWithAudienceQA

8:15_AM HighlightsFromtheUpdatedPADGuidelinesandSCAIAUC Lecturers:DouglasE.Drachman

8:25_AM RoundtableDiscussionWithAudienceQA

8:30_AM MostImportantClinicalTrialsinVascularMedicineandInterventioninthePast10Years Lecturers:JayS.Giri

8:45_AM RoundtableDiscussionWithAudienceQA

8:50AM-10:00AM

SessionII.CoreCurriculum:SoYouThinkYouCanBeaVascularSpecialist?

Moderators:DouglasE.Drachman,MichaelR.Jaff

Discussants:AnvarBabaev,SubhashBanerjee,RaghuKolluri,KennethRosenfield,MehdiH.Shishehbor

8:50_AM ClinicalPearls:CarotidDiseaseDiagnosisandTreatment Lecturers:HerbertD.Aronow

9:00_AM ClinicalPearls:LowerExtremityPADDiagnosisandTreatment Lecturers:DouglasE.Drachman

9:10_AM ClinicalPearls:CLIDiagnosisandTreatment Lecturers:MehdiH.Shishehbor

9:20_AM ClinicalPearls:VTEPEDiagnosisandTreatment Lecturers:KennethRosenfield

9:30_AM ClinicalPearls:AAADiagnosisandTreatment Lecturers:EhrinJ.Armstrong

9:40_AM ClinicalPearlsinSuperficialVenousDisease Lecturers:RaghuKolluri

Page 47: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:47

9:50_AM RoundtableDiscussionWithAudienceQA

10:00AM-11:00AM

SessionIII.CaseReviews:SoYouThinkYouCanBeaVascularSpecialist?

Moderators:EhrinJ.Armstrong,DouglasE.Drachman,MehdiH.Shishehbor

Discussants:HerbertD.Aronow,J.MichaelBacharach,DanielleBajakian,AndrewJ.Klein,KhusrowNiazi

10:00_AM Case1Introduction:IliacDisease CasePresenter:MehdiH.Shishehbor

10:05_AM DiscussionofStrategies

10:15_AM Case1Conclusion:IliacDisease CasePresenter:MehdiH.Shishehbor

10:20_AM Case2Introduction:SFADisease CasePresenter:DouglasE.Drachman

10:25_AM Case2:DiscussionofStrategies

10:35_AM Case2Conclusion:SFADisease CasePresenter:DouglasE.Drachman

10:40_AM Case3:CLI CasePresenter:EhrinJ.Armstrong

10:45_AM Case2:DiscussionofStrategies

10:55_AM Case3Conclusion:CLI CasePresenter:EhrinJ.Armstrong

TCTENDOVASCULAR:EXPERTCASEREVIEWS-CAROTIDANDVERTEBRALINTERVENTIONS

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room32A-B,UpperLevel

12:15PM-1:45PM

ExpertCaseReviews:CarotidandVertebralInterventions

Moderators:AmanB.Patel

Discussants:GavinBritz,MatthewKoch,VirendraIPatel,AdnanSiddiqui,ScottSilverman,JoseM.Wiley

12:15_PM Case1:CarotidArteryInterventionforAsymptomaticCarotidArteryStenosis:WhyAndHow CasePresenter:ScottSilverman

12:25_PM Case2:CarotidArteryInterventionAfterStroke:TimingandOtherConsiderations CasePresenter:ScottSilverman

12:35_PM Case3:EndovascularInterventionforFibromuscularDysplasia CasePresenter:GaryM.Ansel

12:45_PM Case4:CarotidArteryStentingforCarotidArteryDissection:WhyWhenandHow CasePresenter:AdnanSiddiqui

12:55_PM Case5:CarotidArteryStentingWithComplexArchNavigation CasePresenter:GavinBritz

1:05_PM Case6:TransCervicalCarotidArteryStenting:SilkRoad CasePresenter:CharlesMatouk

1:15_PM Case7:StentingofVertebralArteryOrigin:IndicationsTechniquesComplications CasePresenter:RahulSakhuja

1:25_PM Case8:WingspanStentingforIntracranialAtherosclerosis CasePresenter:MatthewKoch

1:35_PM RoundtableDiscussionwithAudienceQA

TCTENDOVASCULAR:EXPERTCASEREVIEWS-SFA,POPLITEAL,ANDBELOWTHEKNEEINTERVENTION

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room30D-E,UpperLevel

Page 48: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:48

12:15PM-1:45PM

ExpertCaseReviews:SFA,Popliteal,andBelowtheKneeIntervention

Moderators:HerbertD.Aronow,BrianG.DeRubertis

Discussants:PhilipGreen,OsamuIida,AndrewJ.Klein,ArthurC.Lee,MatthewT.Menard,KennethRosenfield

12:15_PM Case1:UseofReentryDevicetoPunctureaRetrogradeBallooninaDifficultSFAOcclusion CasePresenter:TonyDas

12:25_PM Case2:CrackandPaveTechniqueforaHighlyCalcifiedSFA CasePresenter:EthanCKorngold

12:35_PM Case3:RetrogradeSFAAccessforaComplexProximalSFAOcclusion CasePresenter:EhrinJ.Armstrong

12:45_PM Case4:IntravascularLithoplastyforaHighlyCalcifiedSFA CasePresenter:PhilipGreen

12:55_PM Case5:PedalLoopReconstructionforCriticalLimbIschemia CasePresenter:LuisMarianoPalena

1:05_PM Case6:TransmetatarsalAccess CasePresenter:ArthurC.Lee

1:15_PM Case7:CombinedAntegradeRetrogradeCrossingofaComplexTibialCTO CasePresenter:BrianG.DeRubertis

1:25_PM Case8:IntravascularTackDeploymenttoTreatInfrapoplitealPostAngioplastyDissection CasePresenter:NicolasWShammas

1:35_PM RoundtableDiscussionWithAudienceQA

TCTENDOVASCULAR:CRITICALLIMBISCHEMIADEEPDIVE

SATURDAY,SEPTEMBER22,2018

2:00PM-4:10PM

Room30D-E,UpperLevel

2:00PM-4:10PM

CriticalLimbIschemiaDeepDive

Moderators:EhrinJ.Armstrong,SahilA.Parikh

Discussants:MasahikoFujihara,MatthewT.Menard,LuisMarianoPalena,NicolasWShammas,RamonLVarcoe

2:00_PM MultidisciplinaryCareinCLI:HowDoWeAccomplishIt Lecturers:MichaelR.Jaff

2:10_PM HowtheBestCLITrialWillChangeClinicalPractice Lecturers:MatthewT.Menard

2:18_PM DisparitiesinCriticalLimbIschemiaTreatment:CanWeMinimizeVariation Lecturers:SchuylerJones

2:26_PM RoundtableDiscussionMultidisciplinaryCareofCLI

2:31_PM HowtoOptimizeSuccessinCrossingTibialOcclusions Lecturers:LarryJ.Diaz-Sandoval

2:39_PM RoleofAtherectomyinTreatingTibialVessels:CaseExamplesandData Lecturers:NicolasWShammas

2:45_PM IntravascularImagingtoOptimizeTibialInterventions Lecturers:SteveHenao

2:51_PM Debate:PedalLoopAngioplastyisCrucialtoOptimizeWoundHealing Lecturers:PeterA.Soukas

2:56_PM Debate:PedalLoopAngioplastyDoesNotImproveOutcomesinCLI Lecturers:GeorgeLAdams

3:01_PM RoundtableDiscussionOptimizingOutcomesofTibialInterventions

3:06_PM AdventitialDrugTherapyforTreatmentofCriticalLimbIschemia Lecturers:EhrinJ.Armstrong

3:14_PM CellBasedandBiologicTherapiesforCriticalLimbIschemia Lecturers:MehdiH.Shishehbor

3:22_PM OptimalMedicalTherapyofPatientsWithCriticalLimbIschemia Lecturers:DouglasE.Drachman

3:30_PM Debate:DrugCoatedBalloonsWillEventuallyShowBenefitforInfrapoplitealArteriesPro Lecturers:BryanT.Fisher

Page 49: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:49

3:35_PM Debate:DrugCoatedBalloonsWillEventuallyShowBenefitforInfrapoplitealArteriesCon Lecturers:CarlosI.Mena-Hurtado

3:40_PM DrugElutingStentsForTibialDisease:DataandCaseExamples Lecturers:RobertA.Lookstein

3:47_PM IntravascularLithotripsyforTreatmentofCalcifiedTibialVessels Lecturers:RamonLVarcoe

3:55_PM RoundtableDiscussionWithAudienceQA

REGIONALSNAPSHOTMEETING:THEBESTOFINTERVENTIONFROMASIA-PACIFIC

SATURDAY,SEPTEMBER22,2018

2:00PM-4:00PM

Room31B-C,UpperLevel

2:00PM-3:00PM

SessionI.MyWorstNightmareComplications

Moderators:VinayK.Bahl,HuayCheemTan

Discussants:Jun-JackCheng,KennethChin,JeehoonKang,SreenivasArramrajuKumar,LindaLison,FazilaT.Malik

2:00_PM Case1:FromIndonesia:CatheterInducedDissectionWithAcuteVesselClosureAorticDissectionandPerforation CasePresenter:SodiqurRifqi

2:07_PM RoundtableDiscussionWithAudienceQA

2:12_PM Case2:FromTaiwan:LighteningWillStrikeAgain2WireBreakagesHappeningin1Procedure CasePresenter:Chih-FanYeh

2:19_PM RoundtableDiscussionWithAudienceQA

2:24_PM Case3:FromIndia:RotationalAtherectomyWithLeftMainPerforation CasePresenter:O.SaiSatish

2:31_PM RoundtableDiscussionWithAudienceQA

2:36_PM Case4:FromSingapore:FindingaMissingBioresorbableScaffold CasePresenter:JoshuaP.Loh

2:43_PM RoundtableDiscussionWithAudienceQA

2:48_PM Case5:FromSouthKorea:TearofaCalcifiedCoronaryArtery CasePresenter:Do-YoonKang

2:55_PM RoundtableDiscussionWithAudienceQA

3:00PM-4:00PM

SessionII.CHIPsfromAsia

Moderators:TeguhSantoso,Wei-HsianYin

Discussants:MohammedBadiuzzaman,KennethChin,SamuelKMathew,Seung-JungPark,HuayCheemTan,ChiungJenWu

3:00_PM Case6:FromMalaysia:RecurrentISRattheDistalAnastomoticSiteofa10YearOldSaphenousVeinGraft CasePresenter:KennethChin

3:07_PM RoundtableDiscussionWithAudienceQA

3:12_PM Case7:FromBangladesh:PostCABGHeavilyCalcifiedLeftMainDoubleStentStrategy CasePresenter:AshokDutta

3:19_PM RoundtableDiscussionWithAudienceQA

3:24_PM Case8:FromIndia:TransRadialRotationalAtherectomyofaCriticalLeftMainStenosis CasePresenter:AnandMRao

3:31_PM RoundtableDiscussionWithAudienceQA

3:36_PM Case9:FromTaiwan:HeavilyCalcifiedLMBifurcationandNearOstialOcclusionofaHighlyAngulatedDominantLCX CasePresenter:Wen-LiengLee

3:43_PM RoundtableDiscussionWithAudienceQA

3:48_PM Case10:FromIndonesia:HalfWayRotationalAtherectomyinaHeavilyAngulatedandHeavilyCalcifiedLesionANewTechnique CasePresenter:TeguhSantoso

3:55_PM RoundtableDiscussionWithAudienceQA

Page 50: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:50

HOTTOPICLUNCH:ECHOGUIDANCEOFINTERVENTIONALPROCEDURES(SPONSOREDBYTHEAMERICANSOCIETYOFECHOCARDIOGRAPHY)

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room33B-C,UpperLevel

12:15PM-1:45PM

EchoGuidanceofInterventionalProcedures

Moderators:RebeccaT.Hahn,StephenH.Little

Discussants:PaulA.Grayburn,ChadKliger,SunilV.Mankad,MuhamedSaric

12:15_PM ImagingPearlsfortheInterventionalCardiologist Lecturers:SunilV.Mankad

12:25_PM WhoistheInterventionalImagerAndHowDoWePayForThem Lecturers:PaulA.Grayburn

12:35_PM RoundtableDiscussionWithAudienceQA

12:40_PM ImagingGuidanceI:PercutaneousASDVSDRepair

12:50_PM ImagingGuidanceII:MitraClipMovingBeyondA2P2 Lecturers:StephenH.Little

1:00_PM ImagingGuidanceIII:TricuspidValveInterventionsImagersBreakingNewGround Lecturers:RebeccaT.Hahn

1:10_PM RoundtableDiscussionwithAudienceQA

1:15_PM DEBATE:TheMinimalistApproachtoImagingisSafeAndHerestheData Lecturers:MuhamedSaric

1:25_PM DEBATE:OptimizingOutcomesMeansTEEImagingAndHeresTheData

1:35_PM RoundtableDiscussionwithAudienceQA

HOTTOPICLUNCH:THEDIABETICPATIENTREVASCULARIZATIONANDMEDICALTHERAPIES

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room23B-C,UpperLevel

12:15PM-1:45PM

TheDiabeticPatient:RevascularizationandMedicalTherapies

Moderators:DavidJ.Maron,StevenP.Marso

Discussants:JayaChandrasekhar,MichaelE.Farkouh,VasimFarooq,FazilaT.Malik,MiodragC.Ostojic,RobertL.Wilensky,ClemensvonBirgelen

12:15_PM Introduction:FramingtheIssues Lecturers:StevenP.Marso

12:20_PM TheDiabetesHeartTeam:RoleforIncorporatingtheEndocrinologist

12:28_PM ComprehensiveCVRiskReductionStrategyinDiabetics Lecturers:KurtHuber

12:36_PM MedicalTherapyforWhomandWhen:WhatistheCeilingofMedicalTherapy Lecturers:NormanE.Lepor

12:44_PM NewerDiabetesAgents:WhatAllInterventionalCardiologistsNeedtoKnow Lecturers:StevenP.Marso

12:52_PM RoundtableDiscussionWithAudienceQA

1:00_PM CABGRemainstheDefaultTherapyForAllDiabeticsWithMultivesselandLeftMainDisease

1:08_PM WhenisPCIaValidAlternativeToOnlyMedicalTherapyorCABGintheDiabeticPatient Lecturers:SripalBangalore

1:16_PM CompleteRevascularizationistheMissingLinktoImproveDiabeticPCIOutcomes Lecturers:J.AaronGrantham

1:24_PM CHIPinTheDiabeticPatient:SpecialConsiderations Lecturers:CindyL.Grines

1:32_PM RoundtableDiscussionWithAudienceQA

Page 51: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:51

1:40_PM SummaryCommentsandTakeHomeMessages Lecturers:DavidJ.Maron

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-BALLOONANGIOPLASTYFORCHRONICTHROMBOEMBOLICPULMONARYHYPERTENSION

(CTEPH)

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room24A-B,UpperLevel

12:15PM-1:45PM

BalloonAngioplastyforChronicThromboembolicPulmonaryHypertension(CTEPH)

Moderators:IreneM.Lang,EhtishamMahmud

Discussants:WilliamR.Auger,RiyazBashir,NickH.Kim,HiromiMatsubara,JohnMoriarty,FrancescoSaia

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:IreneM.Lang

12:20_PM Case1:ACaseofBalloonPulmonaryAngioplastyforCTEPHEmphasizingOptimalClinicalandAnatomicPatientSelection Lecturers:WilliamR.Auger

12:30_PM Case2:ACaseofBalloonPulmonaryAngioplastyforCTEPH:FocusonTechniqueandMetricsforSuccess CasePresenter:FrancescoSaia

12:40_PM Case3:ACaseofBalloonPulmonaryAngioplastyforCTEPH:FocusonVesselSelectionandNumberofProcedures CasePresenter:IreneM.Lang

12:50_PM Case4:ACaseofBalloonPulmonaryAngioplastyforCTEPHDemonstratingtheUtilityofIntravascularImaging CasePresenter:HiromiMatsubara

1:00_PM Case5:ACaseofBalloonPulmonaryAngioplastyforCTEPH:AdvancedTechniquesIncludingFunctionalAssessment CasePresenter:EhtishamMahmud

1:10_PM Case6:ACaseDemonstratingthePotentialLongTermBenefitsofBalloonPulmonaryAngioplastyforCTEPH CasePresenter:RiyazBashir

1:20_PM Case7:ACaseofBalloonPulmonaryAngioplastyforCTEPHComplicatedbyReperfusionPulmonaryEdema CasePresenter:NickH.Kim

1:30_PM Case8:ACaseofBalloonPulmonaryAngioplastyforCTEPHComplicatedbyPerforation CasePresenter:SanjumSSethi

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:EhtishamMahmud

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-COMPLEXADULTCONGENITALINTERVENTION

SATURDAY,SEPTEMBER22,2018

12:15PM-1:53PM

Room28D-E,UpperLevel

12:15PM-1:53PM

ComplexAdultCongenitalIntervention

Moderators:LeeN.Benson,EricHorlick

Discussants:ZahidAmin,MakramR.Ebeid,IoannisIakovou,MichaelJ.Lim,MarkOsten,HarsimranSachdevaSingh,NathanWTaggart

12:15_PM Introduction:WhatdoWeHopetoLearnFromtheseCases Lecturers:LeeN.Benson

12:18_PM Case1:TheDominoEffect CasePresenter:RedaIbrahim

12:27_PM Case2:TheSapienDoubleTrouble CasePresenter:GarethJMorgan

12:36_PM Case3:TricuspidValveinValve CasePresenter:NathanWTaggart

12:45_PM Case4:AFontanBaffleObstruction CasePresenter:MarkOsten

12:54_PM Case5:APeskyASDWithHelpFromModelling CasePresenter:MichaelJ.Lim

1:03_PM Case6:PercutaneousPulmonaryValvePlacement:MishapAfterMishap CasePresenter:ZahidAmin

1:12_PM Case7:BifurcationStentingforPulmonaryVeinStenosis

Page 52: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:52

CasePresenter:HarsimranSachdevaSingh1:21_PM Case8:ALargeCoronaryFistula:ShoulditbeClosedandHow

CasePresenter:IoannisIakovou1:30_PM Case9:CatheterOpeningofOccludedSuperiorBaffleAfterAtrialSwitchWithAssistedTranshepaticApproach

CasePresenter:MakramR.Ebeid1:39_PM Case10:AnArchComplicationAfterAorticCoarctationStenting

CasePresenter:EricHorlick1:48_PM TakehomeMessages:WhatDidWeLearnFromtheseCases

Lecturers:LeeN.Benson

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-CTOANTEGRADEREENTRYTECHNIQUES

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room25A-B,UpperLevel

12:15PM-1:45PM

CTOAntegradeReentryTechniques

Moderators:DimitriKarmpaliotis,EtsuoTsuchikane

Discussants:AlfredoR.Galassi,JunboGe,LukaszKlima,AlexanderGrigorievichOsiev,LeifThuesen,R.MichaelWyman

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:EtsuoTsuchikane

12:20_PM Case1:ACaseofDemonstratingtheContemporaryUtilityoftheParallelWireTechnique CasePresenter:GeraldS.Werner

12:30_PM Case2:ACaseDemonstratinganAdvancedAntegradeDissectionandReentryTechnique CasePresenter:R.MichaelWyman

12:40_PM Case3:ACaseDemonstratingtheKnuckleWireTechnique CasePresenter:SunaoNakamura

12:50_PM Case4:ACaseofAntegradeFenestrationandReEntry CasePresenter:MauroCarlino

1:00_PM Case5:ACTOCaseinWhichAntegradePersistencePayedOff CasePresenter:NicholasJ.Lembo

1:10_PM Case6:ACaseofRealTimeFusionCTImagingtoGuideCTOPCI CasePresenter:FaroucAJaffer

1:20_PM Case7:ACaseDemonstratingActiveAntegradeTrueLumenSeeking CasePresenter:YuejinYang

1:30_PM Case8:AMajorComplicationDuringAntegradeCTOPCIHintNotaPerforation Lecturers:RobertoDiletti

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:DimitriKarmpaliotis

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-FFR-CTCASESTUDIES:NONINVASIVEDIAGNOSISANDPROCEDURALPLANNING

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room32A-B,UpperLevel

12:15PM-1:45PM

FFRCTCaseStudies:NoninvasiveDiagnosisandProceduralPlanning

Moderators:NickCurzen,RobertD.Safian

Discussants:ColinBerry,PamelaS.Douglas,JonathonA.Leipsic,HitoshiMatsuo,ErickSchampaert,DanielI.Simon

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:RobertD.Safian

12:19_PM Case1:AnFFRCTCaseThatConvincedMeofItsUtility CasePresenter:MichaelMooney

12:28_PM Case2:ACaseWhereFFRCTWasMoreAccurateThanAllOtherImagingModalitiesFromPACIFIC CasePresenter:PaulKnaapen

12:37_PM Case3:ACaseWhereFFRCTIdentifiedIschemiainaMildCoronaryStenosisFromtheADVANCERegistry CasePresenter:TakashiAkasaka

12:46_PM Case4:ARealWorldCaseWhereFFRCTProvidedUniqueInsights

Page 53: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:53

CasePresenter:HitoshiMatsuo12:55_PM Case5:ACaseofFFRCTtoEvaluateDyspneaandAtypicalSymptoms

CasePresenter:DanielI.Simon1:04_PM Case6:ACaseofFFRCTAssessmentDuringPlaqueRupture

CasePresenter:JonathonA.Leipsic1:13_PM Case7:ACaseinWhichFFRCTProvidedSomeButNotAlloftheNeededData

CasePresenter:JustinE.Davies1:22_PM Case8:ACaseofRevascularizationPlanningbyFFRCTFromSYNTAXIII

CasePresenter:PatrickW.Serruys1:31_PM Case9:ACaseofPCIPlanningandVirtualStentingUsingtheInteractiveFFRCTPlanner

CasePresenter:AndrejsErglis1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases

Lecturers:NickCurzen

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-INTERVENTIONAL�RICHEMOTIONALEXPERIENCES�(AKACOMPLICATIONS)I:CORONARY

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room28A-B,UpperLevel

12:15PM-1:45PM

Interventional�RichEmotionalExperiences�(AKAComplications)I:Coronary

Moderators:HenningKelbæk,RanKornowski

Discussants:NiratBeohar,MiroslawFerenc,MamasMamas,JamesNolan,ThomasM.Tu,BernhardWitzenbichler

12:15_PM Introduction:WhatDoWeHopeToLearnFromTheseCases Lecturers:RanKornowski

12:20_PM Case1:ACaseofaMassiveCoronaryPerforation CasePresenter:NicholasJ.Lembo

12:30_PM Case2:ACaseofaCollateralPerforation CasePresenter:SanjogKalra

12:40_PM Case3:ACaseofRefractoryNoReflow CasePresenter:RahulSakhuja

12:50_PM Case4:ACaseofaLostStentintheLeftMain CasePresenter:WaleedElAwady

1:00_PM Case5:AComplicationThatOccurredWhenITreatedaPostMIVSD CasePresenter:BiswajitKar

1:10_PM Case6:AMostUncommonPCIComplication CasePresenter:BarryD.Rutherford

1:20_PM Case7:ARadialArteryAccessDisaster CasePresenter:RamonQuesada

1:30_PM Case8:ACaseofMajorPeripheralVascularComplicationsDuringCoronaryIntervention CasePresenter:DmitriyN.Feldman

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:HenningKelbæk

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-MITRACLIPCOMPLEXCASESTUDIESANDTECHNIQUE

SATURDAY,SEPTEMBER22,2018

12:15PM-1:45PM

Room29A-B,UpperLevel

12:15PM-1:45PM

MitraClipComplexCaseStudiesandTechnique

Moderators:HüseyinInce,MatthewJ.Price

Discussants:AnitaAsgar,EricA.Cohen,OscarA.Mendiz,FrederickG.St.Goar,CorradoTamburino,BrianK.Whisenant

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:MatthewJ.Price

12:20_PM Case1:ACaseofProgressiveStenosisAfteraSuccessfulMitraClip CasePresenter:UlrichSchäfer

12:30_PM Case2:MitraClipforAnnuloplastyRingDehiscence

Page 54: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:54

CasePresenter:PeterWenaweser12:40_PM Case3:MitraClipforProlapseofaTrileafletMitralValve

CasePresenter:ManuelPan12:50_PM Case4:TranscatheterMitraClipRepairforCommissuralRegurgitation

CasePresenter:JoachimSchofer1:00_PM Case5:ACaseofTranscatheterMitralValveRepairintheSettingofCardiogenicShock

CasePresenter:PaoloDenti1:10_PM Case6:AChallengingMitraClipDecision:WhethertoImplantaSecondClip

CasePresenter:KonstantinosSpargias1:20_PM Case7:AComplexMitraclipXTCase

CasePresenter:JörgHausleiter1:30_PM Case8:AnIatrogenicASDDuringTranscatheterMitralValveRepair:WhenandWhytoClose

CasePresenter:GeorgeS.Hanzel1:40_PM TakehomeMessages:WhatDidWeLearnFromtheseCases

Lecturers:HüseyinInce

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-TAVRVALVEINVALVE,VALVEINRING,VALVEINMAC,ANDVALVEINBICUSPIDAS

SATURDAY,SEPTEMBER22,2018

12:15PM-1:46PM

Room26A-B,UpperLevel

12:15PM-1:46PM

TAVRValveinValve,ValveinRing,ValveinMACandValveinBicuspidAS

Moderators:DannyDvir,MassimoNapodano

Discussants:RobertJ.Applegate,VinayakBapat,AlaideChieffo,JanKovac,BernardPrendergast,VivekRajagopal

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:DannyDvir

12:19_PM Case1:ACaseofTAVRViVRequiringanAdvancedApproach CasePresenter:MohamedAbdel-Wahab

12:28_PM Case2:ACaseofTAVRinTAVR CasePresenter:MarcoBarbanti

12:37_PM Case3:ACaseofBioprostheticValveFractureToFacilitateTAVRViV CasePresenter:KeithB.Allen

12:47_PM Case4:BioprostheticValveFractureBeforeorAfterTAVRViV CasePresenter:AdnanK.Chhatriwalla

12:56_PM Case5:ACaseofTAVRinaStentlessSurgicalValveTipsandTrickstoKnow CasePresenter:DavidX.Zhao

1:05_PM Case6:ACaseofFailedTAVRViV CasePresenter:PhilippePibarot

1:14_PM Case7:ACaseofTAVRVIRWithComplications CasePresenter:AzeemLatib

1:23_PM Case8:ACaseofaTAVRinMACWithComplications CasePresenter:TorstenP.Vahl

1:32_PM Case9:ACaseofTAVRinBicuspidAorticStenosisTechnicalConsiderations CasePresenter:SimonRedwood

1:41_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:MassimoNapodano

SPECIALSESSION:FEATUREDSESSIONFORINTERNATIONALADVISORYFACULTY-THEBESTOFINDIA:PRACTICEPATTERNSINMODERN

INTERVENTIONALCARDIOLOGY

SATURDAY,SEPTEMBER22,2018

8:30AM-10:00AM

Room24A-B,UpperLevel

8:30AM-10:00AM

FeaturedSessionforInternationalAdvisoryFacultyTheBestofIndia�PracticePatternsinModernInterventionalCardiology

Moderators:SamuelKMathew,ManishA.Parikh,AshokSeth

Discussants:VinayK.Bahl,FatemaBegum,UpendraKaul,SreenivasArramrajuKumar,SundeepMishra,NikhilParchure

Page 55: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:55

8:30_AM IntroductionandSessionGoals Lecturers:ManishA.Parikh

8:34_AM ComplexMultivesselPCI:CABGisNotAlwaysanOptionCaseIntroduction CasePresenter:SreenivasArramrajuKumar

8:40_AM AdvisoryFacultySurveysWithQandA:HowShouldThisCaseBePerformed

8:50_AM ComplexMultivesselPCI:CABGisNotAlwaysanOptionCaseConclusion CasePresenter:SreenivasArramrajuKumar

8:56_AM RoundtableDiscussionWithAudienceQA

9:01_AM STEMIPresentation:ThrombusandBeyondCaseIntroduction CasePresenter:KirtiPunamiya

9:07_AM AdvisoryFacultySurveysWithQandA:HowShouldThisCaseBeperformed

9:17_AM STEMIPresentation:ThrombusandBeyondCaseConclusion CasePresenter:KirtiPunamiya

9:23_AM RoundtableDiscussionWithAudienceQA

9:28_AM MultivesselCADandCongestiveHeartFailureCaseIntroduction CasePresenter:VinayK.Bahl

9:34_AM AdvisoryFacultySurveysWithQandA:HowShouldThisCaseBeperformed

9:44_AM MultivesselCADandCongestiveHeartFailureCaseConclusion CasePresenter:VinayK.Bahl

9:50_AM RoundtableDiscussionWithAudienceQA

9:55_AM SummaryandTakeHomeMessages Lecturers:AshokSeth

SPECIALSESSION:16THANNIVERSARYHBD(HARMONIZATIONBYDOING)

SATURDAY,SEPTEMBER22,2018

9:00AM-5:00PM

Room27A-B,UpperLevel

9:00AM-9:30AM

IntroductionandProspectofHBDActivities

Moderators:MitchellW.Krucoff

9:00_AM HistoryofHBDActivity Lecturers:NealFearnot

9:15_AM IntroductionofHBDforchildren Lecturers:KojiMineta

9:30AM-10:45AM

HowCanWeGenerateRobustReal-WorldEvidenceFromGlobalReal-WorldData?

Moderators:JohnCLaschinger

9:30_AM TheCurrentSituationandPerspectiveinUSRAPIDNEST Lecturers:MitchellW.Krucoff

9:40_AM TheCurrentSituationandPerspectiveinJapanandInternationalActivityCINIMDRF

9:50_AM TheEffortofGeneratingRobustRWEFromUSIndustry Lecturers:TheodoreHeise

10:00_AM SeekingaMoreEffectiveWayofUtilizingBigDataFromDailyPracticeinJapan Lecturers:TetsuyaAmano

10:10_AM HowWeCanUtilizetheRWEforRegulatoryDecisionMakingFDAPerspective Lecturers:JohnCLaschinger

10:20_AM PanelDiscussion

10:45AM-11:00AM

Break

11:00AM-12:30PM

ThinkingAbouttheClinicalPositioningofPercutaneousMitralRegurgitation(MR)andTricuspidRegurgitation(TR)Valve-RelatedDevicesintheMaturityStageof

Page 56: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:56

SurgicalTreatment

Moderators:PhilippeGenereux,ShigeruSaito

Discussants:JaimeRaben

11:00_AM GlobalEarlyFeasibilityStudy:NovelMitralRegurgitationValveTreatmentDevice Lecturers:RobertJThatcher

11:10_AM TheCurrentSituationandTrendfortheMRandTRValveRelatedDevices Lecturers:FumiakiIkeno

11:20_AM MRandTRValveRelatedDeviceWillbeaGameChangerFromUSAcademiasProspective Lecturers:PhilippeGenereux

11:30_AM MRandTRValveRelatedDeviceWillbeaGameChangerFromJapaneseAcademiasProspectiveBasedonPostMarketSurveillanceinJapan Lecturers:MakotoAmaki

11:40_AM PointstoConsiderintheReviewofMRandTRValveRelatedDevicesFDAsView Lecturers:AnkuritaDatta

11:50_AM PointstoConsiderintheReviewofMRandTRValveRelatedDevicesPMDAsView Lecturers:AkihideKonishi

12:00_PM PanelDiscussion

12:30PM-1:30PM

BreakforLunch

1:30PM-3:30PM

WhatistheAppropriateDefinitionandTreatmentforHighRiskBleedingPatients?~FocusedonShortDAPTforCoronaryDESandLeftAtrialAppendageClosureDevice

(LAACDevice)

Moderators:KennethJ.CavanaughJr,HiroyoshiYokoi

Discussants:LydiaSGlaw

3:30PM-3:45PM

Break

3:45PM-5:00PM

RethinkoftheClinicalPositionforRenalSympatheticDenervation(RDN)BasedonCurrentEvidence

Moderators:KennethJ.CavanaughJr,TakafumiUeno

3:45_PM TheOverviewofCurrentEvidenceofRDN:TheResultofRADIANCEHTNSOLOTrialandSPYRALHTNonMEDTrial Lecturers:LauraMauri

3:55_PM WhataretheSuitableTargetPatientsandEndpointsforRDNBasedontheCurrentEvidence Lecturers:FelixMahfoud

4:05_PM JapanesePerspectiveandExperienceonRDNStudies Lecturers:TakafumiUeno

4:15_PM PointtoConsiderintheReviewoftheRDNRelatedDevices:USRegulatory Lecturers:HirenMistry

4:25_PM PanelDiscussion

FASCINATINGLECTURESI:THEGLOBALREACHOFINTERVENTIONALCARDIOLOGY

SATURDAY,SEPTEMBER22,2018

2:00PM-3:00PM

Ballroom6A,UpperLevel

2:00PM-3:00PM

TheGlobalReachofInterventionalCardiology

Moderators:JamesE.Muller,GioraWeisz

Discussants:AndreaAbizaid,GrahamA.Cassel,DavidF.Kong,EhtishamMahmud,RobertD.Safian

2:00_PM BalloonsontheBattlefield:NovelEndovascularTechniquesforMilitaryResuscitation Lecturers:PaulRees

2:10_PM FascinatingQA

2:15_PM PCIforSyrianRefugeesinJordanWiththeSyrianAmericanMedicalSocietySAMS Lecturers:StefanHarb

Page 57: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:57

2:25_PM FascinatingQA

2:30_PM InterventionalCardiologyAcronymsandtheSufferingoftheSyrianPeopleDuringtheCivilWar Lecturers:WaleedYKadro

2:40_PM FascinatingQA

2:45_PM RoboticTeleStentingOverLongGeographicDistances:ProgressandBarriers Lecturers:RyanD.Madder

2:55_PM FascinatingQA

SPECIAL@TCTSESSION:CVREP@TCT-THECHIPFORUM

SATURDAY,SEPTEMBER22,2018

2:30PM-4:00PM

Room23B-C,UpperLevel

2:30PM-2:35PM

IntroductionandSessionGoals

2:30_PM IntroductionandSessionGoals Lecturers:MohamedAhmedSobhy

2:35PM-3:05PM

SessionI.CalcifiedLesions

Moderators:AmrKamal,MohamedAhmedSobhy,SherifWagdy

Discussants:TarekHelmy,AliOto

2:35_PM Case1:ComplexDiffuseCoronaryArteryDisease CasePresenter:AmrMahmoudZaki

2:45_PM RoundtableDiscussion

2:50_PM Case2:ComplexMultivesselPCIWithSeverelyCalcifiedLesions CasePresenter:MohamedSadaka

3:00_PM RoundtableDiscussion

3:05PM-3:30PM

SessionII.CTO

Moderators:AmrKamal,MohamedAhmedSobhy,SherifWagdy

Discussants:AymanAbouElMagd,ZiadA.Ali,TyroneJ.Collins

3:05_PM Case3:AChallengingCTOAntegradeCase CasePresenter:SherifELbeltagui

3:15_PM Case4:AntegradeFenestrationandReEntryANewTechnique CasePresenter:YasserSadek

3:25_PM RoundtableDiscussion

3:30PM-4:00PM

SessionIII.MultivesselWithHighEuroScore

Moderators:AmrKamal,MohamedAhmedSobhy,SherifWagdy

Discussants:GeorgeD.Dangas,HossamI.Kandil,MahmoudSoliman

3:30_PM Case5:ACSAndMultivesselDisease CasePresenter:MohamedLoutfi

3:40_PM Case6:NSTEMIandMultivesselDisease CasePresenter:MohamedElsayedElsetiha

3:50_PM RoundtableDiscussion

3:55_PM SummaryandTakeHomeMessages Lecturers:OriBen-Yehuda

SPECIAL@TCTSESSION:TCTRUSSIA

SATURDAY,SEPTEMBER22,2018

Page 58: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:58

3:00PM-5:00PM

PresentationTheater1,HallB2,GroundLevel

3:00PM-5:00PM

ComplexInterventionalProceduresinthe�High-riskPatient�:ACase-BasedSymposiuminCollaborationWithTCTRussia

Moderators:BagratAlekyan,JuanF.Granada

Discussants:VladimirGanyukov,SamirR.Kapadia,ZazaKavteladze,RoxanaMehran,JeffreyW.Moses,AlexNikanorov,RomanTarasov,NarekZakaryan

3:00_PM Introduction Lecturers:JeffreyW.Moses

3:05_PM FeaturedLecture:HemodynamicSupportinComplexInterventionalProceduresClinicalIndicationsAvailableDevicesandClinicalOutcomes Lecturers:JeffreyW.Moses

3:15_PM CasePresentation:ComplexLeftMainandRetrogradeRightCoronaryRecanalizationProcedure CasePresenter:NarekZakaryan

3:25_PM CasePresentation:ECMOAssistedTAVR CasePresenter:VladimirGanyukov

3:35_PM RoundtableDiscussion

3:45_PM FeaturedLecture:TheHighriskPatient:RiskAssessmentandCurrentRecommendationsforDAPTandOAC Lecturers:RoxanaMehran

3:55_PM CasePresentation:HybridApproachinTreatmentofPatientWithCriticalAorticStenosisUnprotectedLeftMainLesionandStomachCancer CasePresenter:BagratAlekyan

4:05_PM CasePresentation:EndovascularInterventionsFollowingLargeOpenSurgery CasePresenter:ZazaKavteladze

4:15_PM RoundtableDiscussion

4:25_PM FeaturedPresentation:SimultaneousLAAClosureWithStructuralHeartProceduresIndicationsandPostinterventionalManagement Lecturers:SamirR.Kapadia

4:35_PM CasePresentation:StentingoftheRightVentricularOutflowTractinaChildWithTetralogyofFallot:ClinicalResultsandHistologicalDataofthe

ExplantedStent CasePresenter:RomanTarasov

4:45_PM RoundtableDiscussion

4:55_PM TakehomeMessages Lecturers:BagratAlekyan

SPECIALSESSION:DISCUSSIONSWITHTHELATEBREAKINGTRIALPRINCIPALINVESTIGATORSI

SATURDAY,SEPTEMBER22,2018

5:00PM-6:00PM

Ballroom6A,UpperLevel

5:00PM-6:00PM

DiscussionsWiththeLateBreakingTrialPrincipalInvestigatorsI

Moderators:SripalBangalore,LawrenceA.Garcia

Discussants:EvaldH.Christiansen,GiuseppeDeLuca,WilliamA.Gray,MahmoodK.Razavi,LuigiSalemme,PatrickW.Serruys,PieterR.Stella,ClemensvonBirgelen

5:00_PM BIONYX:SummaryandClinicalImplications Lecturers:ClemensvonBirgelen

5:05_PM Discussion Discussants:ClemensvonBirgelen

5:15_PM TALENT:SummaryandClinicalImplications Lecturers:PatrickW.Serruys

5:20_PM Discussion Discussants:PatrickW.Serruys

5:30_PM ReCre8:SummaryandClinicalImplications Lecturers:PieterR.Stella

5:35_PM Discussion Discussants:PieterR.Stella

5:45_PM IMPERIAL:SummaryandClinicalImplications Lecturers:WilliamA.Gray

5:50_PM Discussion Discussants:WilliamA.Gray

Page 59: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:59

PRESENTATIONTHEATERPROGRAM:CONTRAST-INDUCEDACUTEKIDNEYINJURY:PREVENTIVEMEASURESTHATWORK(ORGANIZEDBYCRF,

SPONSOREDBYABIOMED,INC.,GEHEALTHCARE,ANDOSPREYMEDICAL)

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

PresentationTheater2,HallB2,GroundLevel

11:30AM-12:30PM

Contrast-InducedAcuteKidneyInjury:PreventiveMeasuresthatWorkinHighRiskPatients

Chairs:RoxanaMehran

Faculty:EmmanouilS.Brilakis,MichaelP.Flaherty,VishalGupta,MD,HitinderS.Gurm

11:30_AM RenalFunctionContrastMediaDosinginHighRiskPatientPopulations Lecturers:HitinderS.Gurm

11:40_AM ImpellaAssistedPCIandaStrategytoPreventAKIinHighRiskPatients Lecturers:MichaelP.Flaherty

11:50_AM EffectofMARCEIncidenceandEconomicImpactResultingFromContrastMediaUseintheCathLab Lecturers:EmmanouilS.Brilakis

12:00_PM DevelopmentofaKidneyCareProtocolintheCathLab:ScreeningHydrationandDyeMinimization Lecturers:VishalGupta,MD

12:10_PM PanelDiscussionandQA

12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:LOTUSEDGEANDACURATENEO2ANDSENTINELCEREBRALPROTECTIONSYSTEM:NEXT-GENERATIONTAVR

(SPONSOREDBYBOSTONSCIENTIFICCORPORATION)

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

PresentationTheater4,ExhibitHall,GroundLevel

11:30AM-12:30PM

LOTUSEdgeandACURATEneo2andSentinelCerebralProtectionSystem:Next-GenerationTAVR

Chairs:TedFeldman

Faculty:RobertGooley,HelgeMöllmann,MichaelJ.Reardon,MichaelJ.Rinaldi,JuliaSeeger

11:30_AM TheUlmUniversityExperienceWithSentinel Lecturers:JuliaSeeger

11:35_AM Sentinel:ARealWorldExperience Lecturers:MichaelJ.Rinaldi

11:45_AM LOTUSEdge:CuttingEdgeExperience Lecturers:RobertGooley

11:55_AM ACURATEneo2:BuildingtheEvidence Lecturers:HelgeMöllmann

12:05_PM TheFutureClinicalTrialLandscapeofTAVR Lecturers:MichaelJ.Reardon

12:15_PM PanelDiscussion Moderators:TedFeldman

Discussants:RobertGooley,HelgeMöllmann,MichaelJ.Reardon,MichaelJ.Rinaldi,JuliaSeeger12:28_PM WrapUp

Lecturers:TedFeldman12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:MAGMARISMAGNESIUMRMS:INACLASSOFITSOWN(SPONSOREDBYBIOTRONIK)

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

PresentationTheater5,ExhibitHall,GroundLevel

Page 60: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:60

11:30AM-12:30PM

MagmarisMagnesiumRMS:InaClassofItsOwn

CoChairs:MichaelHaude,RonWaksman

Faculty:StefanoGalli,MichaelJoner,PasiKarjalainen,MichaelKang-YinLee

11:30_AM Whydoweneedscaffolds Lecturers:MichaelHaude

11:40_AM Discussion

11:45_AM Magmaris:Reducingtheriskofneoatherosclerosis Lecturers:MichaelJoner

11:55_AM Discussion

12:03_PM NeointimalHealingEvaluatedbyOpticalCoherenceTomographyafterDrugElutingAbsorbableMetalScaffoldImplantationindenovoNativeCoronary

Lesions Lecturers:PasiKarjalainen

12:10_PM Discussion

12:15_PM NewclinicalinsightsfromBIOSOLVEIV Lecturers:MichaelKang-YinLee

12:23_PM Discussion

12:28_PM Keylearningsandtakeaway Lecturers:RonWaksman

12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:TRANSRADIALANGIOCLUB-COMPLEXCORONARYINTERVENTIONSSYMPOSIUM(SPONSOREDBYCORDIS,A

CARDINALHEALTHCOMPANY)

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

PresentationTheater3,ExhibitHall,GroundLevel

11:30AM-12:30PM

TransradialAngioClub-ComplexCoronaryInterventionsSymposium

Chairs:ManishA.Parikh

Faculty:J.DawnAbbott,KevinJ.Croce,YujiIkari,AzeemLatib,JohnC.Wang

PRESENTATIONTHEATERPROGRAM:ACCESSINGANDTREATINGLOWERLIMBDISEASEWITHSUPERA(SPONSOREDBYABBOTT)

SATURDAY,SEPTEMBER22,2018

1:00PM-2:00PM

PresentationTheater2,HallB2,GroundLevel

1:00PM-2:00PM

AccessingandTreatingLowerLimbDiseaseWithSupera

Faculty:EthanCKorngold,MehdiH.Shishehbor

1:00_PM Welcome

1:05_PM AccessingandCrossingLowerLimbDisease Lecturers:EthanCKorngold

1:35_PM TreatingLowerLimbDiseaseWithSupera

1:50_PM ClosingRemarks Lecturers:EthanCKorngold

2:00_PM Adjourn

PRESENTATIONTHEATERPROGRAM:LEADINGTHEWAYASTAVRBECOMESTHEGOLD-STANDARDFORTREATINGAS(ACASE-BASEDDISCUSSION)

(SPONSOREDBYCRF,SUPPORTEDBYEDWARDSLIFESCIENCES)

Page 61: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:61

SATURDAY,SEPTEMBER22,2018

1:00PM-2:00PM

PresentationTheater1,HallB2,GroundLevel

1:00PM-2:00PM

LeadingtheWayasTAVRBecomestheGold-StandardforTreatingAS(ACase-BasedDiscussion)

CoChairs:MartinB.Leon,JohnG.Webb

Faculty:MeganCoylewright,TsuyoshiKaneko,SandraLauck,WilsonY.Szeto,VinodH.Thourani,DavidA.Wood

1:00_PM AnSDMPrimerforTAVR

Lecturers:MeganCoylewright1:08_PM PatientAccessChallengesSecondarytoCurrentTAVRSAVRSiteAvailability

Lecturers:TsuyoshiKaneko1:15_PM Discussion

Moderators:WilsonY.Szeto1:20_PM Brief3MLikeCasePresentationArticulatingtheMinimalistCredo

Lecturers:DavidA.Wood1:27_PM ChangesNecessarytoTransformTAVRintoaGoldStandardTherapy

Lecturers:SandraLauck1:34_PM GentleWarningAgainstExtremeMinimalismStrategies

Lecturers:MartinB.Leon1:39_PM Discussion

Moderators:VinodH.Thourani1:45_PM SAPIEN3UltraCaseandTechnology

Lecturers:JohnG.Webb1:52_PM CENTERAisNextontheHorizon

Lecturers:MartinB.Leon1:57_PM Discussion

Moderators:JohnG.Webb2:00_PM FinalThoughtsAdjourn

PRESENTATIONTHEATERPROGRAM:PREPARETOSUCCEEDINCOMPLEXPCI:CASE-BASEDINSIGHTSFORTECHNICALSUCCESSTHROUGHADVANCED

GUIDANCEANDTREATMENTTOOLS(SPONSOREDBYPHILIPS)

SATURDAY,SEPTEMBER22,2018

1:00PM-2:00PM

PresentationTheater5,ExhibitHall,GroundLevel

1:00PM-2:00PM

PreparetoSucceedinComplexPCI:Case-BasedInsightsforTechnicalSuccessThroughAdvancedGuidanceandTreatmentTools

Chairs:EhrinJ.Armstrong

Lecturers:FaroucAJaffer

Faculty:KevinJ.Croce,JavierEscaned

1:00_PM Introductions Moderators:EhrinJ.Armstrong

Lecturers:KevinJ.Croce,JavierEscaned,FaroucAJaffer1:05_PM TheFutureofPhysiology:ComplexPCIGuidance

Lecturers:JavierEscaned1:20_PM HowtoDealWithISRandMultilayerISR

Lecturers:KevinJ.Croce

Page 62: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:62

1:35_PM ImprovingComplexPCIOutcomesWithIVUS Lecturers:FaroucAJaffer

1:50_PM ConclusionsandQuestions Moderators:EhrinJ.Armstrong

Discussants:KevinJ.Croce,JavierEscaned,FaroucAJaffer2:00_PM Adjourn

PRESENTATIONTHEATERPROGRAM:THECASEFORCOMPLETECEREBRALEMBOLICPROTECTION-REFLECT(SPONSOREDBYKEYSTONEHEART,LTD.)

SATURDAY,SEPTEMBER22,2018

1:00PM-2:00PM

PresentationTheater4,ExhibitHall,GroundLevel

1:00PM-2:00PM

TheCaseforCompleteCerebralEmbolicProtection-REFLECT

Chairs:AlexandraJ.Lansky,TamimNazif

Faculty:AbhijeetDhoble,MD,DariuszDudek,JohnK.Forrest,MichaelJ.Mack,RajMakkar,JeffreyW.Moses,JoachimSchofer,RahulSharma

1:00_PM CurrentCerebralEmbolicProtectionLandscapeKeystoneHeartTriGUARDDataReview Lecturers:JeffreyW.Moses

1:10_PM REFLECTClinicalUpdatewithTriGUARD3 Lecturers:TamimNazif

1:20_PM TriGUARD3CasePresentationEarlyUSExperience Lecturers:MichaelJ.Mack

1:28_PM TriGUARD3PostMarketEURegistryPlan Lecturers:DariuszDudek

1:35_PM TheImportanceofDWMRIandLongitudinalImpactofCerebralIschemicLesions Lecturers:JohnK.Forrest

1:45_PM CerebralEmbolicProtectionPanelDiscussion Lecturers:AlexandraJ.Lansky

PRESENTATIONTHEATERPROGRAM:THERADIANCEGLOBALCLINICALTRIALPROGRAM:THEFUTUREOFRENALDENERVATIONISSOUND!

(SPONSOREDBYRECORMEDICAL)

SATURDAY,SEPTEMBER22,2018

1:00PM-2:00PM

PresentationTheater3,ExhibitHall,GroundLevel

1:00PM-2:00PM

TheRADIANCEGlobalClinicalTrialProgram:TheFutureofRenalDenervationisSOUND!

Chairs:AjayJ.Kirtane

Faculty:MelvinD.Lobo,FelixMahfoud

1:00_PM IntroductiontoSession Lecturers:AjayJ.Kirtane

1:05_PM RADIANCEHTNSOLOoffmedicationcohort:indepthanalysisofprimaryefficacyandsafetyoutcomes Lecturers:AjayJ.Kirtane

1:15_PM QA

1:20_PM RDNprocedurewiththeReCorParadisetechnology:anatomytreatmentlocationprocedurestandardizationandsimplicity Lecturers:FelixMahfoud

1:35_PM QA

1:40_PM ClinicalContextofSOLOResultsandtheRADIANCEGlobalClinicalTrialProgram Lecturers:MelvinD.Lobo

1:55_PM QAClosesession

2:00_PM Adjourn

TRAINING:ABBOTTPAVILION#1-MITRACLIPNTR&XTR:DEVICE&PROCEDURALTECHNIQUES

Page 63: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:63

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

MitraClipNTR&XTR:Device&ProceduralTechniques

InteractiveTrainingFaculty:AnitaAsgar,WayneB.Batchelor,BassemChehab,PaoloDenti,RodrigoEstevez-Loureiro,JamesB.HermillerJr,PaulD.Mahoney,Andrew

Morse,AhmedIMustafa,MarkJ.Ricciardi,MichaelJ.Rinaldi,DavidG.Rizik,EvelioRodriguez,JoshuaRovin,GaganDSingh,MaurizioTaramasso

8:00_AM Introduction

8:05_AM DidacticDeviceOverview

8:25_AM HandsonDeviceDeployment

TRAINING:BOSTONSCIENTIFICPAVILION#1-IMAGING/PHYSIOLOGY:OPTIMIZEPCI-NEWPHYSIOLOGICINDICESANDHIGHDEFINITIONIVUS

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

Imaging/Physiology:OptimizePCI-NewPhysiologicIndicesandHighDefinitionIVUS

InteractiveTrainingFaculty:YiannisSChatzizisis,WilliamF.Fearon,AllenJeremias,MortonJ.Kern

8:00_AM WelcomeRemarks

8:05_AM CoronaryphysiologytoolboxandnewoptionsinnonhyperemicpressureratiosNHPR

8:12_AM Whentousewhatincoronaryphysiology

8:19_AM FFRbestpracticesandcommonartifacts

8:27_AM HDIVUSincomplexcases

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#1-PREPARETOSUCCEEDINCOMPLEXPCI

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

PreparetoSucceedinComplexPCI

InteractiveTrainingFaculty:GeorgeSChrysant,AjayJ.Kirtane,SukhjinderSNijjer,BruceSamuels,JasvindarSingh,JoachimWeil

8:00_AM Introduction

8:05_AM Topic1ProceduralGuidancewithiFRcoregistrationHandsonFeaturedDevices:iFRCoRegistrationonSyncVision

8:25_AM Topic2:VisualizinginstentrestenosiswithIVUScoregistrationHandsonFeaturedDevices:IVUSCoRegistrationonSyncVision

8:45_AM Topic3:VesselTreatmentPreparationCaseReviewFeaturedDevices:ELCALaserAtherectomyAngioSculpt

9:05_AM Topic4:VesselPreparationwithlaseratherectomyHandsonFeaturedDevices:ELCALaserAtherectomysimulation

9:25_AM ClosingAdjourn

TRAINING:ENDOVASCULARPAVILION#1-TIBIOPEDALACCESS

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

Page 64: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:64

8:00AM-9:30AM

BTK(TibiopedalAccess)SessionI

InteractiveTrainingFaculty:GeorgeLAdams,MohammadMehdiAnsari,PhilipGreen,KarthikR.Gujja,JunLi,AravindaNanjundappa,JustinA.Ratcliffe,RamzanZakir

8:00_AM VideoIntroduction:TheNeedforGuidedAlternateAccessTibiopedalAntegrade

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#1-LARGEBOREACCESSANDCLOSURE

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

LargeBoreAccessandClosure

8:00_AM PercutaneousAxillaryAccessLargeBoreAccessandClosure:Overview InteractiveTrainingFaculty:AmirKaki,RajivTayal

8:10_AM HandsonPercutaneousAxillaryAccessLargeBoreAccessandClosure

TRAINING:INTERVENTIONALIMAGINGPAVILION#1-TRANS-SEPTALCROSSINGFORLAAUSINGTEEAND3DVOLUMEICE

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

CHIP-AdvancedPCITechniquesPavilion,InteractiveTrainingWorkshop,UpperLevel

8:00AM-9:30AM

Trans-septalCrossingforLAAUsingTEEand3DVolumeICE

InteractiveTrainingFaculty:IsaacGeorge,RebeccaT.Hahn,OmarK.Khalique,BrijMaini,RobertJ.Sommer,TorstenP.Vahl

TRAINING:MEDTRONICPAVILION#1-STRUCTURALHEART:TAVRINBICUSPIDAORTICVALVETRAININGWORKSHOP

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

StructuralHeart:TAVRinBicuspidAorticValveTrainingWorkshop

InteractiveTrainingFaculty:BaselRamlawi

8:00_AM Introduction

8:05_AM OverviewofBicuspidAorticValveDiseaseState

8:25_AM IdentificationandClassificationofBicuspidAorticValves

8:45_AM SizingmethodologycontroversiesandProceduralConsiderationsforPerformingTAVRinBicuspid

TRAINING:TAVRPAVILION#1-ADVANCINGANESTHESIACARE

SATURDAY,SEPTEMBER22,2018

8:00AM-9:30AM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

AdvancingAnesthesiaCare

InteractiveTrainingFaculty:GeorgeGellert,ChadKliger,KomalDPatel,WilliamMSuh

Page 65: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:65

TRAINING:ABBOTTPAVILION#2-NOWTHATISEEIT,IKNOWHOWTOTREATIT!AHANDS-ONSKILLSLAB

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

NowThatISeeIt,IKnowHowtoTreatIt!AHands-OnSkillsLab

InteractiveTrainingFaculty:ZiadA.Ali,HiramG.Bezerra,JonathanM.Hill,VamsiKrishsna,EvanShlofmitz,RichardShlofmitz,GabrielTensolRodriguesPereira,Armando

Vergara-Martel

10:00_AM OCT:NowthatIseeIt..Presentation

TRAINING:BOSTONSCIENTIFICPAVILION#2-IMAGING/PHYSIOLOGY:OPTIMIZEPCI-NEWPHYSIOLOGICINDICESANDHIGHDEFINITIONIVUS

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

Imaging/Physiology:OptimizePCI-NewPhysiologicIndicesandHighDefinitionIVUS

InteractiveTrainingFaculty:YiannisSChatzizisis,AllenJeremias,MortonJ.Kern

10:00_AM WelcomeRemarks

10:05_AM CoronaryphysiologytoolboxandnewoptionsinnonhyperemicpressureratiosNHPR

10:12_AM Whentousewhatincoronaryphysiology

10:19_AM FFRbestpracticesandcommonartifacts

10:27_AM HDIVUSincomplexcases

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#2-PREPARETOSUCCEEDINCOMPLEXPCI

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

PreparetoSucceedinComplexPCI

InteractiveTrainingFaculty:GeorgeSChrysant,SukhjinderSNijjer,ManishA.Parikh,BruceSamuels,JasvindarSingh,JoachimWeil

10:00_AM Introduction

10:05_AM Topic1ProceduralGuidancewithiFRcoregistrationHandsonFeaturedDevices:iFRCoRegistrationonSyncVision

10:25_AM Topic2:VisualizinginstentrestenosiswithIVUScoregistrationHandsonFeaturedDevices:IVUSCoRegistrationonSyncVision

10:45_AM Topic3:VesselTreatmentPreparationCaseReviewFeaturedDevices:ELCALaserAtherectomyAngioSculpt

11:05_AM Topic4:VesselPreparationwithlaseratherectomyHandsonFeaturedDevices:ELCALaserAtherectomysimulation

11:25_AM ClosingAdjourn

TRAINING:ENDOVASCULARPAVILION#2-TIBIOPEDALACCESS

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

Page 66: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:66

10:00AM-11:30AM

BTK(TibiopedalAccess)SessionII

InteractiveTrainingFaculty:AliF.Aboufares,PhilipGreen,KarthikR.Gujja,SteveHenao,ArthurC.Lee,LuisMarianoPalena,JustinA.Ratcliffe,RamzanZakir

10:00_AM VideoIntroduction:TheNeedforGuidedAlternateAccessTibiopedalAntegrade

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#2-CARDIOGENICSHOCK(NCSI)

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

CardiogenicShock:TheNationalCardiogenicShockInitiative

10:00_AM NCSI:ImprovingOutcomesinCardiogenicShock InteractiveTrainingFaculty:WilliamW.O'Neill

10:30_AM ICUManagement:PositioningTroubleshootingEscalationHandsOn InteractiveTrainingFaculty:SalvatoreFMannino

11:00_AM TreatingtheShockPatient:ChoosingtheOptimalSupportDeviceHarviSimulationHandsOnPACUseandInterpretation InteractiveTrainingFaculty:NavinK.Kapur

TRAINING:INTERVENTIONALIMAGINGPAVILION#2-TRANS-SEPTALCROSSINGFORLAAUSINGTEEAND3DVOLUMEICE

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

10:00AM-11:30AM

Trans-septalCrossingforLAAUsingTEEand3DVolumeICE

InteractiveTrainingFaculty:IsaacGeorge,OmarK.Khalique,ChadKliger,BrijMaini,TamimNazif,TorstenP.Vahl

TRAINING:MEDTRONICPAVILION#2-PV-SFAINTERVENTIONINCOMPLEXLESIONS

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

PV-SFAInterventioninComplexLesions

InteractiveTrainingFaculty:SamerAbbas,S.HinanAhmed,DmitriyN.Feldman

10:00_AM Introduction

10:05_AM UnderstandingComplexLesionsintheSFAandTreatmentOptionsforyourPatients

10:45_AM HandsonRotationsPADManhandsonmodelwithDirectionalAtherectomy

TRAINING:TAVRPAVILION#2-UNDERSTANDINGTHVHEMODYNAMICSANDDURABILITY

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

UnderstandingTHVHemodynamicsandDurability

InteractiveTrainingFaculty:PamelaS.Douglas,RebeccaT.Hahn,VinodH.Thourani,NeilJ.Weissman

Page 67: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:67

TRAINING:ABBOTTPAVILION#3-GUIDEWIREDESIGNANDSELECTION:AHANDS-ONUSER'SGUIDETOGUIDEWIRETECHNOLOGY

SATURDAY,SEPTEMBER22,2018

12:00PM-1:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

GuidewireDesignandSelection:AHands-onUser'sGuidetoGuideWireTechnology

InteractiveTrainingFaculty:DavidDaniels,JackHall,AmirKaki,WilliamNicholson,RobertF.Riley

12:00_PM Introduction

12:05_PM DidacticonGuidewireBuildingBlocksandWHwires

12:15_PM HandsonWorkhorseWiresActivity

12:30_PM PolymerJacketedWiresOverviewandHandsonActivity

12:50_PM ExtraSupportSpecialtywiresOverviewandHandsonActivity

1:10_PM WigglewireOverviewandHandsonActivity

TRAINING:BOSTONSCIENTIFICPAVILION#3-OPTIMIZATIONOFDRUGELUTIONINTHESFA:RESULTSFROMTHEWORLD�S1STHEAD-TO-HEADDESTRIALINPVD�ELUVIAVSZILVERPTX

SATURDAY,SEPTEMBER22,2018

12:00PM-1:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

OptimizationofDrugElutionintheSFA:UpdateontheWorld�s1stHead-to-headDESTrialinPVD�EluviavsZilverPTXInteractiveTrainingFaculty:WilliamA.Gray,RobertA.Lookstein,CarlosI.Mena-Hurtado,SahilA.Parikh

12:00_PM WelcomeRemarks

12:05_PM ImperialClinicalTrialUpdateandTheScienceBehindEluvia

12:30_PM WhentoConsiderAtherectomyVesselPrepPriortoDrugElutingTherapies

12:45_PM PhysicianPanelDiscussion

TRAINING:MEDTRONICPAVILION#3-CORONARY:OPTIMIZINGOUTCOMESINPATIENTSWITHBIFURCATIONLESIONS

SATURDAY,SEPTEMBER22,2018

12:00PM-1:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

Coronary:OptimizingOutcomesinPatientsWithBifurcationLesions

InteractiveTrainingFaculty:AdrianP.Banning,FrancescoBurzotta,DavidHildick-Smith,JensFlenstedLassen

12:00_PM Introduction

12:05_PM BifurcationsaComplexLesionSubset

12:30_PM BifurcationTreatmentTechniques

1:00_PM TheLeftMain

1:15_PM CaseDiscussionsQA

TRAINING:ABBOTTPAVILION#4-SAVETHATSIDEBRANCH!PRESERVINGSIDEBRANCHACCESS:AHANDS-ONPRACTICALSKILLSLAB

Page 68: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:68

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

SaveThatSideBranch!PreservingSideBranchAccess:AHands-onPracticalSkillsLab

InteractiveTrainingFaculty:EmmanouilS.Brilakis,Jean-FrançoisTanguay,NickE.J.West,JasonWollmuth

2:00_PM Introduction

2:05_PM SBATechniqueOverviewandHandOnGuidedSessionTechnique1

2:45_PM SBATechniqueOverviewandHandOnGuidedSessionTechnique2

3:25_PM WrapUp

TRAINING:BOSTONSCIENTIFICPAVILION#4-OPTIMIZATIONOFDRUGELUTIONINTHESFA:RESULTSFROMTHEWORLD�S1STHEAD-TO-HEADDESTRIALINPVD�ELUVIAVSZILVERPTX

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

OptimizationofDrugElutionintheSFA:UpdateontheWorld�s1stHead-to-headDESTrialinPVD�EluviavsZilverPTXInteractiveTrainingFaculty:GaryM.Ansel,AnvarBabaev,WilliamA.Gray,CraigM.Walker

2:00_PM WelcomeRemarks

2:05_PM ImperialClinicalTrialUpdateandTheScienceBehindEluvia

2:30_PM WhentoConsiderAtherectomyVesselPrepPriortoDrugElutingTherapies

2:45_PM PhysicianPanelDiscussion

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#3-UNDERSTANDINGANDPREPARINGFORNEWSTRUCTURALHEARTDISEASE

INTERVENTIONS

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

UnderstandingandPreparingforNewStructuralHeartDiseaseInterventions

InteractiveTrainingFaculty:TilakPasala,RobertA.Quaife

TRAINING:ENDOVASCULARPAVILION#3-TIBIOPEDALACCESS

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

BTK(TibiopedalAccess)SessionIII

InteractiveTrainingFaculty:BeauHawkins,VishalKapur,TakW.Kwan,ArthurC.Lee,JunLi,FrancescoMaisano,S.JayMathews,KevinRogers

2:00_PM VideoIntroduction:TheNeedforGuidedAlternateAccessTibiopedalAntegrade

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#3-HEMODYNAMICSOFSHOCKANDHIGHRISKPCI

Page 69: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:69

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

TEACH:TrainingandEducationinAdvancedCardiovascularHemodynamics

2:00_PM TEACHIntro InteractiveTrainingFaculty:DanielBurkhoff

2:20_PM SimulatedCasesonHRPCIHandsOn InteractiveTrainingFaculty:JohnM.Lasala

3:00_PM SimulatedCasesonAMICGSHandsOn InteractiveTrainingFaculty:PerwaizM.Meraj

TRAINING:INTERVENTIONALIMAGINGPAVILION#3-TRANS-SEPTALCROSSINGFORMITRALUSINGTEEAND3DVOLUMEICE

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

2:00PM-3:30PM

Trans-septalCrossingforMitralUsingTEEand3DVolumeICE

InteractiveTrainingFaculty:RebeccaT.Hahn,OmarK.Khalique,ChadKliger,BrijMaini,TamimNazif,GaganDSingh,TorstenP.Vahl

TRAINING:MEDTRONICPAVILION#4-STRUCTURALHEART:FUNDAMENTALSOFCARDIACANATOMYANDIMAGINGCORRELATION

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

StructuralHeart:FundamentalsofCardiacAnatomyandImagingCorrelation

InteractiveTrainingFaculty:JoãoLCavalcante,BaselRamlawi

2:00_PM Introduction

2:05_PM AnatomyOverviewusingVariousImagingModalitiesforStructuralHeartProcedures

TRAINING:TAVRPAVILION#3-ADVANCINGEFFICIENCYINTAVR

SATURDAY,SEPTEMBER22,2018

2:00PM-3:30PM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

AdvancingEfficiencyinTAVR

InteractiveTrainingFaculty:DavidJ.Cohen,PatriciaKeegan,JamesL.Velianou,DavidA.Wood

TRAINING:ABBOTTPAVILION#5-LARGEBOREACCESSTOCLOSE:WHATYOUWANT(ANDNEED!!)TOKNOW

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

LargeBoreAccesstoClose:WhatYouWant(andNeed!!)toKnow

InteractiveTrainingFaculty:AdhirShroff

Page 70: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:70

4:00_PM Introduction:AccessPlanningandManagementofComplicationsReview

4:20_PM HandsonDeviceDeployment

TRAINING:BOSTONSCIENTIFICPAVILION#5-OPTIMIZATIONOFDRUGELUTIONINTHESFA:RESULTSFROMTHEWORLD�S1STHEAD-TO-HEADDESTRIALINPVD�ELUVIAVSZILVERPTX

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

OptimizationofDrugElutionintheSFA:UpdateontheWorld�s1stHead-to-headDESTrialinPVD�EluviavsZilverPTXInteractiveTrainingFaculty:SteveHenao,CarlosI.Mena-Hurtado,NicolasWShammas,CraigM.Walker

4:00_PM WelcomeRemarks

4:05_PM ImperialClinicalTrialUpdateandTheScienceBehindEluvia

4:30_PM WhentoConsiderAtherectomyVesselPrepPriortoDrugElutingTherapies

4:45_PM PhysicianPanelDiscussion

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#4-UNDERSTANDINGANDPREPARINGFORNEWSTRUCTURALHEARTDISEASE

INTERVENTIONS

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

UnderstandingandPreparingforNewStructuralHeartDiseaseInterventions

InteractiveTrainingFaculty:TilakPasala,RobertA.Quaife,DominikM.Wiktor

TRAINING:ENDOVASCULARPAVILION#4-TIBIOPEDALACCESS

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

BTK(TibiopedalAccess)SessionIV

InteractiveTrainingFaculty:GeorgeSChrysant,TonyDas,LarryJ.Diaz-Sandoval,VishalKapur,EthanCKorngold,TakW.Kwan,JunLi,S.JayMathews

4:00_PM VideoIntroduction:TheNeedforGuidedAlternateAccessTibiopedalAntegrade

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#4-COMPLEXPROTECTEDPCI

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

ComplexProtectedPCI

4:00_PM PatientIdentification InteractiveTrainingFaculty:HiramG.Bezerra

4:20_PM SimulatedCasesonHRPCIHandsOn InteractiveTrainingFaculty:MauricioG.Cohen,DuaneS.Pinto

4:55_PM InsertionRepositioning:HandsOn

Page 71: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:71

InteractiveTrainingFaculty:PaulD.Mahoney,AdhirShroff

TRAINING:INTERVENTIONALIMAGINGPAVILION#4-TRANS-SEPTALCROSSINGFORMITRALUSINGTEEAND3DVOLUMEICE

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

4:00PM-5:30PM

Trans-septalCrossingforMitralUsingTEEand3DVolumeICE

InteractiveTrainingFaculty:IsaacGeorge,OmarK.Khalique,ChadKliger,BrijMaini

TRAINING:MEDTRONICPAVILION#5-CORONARY:DOSIZEANDSHAPEMATTER?HOWTOCHOOSETHE�RIGHT�DIAGNOSTICANDGUIDECATHETERS?

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

Coronary:DoSizeandShapeMatter?HowtoChoosethe�Right�DiagnosticandGuideCatheters?InteractiveTrainingFaculty:MitchellW.Krucoff,SunilV.Rao

4:00_PM Introduction

4:05_PM CaseBasedLearning

4:45_PM QAandSimulatorHandson

TRAINING:TAVRPAVILION#4-HOWTOAPPROACHAORTICANDMITRALVALVE-IN-VALVE

SATURDAY,SEPTEMBER22,2018

4:00PM-5:30PM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

HowtoApproachAorticandMitralValve-in-Valve

InteractiveTrainingFaculty:VinayakBapat,BassemChehab,PaulD.Mahoney,JohnG.Webb

INTERNATIONALSESSION:CHALLENGINGPCICASESANDSCENARIOSINMYCOUNTRY,PRESENTEDBYTHEHONGKONGCOLLEGEOFCARDIOLOGY,

BANGLADESHSOCIETYOFCARDIOVASCULARINTERVENTION,TUNISIANWORKINGGROUPONINTERVENTIONALCARDIOLOGY(GTCI),EMIRATES

CARDIACSOCIETY

SATURDAY,SEPTEMBER22,2018

10:00AM-11:30AM

Room24A-B,UpperLevel

10:00AM-10:45AM

SessionI.GiantThrombusDuringPrimaryPCIinSTEMI

Moderators:Ngai-YinChan,AfzalurRahman

Discussants:KhaldounBenHamda,HabibGamra,NamMomenuzzaman,AbdullahShehab

10:00_AM Introduction Lecturers:AfzalurRahman

10:05_AM Introduction:ACaseofaVeryLargeandPersistentThrombus Lecturers:Kam-TimChan

10:10_AM HowWouldITreatThisCase Lecturers:KaisarNasrullahKhan

10:15_AM HowDidIActuallyTreatThisCase Lecturers:Kam-TimChan

Page 72: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:72

10:20_AM RoundtableDiscussionWithAudienceQA Lecturers:NamMomenuzzaman

10:25_AM Introduction:ACaseofNoReflowDuringPrimaryPCI Lecturers:AfzalurRahman

10:30_AM HowWouldITreatThisCase Lecturers:ChrisKwokYiuWong

10:35_AM HowDidIActuallyTreatThisCase Lecturers:AfzalurRahman

10:40_AM RoundtableDiscussionWithAudienceQA Lecturers:Ngai-YinChan

10:45AM-11:30AM

SessionII:PrimaryPCIforSTEMIinPatientsWithMultivesselDisease

Moderators:KhaldounBenHamda,HabibGamra,AbdullahShehab

Discussants:Ngai-YinChan,NamMomenuzzaman,AfzalurRahman

10:45_AM Introduction:APatientWithSTEMIandMultivesselDisease Lecturers:ArifAlNooryani

10:50_AM HowWouldITreatThisCase Lecturers:KaisBattikh

10:55_AM HowDidIActuallyTreatThisPatient Lecturers:ArifAlNooryani

11:00_AM RoundtableDiscussionWithAudienceQA Lecturers:AbdullahShehab

11:05_AM Introduction:APatientWithSTEMIandMultivesselDisease Lecturers:KaisBattikh

11:10_AM HowWouldITreatThisPatient Lecturers:ArifAlNooryani

11:15_AM HowDidIActuallyTreatThisPatient Lecturers:KaisBattikh

11:20_AM RoundtableDiscussionWithAudienceQA Lecturers:AbdullahShehab

11:25_AM ConclusionsandTakehomeMessages Lecturers:HabibGamra

INTERNATIONALSESSION:PRESENTANDFUTURETREATMENTOFCTOANDTRUEBIFURCATIONLESIONSPRESENTEDBYTHECZECHASSOCIATIONOF

INTERVENTIONALCARDIOLOGY,SLOVAKSOCIETYOFCARDIOLOGY,GERMANSOCIETYOFCARDIOLOGYANDTHEPOLANDCARDIACSOCIETY

SATURDAY,SEPTEMBER22,2018

10:30AM-12:30PM

Room24C,UpperLevel

10:30AM-11:30AM

SessionI.TrueCoronaryBifurcationLesions

Moderators:PetrKala,JochenWöhrle

Discussants:DariuszDudek,MartinHudec,WojtekWojakowski

10:30_AM Introduction:CzechRepublicWojwi Lecturers:PetrKala

10:35_AM SlovakiaPresents:IntroducingaComplexCaseWithaTrueBifurcationLesion CasePresenter:MilanDragula

10:45_AM GermanyComments:HowWouldITreatThisCase CasePresenter:MichaelHaude

10:52_AM SlovakiaPresents:HowDidITreatThisCase CasePresenter:MilanDragula

10:59_AM SlovakiaPresents:CurrentKnowledgeApproachtoTrueBifurcationLesions CasePresenter:AntonFarkas

11:05_AM PolandPresents:IntroducingaCaseofaVeryComplexTrueBifurcationLesion CasePresenter:StanislawBartus

11:12_AM CzechRepublicComments:HowWouldITreatThisCase CasePresenter:PavelCervinka

11:19_AM PolandPresents:HowDidITreatThisCase CasePresenter:StanislawBartus

Page 73: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:73

11:25_AM ConclusionandTakeHomeMessages Lecturers:JochenWöhrle

11:30AM-12:30PM

SessionII.ChronicTotalOcclusions

Moderators:MartinHudec,WojtekWojakowski

Discussants:PetrKala

11:30_AM Introduction Lecturers:WojtekWojakowski

11:35_AM GermanyPresents:PresentandFutureStrategiesforRecanalizatingChronicCoronaryTotalOcclusions Lecturers:MohamedAbdel-Wahab

11:45_AM CzechRepublicPresents:IntroducingaComplexChronicTotalOcclusion CasePresenter:VojtechNovotny

11:52_AM PolandComments:HowWouldITreatThisCase CasePresenter:WojtekWojakowski

11:59_AM CzechRepublicPresents:HowDidITreatThisCase CasePresenter:VojtechNovotny

12:05_PM GermanyPresents:IntroducingaComplexChronicTotalOcclusion CasePresenter:JuliaSeeger

12:12_PM SlovakiaComments:HowWouldITreatThisCase CasePresenter:MartinHudec

12:19_PM GermanyPresents:HowDidITreatThisCase CasePresenter:JuliaSeeger

12:25_PM ConclusionandTakeHomeMessages Lecturers:MartinHudec

INTERNATIONALSESSION:MANAGEMENTSTRATEGIESINPCIPATIENTSATHIGHBLEEDINGRISKPRESENTEDBYTHEWORKINGGROUPONINVASIVE

ANDINTERVENTIONALCARDIOLOGY,CROATIANCARDIACSOCIETY,WORKINGGROUPONINTERVENTIONALCARDIOLOGY,BELGIANWORKING

GROUPOFINTERVENTIONALCARDIOLOGY(BWGIC),AUSTRIANSOCIETYOFCARDIOLOGY,WORKINGGROUPOFINTERVENTIONALCARDIOLOGY,

ANDBELARUSWORKINGGROUPOFINTERVENTIONALCARDIOLOGY

SATURDAY,SEPTEMBER22,2018

1:30PM-3:30PM

Room24C,UpperLevel

1:30PM-3:30PM

ManagementStrategiesinPCIPatientsatHighBleedingRisk

Moderators:WalterDesmet,GuyJ.Friedrich

Discussants:KurtHuber,EduardMargetic,OlegPolonetsky

1:30_PM CasePresentation:ChronicOralAnticoagulantandAntiplateletManagementDecisions CasePresenter:GuyJ.Friedrich

1:50_PM BleedingRiskandManagementStrategiesinElderlyPatientsonChronicOralAnticoagulation Lecturers:KurtHuber

2:10_PM CanIntracoronaryImagingGuideAntithromboticStrategy Lecturers:EduardMargetic

2:30_PM IsThereStillaRoleforTripleTherapyBasedonRecentStudies Lecturers:WalterDesmet

2:50_PM ChronicOralAnticoagulationAfterStenting:StrategyinBelarus Lecturers:OlegPolonetsky

3:10_PM RoundtableDiscussionWithAudienceQA

INTERNATIONALSESSION:CHIPINTERVENTIONS-WORSTSCENARIOSANDBESTSAVESAROUNDTHEWORLD,PRESENTEDBYTHEINTERNATIONAL

SOCIETIESOFEGYPT,KUWAIT,MALAYSIA,COLUMBIA,ANDUKRAINE

SATURDAY,SEPTEMBER22,2018

3:30PM-5:00PM

Room24A-B,UpperLevel

3:30PM-5:00PM

Page 74: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:74

CHIPInterventions:WorstScenariosandBestSavesAroundTheWorld

Moderators:AhmedMagdy

Discussants:MagdyAbdelhamid,MohammadAl-Mutairi,MaximSokolov,JorgeVillegas,RobaayahZambahari

3:30_PM IntroductionandSessionGoals Lecturers:AhmedMagdy

3:32_PM EgyptPresentstoMalaysia:ChallengesandStrategiesforComplexCTOInterventionWithCaseStudies CasePresenter:AmrElHadidy

3:40_PM InformalComments:MalaysiaRespondstoEgyptonComplexCTOInterventions Lecturers:RameshSinghArjanSingh

3:44_PM RoundtableDiscussionWithAudienceQA

3:49_PM KuwaitPresentstoColumbia:ComplexLeftMainInterventionWithSevereLVDysfunctionWithCaseStudies CasePresenter:KhaledAlmerri

3:57_PM InformalComments:ColumbiaRespondstoKuwaitonHighRiskComplexLeftMainIntervention Lecturers:PabloDarioCharryAmaya

4:01_PM RoundtableDiscussionWithAudienceQA

4:06_PM MalaysiaPresentstoUkraine:PrimaryPCIinSTEMIPatientWithAneurysmalCADandExtensiveThrombusWithCaseStudies CasePresenter:WanAzmanWanAhmad

4:14_PM InformalComments:UkraineRespondstoMalaysiaonComplexPrimaryPCIinSTEMI Lecturers:LiliyaSorokhtey

4:18_PM RoundtableDiscussionWithAudienceQA

4:23_PM ColombiaPresentstoEgypt:UnexpectedPCIComplicationsWithCaseStudies CasePresenter:JorgeVillegas

4:31_PM InformalComments:EgyptRespondstoColumbiaonUnexpectedPCIComplications Lecturers:AdelElEtriby

4:35_PM RoundtableDiscussionWithAudienceQA

4:40_PM UkrainePresentstoKuwait:HowtoManageHugeThrombusinSTEMIWithCaseStudies CasePresenter:MaximSokolov

4:48_PM InformalComments:KuwaitRespondstoUkraineonManagementofExtensiveThrombusDuringSTEMIPCI Lecturers:MohammadAl-Mutairi

4:52_PM RoundtableDiscussionWithAudienceQA

4:57_PM WrapupandTakehomeMessages Lecturers:AhmedMagdy

INTERNATIONALSESSION:PCI2018-AREWEDOINGTHINGSBETTERTHANWEDID10YEARSAGO?PRESENTEDBYSOUTHAFRICANSOCIETYOF

CARDIOVASCULARINTERVENTION(SASCI),ISRAELIWORKINGGROUPFORINTERVENTIONALCARDIOLOGY,ITALIANSOCIETYOFINVASIVE

CARDIOLOGY(GISE),ANDIRELANDCARDIACSOCIETY

SATURDAY,SEPTEMBER22,2018

3:30PM-5:00PM

Room24C,UpperLevel

3:30PM-5:00PM

PCI2018:AreWeDoingthingsBetterThanWeDid10YearsAgo?

Moderators:DavidBurke,GrahamA.Cassel,HaimDanenberg,GiuseppeTarantini

Discussants:YaronAlmagor,RiazSDawood,ArielFinkelstein,JacopoA.Oreglia,ItaloPorto

3:30_PM SessionObjectives:ChallengesandInnovationsintheTreatmentofComplexCoronaryLesions Lecturers:HaimDanenberg

3:33_PM IsraelPresentsaCase:ComplexLeftMainCoronaryLesionReadyforPCI CasePresenter:YaronAlmagor

3:41_PM RoundtableDiscussionWithAudienceQA

3:47_PM ItalyPresentsaCase:TrueBifurcationLesionHaveWeGottenAnyBetter CasePresenter:ItaloPorto

3:55_PM RoundtableDiscussionWithAudienceQA

4:01_PM IrelandPresentsaCase:AnIntermediateLesionHowtoMaketheRightDecision CasePresenter:DavidBurke

4:09_PM RoundtableDiscussionWithAudienceQA

Page 75: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:75

4:15_PM IsraelPresentsaCase:AHighlyCalcifiedLesionCanWeBeattheConcrete CasePresenter:ArielFinkelstein

4:23_PM RoundtableDiscussionWithAudienceQA

4:29_PM ItalyPresentsaCase:CTOPCIWhatsNew CasePresenter:JacopoA.Oreglia

4:37_PM RoundtableDiscussionWithAudienceQA

4:43_PM SouthAfricaPresentsaCase:HighThrombusBurdenHowtoTreatWithoutExtendingtheDamage CasePresenter:RiazSDawood

4:51_PM RoundtableDiscussionWithAudienceQA

4:57_PM ClosingRemarksandTakehomemessages Lecturers:GiuseppeTarantini

ORALABSTRACTS:HIGHESTPEER-REVIEWEDORALABSTRACTSOFTCT2018-SPONSOREDBYCCIANDEUROINTERVENTION

SATURDAY,SEPTEMBER22,2018

8:30AM-10:30AM

Room29A-B,UpperLevel

8:30AM-10:30AM

HighestPeer-ReviewedOralAbstractsofTCT2018-SponsoredbyCCIandEuroIntervention

Moderators:StevenR.Bailey,PatrickW.Serruys

Discussants:MichaelJ.Cowley,GeorgeD.Dangas,VasimFarooq,MarcD.Feldman,TedFeldman,GlennVanLangenhove

8:30_AM TCT1:OptimalDurationofDualAntiplateletTherapyAfterLeftMainCoronaryStentingWithEverolimusElutingStents:AnalysisFromtheEXCELTrial Lecturers:SorinJ.Brener

8:40_AM RoundtableDiscussionwithAudienceQA

8:45_AM TCT2:DeepIVUS:AMachineLearningFrameworkforFullyAutomaticIVUSSegmentation Lecturers:DavidMolony

8:55_AM RoundtableDiscussionwithAudienceQA

9:00_AM TCT3:TheLutonixGlobalDrugCoatedBalloonRegistryRealWorldPatientsWithBelowtheKneeDiseaseInterim12MonthOutcomes Lecturers:JihadMustapha

9:10_AM RoundtableDiscussionwithAudienceQA

9:15_AM TCT4:ReductionofStrokeWithUseoftheDoubleFilterCerebralEmbolicProtectionDeviceinPatientsUndergoingTransfemoralAorticValve

ReplacementWithSelfExpandableMechanicallyImplantableAndBalloonExpandableAorticValves Lecturers:JuliaSeeger

9:25_AM RoundtableDiscussionwithAudienceQA

9:30_AM TCT5:LongtermPreclinicalinVivoResultsWithaRestorativeAorticValve Lecturers:ChristianM.Spaulding

9:40_AM RoundtableDiscussionwithAudienceQA

9:45_AM TCT6:TheCENTERCollaboration:OutcomesinPatientsUndergoingTransfemoralTranscatheterAorticValveImplantationWithBalloonExpandable

ValvesversusSelfExpandableValves. Lecturers:RonakDelewi

9:55_AM RoundtableDiscussionwithAudienceQA

10:00_AM TCT7:PredictorsandOutcomesofAbortedProceduresDuringElectiveTranscatheterAorticValveReplacement Lecturers:JenniferRymer

10:10_AM RoundtableDiscussionwithAudienceQA

10:15_AM TCT8:FateOfDeferredLesionsUsingStateOfArtPercutaneousCoronaryRevascularizationInPatientsWithDeNovoThreeVesselDisease:LesionLevel

AnalysisAt2YearsOfTheSYNTAXIIStudy Lecturers:NorihiroKogame

10:25_AM RoundtableDiscussionwithAudienceQA

MODERATEDPOSTERSESSION:ABSORBBIORESORBABLEVASCULARSCAFFOLDSTUDIES

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

Page 76: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:76

8:30AM-9:30AM

ABSORBBioresorbableVascularScaffoldStudies

Moderators:DetlefG.Mathey,YoshinobuOnuma

Discussants:RafaDepukat,VasimFarooq,JuanLuisGutierrez-Chico,UlfLandmesser,MatthiasLutz

8:30_AM TCT156:TheAbsorbBioresorbableVascularScaffoldsDemonstrateLowerWallShearStressComparedtoMetallicXienceVInterimAnalysisFromthe

ABSORBIIIImagingStudy Lecturers:ArnavKumar

8:37_AM Discussion

8:42_AM TCT157:PathologicalVascularHealingFollowingComplexInterventionsWiththeAbsorbBioresorbableVascularScaffold Lecturers:JohanRBennett

8:49_AM Discussion

8:54_AM TCT158:PostimplantationStrutProtrusionandNeointimalThicknessatFollowUpinAbsorbBioresorbableScaffold:aSerialShearStressAnalysisUpto

FiveYears Lecturers:ErhanTenekecioglu

9:01_AM Discussion

9:06_AM TCT159:EndothelialShearStressandLocalViscosityAssessmentofCoronaryBioresorbableScaffoldAFiveYearFollowUp Lecturers:ErhanTenekecioglu

9:13_AM Discussion

9:18_AM TCT160:AttenuatedSignalPlaqueandLongTermVesselResponseAfterBioresorbableScaffoldImplantation:IVUSInsightsFromtheABSORBJapanTrial Lecturers:KozoOkada

9:25_AM Discussion

MODERATEDPOSTERSESSION:ACUTEKIDNEYINJURYDURINGPERCUTANEOUSINTERVENTIONS(PCIORTAVR)I

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

8:30AM-9:30AM

AcuteKidneyInjuryDuringPercutaneousInterventions(PCIorTAVR)I

Moderators:AntonioL.Bartorelli,EugeniaNikolsky

Discussants:ZiadA.Ali,JuliaBaron,WolfgangBocksch,CarloBriguori,GrahamA.Cassel,JosedeRibamarCostaJr,HitinderS.Gurm,JohnA.Spertus

8:30_AM TCT126:PercutaneousCoronaryInterventionofChronicTotalOcclusionsIsNotAssociatedWithaHigherRiskforContrastInduced

NephropathyComparedtoRevascularizationofNonOcclusiveStenoses Lecturers:OzanDemir

8:37_AM Discussion

8:42_AM TCT127:PlatelettoLymphocyteRatioNeutrophiltoLymphocyteRatioandRedCellDistributionWidthAsPredictorsofContrastInducedAcuteKidney

InjuryFollowingCoronaryAngiography Lecturers:JayakumarSreenivasan

8:49_AM Discussion

8:54_AM TCT128:ContrastInducedAcuteKidneyInjuryAfterPercutaneousCoronaryIntervention:ComparisonofFiveContrastMedia Lecturers:LorenzoAzzalini

9:01_AM Discussion

9:06_AM TCT129:EfficacyofUrinaryLiverTypeFattyAcidBindingProteinLevelforPatientsWithAcuteKidneyInjuryFollowingCoronaryAngiographyinAcute

CoronarySyndrome Lecturers:KeisukeKojima

9:13_AM Discussion

9:18_AM TCT130:TheRoutineUseofanIsoOsmolarContrastMediumandtheOccurrenceofAcuteKidneyInjuryFollowingPercutaneousCoronaryIntervention

forSTElevationMyocardialInfarction Lecturers:TimKinnaird

9:25_AM Discussion

MODERATEDPOSTERSESSION:BESTOFMODERATEDTAVRPOSTERABSTRACTSI

Page 77: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:77

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

8:30AM-9:30AM

BestofModeratedTAVRPosterAbstractsI

Moderators:JohnC.Messenger,VinodH.Thourani

Discussants:HemalGada,AaronHorne,Jr.,ZoltanG.Turi,DarrenL.Walters,Wei-HsianYin,KarolZbronski

8:30_AM TCT121:aHighlyPredictiveModelforNewPermanentPacemakerImplantationAfterTranscatheterAorticValveReplacementWithContemporarySelf

ExpandingValves:ImportanceoftheMembranousSeptumLength Lecturers:Zhen-GangZhao

8:37_AM Discussion

8:42_AM TCT122:AcuteKidneyRecoveryAfterTranscatheterAorticValveReplacement:aReportFromtheNorthernNewEnglandCardiovascularDiseaseStudy

Group Lecturers:AmirAzarbal

8:49_AM Discussion

8:54_AM TCT123:ImpactofDeliriumonTAVROutcomes Lecturers:BrettHiendlmayr

9:01_AM Discussion

9:06_AM TCT124:ImpactofLevelofAnaesthesiaUsingtheVancouverClinicalPathwayforTranscatheterAorticValveReplacement:InsightsFromthe3MTAVR

Study Lecturers:JanarthananSathananthan

9:13_AM Discussion

9:18_AM TCT125:EvaluationofEKGGatedandDualSourceAcceleratedComputedTomographyImagingProtocolsforTranscatheterAorticValveSizing Lecturers:NikolaosKakouros

9:25_AM Discussion

MODERATEDPOSTERSESSION:CATHETER-BASEDTREATMENTOFPERIPHERALVASCULARDISEASEI

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

8:30AM-9:30AM

Catheter-basedTreatmentofPeripheralVascularDiseaseI

Moderators:MarkC.Bates,WilliamA.Gray

Discussants:JeffreyG.Carr,AlejandroGoldsmit,BeauHawkins,SchuylerJones

8:30_AM TCT131:HemopericardiumandCardiacTamponadeAsaComplicationofVenaCavalFilters:SystematicReviewofPublishedLiteratureandtheMAUDE

Database Lecturers:BehnoodBikdeli

8:37_AM Discussion

8:42_AM TCT132:BalloonExpandableePTFECoveredStentforObstructiveLesionsintheIliacArtery:24MonthResultsFromtheBOLSTERTrial Lecturers:GeorgiosBouras

8:49_AM Discussion

8:54_AM TCT133:ThirtyDayReadmissionsAfterMedicalvsEndovascularTherapyforAtheroscleroticRenalArteryStenosisInsightsFromtheNational

ReadmissionsDatabase Lecturers:DavidLouis

9:01_AM Discussion

9:06_AM TCT134:UrinaryLeukotrieneE4InnovativeToolinPrognosingRecurringRestenosisinPatientsUndergoingEndovascularTreatmentDuetoLowerLimb

Ischemia Lecturers:MikolajMaga

9:13_AM Discussion

9:18_AM TCT135:ImpactofClinicalFrailtyinPatientsWithPeripheralArteryDisease:FromIPADRegistry Lecturers:TomoakiMochidome

9:25_AM Discussion

Page 78: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:78

MODERATEDPOSTERSESSION:COMORBIDITIESINCADI

SATURDAY,SEPTEMBER22,2018

8:30AM-9:18AM

ModeratedPosters6,ExhibitHall,GroundLevel

8:30AM-9:18AM

ComorbiditiesinCAD-I

Moderators:AndreaAbizaid,CarlL.Tommaso

Discussants:RashaAl-Lamee,MesferAlfadhel,MarkGoldberger,RajivGulati,MichelR.LeMay

8:30_AM TCT147:HighWattageElectronicCigaretteVapingAfterCoronaryStentingInducesArterialHypoxemia:aRandomizedClinicalTrial Lecturers:NadiaDebbas

8:37_AM Discussion

8:42_AM TCT148:AnInternationalAnalysesof122610NSTEMIPatientsWith5YearOutcomes:AssessingtheinfluenceofAgeandComorbiditiesoninvasivelyVs

MedicallyManagedPatientsBetween2004and2014 Lecturers:PhilipFreeman

8:49_AM Discussion

8:54_AM TCT149:TheEffectofChronicObstructivePulmonaryDiseaseonPatientsWithNonSTSegmentElevationMyocardialInfarctiona2014Nationwide

Analysis Lecturers:MariamKhandaker

9:01_AM Discussion

9:06_AM TCT150:CardiovascularDiseaseandPercutaneousCoronaryInterventioninHematologicalMalignanciesKnowledgeIsPower Lecturers:DavidBoone

9:13_AM Discussion

MODERATEDPOSTERSESSION:INTRACORONARYPHYSIOLOGYSTUDIESI

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

8:30AM-9:30AM

IntracoronaryPhysiologyStudiesI

Moderators:ColinBerry,RobertJ.Gil

Discussants:TakashiAkasaka,JooMyungLee,GiampaoloNiccoli,HidetakaNishina,SayanSen

8:30_AM TCT151:InstantaneousWaveFreeRatioFractionalFlowReserveDiscordanceIstheWaveFreePeriodTrulyWaveFree Lecturers:MarkMills

8:37_AM Discussion

8:42_AM TCT152:ClinicalPredictorsofDiscordanceBetweeninstantaneousWaveFreeRatioandFractionalFlowReserve Lecturers:HidekuniKirigaya

8:49_AM Discussion

8:54_AM TCT153:ReducingtheNeedforInvasivePressureWireAssessmentinPatientsUsingaNovelAngiographicScoringTool Lecturers:MichaelMichail

9:01_AM Discussion

9:06_AM TCT154:DiagnosticAccuracyofiFRvsFFRintheLeftvsRightCoronaryArtery Lecturers:AnkitaGore

9:13_AM Discussion

9:18_AM TCT155:TheFFRiFRDiscrepanciesandTheirPossibleReasonsFindingsFromtheCzechJapanFFRiFRRegistry Lecturers:TomasKovarnik

9:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRRISKSTRATIFICATIONANDOUTCOMESI

Page 79: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:79

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

8:30AM-9:30AM

TAVRRiskStratificationandOutcomesI

Moderators:MartinaKellySpeight,CorradoTamburino

Discussants:HolgerM.Nef,ElizabethM.Perpetua,AlexeyProtopopov,TobyRogers,AmitSegev,KimberlyA.Skelding

8:30_AM TCT141:OneYearReadmissionsAfterTranscatheterAorticValveImplantation Lecturers:MouradSenussi

8:37_AM Discussion

8:42_AM TCT142:ThirtyDayReadmissionsAfterEarlyvsDelayedDischargeforTranscatheterAorticValveReplacementInsightsFromtheNationwide

ReadmissionsDatabase Lecturers:MohamedOmer

8:49_AM Discussion

8:54_AM TCT143:HigherInstitutionalTAVRVolumeReducesIndexMortalityButDoesNotImpactReadmissionOutcomes Lecturers:HanningXing

9:01_AM Discussion

9:06_AM TCT144:ImpactofBaselineLeftVentricularEjectionFractiononClinicalOutcomesFollowingTranscatheterAorticValveReplacementforSevereAortic

Stenosis Lecturers:OsungKwon

9:13_AM Discussion

9:18_AM TCT145:NonagenariansWithSevereAorticStenosisHaveComparableMortalityOutcomesAtOneYearComparedtoNonNonagenariansWithSevere

AorticStenosisPostTAVR Lecturers:KhaderHerzallah

9:25_AM Discussion

MODERATEDPOSTERSESSION:TECHNICALASPECTSOFCTOINTERVENTIONSI

SATURDAY,SEPTEMBER22,2018

8:30AM-9:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

8:30AM-9:30AM

TechnicalAspectsofCTOInterventionsI

Moderators:MargaretB.McEntegart,SunaoNakamura

Discussants:LeiGe,PaulKnaapen,MarinPostu,AlexandreSchaanQuadros,SudhirRathore

8:30_AM TCT136:ImpactofSwitchTimeBetweenCTOCrossingStrategies Lecturers:OlegKrestyaninov

8:37_AM Discussion

8:42_AM TCT137:FiveYearClinicalOutcomesforResoluteZotarolimusElutingStentsinTotalOcclusions Lecturers:SigmundSilber

8:49_AM Discussion

8:54_AM TCT138:ComparisonBetweenTraditionalandGuideCatheterExtensionReverseCartInsightsFromtheProgressCTORegistry Lecturers:IosifXenogiannis

9:01_AM Discussion

9:06_AM TCT139:UseofAtherectomyinChronicTotalOcclusionIntervention:InsightsFromthePROGRESSCTORegistry Lecturers:IosifXenogiannis

9:13_AM Discussion

9:18_AM TCT140:LongTermClinicalOutcomesAfterStentImplantationinChronicTotalOcclusionLesions:ImpactofFirstGenerationvsSecondGenerationDrug

ElutingStents Lecturers:HiroyukiTanaka

9:25_AM Discussion

Page 80: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:80

MODERATEDPOSTERSESSION:BESTOFMODERATEDPCIPOSTERABSTRACTSI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

9:30AM-10:18AM

BestofModeratedPCIPosterAbstractsI

Moderators:DavidF.Kong,StefanMot

Discussants:AntonioFiarresga,NingGuo,JavaidIqbal,FahimHaiderJafary,HossamI.Kandil,TalibMajwal

9:30_AM TCT166:PredictorsofTargetLesionRevascularizationAfterImplantationofSecondGenerationDrugElutingStentsinRandomizedTrialsandtheReal

worldAnalysisFromTwoLargeDatasets Lecturers:BehnoodBikdeli

9:37_AM Discussion

9:42_AM TCT167:InHospitalOutcomesofUsingtheHybridApproachofPercutaneousCoronaryInterventionsforChronicTotalOcclusions:UpdateFromthe

PROGRESSCTOPROspectiveGlobalREgiStryfortheStudyofChronicTotalOcclusionInterventionInternational Lecturers:PeterTajti

9:49_AM Discussion

9:54_AM TCT169:Serial3DimensionalOpticalCoherencetomographyAssessmentofJailedSideBranchBySecondGenerationDrugElutingAbsorbableMetal

ScaffoldDREAMS2GinBIOSOLVEIITrial Lecturers:YuichiOzaki

10:01_AM Discussion

10:06_AM TCT170:ImpactofRateofRecruitmentonAllCauseMortality:InsightsFromtheGLOBALLEADERSAllComersTrial Lecturers:KuniakiTakahashi

10:13_AM Discussion

MODERATEDPOSTERSESSION:CARDIOGENICSHOCKANDVENTRICULARASSISTI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

9:30AM-10:30AM

CardiogenicShockandVentricularAssistI

Moderators:BernadetteS.Speiser,DavidX.Zhao

Discussants:BrianClapp,DavidDIsraeli,MichaelJ.Lim,JohnA.McPherson

9:30_AM TCT176:CatheterBasedPercutaneousLeftVentricularAssistDeviceDeactivationACaseSeriesFromaTertiaryCareCenter Lecturers:ArifAlbulushi

9:37_AM Discussion

9:42_AM TCT177:ComparisonofPercutaneousandSurgicalRightVentricularAssistDeviceSupportFollowingDurableLeftVentricularAssistDeviceinsertion Lecturers:EllieCoromilas

9:49_AM Discussion

9:54_AM TCT178:TemporalTrendsintheUtilizationofRightHeartCatheterizationRHCAmongRecipientsofPercutaneousVentricularAssistDevicePVASin

AcuteMyocardialInfarctionComplicatedByCardiogenicShockAMICS Lecturers:NikhilNalluri

10:01_AM Discussion

10:06_AM TCT179:TrendsandOutcomesintheTreatmentofCardiogenicShockandUseofMechanicalCirculatorySupportintheUnitedStates Lecturers:JadOmran

10:13_AM Discussion

10:18_AM TCT180:IncidenceandOutcomesofCardiogenicShockComplicatingInferiorvsAnteriorSTElevationMyocardialInfarction Lecturers:MichaelWeinreich

10:25_AM Discussion

MODERATEDPOSTERSESSION:CHRONICPULMONARYEMBOLISMANDPULMONARYHYPERTENSION

Page 81: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:81

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

9:30AM-10:30AM

ChronicPulmonaryEmbolismandPulmonaryHypertension

Moderators:OriBen-Yehuda,NickH.Kim

Discussants:DanielR.Bensimhon,TeresaL.Carman,MahirElder,J.StephenJenkins,PeterP.Monteleone,ThomasM.Tu,JoachimWeil

9:30_AM TCT161:EndovascularDevicetoImprovePulmonaryArterialComplianceinPulmonaryArterialHypertension Lecturers:IreneM.Lang

9:37_AM Discussion

9:42_AM TCT162:FeasibilityofChronicTotalOcclusionRecanalizationDuringBalloonPulmonaryAngioplasty Lecturers:SanjumSSethi

9:49_AM Discussion

9:54_AM TCT163:TheAnalysisofSafetyandEffectivenessofBalloonPulmonaryAngioplastyforChronicThromboembolicPulmonaryHypertensionWhichHas

indicationforSurgicalTherapy Lecturers:ShunMinatsuki

10:01_AM Discussion

10:06_AM TCT164:BalloonPulmonaryAngioplastyforTotalOcclusionLesions:theSuccessRateandLongTermPatencyRatesDependsontheDifficultyin

PenetratingtheGuideWireoftheOcclusionSite Lecturers:HirotoShimokawahara

10:13_AM Discussion

10:18_AM TCT165:SafetyofBalloonPulmonaryAngioplastyforChronicThromboembolicPulmonaryHypertensionInitialSingleCenterUnitedStatesExperience Lecturers:AlessandroMaolo

10:25_AM Discussion

MODERATEDPOSTERSESSION:CORONARYCALCIFICATIONI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

9:30AM-10:30AM

CoronaryCalcificationI

Moderators:DeanJ.Kereiakes,GertRichardt

Discussants:AkramIbrahim,AdamJanas,SamuelKMathew,NishPatel

9:30_AM TCT185:GlasgowRotationalAtherectomyEfficiencyGRACEStudy:SafetyofaMinimalistApproach Lecturers:TomJFord

9:37_AM Discussion

9:42_AM TCT186:DeterminantsofPoorInHospitalClinicalSuccessofRotationalAtherectomy Lecturers:PiotrKubler

9:49_AM Discussion

9:54_AM TCT187:PeriproceduralComplicationsandProceduralEffectivenessinDiabeticsandNonDiabeticsTreatedWithPercutaneousCoronaryInterventions

andRotablation Lecturers:RafaJanuszek

10:01_AM Discussion

10:06_AM TCT188:CulpritLesionHarbouringCalcifiedNodulePredictsAHigherTargetLesionRevascularizationRateAfterPCIWith2NdgenerationDrugEluting

StentinACSPatients:FindingsFromSerialCoronaryAngiographyStudy Lecturers:HirokiSugane

10:13_AM Discussion

10:18_AM TCT189:ExtendingApplicationofIntravascularLithotripsytoAHighRiskRealWorldPopulation Lecturers:JulianYeoh

10:25_AM Discussion

Page 82: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:82

MODERATEDPOSTERSESSION:DESVSDESI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

9:30AM-10:30AM

DESvsDESI

Moderators:SalvatoreCassese,JohnA.Ormiston

Discussants:SripalBangalore,GiuseppeDeLuca,VergheseMathew,Duk-WooPark

9:30_AM TCT195:UltrathinBioresorbablePolymerSirolimusElutingStentsvsThinDurablePolymerEverolimusElutingStentsinPatientsUndergoingCoronary

Revascularization:TwoYearOutcomesFromtheRandomizedBIOFLOWVTrial Lecturers:DavidE.Kandzari

9:37_AM Discussion

9:42_AM TCT196:BiodegradablevsPolymerFreeDrugElutingStentsfortheTreatmentofCoronaryArteryDisease:AMetaAnalysisofRandomizedControlled

Trials Lecturers:JasonNogic

9:49_AM Discussion

9:54_AM TCT197:EarlyVascularHealingAfterImplantationofABiolimusCoatedBiofreedomStentOrASirolimusElutingOrsiroStentinPatientsWithST

SegmentElevationMyocardialInfarction Lecturers:KirstineHansen

10:01_AM Discussion

10:06_AM TCT198:ComparingLongTermOutcomesofFirstGenerationandSecondGenerationDrugElutingStentsinPatientsWithCoronaryArteryDisease Lecturers:ParthParikh

10:13_AM Discussion

10:18_AM TCT199:ComparisonofRidaforolimusElutingandZotarolimusElutingCoronaryStentsinPatientsWithLongLesions:1YearOutcomesFromthe

RandomizedBIONICSTrial Lecturers:DavidE.Kandzari

10:25_AM Discussion

MODERATEDPOSTERSESSION:INTRAVASCULARIMAGING,PCI,ANDLONG-TERMOUTCOMESI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

9:30AM-10:30AM

IntravascularImaging,PCI,andLong-TermOutcomesI

Moderators:MassoudA.Leesar,JoseM.delaTorreHernandez

Discussants:DavidErlinge,AnandMRao,TakafumiUeno

9:30_AM TCT190:ComparisonofMidTermClinicalOutcomesBetweenOptimalFrequencyDomainImagingGuidedandintravascularUltrasoundGuided

PercutaneousCoronaryInterventionWith2NdGenerationDrugElutingStentsinStableAnginaPectoris Lecturers:HiroakiMatsuda

9:37_AM Discussion

9:42_AM TCT191:ImpactofPostProceduralMinimalStentAreaByIVUSon2YearOutcomeAfterPCIintheSYNTAXIITrial Lecturers:YukiKatagiri

9:49_AM Discussion

9:54_AM TCT192:theComparisonofHealing1Monthand1YearAfterPercutaneousCoronaryInterventionAmongCobaltChromiumEverolimusElutingStentEES

BiodegradablePolymerBPEESandBPSirolimusElutingStent:InsightsFromOpticalCoherenceTomographyan Lecturers:TakaoSato

10:01_AM Discussion

10:06_AM TCT193:TheEffectofPlaqueTypeonStrutEmbedmentProtrusionandShearStressinBioresorbableScaffold:IsThereANewHorizonforBioresorbable

Scaffolds Lecturers:ErhanTenekecioglu

10:13_AM Discussion

10:18_AM TCT194:ImpactofIntravascularImagingMethodsforOptimalScaffoldImplantationReducingThrombosisAfterAbsorbBVSinARealWorldSetting:

Page 83: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:83

IdentificationofProbableFactorsRelatedtoStentFailure Lecturers:SergioTarbine

10:25_AM Discussion

MODERATEDPOSTERSESSION:RACIALANDGENDERDISPARITIESINENDOVASCULARANDSTRUCTURALHEARTDISEASEANDINTERVENTIONI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

9:30AM-10:30AM

RacialandGenderDisparitiesinEndovascularandStructuralHeartDiseaseandInterventionI

Moderators:JulieLogan,MollySzerlip

Discussants:TyroneJ.Collins,KarimElChilali,GiovanniEsposito

9:30_AM TCT171:TimeCourseoftheSurvivalAdvantageofTranscatheterOverSurgicalAorticValveReplacementInterplayBetweenSexandPatientRiskProfile Lecturers:GiuliaMasiero

9:37_AM Discussion

9:42_AM TCT172:AorticValvarComplexandCardiacAnatomyGenderRelatedDifferencesinPatientsUndergoingTranscatheterAorticValveReplacement Lecturers:DanielleSin

9:49_AM Discussion

9:54_AM TCT173:RacialDisparitiesinPatientsUndergoingTranscatheterAorticValveReplacementInsightsoftheHealthcareCostandUtilizationProjects

NationalinpatientSample Lecturers:DagmarHernandez-Suarez

10:01_AM Discussion

10:06_AM TCT174:ComparisonofProceduraland18MonthOutcomesofEndovascularDeviceInterventioninMenvsWomenWithCriticalLimbIschemia

SubanalysisoftheLIBERTY360Study Lecturers:JihadMustapha

10:13_AM Discussion

10:18_AM TCT175:RacialDisparitiesinProceduralComplicationsAfterTranscatheterAorticValveReplacementTAVRARetrospectiveSingleCenterCaseControl

Study Lecturers:NidalGanim

10:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRTECHNIQUESANDOUTCOMESI

SATURDAY,SEPTEMBER22,2018

9:30AM-10:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

9:30AM-10:18AM

TAVRTechniquesandOutcomesI

Moderators:SomjotS.Brar,EthanCKorngold

Discussants:SantiagoGarcia,KishoreJ.Harjai,ThomasHovasse,MichaelKang-YinLee

9:30_AM TCT181:EarlyChangesinQualityofLifeAfterTranscatheterAorticValveReplacement:ResultsFromthe3MTAVRTrial Lecturers:SandraLauck

9:37_AM Discussion

9:42_AM TCT182:OutlookofPatientsUndergoingTranscatheterAorticValveImplantationAfterPriorBalloonAorticValvuloplastyInsightsFromtheMulticenter

RispevaTrial Lecturers:GiuseppeBiondi-Zoccai

9:49_AM Discussion

9:54_AM TCT183:TAVRPatientsConsentingtoStudyParticipationAreHealthierThanThoseWhoDoNot Lecturers:JeroenVendrik

10:01_AM Discussion

10:05_AM TCT497:PredictorsofPostDilatationAfterSelfExpandingTranscatheterAorticValveReplacementLargeSingleCenterExperience Lecturers:RunDu

Page 84: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:84

10:13_AM Discussion

MODERATEDPOSTERSESSION:ACUTEANDLONG-TERMCABGRESULTS

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

10:30AM-11:30AM

AcuteandLong-termCABGResults

Moderators:PascalVranckx,GraysonH.Wheatley

Discussants:AlfredoTrento

10:30_AM TCT205:IncidencePredictorsandOutcomesofUrgentPercutaneousCoronaryInterventionFollowingCoronaryArteryBypassGrafting Lecturers:FahadAlqahtani

10:37_AM Discussion

10:42_AM TCT206:HybridCoronaryRevascularizationvsCoronaryArteryBypassGraftSurgeryinPatientsWithMultivesselCoronaryArteryDisease:AMeta

Analysis Lecturers:ZiadSayedahmad

10:49_AM Discussion

10:54_AM TCT207:IntraoperativeOpticalCoherenceTomographyasaNewModalitytoDetermineCoronaryArteryBypassGraftPatencyOurFirstExperience Lecturers:VladimirLosev

11:01_AM Discussion

11:06_AM TCT208:ResultsandPracticalValueofIntraoperativeBypassAngiographyinSurgicalMyocardialRevascularization Lecturers:OlgaBockeria

11:13_AM Discussion

11:18_AM TCT209:ComparisonofRatesandCausesof30DayReadmissionsAfterCoronaryArteryBypassGraftvsPercutaneousTransluminalCoronary

Angioplasty Lecturers:SushruthEdla

11:25_AM Discussion

MODERATEDPOSTERSESSION:CAROTIDSTENTING,STROKEPREVENTION,ANDACUTESTROKEINTERVENTION

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

10:30AM-11:30AM

CarotidStenting,StrokePrevention,andAcuteStrokeintervention

Moderators:BernhardReimers,ChristopherJ.White

Discussants:FayazShawl,AdnanSiddiqui,PaulD.Varosy

10:30_AM TCT210:3YearExperienceWithCathLabBasedAcuteStrokeRescuePrograminaCommunityHospital Lecturers:StevenGuidera

10:37_AM Discussion

10:42_AM TCT211:TechnicalSuccessofAcuteStrokeInterventionsPerformedByCardiologistsSingleCenterExperience Lecturers:MariusHornung

10:49_AM Discussion

10:54_AM TCT212:NoninvasiveDeviceforCerebralProtectionFromEmbolicStroke:ShouldCarotidCompressionBecomeAStandardofCare Lecturers:MichaelZhadkevich

11:01_AM Discussion

11:06_AM TCT213:CarotidRevascularizationinPatientsWithContralateralCarotidOcclusion:ASystematicReviewandMetaAnalysis Lecturers:SethAvner

11:13_AM Discussion

11:18_AM TCT215:DeepLoopTechniqueforStentingofLICAUsingTransbrachialApproachSingleCentreExperience Lecturers:ZoranStankov

Page 85: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:85

11:25_AM Discussion

MODERATEDPOSTERSESSION:LEFTATRIALAPPENDAGECLOSURE

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

10:30AM-11:30AM

LeftAtrialAppendageClosure

Moderators:ShephalDoshi,ApostolosTzikas

Discussants:MohamadAdnanAlkhouli,TJaredBunch,SimonCheung-chiLam,Jai-WunPark,MuhamedSaric

10:30_AM TCT200:SurgicalLeftAtrialAppendageOcclusionDuringCardiacSurgery:ASystematicReviewandMetaAnalysis Lecturers:MarkTerenceMujer

10:37_AM Discussion

10:42_AM TCT201:DischargeAntithromboticMedicationandClinicalEventsThrough1YearintheGlobalAmuletObservationalStudy Lecturers:DavidHildick-Smith

10:49_AM Discussion

10:54_AM TCT202:EfficacyandSafetyofAspirinMonoTherapyAfterLeftAtrialAppendageOcclusiontoPreventDeviceRelatedThrombusStrokeandMajor

Bleeding Lecturers:KasperKorsholm

11:01_AM Discussion

11:06_AM TCT203:IncidenceandClinicalImpactofDeviceRelatedThrombusAfterPercutaneousLeftAtrialAppendageOcclusionAMetaAnalysis Lecturers:MohammedOsman

11:13_AM Discussion

11:18_AM TCT204:RoleofDifferentAntithromboticRegimensAfterPercutaneousLeftAtrialAppendageOcclusion:ALargeSingleCenterExperience Lecturers:AlessandraLaricchia

11:25_AM Discussion

MODERATEDPOSTERSESSION:LONG-TERMDESSTUDIES

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

10:30AM-11:30AM

Long-termDESStudies

Moderators:R.StefanKiesz,MichaelJ.Rinaldi

Discussants:PeterLDuffy,MohamedAliElsalamony,YasunoriUeda

10:30_AM TCT236:LongTerm813YearClinicalOutcomesAfterDrugElutingStentinginRoutineClinicalPractice Lecturers:StephenG.Ellis

10:37_AM Discussion

10:42_AM TCT237:LongTerm813YearClinicalOutcomesinPreDiabeticsAfterDrugElutingStenting:MoreLikeDiabeticsOrNonDiabetics Lecturers:StephenG.Ellis

10:49_AM Discussion

10:54_AM TCT238:Comparing3YearOutcomesBetweenMedicalTherapyandPercutaneousRevascularisationfortheSurgicallyIneligibleCohort Lecturers:AvedisEkmejian

11:01_AM Discussion

11:06_AM TCT239:ImpactofPostStentingBalloonDilatationon5YearClinicalOutcomesinPatientsWithAcuteCoronarySyndromeUnderwentPercutaneous

CoronaryIntervention Lecturers:JiYoungPark

11:13_AM Discussion

11:18_AM TCT240:LongTerm5to7YearsClinicalOutcomesAfterCobaltChromiumEverolimusElutingStentImplantation Lecturers:ShoichiKuramitsu

Page 86: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:86

11:25_AM Discussion

MODERATEDPOSTERSESSION:MACHINELEARNINGANDARTIFICIALINTELLIGENCE

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

10:30AM-11:30AM

MachineLearningandArtificialIntelligence

Moderators:JustinE.Davies,JamesK.Min

Discussants:StevenL.Almany

10:30_AM TCT231:AnArtificialIntelligenceBasedSolutionforFullyAutomatedCardiacPhaseandEndDiastolicFrameDetectiononCoronaryAngiographies Lecturers:LucianItu

10:37_AM Discussion

10:42_AM TCT232:DiagnosticAccuracyofMachineLearnedAlgorithmsUtilizingaNovelFormofCardiacPhaseTomographyCpstvsSinglePhotonEmission

TomographySpectintheAssessmentofCad Lecturers:ThomasD.Stuckey

10:49_AM Discussion

10:54_AM TCT233:MachineLearnedAlgorithmsUtilizingNovelTomographyforEvaluatingCoronaryArteryDisease Lecturers:ThomasD.Stuckey

11:01_AM Discussion

11:06_AM TCT234:MachineLearningOutperformsACCAHACVDRiskCalculatorinMESANewOpportunitiesforShortTermRiskPredictionandEarlyDetectionof

theVulnerablePatient Lecturers:MortezaNaghavi

11:13_AM Discussion

11:18_AM TCT235:IntelligentRecognitionofCoronaryAngiographyByDeepLearningTechnology:ANovelComputerAidedDiagnosticSystem Lecturers:TianmingDu

MODERATEDPOSTERSESSION:MINIMALISTAPPROACHTOTAVRI

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

10:30AM-11:30AM

MinimalistApproachtoTAVRI

Moderators:BernardR.Chevalier,HeleneEltchaninoff

Discussants:SuzanneV.Arnold,WolfgangBocksch,RedaIbrahim

10:30_AM TCT221:ComparisonofTransfemoralTranscatheterAorticValveReplacementPerformedWithASimplifiedProtocol:FastTAVRvsStandardApproach Lecturers:GrégoireLefèvre

10:37_AM Discussion

10:42_AM TCT222:SafetyandFeasibilityofAnEarlyAmbulationProtocolAfterTransfemoralTranscatheterAorticValveImplantation:ResultsoftheEarly

MobilisationAfterTfTAVIMobiTAVITrial Lecturers:JeroenVendrik

10:49_AM Discussion

10:54_AM TCT223:EfficacyandSafetyofTransfemoralTranscatheterAorticValveReplacementUnderGeneralAnesthesiavsLocalAnesthesiaInsightsFrom

TrytomRegistryInternationalMulticenterLatinAmericanRegistry Lecturers:MarceloAbud

11:01_AM Discussion

11:06_AM TCT224:PredictorsandSafetyofNextDayDischargeAfterMinimalisticTransfemoralAorticValveImplantation Lecturers:GiulianoCosta

11:13_AM Discussion

11:18_AM TCT225:ImpactofFrailtyonaMinimalistApproachandEarlyDischargeFollowingTAVR:InsightsFromthe3MTAVRStudy Lecturers:JanarthananSathananthan

Page 87: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:87

11:25_AM Discussion

MODERATEDPOSTERSESSION:NON-LMBIFURCATIONINTERVENTIONI

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

10:30AM-11:30AM

Non-LMBifurcationInterventionI

Moderators:FrancescoBurzotta,YvesR.Louvard

Discussants:WaqarH.Ahmed,AhmedMagdy,FazilaT.Malik,HolgerM.Nef

10:30_AM TCT216:ComparisonBetweenTAPandDoubleKissingCrushTechniques:OpticalCoherenceTomographyandComputationalFlowReconstructionFrom

inVitroModels Lecturers:ValeriaParadies

10:37_AM Discussion

10:42_AM TCT217:StentingofCoronaryBifurcationLesionsWithBioresorbableEverolimusElutingScaffoldsLongtermOutcomeFromPoznanBifurcationAbsorb

Registry Lecturers:MagdalenaLanocha

10:49_AM Discussion

10:54_AM TCT218:ImpactofSideBranchPreDilationonAngiographicOutcomesinProvisionalStentStrategyinNonLeftMainCoronaryBifurcationLesions:A

SystematicReviewandMetaAnalysis Lecturers:MourushiIsa

11:01_AM Discussion

11:06_AM TCT219:BenefitsofFinalProximalOptimizationTechniquePOTinProvisionalStentingABenchExperimentalStudy Lecturers:FrancoisDerimay

11:13_AM Discussion

11:18_AM TCT220:OptimalBalloonPositioningforaBestProximalOptimizationTechniquePOTAnExperimentalBenchStudy Lecturers:FrancoisDerimay

11:25_AM Discussion

MODERATEDPOSTERSESSION:PCIANDDRUG-COATEDBALLOONSI

SATURDAY,SEPTEMBER22,2018

10:30AM-11:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

10:30AM-11:30AM

PCIandDrug-CoatedBalloonsI

Moderators:JorgeF.Saucedo,CraigM.Walker

Discussants:GeorgeLAdams,JJGoy,Hsuan-LiHuang,JuyingQian

10:30_AM TCT226:ResultsofPercutaneousCoronaryInterventionWithSecondGenerationDrugCoatedBalloonsataLongTermFollowup Lecturers:IgnacioSanchez-Perez

10:37_AM Discussion

10:42_AM TCT227:OutcomesWithDrugCoatedBalloonsinSmallVesselCoronaryArteryDisease Lecturers:MichaelMegaly

10:49_AM Discussion

10:54_AM TCT228:OutcomesAfterTreatmentofCoronaryInStentRestenosisWithDrugCoatedBalloonvsDrugElutingStentAccordingtothePresenceor

AbsenceofDiabetesMellitus:APrespecifiedAnalysisoftheDAEDALUSStudy Lecturers:DanieleGiacoppo

11:01_AM Discussion

11:06_AM TCT229:OutcomesWithDrugCoatedBalloonsvsDrugElutingStentsinPercutaneousCoronaryInterventioninDiabeticPatients Lecturers:MichaelMegaly

11:13_AM Discussion

11:18_AM TCT230:FFRGuidedAngioplastyUsingPaclitaxelCoatedBalloonsWithoutStentsvsBioresorbableScaffolds:ARandomizedClinicalTrialinStable

Page 88: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:88

CoronaryArteryDisease Lecturers:TudorPoerner

11:25_AM Discussion

MODERATEDPOSTERSESSION:ASDANDPFOCLOSUREI

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters1,ExhibitHall,GroundLevel

11:30AM-12:30PM

ASDandPFOClosureI

Moderators:EricEeckhout,StevenL.Goldberg

Discussants:Kee-SikKim,DavidW.M.Muller,RomanTarasov

11:30_AM TCT241:AssessmentoftheIntraAtrialSeptumOrientationandItsMeanCurvatureforStructuralHeartDiseaseInterventions Lecturers:NilsPetri

11:37_AM Discussion

11:42_AM TCT242:ResidualShuntAfterPatentForamenOvaleDeviceClosureinPatientsWithCryptogenicStroke:SerialBubbleContrastTransesophageal

EchocardiographyData Lecturers:PyungChunOh

11:49_AM Discussion

11:54_AM TCT243:ArePercutaneousPatentForamenOvaleClosureDevicesEffectiveAComprehensiveMetaAnalysisAssessingTheirLongTermOutcomes Lecturers:ArmaghanSoomro

12:01_PM Discussion

12:06_PM TCT244:PercutaneousSuturemediatedPatentForamenOvalePFOClosurewiththeNobleStitchELSystem:CenterExperienceEffect Lecturers:GregorySgueglia

12:13_PM Discussion

MODERATEDPOSTERSESSION:CATHETER-BASEDTREATMENTOFPERIPHERALVASCULARDISEASEII

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters3,ExhibitHall,GroundLevel

11:30AM-12:30PM

Catheter-basedTreatmentofPeripheralVascularDiseaseII

Moderators:MichaelR.Jaff,CraigM.Walker

Discussants:JunNakazato,RahulS.Patel,RamonLVarcoe,MitchellWeinberg

11:30_AM TCT249:PopulationBasedOutcomesFollowingEndovascularInterventionsandBypassSurgeryforLowerExtremityPeripheralArterialDisease Lecturers:KhalidHamidChangal

11:37_AM Discussion

11:42_AM TCT250:ANovelLargeSizeTranscatheterPulmonaryHeartValveProsthesisforPatientsWithPulmonaryRegurgitation Lecturers:AnnaGrünwald

11:49_AM Discussion

11:54_AM TCT251:UseSafetyandEffectivenessofSubintimalAngioplastyandReEntryDevicesfortheTreatmentofFemoropoplitealChronicTotalOcclusionsA

SystematicReviewof87Studiesand4671Patients Lecturers:DamianosKokkinidis

12:01_PM Discussion

12:06_PM TCT252:AProspectiveMultiCenterPilotStudyEvaluatingPlaquePhotoablationUsingtheNovelNonGuidewireBasedRA308ExcimerLaserinSubjects

WithSymptomaticInfrainguinalLowerExtremityVascularOcclusions Lecturers:EhtishamMahmud

12:13_PM Discussion

12:18_PM TCT253:PlacementofAxillaryintraaorticBalloonPumpLeadstoHigherAdverseEventRateWhenComparedtoPlacementofFemoralIntraaortic

BalloonPump Lecturers:BaldeepDhaliwal

Page 89: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:89

12:25_PM Discussion

MODERATEDPOSTERSESSION:CATHLABOFTHEFUTURE:STRATEGIESTOCONTROLRADIATIONEXPOSUREI

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters2,ExhibitHall,GroundLevel

11:30AM-12:30PM

CathLaboftheFuture:StrategiestoControlRadiationExposureI

Moderators:StephenBalter,PeterJ.Fitzgerald

Discussants:MChadiAlraies,JamesFlaherty,RichardR.Heuser,ParthaSardar,CarlL.Tommaso,JamesP.Zidar

11:30_AM TCT245:ASignificantReductionintheFrequencyofSubstantialDoseInterventionalCoronaryProceduresFrom2007to2017 Lecturers:StephenBalter

11:37_AM Discussion

11:42_AM TCT246:UtilityofImageMagnificationSoftwaretoReduceRadiationEmissionDuringInvasiveCoronaryAngiography Lecturers:RaminEbrahimi

11:49_AM Discussion

11:54_AM TCT247:ReducingRadiationExposuretoOperatorsDuringInvasiveCardiacProceduresWithANovelLeadBasedArmBoardRadar Lecturers:TawfiqChoudhury

12:01_PM Discussion

12:06_PM TCT248:ANewDevicetoMarkedlyReduceCardiacCathLabRadiationLevels Lecturers:RobertWilson

12:13_PM Discussion

MODERATEDPOSTERSESSION:ISTHERESTILLAROLEFORBAREMETALSTENTS?

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters8,ExhibitHall,GroundLevel

11:30AM-12:30PM

IsThereStillaRoleforBareMetalStents?

Moderators:RafaelBeyar,HemalGada

Discussants:BernardoCortese,DarshanDoshi,AdelElEtriby,AndreaGagnor,PatrickJGoleski

11:30_AM TCT270:ProspectiveRandomizedComparisonofPaclitaxelCoatedBalloonvsBareMetalStentinHighBleedingRiskPatientsWithDeNovoNative

CoronaryArteryLesions Lecturers:Eun-SeokShin

11:37_AM Discussion

11:42_AM TCT271:DrugElutingStentsComparedWithBareMetalStentsinHighRiskPatientsUndergoingPercutaneousCoronaryInterventions:AMetaAnalysis Lecturers:SarojNeupane

11:49_AM Discussion

11:54_AM TCT272:OutcomesofDrugElutingvsBareMetalStentsinSaphenousVeinGraftLesions:AMetaAnalysisofRandomizedControlledTrials Lecturers:ToufikMahfoodHaddad

12:01_PM Discussion

12:06_PM TCT273:ItalianMulticenterRegistryofBareMetalStentUseinModernPercutaneousCoronaryInterventionEra:AMulticenterObservationalStudy Lecturers:MatteoPagnesi

12:13_PM Discussion

12:18_PM TCT274:DrugElutingStentsvsBareMetalStentsforSaphenousVeinGraftInterventions:AMetaAnalysisofRandomizedControlledTrials Lecturers:AakashGarg

12:25_PM Discussion

MODERATEDPOSTERSESSION:MINIMALISTAPPROACHTOTAVRII

Page 90: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:90

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters5,ExhibitHall,GroundLevel

11:30AM-12:30PM

MinimalistApproachtoTAVRII

Moderators:CarloDiMario,MaurizioTaramasso

Discussants:ItshacItsikBen-dor,NicolaCorvaja,ChandanDevireddy,KendraJ.Grubb

11:30_AM TCT258:ComparingOutcomesofLocalandGeneralAnesthesiainTranscatheterAorticValveReplacementCOLGATEAVR:theClevelandClinic

FoundationExperience Lecturers:JimmyKerrigan

11:37_AM Discussion

11:42_AM TCT259:1000MinimalistTAVR:SAPIENThroughSAPIEN3 Lecturers:NorihikoKamioka

11:49_AM Discussion

11:54_AM TCT260:OutcomesofTranscatheterAorticValveReplacementinPatientsUndergoingConsciousSedationComparedtoGeneralAnesthesia Lecturers:BrettHiendlmayr

12:01_PM Discussion

12:06_PM TCT261:MinimalisticApproachinTranscatheterAorticValveReplacement:ASystematicReviewandMetaAnalysis Lecturers:HarshRawal

12:13_PM Discussion

MODERATEDPOSTERSESSION:MISCELLANEOUSPCITECHNIQUES

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters4,ExhibitHall,GroundLevel

11:30AM-12:30PM

MiscellaneousPCITechniques

Moderators:BagratAlekyan,ManishA.Parikh

Discussants:SergeyA.Abugov,KhaledAlmerri,PeterBarlis,JeffChambers,AndrzejJ.Ochala

11:30_AM TCT254:StrutImpingementPhenomenonByABioresorbablePolymerSirolimusElutingUltimasterStent Lecturers:YutakaTadano

11:37_AM Discussion

11:42_AM TCT255:ResultsofthePercutaneousCoronaryInterventionWithOverlappingStentsWithHomogeneousOrHeterogeneousDrugfortheTreatmentof

DiffuseCoronaryDiseaseinRealClinicalPractice Lecturers:IgnacioSanchez-Perez

11:49_AM Discussion

11:54_AM TCT256:ImpactofCoronaryArteryTortuosityonPCIOutcomes:AnindividualPatientDataPooledAnalysisFrom6RandomizedControlledTrials Lecturers:BjornRedfors

12:01_PM Discussion

12:06_PM TCT257:ImpactofPercutaneousCoronaryInterventionofOstialVsNonOstialLesionsonShortandLongTermClinicalOutcomes Lecturers:JiYoungPark

12:13_PM Discussion

MODERATEDPOSTERSESSION:NEWOCTSTUDIES

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters7,ExhibitHall,GroundLevel

11:30AM-12:30PM

NewOCTStudies

Page 91: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:91

Moderators:DanielChamie,StephenWLLee

Discussants:OtavioBerwanger,HaiboJia,OlliA.Kajander,JunyaShite,RichardShlofmitz,MarcoZimarino

11:30_AM TCT266:OCTandHistopathologicalAssessmentofCoronaryPlaqueObtainedbyDirectionalCoronaryAthereCTOmy Lecturers:HiroshiOkamoto

11:37_AM Discussion

11:42_AM TCT267:SerialStentHealingAnalysisofBioresorbableStentImplantedinCoronaryBifurcationsWithOpticalCoherenceTomography:CorrelationWith

BaselineShearStress Lecturers:ShengxianTu

11:49_AM Discussion

11:54_AM TCT268:FiveYearClinicalOutcomesofPatientsWithOCTDetectedFeaturesofVulnerablePlaqueinIntermediateGradeCoronaryStenosesProven

InsignificantByFFR Lecturers:DorotaOchijewicz

12:01_PM Discussion

12:06_PM TCT269:OpticalCoherenceTomographyEvaluationofVeryEarlyEndothelializationAfterDualTherapyDrugElutingStentWithEPCCaptUREOCT

VENTURE Lecturers:BryanYan

12:13_PM Discussion

MODERATEDPOSTERSESSION:PCIANDDRUG-COATEDBALLOONSII

SATURDAY,SEPTEMBER22,2018

11:30AM-12:30PM

ModeratedPosters6,ExhibitHall,GroundLevel

11:30AM-12:30PM

PCIandDrug-CoatedBalloonsII

Moderators:FernandoAlfonso,BrunoScheller

Discussants:SubhashBanerjee,YunDaiChen,KennethChin,MariannGyöngyösi,GrzegorzL.Kaluza

11:30_AM TCT262:PreClinicalInvestigationofKeratoseAsANovelExcipientofPaclitaxelCoatedBalloons Lecturers:SaamiYazdani

11:37_AM Discussion

11:42_AM TCT263:DrugElutingBalloonCoronaryAngioplastyWithoutStentingforDeNovoLesionsinVerySmallCaliberVessels:AFiveYearsExperience Lecturers:LucDoutrelant

11:49_AM Discussion

11:54_AM TCT264:SirolimusCoatedBalloonintheTreatmentofSmallVesselDisease:LongTermFollowUpFromtheIndianNanoluteRegistry Lecturers:BernardoCortese

12:01_PM Discussion

12:06_PM TCT265:ComparisonofLongTermOutcomesofPercutaneousCoronaryInterventionWithSequentPleasevsinPactFalconPaclitaxelElutingBalloon

Catheter Lecturers:IgnacioSanchez-Perez

12:13_PM Discussion

MODERATEDPOSTERSESSION:AORTICDISEASESANDINTERVENTION

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

12:45PM-1:45PM

AorticDiseasesandIntervention

Moderators:ChristophA.Nienaber,EricE.Roselli

Discussants:SergeyA.Abugov,SomjotS.Brar,CostantinoDelGiudice,NimeshDesai,IvoPetrov,DarrenBSchneider

12:45_PM TCT285:DevelopmentofALocalTreatmentStrategyforVesselWallStabilizationWithamiR29bInhibitorinAneurysmsandAtheroscleroticPlaques Lecturers:StephanieBettink

Page 92: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:92

12:52_PM Discussion

12:57_PM TCT286:NovelApproachforTreatmentofAorticStentGraftEndoleak:APreclinicalFeasibilityStudyofCatheterDeliveredExpandableFoam Lecturers:GilbertoMelnick

1:04_PM Discussion

1:09_PM TCT287:EfficacyofIntravascularUltrasoundforPatientsWithPeripheralArteryDiseasesPresentingAortoIliacArteryDisease Lecturers:TakuyaTsujimura

1:16_PM Discussion

1:21_PM TCT288:EarlyThoracicEndovascularAorticRepairTEVARofUncomplicatedTypeBThoracicAorticDissectionintheCardiacCatheterizationLaboratory:

TheRiseoftheCardioVascularInterventionalist Lecturers:MattewMcDiarmid

1:28_PM Discussion

1:33_PM TCT289:LocoRegionalvsGeneralAnesthesiaforEndovascularAbdominalAorticAneurysmRepair:AnUpdatedMetaAnalysis Lecturers:JaiParekh

1:40_PM Discussion

MODERATEDPOSTERSESSION:BIORESORBABLESCAFFOLDSVSMETALLICSTENTS

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

12:45PM-1:45PM

BioresorbableScaffoldsvsMetallicStents

Moderators:AlokeV.Finn,JohnA.Ormiston

Discussants:SalvatoreCassese,DanielChamie,Jun-JackCheng,MichaelJoner,GrzegorzL.Kaluza,VincentOn-HingKwok

12:45_PM TCT310:FourYearClinicalOutcomesFromRandomizedComparisonofEverolimusElutingBioresorbableVascularScaffoldsvsEverolimusEluting

MetallicStentsinPatientsWithCoronaryArteryDiseaseFromABSORBChinaTrial Lecturers:RunlinGao

12:52_PM Discussion

12:57_PM TCT311:LongTermVascularResponsetoBioresorbableScaffoldsvsMetallicStentsinCoronaryLesionsWithMyocardialBridgingAPotentialBenefitof

VascularRestorationUnderDynamicCompressionforce Lecturers:RyoKameda

1:04_PM Discussion

1:09_PM TCT312:4YearClinicalResultsofaRandomizedTrialEvaluatingtheAbsorbBioresorbableVascularScaffoldvsMetallicDrugElutingStentinDeNovo

NativeCoronaryArteryLesions:DataFromtheABSORBJapanTrial Lecturers:KengoTanabe

1:16_PM Discussion

1:21_PM TCT313:InVivoAcuteExpansionofBioresorbableScaffoldsandMetallicStentsinNormalPorcineCoronaryArteriesACriticalAppraisalofCompliance

ChartAccuracy Lecturers:NicolasIsaza

1:28_PM Discussion

1:33_PM TCT314:FactorsinfluencingBioresorbablevsMetallicStentRecoilandUnderexpansionInVivoIndependentofAtherosclerosis:AngiographicStudyin

NormalPorcineCoronaryArteries Lecturers:NicolasIsaza

1:40_PM Discussion

MODERATEDPOSTERSESSION:COMPUTATIONALFLUIDDYNAMICS(CT-FFR,QFR,INTRAVASCULARIMAGING-FFR,ANDOTHERS)I

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

12:45PM-1:45PM

ComputationalFluidDynamics(CT-FFR,QFR,IntravascularImaging-FFR,andothers)I

Moderators:JamesK.Min,WojtekWojakowski

Page 93: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:93

Discussants:CheeYangChin,PeterJ.Fitzgerald,JuanLuisGutierrez-Chico,MarcoZimarino

12:45_PM TCT305:Comparisonof2DQCA3DQCAandCoronaryAngiographyDerivedFFRinPredictingMyocardialIschemiaAssessedByDSPECT Lecturers:NengDai

12:52_PM Discussion

12:57_PM TCT306:AngiographyDerivedFunctionalAssessmentofNonCulpritStenosesWithQuantitativeFlowRatioAttheTimeofSTElevationMyocardial

Infarction Lecturers:HernanMejia-Renteria

1:04_PM Discussion

1:09_PM TCT307:MechanismTriggeringAcuteCoronarySyndromeByRupturingPlaqueBasedontheCavitationPhenomenonBubbleFormationandExplosionAt

theDistalLeftMainBifurcationByComputationalFluidDynamicStudy Lecturers:PhucLuong

1:16_PM Discussion

1:21_PM TCT308:ComparisonBetweenFractionalFlowReserveFFRandComputationalFractionalFlowReserveDerivedFromThreeDimensionalintravascular

UltrasoundFFRIvusPercentageofDiameterStenosisByVisualEstimationandBiDimensionalQuantitativeCo Lecturers:AlexandreHideo-Kajita

1:28_PM Discussion

1:33_PM TCT309:AngiographyDerivedFractionalFlowReserveintheSYNTAXIITrial:DiagnosticAccuracyofQFRandClinicalPrognosticValueofFunctional

SYNTAXScoreDerivedFromQFR Lecturers:TakuAsano

1:40_PM Discussion

MODERATEDPOSTERSESSION:LMCADISEASEANDINTERVENTIONI

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters4,ExhibitHall,GroundLevel

12:45PM-1:45PM

LMCADiseaseandInterventionI

Moderators:DavideCapodanno,TalibMajwal

Discussants:NingGuo,StefanHarb,LucianMariusPredescu,JoseM.delaTorreHernandez

12:45_PM TCT290:DrugElutingBalloonCathetersintheEndovascularTreatmentofPatientsWithTrueLeftMainBifurcationLesions Lecturers:DaniilMaximkin

12:52_PM Discussion

12:57_PM TCT291:ImpactofChronicKidneyDiseaseonLeftMainCoronaryArteryDiseaseUndergoingPercutaneousCoronaryInterventionIRISMAINRegistry Lecturers:JeeHyukKim

1:04_PM Discussion

1:09_PM TCT292:SuperimposedStentsforSuboptimalImmediateAngiographicResultinLeftMainCoronaryArteryLesionsAfterImplantationofAFirstStent

AngiographicandClinicalOutcomes Lecturers:KarlIsaaz

1:16_PM Discussion

1:21_PM TCT293:IncidenceProceduralAspectsandPrognosisofPercutaneousCoronaryInterventionofUnprotectedLeftMainCoronaryArteryDiseasein

PatientsWithSTSegmentElevationMyocardialInfarction Lecturers:VictoriaVilalta

1:28_PM Discussion

1:33_PM TCT294:LongTermOutcomeofUnprotectedLeftMainCoronaryArteryDisease:ComparisonBetweenCoronaryArteryBypassGraftingCABGand

PercutaneousCoronaryInterventionPCIinKoreanSingleCenter Lecturers:MooHyunKim

1:40_PM Discussion

MODERATEDPOSTERSESSION:MISCELLANEOUSTAVRCOMPLICATIONSI

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

Page 94: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:94

ModeratedPosters5,ExhibitHall,GroundLevel

12:45PM-1:45PM

MiscellaneousTAVRComplicationsI

Moderators:PhilippeGenereux,SusheelK.Kodali

Discussants:SaifAnwaruddin,ColinM.Barker,StephanM.Ensminger,MarekGrygier,FabienPraz

12:45_PM TCT295:DifferentialPrognosticValueofGalectin3AccordingtoLevelsofCarbohydrateAntigen125inTranscatheterAorticValveImplantation Lecturers:TobiasRheude

12:52_PM Discussion

12:57_PM TCT296:CardiacSurgeryComparedtoAntibioticsOnlyinPatientsDevelopingInfectiveEndocarditisAfterTranscatheterAorticValveReplacement Lecturers:NormanMangner

1:04_PM Discussion

1:09_PM TCT297:InfluenceofValveTypeonThrombocytopeniaFollowingTranscatheterAorticValveImplantationTAVI Lecturers:SallyHickman

1:16_PM Discussion

1:21_PM TCT298:AutoimmuneConnectiveTissueDiseasesAreAssociatedWithIncreasedInfectiousComplicationsAfterTAVR Lecturers:SarahRudasill

1:28_PM Discussion

1:33_PM TCT299:PulseWaveVelocityandAorticDistensibilityinPatientsWithHypertensiveResponsePostTranscatheterAorticValveReplacement Lecturers:EyalBenAssa

1:40_PM Discussion

MODERATEDPOSTERSESSION:PCIINHIGHBLEEDINGRISK(HBR)PATIENTSI

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

12:45PM-1:45PM

PCIinHighBleedingRisk(HBR)PatientsI

Moderators:VincentJ.Pompili,RobertW.Yeh

Discussants:MariannGyöngyösi,ZuzanaMotovska,AdhirShroff

12:45_PM TCT300:FeasibilityandClinicalImpactofEsophagogastrodudenoscopyWithin7DaysinPatientsReceivingCoronaryStentDuetoSTSegmentElevation

MyocardialInfarction Lecturers:SangMinPark

12:52_PM Discussion

12:57_PM TCT301:CHA2DS2VAScScoreisHighlyPredictiveofInHospitalMortalityandProceduralComplicationsinPatientsWithAcuteCoronarySyndrome

UndergoingPercutaneousCoronaryIntervention Lecturers:AshrafAbugroun

1:04_PM Discussion

1:09_PM TCT302:ASimpleCHA2DD2VASCDerivedScoreforAssessingLongTermPrognosisinSTEMIPatientsCardioCHUSSTEMIRegistry Lecturers:AlfredoRedondoDiéguez

1:16_PM Discussion

1:21_PM TCT303:AssociationofCHADVASCScoreWithHemorrhagicStrokeinPatientsUndergoingFibrinolyticTherapyforSTElevationMyocardialInfarction Lecturers:GbolahanOgunbayo

1:28_PM Discussion

1:33_PM TCT304:LongTermClinicalOutcomesinAcuteCoronarySyndromePatientsAtHighBleedingRiskUndergoingPCIWithImplantationofEverolimus

ElutingStents:ResultsFromthePatientLevelPooledAnalysisofEESPostApprovalStudies Lecturers:SabatoSorrentino

1:40_PM Discussion

MODERATEDPOSTERSESSION:PERI-DEVICELEAKS

Page 95: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:95

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters1,ExhibitHall,GroundLevel

12:45PM-1:45PM

Peri-DeviceLeaks

Moderators:LindaD.Gillam,PinakB.Shah

Discussants:CameronDowling,OmerGoktekin

12:45_PM TCT275:PercutaneousTransapicalLeftVentricularAccesstoTreatParavalvularLeakandVentricularSeptalDefectIsClinicallyEffectiveandAssociated

WithinfrequentAdverseEvents Lecturers:JosephVenturini

12:52_PM Discussion

12:57_PM TCT276:PercutaneousTreatmentofResidualLeaksAfterLeftAtrialAppendageClosure Lecturers:MarcusSandri

1:04_PM Discussion

1:09_PM TCT277:SafetyandFeasibilityofTransCatheterInterruptionofRupturedSinusofValsalvaAneurysmRSOVAUsingtheCoccoonDuctOccluderCDO:

ImmediateResultsandMidTermFollowUp Lecturers:PuneetAggarwal

1:16_PM Discussion

1:21_PM TCT278:IncidenceCharacteristicsandManagementofResidualPeriDeviceLeakAfterPercutaneousLeftAtrialAppendageOcclusion Lecturers:ZakeihChaker

1:28_PM Discussion

1:33_PM TCT279:ElectivePercutaneousParavalvularLeakClosureUnderMonitoredAnesthesiaCare:TheSafetyofConsciousSedationWithIntraProceduralTee

forPVLRepair Lecturers:AliAbdulJabbar

1:40_PM Discussion

MODERATEDPOSTERSESSION:VULNERABLEPLAQUESANDVULNERABLEPATIENTSI

SATURDAY,SEPTEMBER22,2018

12:45PM-1:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

12:45PM-1:45PM

VulnerablePlaquesandVulnerablePatientsI

Moderators:MauriceBuchbinder,PeterH.Stone

Discussants:GermanoDiSciascio,KonstantinosToutouzas,ZhaoWang

12:45_PM TCT280:UsefulnessofWhiteBloodCellCounttoMeanPlateletVolumeRatioforPredictingLongTermPrognosisAfterPrimaryPercutaneousCoronary

InterventioninPatientsWithAcuteCoronarySyndrome Lecturers:NaXu

12:52_PM Discussion

12:57_PM TCT281:ValidationofComputedTomographyLeamanScoreforRiskAssessmentofPatientsTreatedByPercutaneousCoronaryIntervention Lecturers:SimoneKim

1:04_PM Discussion

1:09_PM TCT282:UnstableCoronaryMicrovascularPhysiologyTheCriticalRelationshipofPatencyandPerfusionPressureAssessedByControlledFlowInfusion Lecturers:RobertS.Schwartz

1:16_PM Discussion

1:21_PM TCT283:IncreaseinCarotidInflammationinPatientsWithCADIndependentlyPredictsTwoYearMACE Lecturers:KonstantinosToutouzas

1:28_PM Discussion

1:33_PM TCT284:CoronaryComputedTomographyAngiographyDefinedLowAttenuationPlaquetoPredictTrueLipidicPlaqueDeterminedByCombined

IntravascularImaging Lecturers:RafalWolny

1:40_PM Discussion

Page 96: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:96

MODERATEDPOSTERSESSION:LMCADISEASEANDINTERVENTIONII

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters4,ExhibitHall,GroundLevel

1:45PM-2:45PM

LMCADiseaseandInterventionII

Moderators:AnthonyH.Gershlick,MarcoV.Wainstein

Discussants:JavaidIqbal,Kee-SikKim,IoannaKosmidou,StefanMot

1:45_PM TCT329:ProspectiveEvaluationofDrugElutingSelfApposingStentfortheTreatmentofUnprotectedLeftMainCoronaryArteryDisease1YearResults

oftheTRUNCStudy Lecturers:CorradoTamburino

1:52_PM Discussion

1:57_PM TCT330:OneYearEffectivenessandSafetyofSelfApposingStentysDrugElutingStentinLeftMainCoronaryArteryPCIMulticentreLMSTENTYS

Registry Lecturers:WojciechWanha

2:04_PM Discussion

2:09_PM TCT331:SecularTrendsofCharacteristicsTreatmentsandLongTermOutcomesinPatientsWithOstialOrMidShaftLeftMainCoronaryArteryDisease Lecturers:Yong-HoonYoon

2:16_PM Discussion

2:21_PM TCT332:SerialIVUSSubstudyResultsFromJLesson:JapanUnprotectedLeftMainCoronaryArteryDiseasePCIStrategyonNewGenerationStents Lecturers:AkikoMaehara

2:28_PM Discussion

2:33_PM TCT333:RoleofOpticalCoherenceTomographyAcknowledgedforLeftMainStemAngioplastytheROCKCohortIStudy Lecturers:BernardoCortese

2:40_PM Discussion

MODERATEDPOSTERSESSION:MANAGEMENTOFIN-STENTRESTENOSISI

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

1:45PM-2:45PM

ManagementofIn-stentRestenosisI

Moderators:ChristianW.Hamm,DetlefG.Mathey

Discussants:MohamedAliElsalamony,Hsuan-LiHuang,VergheseMathew,IssamD.Moussa,Duk-WooPark

1:45_PM TCT339:PaclitaxelElutingBalloonvsEverolimusElutingStentinPatientsWithDiabetesMellitusandInStentRestenosisInsightsFromtheRandomized

DARETrial Lecturers:BimmerE.Claessen

1:52_PM Discussion

1:57_PM TCT340:InfluenceofNeoatherosclerosisonLongTermOutcomeofPatientsWithinStentRestenosisTreatedWithPaclitaxelCoatedBalloonor

EverolimusElutingStentInsightsFromPooledRibsIVandVRandomizedTrials Lecturers:NievesGonzalo

2:04_PM Discussion

2:09_PM TCT341:ResultsofPercutaneousCoronaryInterventioninRestenosisLesionsWithSecondGenerationPaclitaxelCoatedBalloonsAtaLongTermFollow

up Lecturers:IgnacioSanchez-Perez

2:16_PM Discussion

2:21_PM TCT342:ExcimerLaserLesionModificationInStentRestenosisandNonOptimalDilatedStentstheELMRegistry Lecturers:PiotrWacinski

2:28_PM Discussion

2:33_PM TCT343:VariationsinEfficacyandSafetyOverTimeBetweenDrugCoatedBalloonandDrugElutingStentfortheTreatmentofCoronaryInStent

RestenosisResultsFromtheDAEDALUSStudy

Page 97: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:97

Lecturers:DanieleGiacoppo2:40_PM Discussion

MODERATEDPOSTERSESSION:METALLICBIORESORBABLEVASCULARSCAFFOLDSI

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

1:45PM-2:45PM

MetallicBioresorbableVascularScaffoldsI

Moderators:AlexandreAbizaid,MichaelHaude

Discussants:OlivierF.Bertrand,PieraCapranzano,YalingHan,DeanJ.Kereiakes,DavidG.Rizik,AlanC.Yeung

1:45_PM TCT349:TheAcuteandEarlyOutcomeofMagnesiumBioresorbableScaffoldImplantationinAcuteCoronarySyndromeInitialReportFromACS

MagmarisRegistry Lecturers:MagdaleaLancha

1:52_PM Discussion

1:57_PM TCT350:SafetyandPerformanceoftheResorbableMagnesiumScaffoldMagmarisinaRealWorldSettingFirst400SubjectsAt12MonthFollowUpof

theBiosolveIVRegistry Lecturers:MichaelKang-YinLee

2:04_PM Discussion

2:09_PM TCT351:DescriptiveAnalysisofConsecutiveAdverseAngiographicandClinicalEventsinPooledItalianSeriesofMagnesiumBioabsorbableMetallic

ScaffoldMagmarisTM Lecturers:StefanoGalli

2:16_PM Discussion

2:21_PM TCT352:LongTermClinicalDataandMultimodalityImagingAnalysisoftheBIOSOLVEIIStudyWiththeDrugElutingAbsorbableMetalScaffoldinthe

TreatmentofSubjectsWithDeNovoLesionsinNativeCoronaryArteriesBIOSOLVEII Lecturers:MichaelHaude

2:28_PM Discussion

2:33_PM TCT353:AcuteandMidTermPerformanceofMagmarisBioresorbableScaffoldImplantationinComplexLesionsAMulticenterExperience Lecturers:FrancescoTomassini

2:40_PM Discussion

MODERATEDPOSTERSESSION:OPTICALCOHERENCETOMOGRAPHY(OCT)OBSERVATIONSDURINGPRIMARYPCIINSTEMI

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

1:45PM-2:45PM

OpticalCoherenceTomography(OCT)ObservationsDuringPrimaryPCIinSTEMI

Moderators:TakashiKubo,FrancescoPrati

Discussants:ZiadA.Ali,GaryS.Mintz,JunPu,EvelynRegar,GuillermoTearney

1:45_PM TCT345:OpticalCoherenceTomographyAppraisalofResidualThrombusBurdeninPatientsWithSTSegmentElevationMyocardialInfarction

UndergoingBivalirudinvsUnfractionatedHeparinInfusiontheMATRIXMinimizingAdverseHaemorrhagicEventsByTransra Lecturers:HectorM.Garcia-Garcia

1:52_PM Discussion

1:57_PM TCT344:ComparisonofTissueProlapseAfterStentDeploymentAtCulpritLesionandNonCulpritLesioninAcuteMyocardialInfarction Lecturers:HyuckJunYoon

2:04_PM Discussion

2:09_PM TCT346:PrimaryPCIinSTEMIWithSirolimusElutingFantomBioresorbableVascularScaffoldFirstGuidedWithOpticalCoherenceTomographyAcute

ResultsFromaFantomSTEMIPilotStudy Lecturers:LukaszKoltowski

2:16_PM Discussion

2:21_PM TCT347:CulpritLesionTypesandVascularHealinginPatientsWithSTSegmentElevationMyocardialInfarctionAfterPrimaryPercutaneousIntervention Lecturers:KirstineHansen

Page 98: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:98

2:28_PM Discussion

2:33_PM TCT348:EarlyChangesinMalappositionAssessedWithOpticalCoherencetomographyAfterBiolimusCoatedBiofreedomStentOrSirolimusEluting

OrsiroStentinPatientsWithSTSegmentElevationMyocardialInfarction Lecturers:ChristianOliverFallesen

2:40_PM Discussion

MODERATEDPOSTERSESSION:SYNTAXSCOREANDSYNTAXTRIALSTUDIESI

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

1:45PM-2:45PM

SYNTAXScoreandSYNTAXTrialStudiesI

Moderators:PetrKala,PatrickW.Serruys

Discussants:MohammadElTahlawi,JavierEscaned,MargaretB.McEntegart,JohnA.Ormiston,NadiaRSutton

1:45_PM TCT320:ImpactofPreproceduralHighSensitivityCReactiveProteinLDLCandSyntaxScoreonOutcomesFollowingPercutaneousCoronaryIntervention Lecturers:AntonCamaj

1:52_PM Discussion

1:57_PM TCT321:MulticenterValidationoftheSimplifiedSYNTAXScoreAnAccurateMemorizableToolforRapidObjectiveAssessmentofAnatomical

Complexity Lecturers:SonyaBurgess

2:04_PM Discussion

2:09_PM TCT322:AgreementBetweenCoronaryCTAandConventionalAngiographyontheSYNTAXScoreTertilesStratifiedByAnatomicalComplexityinthe

SYNTAXIIIRevolutionTrial Lecturers:YoshinobuOnuma

2:16_PM Discussion

2:21_PM TCT323:ComparisonofthePrognosticPredictiveValueoftheSYNTAXIIandNERSIIRiskScoresinUnprotectedLeftMainPercutaneousCoronary

Intervention Lecturers:XacobeFlores-Rios

2:28_PM Discussion

MODERATEDPOSTERSESSION:TAVRANDCADI

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters1,ExhibitHall,GroundLevel

1:45PM-2:45PM

TAVRandCADI

Moderators:PhilippBlanke,HorstSievert

Discussants:ElvinKedhi,NickolasNodarKipshidze,GraysonH.Wheatley

1:45_PM TCT315:CorrelationBetweenFractionalFlowReserveandNonInvasiveMyocardialPerfusionImaginginPatientsWithSevereAorticStenosisand

CoronaryArteryDisease Lecturers:RobertoScarsini

1:52_PM Discussion

1:57_PM TCT316:PercutaneousCoronaryInterventionBeforeTranscatheterAorticValveReplacement Lecturers:FrancoFabbiocchi

2:04_PM Discussion

2:09_PM TCT317:ImpactofCoronaryArteryDiseaseonTranscatheterAorticValveReplacementOutcome Lecturers:PaoloOlivares

2:16_PM Discussion

2:21_PM TCT318:ImpactofCoronaryArteryDiseaseandPriorCoronaryArteryBypassGraftingonPatientsUndergoingTranscatheterAorticValveReplacement Lecturers:TobyRogers

2:28_PM Discussion

Page 99: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:99

2:33_PM TCT319:ClinicalCharacteristicsandVascularComplicationsinPatientsUndergoingTranscatheterAorticValveReplacementandPercutaneousCoronary

Interventions Lecturers:ShawnReginauld

2:40_PM Discussion

MODERATEDPOSTERSESSION:TREATMENTOFPULMONARYEMBOLISM

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

1:45PM-2:45PM

TreatmentofPulmonaryEmbolism

Moderators:StephaneNoble,VictorF.Tapson

Discussants:MahirElder,PeterP.Monteleone,GregoryPiazza

1:45_PM TCT324:AFiveYearandSingleCentreExperienceonUltrasoundAsssistedCatheterDirectedThrombolysisinPatientsWithPulmonaryEmbolismAtHigh

RiskandIntermediateHighRisk Lecturers:CihangirKaymaz

1:52_PM Discussion

1:57_PM TCT325:QualityofLifeAfterUltrasoundAssistedvsStandardCatheterDirectedThrombolysisforAcutePulmonaryEmbolismAMultiCenterExperience Lecturers:GauravRao

2:04_PM Discussion

2:09_PM TCT326:CatheterDirectedThrombolyticTherapyandAspirationThrombectomyinIntermediatePulmonaryEmbolismLongTermResults Lecturers:ZoltanRuzsa

2:16_PM Discussion

2:21_PM TCT327:SingleCenterExperienceonPercutaneousRheolyticThrombectomyinPatientsWithPulmonaryEmbolismAtHighRiskOrIntermediateHigh

Risk Lecturers:OzgurAkbal

2:28_PM Discussion

2:33_PM TCT328:EndovascularTreatmentWithCatheterDirectedThrombolysisinPatientsWithAcuteMassiveandSubmassivePulmonaryEmbolism Lecturers:IvoPetrov

2:40_PM Discussion

MODERATEDPOSTERSESSION:VALVE-IN-VALVEPROCEDURESII

SATURDAY,SEPTEMBER22,2018

1:45PM-2:45PM

ModeratedPosters5,ExhibitHall,GroundLevel

1:45PM-2:45PM

Valve-in-ValveProceduresII

Moderators:HowardC.Herrmann,MathewWilliams

Discussants:MarkusFlorianKrackhardt,AxelLinke,AdamWitkowski

1:45_PM TCT374:MitralProstheticFracturetoFacilitateTranscatheterMitralProcedures:ResultsofinVitroBenchTesting Lecturers:DawnHui,MD

1:52_PM Discussion

1:52_PM TCT375:CurrentGenerationBalloonExpandableTranscatheterValvePositioningDuringAorticValveinValveProceduresandClinicalOutcomes Lecturers:MatheusSimonato,MD

1:59_PM Discussion

2:04_PM TCT376:BioprostheticValveFracturetoImproveHemodynamicFunctionFollowingAorticValveinValveImplantationWithCTFollowUp Lecturers:AbdullahAlenezi,MD

2:11_PM Discussion

2:16_PM TCT377:TranscatheterAorticValveImplantationTAVIforDegenerativeSurgicalBioprosthesis:ASingleCentreValveinValveViV5YearsExperience Lecturers:MohammadWaleed,MD

Page 100: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:100

2:23_PM Discussion

MODERATEDPOSTERSESSION:COMPUTATIONALFLUIDDYNAMICS(CT-FFR,QFR,INTRAVASCULARIMAGING-FFR,ANDOTHERS)II

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

2:45PM-3:45PM

ComputationalFluidDynamics(CT-FFR,QFR,IntravascularImaging-FFR,andothers)II

Moderators:PaulKnaapen,PhilipM.Urban

Discussants:ThomasEngstrøm,KarlisGrikis,ArnoldSeto,RaulSolerno,KhalidOmarTammam

2:45_PM TCT383:ClinicalUtilityofANovelOnSiteVirtualFractionalFlowReserveParallelComputingSystem:ComparisonWithinvasiveFractionalFlowReserve Lecturers:Hyung-BokPark,MD

2:52_PM Discussion

2:57_PM TCT384:DiagnosticUtilityofNoninvasiveFractionalFlowReserveDerivedFromCoronaryComputedTomographyAngiographyinPatientsWithStable

CoronaryArteryDisease Lecturers:HiroakiSawada,MD

3:04_PM Discussion

3:09_PM TCT385:DiagnosticPerformanceofNoninvasiveFractionalFlowReserveDerivedFromComputedTomographyinDiabeticPatients Lecturers:ShinichiroSakurai,MD

3:16_PM Discussion

3:21_PM TCT386:EthnicDifferencesinCoronaryLuminalVolumeLeftVentricularMassandCTDerivedFractionalFlowReserve Lecturers:AbdulRahmanIhdayhid,MD

3:28_PM Discussion

3:33_PM TCT387:MorphologicalCorrelatesofSymptomaticProgressionAfterCoronaryComputedTomographyAngiographyDerivedHighRiskLesionsAre

AssessedByOpticalCoherencetomography Lecturers:MitsuakiMatsumura,MD

3:40_PM Discussion

MODERATEDPOSTERSESSION:CRITICALLIMBISCHEMIA

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

2:45PM-3:45PM

CriticalLimbIschemia

Moderators:EmersonC.Perin,ChristopherJ.White

Discussants:J.MichaelBacharach,SubhashBanerjee,MichaelR.Jaff

2:45_PM TCT364:PercutaneousDeepVeinArterializationfortheTreatmentofLateStageCriticalLimbIschemiaThePROMISETrial:EarlyFeasibilityInterim

Results Lecturers:JihadMustapha

2:52_PM Discussion

2:57_PM TCT365:ContemporaryOutcomesinNoOptionChronicCriticalLimbIschemiaASystematicReviewandMetaAnalysis Lecturers:MohammedImranGhare

3:04_PM Discussion

3:09_PM TCT366:EndovascularvsSurgicalRevascularizationforAcuteLowerLimbIschemia Lecturers:TariqEnezate

3:16_PM Discussion

3:21_PM TCT367:FirstReportShowingtheVeryLongTermOutcomesofTherapeuticAngiogenesisUsingBoneMarrowDerivedMononuclearCellTherapyinNo

OptionCriticalLimbIschemiaPatientsWithScleroderma Lecturers:KeisukeShoji

3:28_PM Discussion

3:33_PM TCT368:FeasibilityandOutcomesofEndovascularTreatmentofInfrapoplitealPeripheralArterialDiseaseinPatientsWithCriticalLimbIschemia

Page 101: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:101

RetrogradeTibiopedalAccessApproach Lecturers:ApurvaPatel

3:40_PM Discussion

MODERATEDPOSTERSESSION:HEARTTEAMSTUDIES

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

2:45PM-3:45PM

HeartTeamStudies

Moderators:StuartJ.Head,A.PieterKappetein

Discussants:CostantinoDelGiudice,IsaacGeorge,ArunKalyanasundaram,AlfredoTrento,DominikM.Wiktor

2:45_PM TCT359:ImprovingManagementofCardiogenicShockTheINOVAHeartandVascularInstituteStandardizedTeamBasedApproach Lecturers:BehnamTehrani

2:52_PM Discussion

2:57_PM TCT360:AssessmentofHeartTeamsTreatmentDecisionVariabilityInsightsFromtheSYNTAXIIIRevolutionTrial Lecturers:YoshinobuOnuma

3:04_PM Discussion

3:09_PM TCT361:HeartTeamApproachtoCADManagementinPatientsUndergoingElectiveVascularSurgeryWhoHaveAsymptomaticIschemiaProducing

CoronaryStenosis Lecturers:AndrejsErglis

3:16_PM Discussion

3:21_PM TCT362:CheckingtheRealityoftheSYNTAXIIIRevolutionTrialComparisonoftheVirtualHeartTeamDecisionWiththeTreatmentExecuted Lecturers:JeroenSonck

3:28_PM Discussion

3:33_PM TCT363:ImpactoftheHeartTeaminDecisionMakinginPatientsWithSevereAorticStenosisDataFromtheIMPULSERegistry Lecturers:StefanoSalizzoni

3:40_PM Discussion

MODERATEDPOSTERSESSION:NEWPOLYMERICBIORESORBABLEVASCULARSCAFFOLDSI

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

2:45PM-3:45PM

NewPolymericBioresorbableVascularScaffoldsI

Moderators:LorenzRaber,AshokSeth

Discussants:ArifAlNooryani,RafaDepukat,AndrejsErglis,NicolasFoin,MarvinJ.Slepian

2:45_PM TCT388:RealWorldFollowUpOneYearoftheNovelMeRes100 Lecturers:MarcosOrtega,MD

2:52_PM Discussion

2:57_PM TCT389:PreClinicalEvaluationofaNovelThinStrut85mUltraHighMolecularWeightPLLASirolimusElutingBioresorbableScaffold:AComparative

MultiModalityImagingBasedStudy Lecturers:MarcoFerrone,MD

3:04_PM Discussion

3:09_PM TCT390:ImpactofStrutThicknessonRadialForceandLateVascularRecoilofaNovelThinStrutUltraHighMolecularWeightPLLASirolimusEluting

BioresorbableCoronaryScaffold Lecturers:NicolasIsaza,MD

3:16_PM Discussion

3:21_PM TCT391:PostImplantationShearStressAnalysisAnEmergingToolforDifferentiationinBioresorbableScaffolds Lecturers:ErhanTenekecioglu,MD

3:28_PM Discussion

Page 102: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:102

3:33_PM TCT392:AFirstinManStudyoftheBioheartSirolimusElutingBioresorbableScaffoldinPatientsWithCoronaryArteryDiseaseOneYearClinicaland

ImagingOutcomes Lecturers:LeiSong

3:40_PM Discussion

MODERATEDPOSTERSESSION:OPTIMALDIAGNOSISANDTREATMENTOFPATIENTSWITHSTEMIORNSTEMII

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

2:45PM-3:45PM

OptimalDiagnosisandTreatmentofPatientswithSTEMIorNSTEMII

Moderators:PeterLDuffy,FranciscoFdez-Aviles

Discussants:AlejandroCherro,KonstantinosP.Tsioufis,AzfarG.Zaman

2:45_PM TCT378:AngiographicEchocardiographicandClinicalOutcomesAmongSTEMIPatientsWithPreInfarctionAnginaUndergoingPrimaryPercutaneous

CoronaryIntervention Lecturers:HosamHasan,MD

2:52_PM Discussion

2:57_PM TCT379:EffectofFamilyCharacteristicsonTherapeuticDelayinPatientsWithSTElevationMyocardialInfarction Lecturers:YukioMizuguchi,MD

3:04_PM Discussion

3:09_PM TCT380:ImpactofDirectStentingonMyocardialInjuryAssessedByCardiacMagneticResonanceImagingandPrognosisinSTElevationMyocardial

Infarction Lecturers:MohammedSaad,MD

3:16_PM Discussion

3:21_PM TCT381:TheSCAMINSTEMIScore:ASimplifiedRiskScoreBasedonChinaAcuteMyocardialInfarctionRegistrytoPredictInHospitalMortalityofNonST

SegmentElevationMyocardialInfarctionPatients Lecturers:RuiFu,MD

3:28_PM Discussion

3:33_PM TCT382:Safetyof2DayDischargeFollowingPPCIinSTEMIPatients Lecturers:ManishRamlall,MD

3:40_PM Discussion

MODERATEDPOSTERSESSION:TAVR,STROKE,ANDEMBOLICPROTECTIONI

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters1,ExhibitHall,GroundLevel

2:45PM-3:45PM

TAVR,Stroke,andEmbolicProtectionI

Moderators:HenriqueB.Ribeiro,PeterWenaweser

Discussants:AnthonyA.Bavry,FrancescoBedogni,JayaChandrasekhar

2:45_PM TCT354:PreproceduralLeftHeartDebrisIdentifiedByTEEDoesNotAppeartoBeaRiskFactorforStrokeDuringTAVR Lecturers:AddisAsfaw

2:52_PM Discussion

2:57_PM TCT355:StrokeAfterTranscathetervsSurgicalAorticValveReplacementAMetaAnalysisofRandomizedTrialsandPropensityMatchedObservational

Studies Lecturers:KuldeepShah

3:04_PM Discussion

3:09_PM TCT356:CorrelationofNeuromarkersandBrainInjuryAfterTAVRResultsFromCLEANTAVITrial Lecturers:StephanHaussig

3:16_PM Discussion

3:21_PM TCT357:InitialOutcomesWithaSystematicApplicationofSentinalCerebralEmbolicProtectionforBalloonExpandableTAVR Lecturers:MichaelJ.Rinaldi

Page 103: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:103

3:28_PM Discussion

3:33_PM TCT358:ReducingStrokeWhileincreasingTranscatheterAorticValveReplacementsCaseControlAnalysisof1658ProceduresOver6Years Lecturers:DominiqueMonlezun

3:40_PM Discussion

MODERATEDPOSTERSESSION:TECHNICALASPECTSOFCTOINTERVENTIONSII

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters4,ExhibitHall,GroundLevel

2:45PM-3:45PM

TechnicalAspectsofCTOInterventionsII

Moderators:ToshiyaMuramatsu,WilliamNicholson

Discussants:SanjogKalra,RobertF.Riley,BarryD.Rutherford,JoãoASilveira,MinhN.Vo

2:45_PM TCT369:AntegradeWireEscalationWithCompositeCoreDualCoilWireTechnologyintheTreatmentofCoronaryChronicTotalOcclusions Lecturers:JeffreyRossi,MD

2:52_PM Discussion

2:57_PM TCT370:IncreasedSpecialisationofChronicTotalOcclusionPCIImprovesSuccessRatesButIncreasesProceduralComplexity:ASingleCentreExperience Lecturers:LeongLee,MD

3:04_PM TCT371:AntegradeFenestrationandReEntry:ANovelSubintimalTechniqueforChronicTotalOcclusionRecanalization Lecturers:LorenzoAzzalini,MD

3:11_PM Discussion

3:16_PM TCT372:PooledAnalysisofCollateralChannelTypeandMorphologyDuringRetrogradeChronicTotalOcclusionPercutaneousCoronaryIntervention Lecturers:SudhirRathore

3:23_PM Discussion

3:28_PM TCT373:SafetyandEfficacyofTransradialvsTransfemoralApproachforChronicTotalOcclusion:AMetaAnalysis Lecturers:MuhammadKhalid,MD

3:35_PM Discussion

MODERATEDPOSTERSESSION:VALVE-IN-VALVEPROCEDURESI

SATURDAY,SEPTEMBER22,2018

2:45PM-3:45PM

ModeratedPosters5,ExhibitHall,GroundLevel

2:45PM-3:45PM

Valve-in-ValveProceduresI

Moderators:MohamedAbdel-Wahab,DarrenL.Walters

Discussants:KeithB.Allen,AdnanK.Chhatriwalla,JamesB.HermillerJr

2:45_PM TCT334:TreatmentofDegeneratedAorticBioprosthesesAComparisonBetweenValveInValveTransfemoralTranscatheterAorticValveReplacement

andConventionalReoperation Lecturers:NormanMangner

2:52_PM Discussion

2:57_PM TCT335:PredictorsofElevatedGradientsAfterTranscatheterAorticValveReplacementforFailingBioprostheticAorticValveReplacement Lecturers:RobertL.Richmond

3:04_PM Discussion

3:09_PM TCT336:TransfemoralTAVRTreatmentofFailingAorticValveBioprosthesesMidTermResultsandOutcome Lecturers:FelixWoitek

3:16_PM Discussion

3:21_PM TCT337:TheEffectofTranscatheterLacerationofDegeneratedBioprostheticValveLeafletsontheLikelihoodofLeafletThrombosisFollowing

TranscatheterAorticValveInValveImplantationAComputationalSimulationStudy Lecturers:FarhanKhodaee

3:28_PM Discussion

3:33_PM TCT338:ComparisonofRedoTranscatheterAorticValveReplacementWithValveinValveforFailedSurgicalAorticBioprostheses:aMulticenter

Page 104: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:104

AnalysisofClinicalandLongTermOutcome Lecturers:MatthiasRaschpichler

3:40_PM Discussion

MODERATEDPOSTERSESSION:INTRAVASCULARIMAGING,PCI,ANDLONG-TERMOUTCOMESII

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

3:45PM-4:45PM

IntravascularImaging,PCI,andLong-TermOutcomesII

Moderators:PeterH.Stone,AlanC.Yeung

Discussants:OlliA.Kajander,EliasSanidas,ShiroUemura,MladenI.Vidovich

3:45_PM TCT423:IncidenceandPrognosticImpactoftheCalcifiedNoduleinCoronaryArteryDiseasePatientsonHemodialysis Lecturers:AkihikoOkamura

3:52_PM Discussion

3:57_PM TCT424:ANewIntravascularUltrasoundGuidedStentingStrategyComparedWithAngiographyonStentExpansionandProceduralOutcomesin

PatientsWithPositiveLesionRemodeling Lecturers:DiaaHakim

4:04_PM Discussion

4:09_PM TCT425:ImpactofExternalElasticLaminaDiameterBasedSizingvsLumenDiameterBasedSizingonEarlyVascularHealing Lecturers:WataruSasaki

4:16_PM Discussion

4:21_PM TCT426:RelationshipBetweenLesionCharacteristicsasAssesedByintravascularUltrasoundandClinicalOutcomesVAMPIRE3IVUSSubstudy Lecturers:NobuhikoMaejima

4:28_PM Discussion

4:33_PM TCT427:RoleofResidualStentUnderExpansionErsusInStentMinimumLumenAreainPercutaneousCoronaryInterventionOutcomeACLIOPCI

ProjectSubstudy Lecturers:EnricoRomagnoli

4:40_PM Discussion

MODERATEDPOSTERSESSION:NEWPOLYMERICBIORESORBABLEVASCULARSCAFFOLDSII

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

3:45PM-4:45PM

NewPolymericBioresorbableVascularScaffoldsII

Moderators:AntoineLafont,SigmundSilber

Discussants:BrianG.DeRubertis,JeehoonKang,VojtechNovotny

3:45_PM TCT428:AFirstinManStudyoftheFiresorbSirolimusTargetElutingBioresorbableVascularScaffoldinPatientsWithCoronaryArteryDiseaseFUTUREI:

TwoYearClinicalandImagingOutcomes Lecturers:LeiSong

3:52_PM Discussion

3:57_PM TCT429:ARandomizedTrialComparingANovelSirolimusElutingBioresorbableScaffoldWithEverolimusElutingMetallicStentsinPatientsWith

CoronaryArteryDisease:TwoYearClinicalOutcomes Lecturers:YalingHan

4:04_PM Discussion

4:09_PM TCT430:InVitroandPreclinicalEvaluationofaThinStrutBioresorbableScaffold:ResultsFromBenchTestingandAcutePhaseStudyinaNon

AtheroscleroticPorcineModel Lecturers:YukiKatagiri

4:16_PM Discussion

4:21_PM TCT431:TwentyFourMonthsHealingPatternsAfterImplantationoftheFantomBioresorbableScaffoldEvaluatedByOpticalCoherenceTomography Lecturers:EmilHolck

Page 105: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:105

4:28_PM Discussion

4:33_PM TCT432:FantomIITrial:SafetyPerformanceStudyoftheFantomSirolimusElutingBioresorbableCoronaryScaffold24MonthFollowUpClinical

OutcomesFinalResults Lecturers:GeorgiosBouras

4:40_PM Discussion

MODERATEDPOSTERSESSION:NON-ATHEROSCLEROSISCORONARYARTERYDISEASEI

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

3:45PM-4:45PM

Non-atherosclerosisCoronaryArteryDiseaseI

Moderators:BernardJ.Gersh,AliceK.Jacobs

Discussants:FernandoAlfonso,RajivGulati,JacekLegutko,JoseL.Leiva-Pons,MichelleO'Donoghue,IosifXenogiannis

3:45_PM TCT398:EvaluationofMicrovascularDysfunctioninPatientsWithTakotsuboSyndrome Lecturers:DomenicoNobile,MD

3:52_PM Discussion

3:57_PM TCT399:IschemicStrokeinPatientsWithTakotsuboCardiomyopathyAnalysisoftheNationalInpatientSampleDatabase Lecturers:ShunsukeAoi,MD

4:04_PM Discussion

4:09_PM TCT400:PrevalenceofMyocardialBridgingAssociatedWithCoronaryEndothelialDysfunctioninPatientsWithChestPainandNonObstructiveCoronary

ArteryDisease Lecturers:JaskanwalDeepSara,MD

4:16_PM Discussion

4:21_PM TCT401:AStrategyofPercutaneousCoronaryInterventionWithDrugElutingStentsfortheTreatmentofCardiacAllograftVasculopathyMayNormalize

Survival Lecturers:RichardCheng,MD

4:28_PM Discussion

4:33_PM TCT402:SerumUricAcidLevelsPredictLongtermAdverseCardiovascularOutcomesAfterCardiacTransplantation Lecturers:MeghaPrasad

4:40_PM Discussion

MODERATEDPOSTERSESSION:NON-LMBIFURCATIONINTERVENTIONII

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters4,ExhibitHall,GroundLevel

3:45PM-4:45PM

Non-LMBifurcationInterventionII

Moderators:Marie-ClaudeMorice,MarcoA.Perin

Discussants:MamasMamas,StefanMot,SunaoNakamura,ManishA.Parikh,AfzalurRahman,SudhirRathore

3:45_PM TCT408:BifurcationandOstialOpticalCoherenceTomographyMappingBOOMAnalysisofaNovelCoRegistrationBasedTechnique Lecturers:EvanShlofmitz

3:52_PM Discussion

3:57_PM TCT409:BifurcationalPercutaneousCoronaryInterventioninSTElevationMyocardialInfarction Lecturers:VimalrajBoganaShanmugam

4:04_PM Discussion

4:09_PM TCT410:CriticalAspectsoftheFinalProximalOptimizationTechniquePOTDuringBifurcationStenting Lecturers:LeneNyhusAndreasen

4:16_PM Discussion

4:21_PM TCT411:ComparisonoftheStrategiesforSideBranchInterventionAccordingtoFractionalFlowReserveinCoronaryBifurcationLesions Lecturers:Sang-CheolCho

Page 106: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:106

4:28_PM Discussion

4:33_PM TCT412:SideBranchInterventionforNonLeftMainTrueBifurcationLesions:PooledAnalysisofKoreanMulticenterDrugElutingStentCohort Lecturers:GyuChulOh

4:40_PM Discussion

MODERATEDPOSTERSESSION:OBESITYINCAD

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

3:45PM-4:33PM

ObesityinCAD

Moderators:HenningKelbæk,MichaelC.C.Kim

Discussants:WaleedYKadro,JaikirshanKhatri,VijayKunadian,DavidJ.Maron,Jean-FrançoisTanguay

3:45_PM TCT418:AssociationBetweenBodyMassIndexand1YearMACCEAfterAcuteMyocardialInfarction Lecturers:MyunHeeLee

3:52_PM Discussion

3:57_PM TCT419:EffectsofBodyMassIndexontheComparativeEffectivenessofPCIvsCABGforLeftMainCoronaryArteryDiseaseInsightsFromtheEXCEL

Trial Lecturers:SabatoSorrentino

4:04_PM Discussion

4:09_PM TCT420:TheEffectofBodyMassIndexonClinicalOutcomesinPatientsWithAcuteCoronarySyndrome Lecturers:MesferAlfadhel

4:16_PM Discussion

4:21_PM TCT422:TheImpactofWeightLossonCardiovascularOutcomesFollowingPercutaneousCoronaryRevascularizationAContemporaryRealWorld

Experience Lecturers:TrevorSimard

4:28_PM Discussion

MODERATEDPOSTERSESSION:RACIALANDGENDERDISPARITIESINENDOVASCULARANDSTRUCTURALHEARTDISEASEANDINTERVENTIONII

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

3:45PM-4:45PM

RacialandGenderDisparitiesinEndovascularandStructuralHeartDiseaseandInterventionII

Moderators:AaronHorne,Jr.,JamesP.Zidar

Discussants:DouglasE.Drachman,RogerJ.Laham

3:45_PM TCT406:ElevatedUricAcidIsAssociatedWithIncreasedLesionCalcificationandIncreasedMortalityinWomenUndergoingPercutaneousCoronary

Intervention Lecturers:MeghaPrasad

3:52_PM Discussion

3:57_PM TCT403:TheSurgeryAfterStentSASRegistry:AGenderBasedAnalysisonClinicalOutcomesinWomenUndergoingCardiacandNonCardiacSurgery Lecturers:DanielaTrabattoni

4:04_PM Discussion

4:09_PM TCT404:TakotsuboSyndromeandOxidativeStressinWomen:WhatHappenstotheClot Lecturers:DanielaTrabattoni

4:16_PM Discussion

4:21_PM TCT405:SexDifferencesandOutcomesFollowingRotationalAtherectomy:DoWomenReceiveOptimalCare Lecturers:TomJFord

4:28_PM Discussion

4:33_PM TCT407:SexDifferencesinSymptomPatternofChestPainandResolutionFollowingCoronaryRevascularization Lecturers:PietroDiSanto

Page 107: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:107

4:40_PM Discussion

MODERATEDPOSTERSESSION:TAVRINBICUSPIDAORTICVALVEDISEASE

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters5,ExhibitHall,GroundLevel

3:45PM-4:45PM

TAVRinBicuspidAorticValveDisease

Moderators:IoannisIakovou,EricE.Roselli

Discussants:MohammadMehdiAnsari,JanKovac,GilbertH.L.Tang

3:45_PM TCT413:NationalTrendsandOutcomesofTranscatheterAorticValveReplacementinPatientsWithBicuspidAorticValveStenosis Lecturers:MohamadSoud

3:52_PM Discussion

3:57_PM TCT414:PatientSpecificComputerSimulationtoOptimiseTranscatheterHeartValveSizingandPositioninginBicuspidAorticValveMorphology Lecturers:CameronDowling

4:04_PM Discussion

4:09_PM TCT415:TranscatheterAorticValveImplantationUsingSymetisACURATEinBicuspidAorticValveStenosis:InsightsFromAMulticenterExperience Lecturers:AntonioMangieri

4:16_PM Discussion

4:21_PM TCT416:BalloonvsSelfExpandableValvefortheTreatmentofBicuspidAorticValveSTenosis:InsightsfromtheBEATInternationalCollaborative

Registry Lecturers:AntonioMangieri

4:28_PM Discussion

4:33_PM TCT417:LongTermMortalityofPatientsUndergoingTranscatheterAorticValveReplacementforBicuspidvsTricuspidAorticStenosis Lecturers:RaymundoQuintana

4:40_PM Discussion

MODERATEDPOSTERSESSION:VASCULARACCESSINSTRUCTURALHEARTDISEASEPROCEDURES

SATURDAY,SEPTEMBER22,2018

3:45PM-4:45PM

ModeratedPosters1,ExhibitHall,GroundLevel

3:45PM-4:45PM

VascularAccessinStructuralHeartDiseaseProcedures

Moderators:DavidJ.Cohen,JoachimSchofer

Discussants:FrancescoBurzotta,JasvindarSingh,A.J.ConradC.Smith

3:45_PM TCT393:TranscarotidApproachforTAVIWiththeSAPIEN3ProsthesisAMulticentreFrenchRegistry Lecturers:PavelOvertchouk,MD

3:52_PM Discussion

3:57_PM TCT394:EfficacyandSafetyofFishermansKnotTechniquetoAchieveVenousHaemostasisAfterRemovalofLargeSheath12Fr Lecturers:PuneetAggarwal

4:04_PM Discussion

4:09_PM TCT395:APropensityMatchedComparisonofSuprasternalandTransfemoralTranscatheterAorticValveReplacementInominatevsFemoral Lecturers:AnnaOlds,MD

4:16_PM Discussion

4:21_PM TCT396:AssociationofPeripheralArteryDiseaseWithInHospitalOutcomesAfterEndovascularTranscatheterAorticValveReplacement Lecturers:DivyanshuMohananey,MD

4:28_PM Discussion

4:33_PM TCT397:IpsilateralBalloonOcclusionTechniqueforPercutaneousClosureAfterTransfemoralAorticValveReplacement Lecturers:SunnyGoel,MD

4:40_PM Discussion

Page 108: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:108

EVENINGPROGRAM:ANEXPERTTRANSRADIALQ&APANEL:GENERATINGCLINICALANDECONOMICVALUE(SPONSOREDBYTERUMO)

SATURDAY,SEPTEMBER22,2018

6:00PM-8:00PM

PacificBallroom21-22,LevelOne

6:00PM-8:00PM

AnExpertTransradialQ&APanel:GeneratingClinicalandEconomicValue

Chairs:SunilV.Rao,GreggW.Stone

Faculty:AmitAmin,MD,AjayJ.Kirtane,SahilA.Parikh,ArnoldSeto,BinitaShah

6:00_PM CheckinReception

6:30_PM Thispanelofexpertswilladdressthecurrentclinicalcontroversiesrelatedtotransradialaccessandinterventionduringcardiologyandperipheral

interventionthatarekeepingradialaccessfromreachinghigherlevelsofproceduralpenetration.Antici Lecturers:AmitAmin,MD,AjayJ.Kirtane,SahilA.Parikh,SunilV.Rao,ArnoldSeto,BinitaShah,GreggW.Stone

EVENINGPROGRAM:CHIPANGIOGRAMREVIEW:WHAT'SNEWWITHFOCUSEDCASEPRESENTATIONS(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,

ABIOMED,INC.,BOSTONSCIENTIFICCORPORATION,BTGGROUPINTERNATIONAL,CARDIOVASCULARSYSTEMS,INC.,CORDIS,ACARDINALHEALTH

COMPANY,ANDMEDTRONIC)

SATURDAY,SEPTEMBER22,2018

6:00PM-8:00PM

PacificBallroom18-19,LevelOne

6:00PM-6:30PM

Check-In&Reception

6:30PM-8:00PM

CHIPAngiogramReview:Rapid-FireCasePresentationsoftheGood,Bad,andtheUgly

CoChairs:DimitriKarmpaliotis,AjayJ.Kirtane,MartinB.Leon,WilliamL.Lombardi,JeffreyW.Moses

Faculty:MirvatAlasnag,ZiadA.Ali,EmmanouilS.Brilakis,AlaideChieffo,EvaldH.Christiansen,AntonioColombo,GeorgeD.Dangas,CindyL.Grines,JonathanM.Hill,

AaronHorne,Jr.,AllenJeremias,JaikirshanKhatri,NicholasJ.Lembo,JamesM.McCabe,MargaretB.McEntegart,RoxanaMehran,WilliamNicholson,ManishA.Parikh,

BinitaShah,AndrewSharp,RobertW.Yeh

6:30_PM OpeningRemarks:CHIPStatusUpdate Lecturers:JeffreyW.Moses

Panel#1

Moderators:MartinB.Leon

Panel#1

PanelDiscussant:MirvatAlasnag,AlaideChieffo,J.AaronGrantham,AllenJeremias,JamesM.McCabe,ManishA.Parikh,BinitaShah

6:42_PM Case1:LeftMainBifurcationDisease CasePresenter:EvaldH.Christiansen

6:59_PM Case2:CalciumCalciumCalcium CasePresenter:EmmanouilS.Brilakis

Panel#2

Moderators:AjayJ.Kirtane

Panel#2

PanelDiscussant:ZiadA.Ali,AntonioColombo,GeorgeD.Dangas,JonathanM.Hill,WilliamL.Lombardi,MargaretB.McEntegart,RoxanaMehran,RobertW.Yeh

7:14_PM Case3:InStentRestenosis CasePresenter:WilliamNicholson

7:29_PM Case4:MultivessselDiseaseElective CasePresenter:AndrewSharp

7:44_PM Case5:MultivesselDiseaseShock CasePresenter:DimitriKarmpaliotis

Page 109: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:109

8:00_PM Adjourn

EVENINGPROGRAM:EVERYDAYANTIPLATELETDECISIONS:MAKINGTHERIGHTCHOICES(SPONSOREDBYCRF,SUPPORTEDBYCHIESIUSA,INC.)

SATURDAY,SEPTEMBER22,2018

6:00PM-8:00PM

PacificBallroom14-17,LevelOne

6:00PM-6:30PM

Check-In&Reception

6:30PM-8:00PM

EverydayAntiplateletDecisions:MakingtheRightChoices

CoChairs:DeepakL.Bhatt,PascalVranckx

Discussants:JohnA.Bittl,DavideCapodanno,ChristianW.Hamm,RoxanaMehran,MatthewJ.Price,DanielI.Simon

Faculty:DominickJ.Angiolillo,C.MichaelGibson,TullioPalmerini,GreggW.Stone,MarcoValgimigli,MD,RobertW.Yeh

6:30_PM FirstDecision.AcuteCare:WhentoUsePotentIntravenousP2Y12Inhibition Lecturers:GreggW.Stone

6:40_PM CaseStudy1WithDiscussion:ACaseinWhichIWishIhadUsedPotentIVP2Y12Inhibition CasePresenter:DominickJ.Angiolillo

6:50_PM SecondDecision.DAPTDuration:WhatVariablesReallyMatterWhenBalancingIschemicvsBleedingRisk Lecturers:DeepakL.Bhatt

7:00_PM CaseStudy2WithDiscussion:DAPTDurationDecisioninaPatientatHighRiskforIschemiaandBleeding CasePresenter:TullioPalmerini

7:10_PM ThirdDecision.AntiplateletMonotherapy:WhoWhichWhenandWhy Lecturers:PascalVranckx

7:20_PM CaseStudy3WithDiscussion:ACaseforAntiplateletMonotherapy CasePresenter:MarcoValgimigli,MD

7:30_PM FourthDecision.DAPTUseAfterDESinthePatientWithAtrialFibrillation:PracticalRecommendations Lecturers:C.MichaelGibson

7:40_PM CaseStudy4WithDiscussion:AcuteandChronicManagementofaPatientWithSTEMIHighThrombusBurdenandAtrialFibrillation CasePresenter:RobertW.Yeh

7:50_PM UnansweredQuestionsFromtheAudience

8:00_PM Adjourn

CARDIOVASCULARPROFESSIONALS(CVP)COURSE:27THANNUALCARDIOVASCULARNURSEANDTECHNOLOGISTSYMPOSIUM:INTERACTIVE

TRAININGWORKSHOP

SATURDAY,SEPTEMBER22,2018

1:00PM-4:00PM

Room6C,UpperLevel

1:00PM-4:00PM

*InteractiveTrainingRotationsAreFrom:[1:00PM-1:50PM];[2:00PM-2:50PM];[3:00PM-3:50PM]

Moderators:JulieLogan

1:00PM-4:00PM

CoronarySession(50MinuteRotations)

InteractiveTrainingFaculty:MartinaKellySpeight

1:00_PM CoronaryAssessmentandImagingUsingthePOLARISMultiModalityGuidanceSystemSupportedbyBostonScientificCorporation10MinuteRotations

1:00_PM CoronaryPhysiologicAssessmentandImagingUsingtheCOREandSyncVisionSystemsSupportedbyPhilips10MinuteRotations

1:00_PM LesionModificationSessionUsingLaserAtherectomyandANGIOSCULPTBalloonCathetersSupportedbyPhilips10MinuteRotations

1:00_PM ChronicTotalOcclusionsSessionsUsingCROSSBOSSCatheterSTINGRAYLPSystemSupportedbyBostonScientificCorporation10MinuteRotation

Page 110: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:110

1:00_PM LesionModificationSessionUsingRotationalAtherectomySystemSupportedbyBostonScientificCorporation10MinuteRotation

1:00_PM TransradialExperienceSupportedbyMedtronic10MinuteRotation

2:50_PM BreakforRotationTransition

1:00PM-4:00PM

PeripheralVascularSession(50MinuteRotations)

InteractiveTrainingFaculty:JeffDavis

1:00_PM JetStreamforAtherectomySupportedbyBostonScientificCorporation

1:50_PM BreakforRotationTransition

1:00_PM JetStreamforAtherectomySupportedbyBostonScientificCorporation

2:50_PM BreakforRotationTransition

1:00PM-4:00PM

StructuralHeartSession(50MinuteRotations)

InteractiveTrainingFaculty:MarianC.Hawkey

1:00_PM CerebralEmbolicProtectionforTAVRSupportedbyBostonScientificCorporation10MinuteRotation

1:00_PM TranscatheterAorticValveSession:UnderstandingEvolutTAVRPlatformSupportedbyMedtronic10MinuteRotation

1:00_PM TranscatheterAorticValveSession:UnderstandingSapien3ValveSupportedbyEdwardsLifesciences10MinuteRotation

1:00_PM TranscatheterPulmonaryValveSession:UnderstandingMelodyTPVSystemSupportedbyMedtronic

1:00_PM LeftAtrialAppendageClosureSession:UnderstandingWatchmanLAADeviceandDeliverySystemSupportedbyBostonScientificCorporation

1:50_PM BreakforRotationTransition

1:00_PM CerebralEmbolicProtectionforTAVRSupportedbyBostonScientificCorporation10MinuteRotation

1:00_PM TranscatheterAorticValveSession:UnderstandingEvolutTAVRPlatformSupportedbyMedtronic10MinuteRotation

1:00_PM TranscatheterAorticValveSession:UnderstandingSapien3ValveSupportedbyEdwardsLifesciences10MinuteRotation

1:00_PM TranscatheterPulmonaryValveSession:UnderstandingMelodyTPVSystemSupportedbyMedtronic

1:00_PM LeftAtrialAppendageClosureSession:UnderstandingWatchmanLAADeviceandDeliverySystemSupportedbyBostonScientificCorporation

2:50_PM BreakforRotationTransition

FDATOWNHALLMEETINGPART1:IMPORTANTPROGRAMS

SATURDAY,SEPTEMBER22,2018

2:00PM-6:00PM

Room29A-B,UpperLevel

2:00PM-2:50PM

SessionI.TwentyYearsofTownHallOpenDialogueBetweenFDA,CliniciansResearchers,andIndustry

Moderators:MitchellW.Krucoff,GreggW.Stone

Discussants:DavidE.Kandzari,AaronV.Kaplan,WilliamH.Maisel,LauraMauri,RoxanaMehran,MichaelA.Mussallem,CampbellRogers,SeanSalmon,BramD.

Zuckerman

2:00_PM TheTCTFDATownHallMeetingsinPerspective:AMultidisciplinaryCollaborativeVenture Lecturers:MartinB.Leon

2:05_PM KeynoteLecture:FDACDRHTheYearinReview Lecturers:WilliamH.Maisel

2:50PM-3:50PM

SessionII.PatientEngagementinClinicalTrials:StridesandTribulations

Moderators:JohnCLaschinger

Page 111: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SATURDAY,SEPTEMBER22,2018

LastUpdated09/10/2018Page:111

CoModerator:WayneB.Batchelor,MeganCoylewright

Discussants:J.DawnAbbott,LoriMAshby,RobertA.Byrne,DavidA.Cox,MonaFiuzat,ChristopherO'Connor,JohnA.Spertus,SusanStrong

2:50_PM FDAsPatientEngagementInitiatives:HowFDACanIncorporatePatientCenteredandPatientReportedOutcomesinRegulatoryDecisionMaking Lecturers:JohnCLaschinger

2:58_PM PatientCenteredEngagementinTrials:CaseExampleADAPTABLE CasePresenter:SchuylerJones

3:06_PM PatientPerspectives Lecturers:SusanStrong

3:14_PM ClinicianPerspectives Lecturers:MeganCoylewright

3:22_PM CMSPerspectives Lecturers:LoriMAshby

3:30_PM RoundtableDiscussionwithAudienceQA

3:50PM-5:00PM

SessionIII:EvaluationandRegulationofDevicesUsingMachineLearningandArtificialIntelligence

Moderators:C.MichaelGibson,WilliamH.Maisel

Discussants:MohuaChoudhury,PeterJ.Fitzgerald,RanKornowski,JamesK.Min,PeterP.Monteleone,ChristopherO'Connor,CampbellRogers,LarryL.Wood,BramD.

Zuckerman

3:50_PM KeynoteLecture:ThePotentialImpactofMachineLearningArtificialIntelligenceonCardiovascularMedicalDeviceDevelopment Lecturers:PeterJ.Fitzgerald

4:00_PM FDAPerspectives Lecturers:MohuaChoudhury

4:08_PM ClinicianScientistTrialistPerspective Lecturers:JamesK.Min

4:16_PM IndustryPerspective Lecturers:CampbellRogers

4:24_PM PatientPerspective Lecturers:SusanStrong

4:32_PM RoundtableDiscussionwithAudienceQA

5:00PM-6:00PM

SessionIV.DeviceInnovation:EarlyFeasibilityStudies,EFSNetwork,andBeyond

Moderators:AndrewFarb,MartinB.Leon

Discussants:LaurenS.Baker,RickGeoffrion,JuanF.Granada,DavidR.HolmesJr.,MichaelJ.Mack,LizMcDermott,SeanSalmon,JaimeWalkowiak,ChangfuWu

5:00_PM TheUSEFSProgram:FDAUpdate Lecturers:AndrewFarb

5:08_PM TheSecondGenerationCardiovascularEFSPilot:ProgressReport Lecturers:DavidR.HolmesJr.

5:18_PM PromotingMedicalDeviceInnovation:MDICPerspectives Lecturers:LizMcDermott

5:26_PM EFSDecisions:StartupCompanyConsiderations Lecturers:BeverlyAHuss

5:34_PM EFSExperiencesGromtheIndustryClientPerspective:WhatsGoodandWhatNeedstoChange Lecturers:DonaldE.BoboJr

5:42_PM RoundtableDiscussionwithAudienceQA

Page 112: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:112

SUNDAY,SEPTEMBER23,2018-

BREAKFASTPROGRAM:ADVANCESINSFAINTERVENTION-ACASEBASEDREVIEW(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,BOSTON

SCIENTIFICCORPORATION,ANDMEDTRONIC)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room27A-B,UpperLevel

6:30AM-7:00AM

Check-in&Breakfast

7:00AM-8:00AM

BreakfastProgram:AdvancesinSFAIntervention-ACaseBasedReview

Chairs:SahilA.Parikh

Faculty:EhrinJ.Armstrong,ArthurC.Lee,MehdiH.Shishehbor

7:00_AM CTOCrossing:AlternateAccessorAlternateDevices Lecturers:ArthurC.Lee

7:10_AM PanelDiscussion:LesionCrossingChallenges

7:20_AM LesionPreparationinSFAIntervention:ToCutSpinVaporizeorNot Lecturers:EhrinJ.Armstrong

7:30_AM DrugCoatedBalloons:WhatstheSecretSauce Lecturers:MehdiH.Shishehbor

7:40_AM StentsfortheSFA:IsaStentJustaStent Lecturers:SahilA.Parikh

7:50_AM PanelDiscussion:WhatsMySFATreatmentAlgorithm

8:00_AM Adjourn

BREAKFASTPROGRAM:ANTITHROMBOTICMANAGEMENTINTAVRWITHATRIALFIBRILLATION(ORGANIZEDBYCRF,SPONSOREDBYDAIICHI

SANKYO,INC.)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room26A-B,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

AntithromboticManagementinTAVRWithAtrialFibrillation

CoChairs:GeorgeD.Dangas

Faculty:RajMakkar,JosepRodés-Cabau

7:00_AM AtrialFibrillationAFinTAVR:NotJustanInnocentBystander

7:10_AM WarfarinTherapyinTAVRPatientswithAF Lecturers:JosepRodés-Cabau

7:20_AM TheDOACLandscapeinPerspective:NuancesandSubtleties

7:30_AM WhatistheRationaleforDOACinTAVRWithAF Lecturers:GeorgeD.Dangas

7:40_AM LeafletThrombosisAfterAVR:IsDOACtheAnswer Lecturers:RajMakkar

7:50_AM PanelDiscussion

8:00_AM Adjourn

Page 113: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:113

BREAKFASTPROGRAM:AVIRTUALREALITYINPRACTICEVIEW-MAXIMIZINGCLINICALBENEFITTHROUGHOPTIMALLDL-CREDUCTIONSIN

PATIENTSWITHATHEROSCLEROTICDISEASE(SPONSOREDBYMEDLEARNINGGROUP,SUPPORTEDBYSANOFIUS)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room30D-E,UpperLevel

6:30AM-8:00AM

AVirtualRealityinPracticeView:MaximizingClinicalBenefitThroughOptimalLDL-CReductionsinPatientsWithAtheroscleroticDisease

CoChairs:HaroldEBays,DeepakL.Bhatt

6:30_AM CheckinandBreakfast

7:00_AM PathogenesisofAtheroscleroticCardiovascularDisease

7:10_AM HypercholesterolemiaManagementinthePostACSPatient

7:20_AM PCSK9InhibitorsEfficacySafetyandMechanismofActionintheACSPatient

7:30_AM MedicalEconomicsofPCSK9InhibitionintheACSPatient

7:40_AM ClinicalCaseStudies

7:50_AM ConclusionsandQuestionsAnswers

8:00_AM Adjourn

BREAKFASTPROGRAM:MANAGEMENTOFCOMPLEXPCIPATIENTS:AWARDWINNINGCASEPRESENTATIONS(ORGANIZEDBYCRF,SPONSOREDBY

ABIOMED,INC.)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room23B-C,UpperLevel

6:30AM-8:00AM

ManagementofComplexPCIPatients:AwardWinningCasePresentations

Chairs:TheodoreL.Schreiber,MD

PanelDiscussant:AmirKaki,DavidWohns,MD

Faculty:AliFarooq,HirofumiOhtani,AbhishekSharma

6:30_AM CheckinBreakfast

7:00_AM UseofImpellaVentricularAssistDeviceInMassivePulmonaryEmbolismAssociatedCardiogenicShock Lecturers:AliFarooq

7:15_AM QA

7:20_AM SuccessfulImpellaCPDeviceUseForHighRiskUnprotectedLeftMainPercutaneousCoronaryInterventionInaPatientWithAcuteMyocardialInfarction

WithSevereAorticRegurgitation Lecturers:HirofumiOhtani

7:35_AM QA

7:40_AM HighRiskPCIWithAxillaryImpellaSupport Lecturers:AbhishekSharma

7:55_AM QA

8:00_AM Adjourn

BREAKFASTPROGRAM:NEWFRONTIERSINROBOTICINTERVENTIONS:CURRENT&FUTURETECHNOLOGY(SPONSOREDBYCORINDUSVASCULAR

ROBOTICS)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room31B-C,UpperLevel

Page 114: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:114

6:30AM-8:00AM

NewFrontiersinRoboticInterventions:Current&FutureTechnology

Faculty:J.AaronGrantham,MitchellW.Krucoff,RyanD.Madder,EhtishamMahmud,ManishA.Parikh

6:30_AM CheckinandBreakfast

7:00_AM WelcomeIntroduction Lecturers:J.AaronGrantham

7:05_AM NewClinicalEvidenceinRoboticInterventions Lecturers:EhtishamMahmud

7:15_AM RoboticsforComplexPCI:ACaseSeries Lecturers:ManishA.Parikh

7:25_AM The1stRemotePCIfrom100MilesAway Lecturers:RyanD.Madder

7:40_AM BuildingtheNextGenerationRobot Lecturers:MitchellW.Krucoff

7:50_AM QAwModerator Lecturers:J.AaronGrantham

8:00_AM Adjourn

BREAKFASTPROGRAM:OPTIMIZATIONOFVESSELACCESSANDCLOSUREINLARGEBORECATHETERPROCEDURES(SPONSOREDBYCRF,SUPPORTED

BY...)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room32A-B,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

OptimizationofVesselAccessandClosureinLargeBoreCatheterProcedures:TipsandTricksCase-BasedReview

CoChairs:PhilippeGenereux,MartinB.Leon

Faculty:AmirKaki,JamesM.McCabe,MichaelJ.Rinaldi,RajivTayal,DavidA.Wood

7:00_AM Introduction Lecturers:MartinB.Leon

7:02_AM GettingOptimalArterialandVenousAccessforLargeBoreCatheterProcedures Lecturers:MichaelJ.Rinaldi

7:12_AM LargeBoreVesselClosureManagement:TipsandTricksandAdjunctiveTechniques Lecturers:AmirKaki

7:22_AM AccessandClosureforAlternativeAccess:FocusonPercutaneousTransaxillaryApproach Lecturers:JamesM.McCabe

7:32_AM RealTimeBleedDetection:NovelSaranasEarlyBirdBleedMonitoring Lecturers:PhilippeGenereux

7:42_AM UpcomingClosureDeviceSystemDedicatedtoLargeBoreProcedure Lecturers:DavidA.Wood

7:52_AM DiscussionandConclusion

8:00_AM Adjourn

BREAKFASTPROGRAM:PFOCLOSUREFORCRYPTOGENICSTROKERISKREDUCTION:LATESTCLINICALDATA,BESTIMAGINGPRACTICESANDREAL-

WORLDCASES(SPONSOREDBYABBOTT)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room28A-B,UpperLevel

6:30AM-8:00AM

Page 115: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:115

PFOClosureforCryptogenicStrokeRiskReduction:LatestClinicalData,BestImagingPracticesandReal-WorldCases

Faculty:JohnD.Carroll,VaikomSubraMahadevan,MD,DavidE.Thaler

6:30_AM CheckinBreakfast

7:00_AM Welcome Lecturers:JohnD.Carroll

7:05_AM TheLatestClinicalData:UpdatedPFOClosureforCryptogenicStrokeClinicalTrialReviewandGuidelines Lecturers:DavidE.Thaler

7:20_AM PFOClosure:ImagingBestPracticesandRealWorldCaseStudies Lecturers:VaikomSubraMahadevan,MD

7:35_AM WhatIsaPFOClinicandHowDoesItWorkToGrowYourPractice Lecturers:JohnD.Carroll

7:50_AM ClosingRemarks Lecturers:JohnD.Carroll

8:00_AM Adjourn

BREAKFASTPROGRAM:TAVRSHIFTTOINTERMEDIATERISKPATIENTS:PRACTICALCONSIDERATIONSFORTHEHEARTTEAMANDHOSPITALS

(ORGANIZEDBYCRF,SPONSOREDBYMEDTRONIC)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room25A-B,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

TAVRShifttoIntermediateRiskPatients:PracticalConsiderationsfortheHeart

Chairs:MichaelJ.Reardon

Faculty:DannyDvir,HemalGada,JamesB.HermillerJr,DidierTchetche

7:00_AM Hemodynamics:FromLowerGradientstoLessLeafletImmobility:WhyShouldYouCare Lecturers:DannyDvir

7:10_AM LearningsThatareApplicabletoALLCentersonProceduralEfficiency Lecturers:DidierTchetche

7:20_AM PostTAVRPCI:WhatDoestheDataSayandWhatHaveWeLearned Lecturers:JamesB.HermillerJr

7:30_AM SingleDigitPacemakerImplantationRatesHowIAchieveTheminMyCenter Lecturers:HemalGada

7:40_AM TAVRinBiscuspidValves Lecturers:DidierTchetche

7:50_AM Discussion

8:00_AM Adjourn

BREAKFASTPROGRAM:THENEXTGENCATHLAB�ADDRESSINGCRITICALISSUESIN2019ANDBEYOND(SPONSOREDBYACIST)

SUNDAY,SEPTEMBER23,2018

6:30AM-8:00AM

Room28D-E,UpperLevel

6:30AM-8:00AM

TheNextGenCathLab�AddressingCriticalIssuesin2019andBeyondChairs:MortonJ.Kern

Faculty:JeffChambers,RobertF.Wilson,MD

6:30_AM CheckinBreakfast

7:00_AM Welcome Lecturers:MortonJ.Kern

Page 116: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:116

7:15_AM ContrastMediaToxicityLimitingtheEffectsofAKIthroughVolumeControl Lecturers:JeffChambers

7:25_AM ReducingRadiationExposurefortheEntireHeartTeam Lecturers:RobertF.Wilson,MD

7:40_AM ImprovingCADAssessmentintheCathLab:SensorandAngiographicallyBasedFFRandTranslesionalPhysiology Lecturers:MortonJ.Kern

7:55_AM WrapupQA Lecturers:MortonJ.Kern

8:00_AM Adjourn

MAINARENAII,SUNDAY,SEPT.23

SUNDAY,SEPTEMBER23,2018

8:00AM-1:05PM

MainArena,HallF,GroundLevel

8:00AM-9:30AM

LiveCases#3

LiveCaseModerators:GreggW.Stone

LiveCaseCoModerators:AlainG.Cribier

LiveCaseDiscussants:PeterC.Block,SammyElmariah,IsaacGeorge,RebeccaT.Hahn,JamesB.HermillerJr,HowardC.Herrmann,EricHorlick,RuedigerS.Lange,Raj

Makkar,WilsonY.Szeto

FactoidFaculty:ChristineJ.Chung,AmiraliMasoumi,MeghaPrasad,SabatoSorrentino,EisukeUsui

8:00_AM ErasmusMedicalCenterRotterdamNetherlands LiveCaseOperators:NicolasM.VanMieghem

LiveCaseGuestOperators:DidierTchetche8:45_AM HenryFordHospitalDetroitMI

LiveCaseOperators:KhaldoonAlaswad,TiberioFrisoli,WilliamW.O'Neill

9:30AM-9:35AM

TCT2018:WelcomeandAnnouncements

9:30_AM WelcomeMessagefromDr.Granada Lecturers:JuanF.Granada

9:35AM-10:05AM

RapidFireCaseControversies:Structural

Moderators:VinayakBapat,SusheelK.Kodali

Discussants:PhilippeGenereux,MartinB.Leon,ScottLim,MichaelJ.Mack,RajMakkar,PatrickT.O'Gara,MichaelJ.Reardon,AllanSchwartz

9:35_AM LowSurgicalRiskAorticStenosisInTheUs:ThePatientReallyWantsTAVR CasePresenter:MathewWilliams

9:45_AM BicuspidAorticStenosis:HowToTreat CasePresenter:RanKornowski

9:55_AM SecondaryMitralRegurgitationWithSeverelyReducedLVEF CasePresenter:SaibalKar

10:05AM-10:20AM

TCT2018CareerAchievementAward

Moderators:MartinB.Leon,GreggW.Stone

AwardRecipients:BramD.Zuckerman

10:05_AM TCT2018CareerAchievementAward Lecturers:MartinB.Leon

10:20AM-11:20AM

Late-BreakingTrials3,SponsoredbyJAMA

Moderators:MartinB.Leon

CoModerator:RobertO.Bonow,EricD.Peterson

Discussants:StefanAnker,StephanBaldus,BlaseA.Carabello,ScottLim,MichaelJ.Mack,Jean-FrancoisObadia,MichaelJ.Reardon,JoachimSchofer,StephanWindecker

10:20_AM COAPT:ARandomizedTrialofTranscatheterMitralValveLeafletApproximationinPatientsWithHeartFailureandSecondaryMitralRegurgitation Lecturers:GreggW.Stone

10:35_AM RoundtableDiscussion

Page 117: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:117

10:45_AM REDUCEFMR:AShamControlledRandomizedTrialofTranscatheterMitralValveIndirectAnnuloplastyinPatientsWithHeartFailureandSecondary

MitralRegurgitation Lecturers:HorstSievert

10:55_AM RoundtableDiscussion

11:00_AM SOLVETAVI:A2x2RandomizedTrialofSelfExpandablevsBalloonExpandableValvesandGeneralvsLocalAnesthesiainPatientsUndergoing

TranscatheterAorticValveImplantation Lecturers:HolgerThiele

11:12_AM RoundtableDiscussion

11:20AM-12:05PM

LiveCases#4

LiveCaseModerators:SahilA.Parikh

LiveCaseCoModerators:TonyDas

LiveCaseDiscussants:SomjotS.Brar,BrianG.DeRubertis,LawrenceA.Garcia,VishalKapur,RobertA.Lookstein,OscarA.Mendiz,AmanB.Patel,VirendraIPatel,JamesP.

Zidar

FactoidFaculty:ChristineJ.Chung,AmiraliMasoumi,MeghaPrasad,SabatoSorrentino,EisukeUsui

11:20_AM WellmontHolstonValleyHospitalKingsportTN LiveCaseOperators:MarkAziz,D.ChristopherMetzger,RahulSakhuja

12:05PM-1:05PM

Late-BreakingClinicalScience1,Co-SponsoredbyTheJournalofTheAmericanCollegeofCardiology

Moderators:ValentinFuster

CoModerator:JayaChandrasekhar,HabibSamady,StephanWindecker

Discussants:MauricioG.Cohen,CarloDiMario,MayraGuerrero,RebeccaT.Hahn,DavidHildick-Smith,Karl-HeinzKuck,IreneM.Lang,AlexM.K.Rothman

12:05_PM PADN5:ARandomizedTrialofPulmonaryArteryDenervationinPatientsWithCombinedPreandPostcapillaryPulmonaryHypertension Lecturers:Shao-LiangChen

12:15_PM RoundtableDiscussion

12:20_PM PARTNERVALVEINVALVE:LateFollowupAfterTreatmentofFailingSurgicalAorticBioprostheticValvesWithaBalloonExpandableTranscatheterHeart

Valve Lecturers:JohnG.Webb

12:30_PM RoundtableDiscussion

12:35_PM ProsthesisPatientMismatch:IncidencePredictorsandOutcomeofProsthesisPatientMismatchAfterTranscatheterAorticValveReplacement Lecturers:HowardC.Herrmann

12:45_PM RoundtableDiscussion

12:50_PM TRIVALVE:EvaluationofEdgetoEdgeValveRepairforSymptomaticTricuspidRegurgitation Lecturers:JörgHausleiter

1:00_PM RoundtableDiscussion

KEYNOTEINTERVENTIONALSTUDIESIV:DRUG-ELUTINGSTENTS,BIORESORBABLESCAFFOLDS,ANDDRUG-COATEDBALLOONSI

SUNDAY,SEPTEMBER23,2018

8:00AM-9:00AM

Ballroom6A,UpperLevel

8:00AM-9:00AM

KeynoteInterventionalStudiesIV:Drug-ElutingStents,BioresorbableScaffolds,andDrug-CoatedBalloonsI

Moderators:MichaelHaude,Robert-JanvanGeuns

Discussants:RobertJ.Applegate,AntonioL.Bartorelli,BernardoCortese,FaustoFeres,MitchellW.Krucoff,ManelSabate,AshokSeth,HuayCheemTan

8:00_AM RENASCENTIII:NineMonthClinicalandImagingOutcomesWithaThinStrut98micrometerBioresorbableCoronaryScaffold Lecturers:AntonioColombo

8:10_AM Discussion

8:15_AM BIOSOLVEIV:TwelveMonthOutcomesWithaResorbableMagnesiumScaffoldinaRealworldSetting Lecturers:MichaelKang-YinLee

8:25_AM Discussion

8:30_AM NEOVAS:ThreeYearOCTandFFRResultsFromaRandomizedTrialEvaluatingaPolymericBioresorbableScaffold Lecturers:BoXu

8:40_AM Discussion

Page 118: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:118

8:45_AM ILOVEIT2:FiveYearResultsFromaRandomizedTrialofBiodegradablePolymerBasedandDurablePolymerBasedDrugElutingStents Lecturers:YalingHan

8:55_AM Discussion

KEYNOTEINTERVENTIONALSTUDIESV:DRUG-ELUTINGSTENTS,BIORESORBABLESCAFFOLDS,ANDDRUG-COATEDBALLOONSII

SUNDAY,SEPTEMBER23,2018

9:00AM-10:00AM

Ballroom6A,UpperLevel

9:00AM-10:00AM

KeynoteInterventionalStudiesV:Drug-ElutingStents,BioresorbableScaffolds,andDrug-CoatedBalloonsII

Moderators:FernandoAlfonso,JuanF.Granada

Discussants:AlaideChieffo,KennethChin,AlokeV.Finn,MichaelJoner,ElvinKedhi,HenningKelbæk,VergheseMathew,JorgeF.Saucedo

9:00_AM BIOFLOWV:TwoYearResultsofaRandomizedTrialEvaluatinganUltraThinStrutBioresorbablePolymerBasedDrugElutingStent Lecturers:DavidE.Kandzari

9:10_AM Discussion

9:15_AM RESTOREISRChina:ARandomizedTrialofTwoDifferentDrugCoatedBalloonsforTreatmentofInStentRestenosisAfterDrugElutingStentImplantation Lecturers:YunDaiChen

9:25_AM Discussion

9:30_AM RESTORESVDChina:RandomizedTrialofDrugCoatedBalloonsvsDrugElutingStentsforTreatmentofSmallVesselDisease Lecturers:RunlinGao

9:40_AM Discussion

9:45_AM PEPCADNSTEMI:ARandomizedTrialEvaluatingaDrugCoatedBallooninPatientsWithNonSTSegmentElevationMyocardialInfarction Lecturers:BrunoScheller

9:55_AM Discussion

KEYNOTEINTERVENTIONALSTUDIESVI:STRUCTURALHEARTINTERVENTIONSI

SUNDAY,SEPTEMBER23,2018

12:45PM-2:00PM

Ballroom6A,UpperLevel

12:45PM-2:00PM

KeynoteInterventionalStudiesVI:StructuralHeartInterventionsI

Moderators:HorstSievert,BrianK.Whisenant

Discussants:StevenR.Bailey,AlainG.Cribier,OliverHusser,JanKovac,Jean-ClaudeLaborde,DavidW.M.Muller,ZoltanG.Turi,StephenG.Worthley

12:45_PM SURTAVI:TwoYearCompleteResultsFromaRandomizedTrialofaSelfExpandingTranscatheterHeartValvevsSurgicalAorticValveReplacementin

PatientsWithSevereAorticStenosisatIntermediateSurgicalRisk Lecturers:JeffreyJ.Popma

12:55_PM Discussion

1:00_PM CENTERCollaborationI:NonrandomizedComparisonofTranscatheterAorticValveImplantationWithBalloonExpandableValvesvsSelfExpandable

Valves Lecturers:RonakDelewi

1:10_PM Discussion

1:15_PM OBSERVANT:FiveYearOutcomesAfterTranscatheterorSurgicalAorticValveReplacementinaLowIntermediateRiskRealworldPopulation Lecturers:MarcoBarbanti

1:25_PM Discussion

1:30_PM TAVILAAO:ARandomizedTrialofLeftAtrialAppendageOcclusionvsStandardMedicalTherapyinPatientsWithAtrialFibrillationUndergoing

TranscatheterAorticValveImplantation Lecturers:FabianNietlispach

1:40_PM Discussion

1:45_PM EWOLUTION:TwoYearEfficacyofLeftAtrialAppendageClosureinHighRiskPatientsSingleAntiplateletNoTherapySubgroupAnalysis Lecturers:MartinW.Bergmann

Page 119: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:119

1:55_PM Discussion

DIDACTICSESSION:INTRAVASCULARIMAGING-STENTGUIDANCEANDVULNERABLEPLAQUEASSESSMENTANDMANAGEMENT

SUNDAY,SEPTEMBER23,2018

8:00AM-12:00PM

Room2,UpperLevel

8:00AM-9:30AM

SessionI.VulnerablePlaqueandCulpritLesionImaging

Moderators:JamesE.Muller,PatrickW.Serruys

Discussants:TakashiAkasaka,DavidErlinge,HectorM.Garcia-Garcia,PeterH.Stone,GuillermoTearney,RonWaksman

8:00_AM IntravascularImagingandCulpritLesionAssessmentinACS:PotentialImpactonPCIStrategiesandPatientManagement Lecturers:HaiboJia

8:10_AM VulnerablePlaqueNonInvasiveImaging:TheEmergingRoleforCTA Lecturers:JamesK.Min

8:20_AM VulnerablePlaqueInvasiveImaging:ContrastingtheDifferentAlternativesTheoryandData Lecturers:YoshinobuOnuma

8:32_AM TheLatestonPlaqueProfilingandShearStressImaging Lecturers:PeterH.Stone

8:40_AM RationaleImagingInsightsandOutcomesofStentandScaffoldVulnerablePlaqueTreatment Lecturers:SalvatoreBrugaletta

8:50_AM Case1SpontaneousCoronaryDissection:ToStentorNottoStent CasePresenter:NingGuo

8:57_AM Case2IsitaPlaqueErosionoraPlaqueRuptureandHowtoTreat CasePresenter:TakashiKubo

9:04_AM Case3VulnerablePlaqueandPeriProceduralMyocardialInfarction:IShouldHaveUsedProtection CasePresenter:EmmanouilS.Brilakis

9:11_AM Case4APatientWithaVulnerablePlaqueWhoDevelopedaLateEvent CasePresenter:RyanD.Madder

9:18_AM RoundtableDiscussionWithAudienceQA

9:30AM-10:12AM

SessionII.Pre-InterventionLesionAssessment

Moderators:JavierEscaned,GaryS.Mintz

Discussants:JustinE.Davies,AllenJeremias,MassoudA.Leesar,MinaMadan,RichardShlofmitz,MladenI.Vidovich

9:30_AM IntravascularImagingtoAssessLMCAStenosisSeverity:ComparisonWithFFR Lecturers:JoseM.delaTorreHernandez

9:40_AM IsItReasonabletoUseIntravascularImagingtoAccessNonLMCAStenosisSeverityInsteadofFFR Lecturers:EvelynRegar

9:50_AM IVUSandorOCTintheAssessmentofCoronaryCalcificationandGuidanceofPlaqueModificationStrategies Lecturers:AkikoMaehara

10:00_AM RoundtableDiscussionWithAudienceQA

10:12AM-11:15AM

SessionIII.OptimizingStentImplantation

Moderators:AkikoMaehara,EvelynRegar

Discussants:StephanAchenbach,AdnanK.Chhatriwalla,NingGuo,TakashiKubo,Seung-JungPark,FrancescoPrati,MatthewJ.Price

10:12_AM IntravascularImagingtoSizeandOptimizeStentImplantation:AStepbyStepAlgorithm Lecturers:ZiadA.Ali

10:27_AM Case5ZeroContrastPCI:HowWeDoIt CasePresenter:JeffreyW.Moses

10:34_AM StepbyStepAlgorithmforDecisionmakingDuringCTOPCIUsingIntravascularImaging Lecturers:AlfredoR.Galassi

10:48_AM Case6CTOinWhichIVUSMadetheDifferenceBetweenSuccessandFailure CasePresenter:LeiGe

10:56_AM Case7IntravascularImagingandAngiographyCoRegistrationandPCIGuidance CasePresenter:RichardShlofmitz

Page 120: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:120

11:03_AM RoundtableDiscussionWithAudienceQA

11:15AM-12:00PM

SessionIV.ImagingAssessmentofStentFailure

Moderators:FernandoAlfonso,HiramG.Bezerra

Discussants:DanielChamie,LisetteOkkelsJensen,MichaelJoner,GaryS.Mintz,LorenzRaber,AndrewSharp

11:15_AM IntravascularImagingtoEvaluateStentThrombosisandRestenosis Lecturers:LorenzRaber

11:30_AM Case8:VeryLateStentThrombosis CasePresenter:JosedeRibamarCostaJr

11:37_AM Case9:UnderExpandedStentwithISRTreatedbyLaserAtherectomyorLithotripsy CasePresenter:JonathanM.Hill

11:44_AM RoundtableDiscussionWithAudienceQA

11:55_AM FinalThoughtsandTakehomeMessages Lecturers:GaryS.Mintz

DIDACTICSESSION:THELEFTMAINANDBIFURCATIONSUMMIT,PART1

SUNDAY,SEPTEMBER23,2018

8:00AM-12:03PM

Room5,UpperLevel

8:00AM-9:08AM

SessionI.BifurcationTechniqueIntroduction

Moderators:BernardR.Chevalier,DavidHildick-Smith

Discussants:RanKornowski,AhmedMagdy,DetlefG.Mathey,SunaoNakamura,ManishA.Parikh,YuejinYang

8:00_AM BifurcationandLeftMainStentingIntroduction:WhatYouMayHaveMissedintheLastYear Lecturers:BimmerE.Claessen

8:10_AM RoundtableDiscussionWithAudienceQA

8:15_AM NewBenchInsightsIntoOptimalBifurcationStentingLMandNonLM Lecturers:JohnA.Ormiston

8:23_AM ImplicationsofVariedStentDesignsforBifurcationStentingLMandNonLM Lecturers:NicolasFoin

8:31_AM RoundtableDiscussionWithAudienceQA

8:36_AM MoreThanaDecadeofInsightsFromtheEuropeanBifurcationClubLMandNonLM Lecturers:JensFlenstedLassen

8:46_AM RoundtableDiscussionWithAudienceQA

8:51_AM Pro:ProvisionalStentingIsMoreUsefulTodayThanEver

Lecturers:AfzalurRahman8:57_AM Con:TheBenefitsofProvisionalStentingHaveBeenVastlyOverRated

Lecturers:AzeemLatib9:03_AM RoundtableDiscussionWithAudienceQA

9:08AM-10:49AM

SessionII.BifurcationTechniqueDeeperDive

Moderators:AntonioColombo,JeanFajadet

Discussants:AjayJ.Kirtane,ShigeruSaito,GennaroSardella,TerjeK.Steigen,CarlosE.Uribe,DavidX.Zhao

9:08_AM WhenShouldtheSideBranchBeDilatedBeforeandAfterMainBranchStenting Lecturers:Hyeon-CheolGwon

9:16_AM RoundtableDiscussionWithAudienceQA

9:19_AM JailingandRemovingSideBranchWires:TechniqueandSafety Lecturers:DavidHildick-Smith

9:26_AM TheSideBranchBalloonProtectionTechnique Lecturers:FrancescoBurzotta

9:33_AM AreDrugElutingBalloonsanImportantAdjunctforSideBranchTreatment

Page 121: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:121

Lecturers:PieterR.Stella9:41_AM RoundtableDiscussionWithAudienceQA

9:48_AM WhentoPOTandHowtoDoIt Lecturers:AdrianP.Banning

9:55_AM TheSpectrumofPOTTechniques Lecturers:Hyeon-CheolGwon

10:02_AM RoundtableDiscussionWithAudienceQA

10:07_AM OCTGuidanceforBifurcationLesions:RationaleandDesignofOCTOBER Lecturers:NielsR.Holm

10:15_AM 2Dand3DOCTGuidanceforNonLMBifurcationLesions Lecturers:YoshinobuOnuma

10:23_AM BifurcationandOstialOpticalCoherenceTomographyMappingBOOM:ANewTechnique Lecturers:RichardShlofmitz

10:30_AM RoundtableDiscussionWithAudienceQA

10:38_AM IsThereaRoleforFFRoriFRSideBranchAssessment Lecturers:NickCurzen

10:46_AM RoundtableDiscussionWithAudienceQA

10:49AM-12:03PM

SessionIII.HowtoPerform:ProvisionalandTwo-StentTechniques

Moderators:NielsR.Holm,IoannisIakovou

Discussants:ArifAlNooryani,CarloBriguori,PhilippeGarot,JorgeGaspar,MichaelS.Lee,DavidG.Rizik

10:49_AM HowtoPerformtheProvisionalApproach:TipsandTricks Lecturers:LeifThuesen

10:57_AM WhenaPlannedProvisionalApproachRequires2Stents:OptionsandTechnique Lecturers:AlaideChieffo

11:04_AM WhenandWhichPlanned2StentTechniqueforNonLMBifurcations Lecturers:JamesB.HermillerJr

11:12_AM Planned2StentTechniqueStepbyStep:HowtoTModifiedTandTAPStent Lecturers:MiroslawFerenc

11:19_AM Planned2StentTechniqueStepbyStep:HowtoCulotte Lecturers:JamesCockburn

11:26_AM Planned2StentTechniqueStepbyStep:HowtoCrushMiniCrushandDKCrush Lecturers:JunjieZhang

11:33_AM Planned2StentTechniqueStepbyStep:HowtoUseTryton Lecturers:PhilippeGenereux

11:40_AM CurrentStatusofDedicatedBifurcationStents Lecturers:RobertJ.Gil

11:48_AM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:TRICUSPIDVALVEINTERVENTIONS

SUNDAY,SEPTEMBER23,2018

8:00AM-12:00PM

Room6D,UpperLevel

8:00AM-9:00AM

Session1.SettingtheStage�NaturalHistory,Patho-anatomy,andImagingConsiderations

Moderators:SamirR.Kapadia,RalphStephanvonBardeleben

Discussants:JoãoLCavalcante,CharlesJ.Davidson,VictoriaDelgado,OmarK.Khalique,StephenH.Little,FabienPraz,GilbertH.L.Tang,YanTopilsky

8:00_AM TricuspidistheForgottenValveNoMoreTRNaturalHistoryReflectionsandRationaleforTreatment Lecturers:JeroenJ.Bax

8:10_AM OneCompellingQuestion

8:12_AM PathoanatomyReferencePointsforTranscatheterTherapiesWhytheTricuspidValveComplexandRightHeartareDistinctive Lecturers:MarkReisman

8:22_AM OneCompellingQuestion

8:24_AM EtiologiesandClinicalPresentationofTR:ImplicationsforTherapy

Page 122: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:122

Lecturers:YanTopilsky8:34_AM OneCompellingQuestion

8:36_AM MultimodalityImagingEssentialsoftheTricuspidValveandRightHeartEchoandCT Lecturers:OmarK.Khalique

8:46_AM AssessingtheSeverityofTR:ChallengesInconsistenciesandGradingSchemes Lecturers:JoãoLCavalcante

8:56_AM Disucussion

9:00AM-10:00AM

Session2:MedicalandSurgicalTreatmentofTR:GuidelinesandControversies

Moderators:StevenF.Bolling,MauriceE.Sarano

Discussants:SaifAnwaruddin,StamatiosLerakis,G.BurkhardMackensen,JoseLuisNavia,OsamaSoliman,AlfredoTrento

9:00_AM TimingandGuidelinesforMedicalTherapyofTRIsthereaStandardApproach Lecturers:OsamaSoliman

9:08_AM OneCompellingQuestion

9:10_AM CurrentSurgicalApproachesandPreferencesforTRTherapy Lecturers:AlfredoTrento

9:18_AM OneCompellingQuestion

9:20_AM ClinicalOutcomesandRecurrenceAfterSurgeryforTRCanWeLearnFromOurMistakes Lecturers:JoseLuisNavia

9:28_AM OneCompellingQuestion

9:30_AM POINT:FocusontheAnnulusSizeSeverityIsLessImportant

9:36_AM COUNTERPOINT:FocusontheSeverityofTR

Lecturers:StevenF.Bolling9:42_AM OPINION:TheCaseforAggressiveTRRepairDuringMitralValveSurgery

Lecturers:PaoloDenti9:48_AM RebuttalsandDiscussion

9:54_AM ACuriousCaseofSurgicalTRRepairCasePresentationOutcomeandLessonsLearned CasePresenter:IsaacGeorge

10:00AM-11:30AM

Session3:TranscatheterTherapiesforTR�PromiseandPitfalls

Moderators:AzeemLatib,FrancescoMaisano

Discussants:PaoloDenti,NeilP.Fam,JohnCLaschinger,JoseLuisNavia,PetrNeuzil,JosepRodés-Cabau,MaurizioTaramasso

10:00_AM CurrentOutcomesofTranscatheterTRTherapies:ResultsfromtheInternationalTriValveRegistry Lecturers:MaurizioTaramasso

10:08_AM OneCompellingQuestion

11:30AM-12:00PM

Session4:ChallengingTRCaseVignettes�HowtoTreatTHIS�Moderators:ScottLim,MarkReisman

Discussants:AnitaAsgar,BrijMaini,JasonH.Rogers,CarlosE.Ruiz,MauriceE.Sarano,GilbertH.L.Tang,RalphStephanvonBardeleben

DIDACTICSESSION:CLINICALTRIALDESIGN,STATISTICSANDLITERATUREINTERPRETATION¬THEEVIDENCE-BASEDMEDICINEEXPERT

SUNDAY,SEPTEMBER23,2018

2:00PM-6:20PM

Room6D,UpperLevel

2:00PM-2:55PM

SessionI.ClinicalTrialEndpointsinContext

Moderators:E.MagnusOhman,StuartJ.Pocock

Discussants:SripalBangalore,OvidiuDressler,SanjayKaul,DavidF.Kong,DavidJ.Maron,PascalVranckx,RobertW.Yeh

2:00_PM CompositeEndpoints:WhenAreTheyValidandWhenShouldTheyBeDiscarded Lecturers:SanjayKaul

Page 123: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:123

2:12_PM ISCHEMIATrialintheSpotlight:WhyAlltheFussOvertheChangeinthePrimaryEndpoint Lecturers:DavidJ.Maron

2:28_PM AllCauseMortalityandInterpretationofSecondaryEndpoints:TheVESTandODYSSEYExamples Lecturers:StuartJ.Pocock

2:40_PM RoundtableDiscussionWithAudienceQA

2:55PM-3:50PM

SessionII:Sham-ControlledTrials

Moderators:AjayJ.Kirtane,StuartJ.Pocock

Discussants:RashaAl-Lamee,ColinBerry,DavidJ.Cohen,BernardJ.Gersh,AndrewSharp,PaulA.Sobotka,JanG.P.Tijssen

2:55_PM ORBITAintheSpotlight:HowIInterpretORBITAasanInterventionalCardiologist Lecturers:RashaAl-Lamee

3:05_PM ORBITAintheSpotlight:HowIWouldHaveDonetheTrialDifferently Lecturers:AjayJ.Kirtane

3:15_PM ShamControlledTrialsShouldBetheNewGoldStandardforDeviceTrials Lecturers:BernardJ.Gersh

3:25_PM ShamControlledTrialsforDevicesAreUnethicalUnfeasibleandUnnecessary Lecturers:WilliamF.Fearon

3:35_PM RoundtableDiscussionwithAudienceQA

3:50PM-4:45PM

SessionIII:ClinicalTrialDesigninContext

Moderators:PeterJuni,RobertW.Yeh

Discussants:JohnA.Bittl,EugeneH.Blackstone,SchuylerJones,ThomasC.McAndrew,RoxanaMehran,StuartJ.Pocock,MatthewT.Roe

3:50_PM HowtoMakeTrialsLargerSimplerandLessExpensive Lecturers:MatthewT.Roe

4:00_PM MostFrequentErrorsISeeintheAnalysisandInterpretationofTrials Lecturers:PeterJuni

4:10_PM NonInferiorityTrialsGoneWrong:ExamplesFromtheRecentLiterature Lecturers:DavidJ.Cohen

4:20_PM StentTrialsinHighBleedingRiskPatients:WhatistheLevelofEvidenceWeNeed Lecturers:RoxanaMehran

4:30_PM RoundtableDiscussionwithAudienceQA

4:45PM-5:35PM

SessionIV:FactsorFakeNews:AdventuresinDataAnalysis

Moderators:StuartJ.Pocock,JanG.P.Tijssen

Discussants:EugeneH.Blackstone,OvidiuDressler,DanieleGiacoppo,SchuylerJones,PeterJuni,RoseannMWhite,RobertW.Yeh

4:45_PM NoRoleforObservationalStudiesinEffectivenessComparisons:TheStagedvs.CulpritOnlyPCIforSTEMICaseStudy Lecturers:RobertW.Yeh

4:55_PM GarbageinGarbageOut:RiskstoBigDataAnalysisinInterventionalCardiology Lecturers:OtavioBerwanger

5:05_PM IsitTimetoToughenUptheP0.05 Lecturers:PeterJuni

5:15_PM ShouldWeAllBecomeBayesians Lecturers:StuartJ.Pocock

5:25_PM RoundtableDiscussionwithAudienceQA

5:35PM-6:20PM

SessionV:ACCandESC2018LateBreakingTrials:CritiquesandPotentialImpactonClinicalPractice

Moderators:DeepakL.Bhatt,GreggW.Stone

Discussants:OtavioBerwanger,PeterJuni,SanjayKaul,RoxanaMehran,E.MagnusOhman,StuartJ.Pocock,GiulioStefanini

5:35_PM ACC2018LateBreakingTrial1ODYSSEYOutcomes:WhatILikedandWhatIQuestion CasePresenter:JohnA.Bittl

5:40_PM RoundtableDiscussionWithAudienceQA

5:45_PM ACC2018LateBreakingTrial2COMPASS:WhatILikedandWhatIQuestion Lecturers:KurtHuber

Page 124: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:124

5:50_PM RoundtableDiscussionwithAudienceQA

5:55_PM ESC2018LateBreakingTrial1GlobalLeaders:WhatILikedandWhatIQuestion Lecturers:GiuseppeBiondi-Zoccai

6:00_PM RoundtableDiscussionWithAudienceQA

6:05_PM ESC2018LateBreakingTrial2MitraFR:WhatILikedandWhatIQuestion Lecturers:StephanWindecker

6:10_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:PCIPHARMACOTHERAPY-PROCEDURALANTITHROMBINSANDACUTE/CHRONICDAPT

SUNDAY,SEPTEMBER23,2018

2:00PM-6:00PM

Room2,UpperLevel

2:00PM-3:20PM

SessionI.PCIPharmacotherapy:PeriproceduralAntithromboticandAntiplateletTherapy

Moderators:JohnA.Bittl,C.MichaelGibson

Discussants:JoseDiez,DavidErlinge,DmitriyN.Feldman,HitinderS.Gurm,ZuzanaMotovska,MatthewT.Roe,DanielI.Simon

2:00_PM FeaturedLecture:DoesthePolypillEnhanceDrugAdherenceandImproveCardiovascularOutcomes Lecturers:ValentinFuster

2:10_PM RoundtableDiscussion

2:15_PM BenefitsofPretreatmentWithDualAntiplateletTherapyPriortoPCIinStableCADandACS:MythorReality Lecturers:GiuseppeTarantini

2:23_PM SwitchingDualAntiplateletTherapyAfterPCI:WhoWhenWhyandHow Lecturers:MatthewJ.Price

2:31_PM TheLatestAntithromboticData:MATRIXat1Year Lecturers:StephanWindecker

2:39_PM TheCaseforBivalirudinWithRadialandFemoralAccess Lecturers:CareyD.Kimmelstiel

2:47_PM HowStrongarethePharmacodynamicDataandClinicalEvidenceforCrushedTicagrelorandPrasugrel Lecturers:DimitriosAlexopoulos

2:55_PM UtilityofCangrelorDuringPCIandBridgingWhoBenefitsMost Lecturers:DeepakL.Bhatt

3:05_PM RoundtableDiscussion

3:20PM-4:09PM

SessionII.OptimalDAPTDurationAfterDESPlacement

Moderators:DeepakL.Bhatt,TullioPalmerini

Discussants:SorinJ.Brener,FaustoFeres,Hyeon-CheolGwon,YalingHan,JavaidIqbal,NealS.Kleiman,HuayCheemTan

3:20_PM WhoIstheHighBleedingRiskPatientandHowShouldDAPTDurationBeWeighedAgainstIschemicRisk Lecturers:RoxanaMehran

3:28_PM PatientSelectionforProlongedDAPT:RiskScoresorWiseClinicalJudgement Lecturers:UsmanBaber

3:36_PM UltraShortDAPT13Months:ForWhichPatientsandStentsDoWeHaveEvidence Lecturers:PhilipM.Urban

3:44_PM COMPASSTrialRevisited:WeighingRivaroxabanSecondaryPreventionvsDAPTAfterPCI Lecturers:MichaelMaeng

3:54_PM RoundtableDiscussion

4:09PM-5:10PM

SessionIII.AntiplateletTherapyAfterDESinPatientsonChronicOralAnticoagulation

Moderators:DavideCapodanno,GiulioStefanini

Discussants:RobertA.Byrne,PieraCapranzano,GermanoDiSciascio,KurtHuber,RoxanaMehran,MichelleO'Donoghue

4:09_PM PharmacotherapyChallengesandPossibleSolutionsinthePCIPatientonChronicOralAnticoagulation Lecturers:TullioPalmerini

4:19_PM HasPIONEERandREDUALChangedMyPracticeWhatAretheOutstandingIssues Lecturers:C.MichaelGibson

Page 125: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:125

4:29_PM In2018WhenIsWarfarinTherapyRequiredvsAcceptableandHowShoulditBeDosedAfterPCI Lecturers:FreekW.A.Verheugt

4:37_PM USandESCGuidelinesandConsensusonAntithromboticTherapyinPatientsWithAtrialFibrillationUndergoingPCI Lecturers:DominickJ.Angiolillo

4:47_PM PeriproceduralManagementofAnticoagulationinPatientsWithNonvalvularAtrialFibrillation Lecturers:RobertA.Byrne

4:55_PM RoundtableDiscussion

5:10PM-6:00PM

SessionIV.AntiplateletPotpourri

Moderators:DominickJ.Angiolillo,ElmirOmerovic

Discussants:AndreaAbizaid,JayaChandrasekhar,GregoryDucrocq,MichaelA.Kutcher,JorgeF.Saucedo,ThomasD.Stuckey

5:10_PM ManagingAspirinAllergyBeforeDESPlacement Lecturers:JohnA.Bittl

5:18_PM GLOBALLEADERSinPerspective:PerspectivesonTicagrelorMonotherapy Lecturers:PatrickW.Serruys

5:28_PM DeEscalationofDAPTAfterDESPlacement:IsThereaRoleforPersonalizedTreatment Lecturers:DánielAradi

5:36_PM TheAsianAntiPlateletTherapyParadox:GeneticFactorsDosingBleedingandStentThrombosisRisk Lecturers:Duk-WooPark

5:44_PM RoundtableDiscussion

DIDACTICSESSION:THELEFTMAINANDBIFURCATIONSUMMIT,PART2

SUNDAY,SEPTEMBER23,2018

2:00PM-6:08PM

Room5,UpperLevel

2:00PM-3:06PM

SessionIV.SpecialSituationsinBifurcations

Moderators:JensFlenstedLassen,YvesR.Louvard

Discussants:KennethChin,JeanFajadet,Young-HakKim,JohnA.Ormiston,IvoPetrov,ShiroUemura

2:00_PM WhenWilltheSideBranchOccludeWithCaseExamples Lecturers:KefeiDou

2:07_PM TechniquesforWiringaDifficultBifurcationandWhatToDoThen Lecturers:ThomasHovasse

2:14_PM HowtoTreattheMedina001Lesion

2:21_PM WhyDoesMyBalloonNotCrossandWhatShouldIDo Lecturers:ManuelPan

2:28_PM CasePresentation:WhyILostThisSideBranchandWhatIShouldHaveDoneInstead CasePresenter:YvesR.Louvard

2:35_PM CasePresentation:WhyILostThisSideBranchandWhatIShouldHaveDoneInstead CasePresenter:AnnapoornaKini

2:42_PM CasePresentation:MyWorstBifurcationMistake CasePresenter:JensFlenstedLassen

2:49_PM CasePresentation:MyWorstBifurcationMistake CasePresenter:AdrianP.Banning

2:56_PM RoundtableDiscussionWithAudienceQA

3:06PM-4:20PM

SessionV.FocusonLeftMainStentingOutcomes

Moderators:RajMakkar,PatrickW.Serruys

Discussants:AnthonyH.Gershlick,RobertA.Guyton,Seung-JungPark,AlfredoE.Rodriguez,ErickSchampaert,MarcoV.Wainstein

3:06_PM FirstPresentationofthe4YearEXCELOutcomes Lecturers:GreggW.Stone

3:14_PM NewDataFromtheNOBLETrial Lecturers:EvaldH.Christiansen

3:22_PM SummaryofAlltheLMPCIvs.CABGMetaAnalyses:TakeHomeMessages

Page 126: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:126

Lecturers:StuartJ.Head3:32_PM LMStenting:NewInsightsFromtheDELTA2Registry

Lecturers:AlaideChieffo3:40_PM TenYearOutcomesofLMPCI:FromtheFuWaiLeftMainRegistry

Lecturers:BoXu3:48_PM LongTermOutcomesofLMPCIvsCABG:NewInsightsFromtheMAINCOMPAREandIRISMAINRegistries

Lecturers:Duk-WooPark3:56_PM CaseSettled:PCIforMost

Lecturers:Marie-ClaudeMorice4:02_PM Casesettled:CABGforMost

Lecturers:RobertA.Guyton4:08_PM RoundtableDiscussionWithAudienceQA

4:20PM-6:08PM

SessionVI.FocusonLeftMainStentingTechnique

Moderators:AntonioColombo,LeifThuesen

Discussants:VinayK.Bahl,AllenJeremias,FazilaT.Malik,AshishPershad,TanveerRab,GiuseppeTarantini,CarlosE.Uribe

4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta4:32_PM EBCPerspectivesonLMStentingTechniqueandtheEBCMainTrial

Lecturers:DavidHildick-Smith4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta4:39_PM RoundtableDiscussionWithAudienceQA

4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta4:44_PM WhytoUseIVUStoGuideLMStenting:EvidenceandCaseExamples

Lecturers:JoseM.delaTorreHernandez4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta4:52_PM HowtoUseIVUStoGuideLMStenting:EvidenceandCaseExamples

Lecturers:AkikoMaehara4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:00_PM PhysiologicalAssessmentofLeftMainCoronaryArteryDisease

Lecturers:DivakaPerera4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:08_PM LeftMainLongitudinalStentDistortion

Lecturers:YvesR.Louvard4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:16_PM RoundtableDiscussionWithAudienceQA

Page 127: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:127

Lecturers:YvesR.Louvard4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:21_PM TechnicalApproachestotheLeftMainTrifurcationLesionWithCaseExamples

Lecturers:AntonioColombo4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:29_PM SKSStentTechniqueforTrueLMBifurcationDisease:AdvantagesandPitfallsWithCaseExamples

Lecturers:JavaidIqbal4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:37_PM LesionPreparationsStrategiesfortheLeftMainBifurcationWithCaseExamples

Lecturers:NiratBeohar4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:45_PM WhenIsMechanicalCirculatorySupportRequiredforLeftMainPCIWithCaseExamples

Lecturers:AnuTunuguntla4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta5:52_PM LeftMainRestenosisandTreatmentWithCaseExamples

Lecturers:ImadSheiban4:20_PM ProTheDataSpeaks

Lecturers:Shao-LiangChen4:26_PM ConCommonSenseRules

Lecturers:FrancescoBurzotta6:00_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:TRANSCATHETERMITRALVALVETHERAPIES,PART1-MITRALVALVEREPAIR

SUNDAY,SEPTEMBER23,2018

2:00PM-6:17PM

Room1,UpperLevel

2:00PM-2:52PM

SessionI.Overview,Imaging,andPatientSelection

Moderators:PaulA.Grayburn,RobertJ.Siegel

Discussants:VictoriaDelgado,LindaD.Gillam,JonathonA.Leipsic,StephenH.Little,G.BurkhardMackensen,SherifF.Nagueh,CarlosE.Ruiz

2:00_PM MRQuantification2018:TheLatestinMRGradingandReporting Lecturers:MauriceE.Sarano

2:07_PM PrimaryMR:SpectrumofDiseaseandInfluenceonTranscatheterTherapyApplicabilityandOutcomes Lecturers:ScottLim

2:14_PM FunctionalMR:SpectrumofDiseaseandInfluenceonTranscatheterTherapyApplicabilityandOutcomes Lecturers:PaulA.Grayburn

2:21_PM TEEImagingEssentials:ScreeningPatientsforMitraClipTranscatheterAnnuloplastyandTMVRProcedures Lecturers:RandolphP.Martin

2:28_PM CTImagingEssentials:ScreeningPatientsforMitraClipTranscatheterAnnuloplastyandTMVRProcedures Lecturers:PhilippBlanke

2:35_PM ImagingMakeorBreak:ChallengingImagingScenariosDuringTranscatheterMitralRepairProceduralGuidance Lecturers:RebeccaT.Hahn

Page 128: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:128

2:42_PM RoundtableDiscussionWithAudienceQA

2:52PM-3:34PM

SessionII.MitraClipRegistryand(atLast)RandomizedTrialOutcomes

Moderators:StefanAnker,SaibalKar

Discussants:BlaseA.Carabello,JörgHausleiter,HüseyinInce,Jean-FrancoisObadia,PaulSorajja,NeilJ.Weissman

2:52_PM TheCOAPTTrial:PrincipalandSecondaryResults Lecturers:MichaelJ.Mack

2:59_PM TheMitraFRTrial:ResultsExpectedandUnexpected Lecturers:Jean-FrancoisObadia

3:02_PM MitraClipintheUS:LatestTVTRegistryResults Lecturers:PaulSorajja

3:19_PM RoundtableDiscussionWithAudienceQA

3:34PM-4:49PM

SessionIII.Edge-to-EdgeMitralValveRepair:MitraClipandBeyond

Moderators:TedFeldman,JoachimSchofer

Discussants:SaifAnwaruddin,KarelT.Koch,ScottLim,RobertE.Michler,MatthewJ.Price,MichaelJ.Rinaldi

3:34_PM TheMitralSurgeonsPerspective:WhatTranscatheterToolsAreNecessarytoEmulateSurgicalResults Lecturers:StevenF.Bolling

3:41_PM MitraClipPatientSelection2018:CanWePredictAnExcellentResultSustainedMRLessThanorEqualto1 Lecturers:Karl-HeinzKuck

3:48_PM ExperiencesWithNextGenerationMitraClip:WhatAretheMeaningfulDifferences Lecturers:SaibalKar

3:55_PM TwoCasePresentations:OneHighlySuccessfulandOneHighlyUnsuccessfulMitraClipinPrimaryMR CasePresenter:JamesB.HermillerJr

4:03_PM TwoCasePresentations:OneHighlySuccessfulandOneHighlyUnsuccessfulMitraClipinSecondaryMR CasePresenter:StephanBaldus

4:11_PM SurgeryAfterFailedMitraClip:FeasibilityandOutcomes Lecturers:GoravAilawadi

4:18_PM MitraClipAfterFailedSurgicalRepair:ApproachandChallenges Lecturers:SaibalKar

4:25_PM SingleLeafletDetachmentandClipEmbolization:CausesandManagement Lecturers:SamirR.Kapadia

4:32_PM PASCALEdgetoEdgeRepair:InitialExperienceandOutcomes Lecturers:NeilP.Fam

4:39_PM RoundtableDiscussionWithAudienceQA

4:49PM-6:17PM

SessionIV.TheTranscatheterMitralValveRepairWorldBeyondMitraClip

Moderators:JasonH.Rogers,RalphStephanvonBardeleben

Discussants:StevenF.Bolling,StevenL.Goldberg,AzeemLatib,FrancescoMaisano,MollySzerlip,StephenG.Worthley

4:49_PM CardiobandDirectAnnuloplastyforFunctionalMR:DeviceDataSynthesisandPivotalClinicalTrialProgress Lecturers:VinodH.Thourani

4:57_PM CarillonIndirectAnnuloplastyforFunctionalMR:DeviceDataSynthesisandPivotalClinicalTrialProgress Lecturers:RalphStephanvonBardeleben

5:05_PM AccuCinchBasalVentriculoplastyforFunctionalMRandHeartFailure:DeviceProcedureandUpdatedOutcomes Lecturers:MarkReisman

5:12_PM MillipedeDirectAnnuloplastyforFunctionalMR:DeviceProcedureandUpdatedOutcomes Lecturers:JasonH.Rogers

5:19_PM AmendRingAnnuloplastySystem:DeviceProcedureandUpdatedOutcomes Lecturers:AndreaColli

5:26_PM ARTOIndirectAnnuloplastyforFunctionalMR:UpdateandCasePresentation Lecturers:StephenG.Worthley

5:33_PM MitralCerclageAnnuloplasty Lecturers:TobyRogers

5:40_PM NeochordforDegenerativeMR:DeviceDataSynthesisandPivotalClinicalTrialProgress Lecturers:KhalilFattouch

5:48_PM HarpoonforDegenerativeMR:DeviceandUpdatedClinicalData

Page 129: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:129

Lecturers:AndreaColli5:55_PM ThinkingHybridMitralProcedures:CaseExamplesandRecommendations

Lecturers:SamirR.Kapadia6:02_PM RoundtableDiscussionWithAudienceQA

TCTENDOVASCULAR:EXPERTCASEREVIEWS-ACUTESTROKEINTERVENTIONS

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Room30D-E,UpperLevel

12:15PM-1:45PM

ExpertCaseReviews:AcuteStrokeInterventions

Moderators:AmanB.Patel,AdnanSiddiqui

Discussants:MohammadAliAziz-Sultan,AlexanderA.Khalessi,DemetriusLopes,CharlesMatouk,ScottSilverman

12:15_PM Case1:AcuteStrokeTreatedWithM1MiddleCerebralArteryThrombectomy CasePresenter:MatthewKoch

12:25_PM Case2:AcuteStrokeWithCervicalICADissectionandIntracranialOcclusion CasePresenter:AlexanderA.Khalessi

12:35_PM Case3:AcuteStrokeWithAtheroscleroticICAOcclusionandIntracranialOcclusion CasePresenter:AdnanSiddiqui

12:45_PM Case4:RadialAccessforAcuteStrokeThrombectomy CasePresenter:DemetriusLopes

12:55_PM Case5:DirectCarotidAccessforAcuteStrokeThrombectomy CasePresenter:CharlesMatouk

1:05_PM Case6:LateWindowThrombectomy CasePresenter:MatthewKoch

1:15_PM Case7:AcuteStrokeThrombectomyforaPatientWithanAlreadyLargeEstablishedCoreInfarct CasePresenter:AlexanderA.Khalessi

1:25_PM Case8:AcuteStrokeThrombectomyForLargeVesselOcclusionWithLowNIHSS CasePresenter:MatthewKoch

1:35_PM RoundtableDiscussionWithAudienceQA

TCTENDOVASCULAR:HOTTOPICLUNCH-CURRENTISSUESINCONTEMPORARYOFFICE-BASEDLABORATORYPRACTICE

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Room31B-C,UpperLevel

12:15PM-1:00PM

SessionI:WhyandHowtoStartanOffice-basedSuite

Moderators:JeffreyG.Carr,BrianG.DeRubertis

Discussants:AliF.Aboufares,GaryM.Ansel,KarthikR.Gujja,CraigM.Walker

12:15_PM ConsiderationsWhenStartinganOfficeBasedLaboratoryorAmbulatorySurgeryCenter Lecturers:CraigM.Walker

12:25_PM OutpatientProcedureAdoptionandImplicationsofOverUtilization Lecturers:JeffreyG.Carr

12:35_PM OBLsasaModelforIncreasedDeliveryofVascularCare Lecturers:BrianG.DeRubertis

12:45_PM RoundDiscussionWithAudienceQA

1:00PM-1:45PM

SessionII:ProceduralConsiderationsintheOBL�CaseSelection,PatientFactors,andSafetyConcernsModerators:JeffreyG.Carr,BrianG.DeRubertis

Discussants:AliF.Aboufares,SteveHenao,TakW.Kwan,RobertA.Lookstein

1:00_PM CasestoAvoidandComplicationManagement CasePresenter:AliF.Aboufares

Page 130: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:130

1:10_PM BenefitsforPatientsandProvidersintheOutpatientSetting Lecturers:BrianG.DeRubertis

1:20_PM MaintainingQualityintheOBLSetting Lecturers:JeffreyG.Carr

1:30_PM RoundDiscussionwithAudienceQA

TCTENDOVASCULAR:HOTTOPICLUNCH-TREATMENTOFACUTEPULMONARYEMBOLISM�CO-SPONSOREDBYTHEPERTCONSORTIUM

SUNDAY,SEPTEMBER23,2018

12:15PM-1:40PM

Room32A-B,UpperLevel

12:15PM-1:40PM

TreatmentofAcutePulmonaryEmbolism�Co-SponsoredbythePERTConsortium

Moderators:RiyazBashir,VictorF.Tapson

Discussants:VikasAggarwal,MahirElder,JayS.Giri,GregoryPiazza,KennethRosenfield,AkhileshK.Sista

12:15_PM AcutePulmonaryEmbolism:RiskStratificationTreatmentAlternativesandRoleofthePERTTeam Lecturers:KennethRosenfield

12:30_PM RoundtableDiscussionWithAudienceQA

12:35_PM Case1Introduction:APatientWithSubMassivePEHowShouldWeTreat CasePresenter:GregoryPiazza

12:38_PM FirstDebate:CatheterDirectedThrombolysisShouldBeUsedforAllSubmassivePE Lecturers:RiyazBashir

12:46_PM FirstDebate:CatheterDirectedThrombolysisShouldBeReservedforSelectedSubmassivePE Lecturers:JayS.Giri

12:54_PM RoundtableDiscussionWithAudienceQA

1:02_PM Case1Conclusion:APatientWithSubMassivePEHowDidWeTreat CasePresenter:GregoryPiazza

1:05_PM Case2Introduction:APatientWithMassivePEHowShouldWeTreat CasePresenter:VikasAggarwal

1:08_PM SecondDebate:TheCaseforCatheterBasedTherapyforMassivePEAsThePrincipalApproach Lecturers:AkhileshK.Sista

1:11_PM SecondDebate:SurgicalTherapyforMassivePEShouldBeFirstlineTherapy

1:19_PM CaseBasedDebate:ECMOorOtherRVSupportIstheIdealTreatmentforMassivePE Lecturers:MahirElder

1:27_PM RoundtableDiscussionWithAudienceQA

1:37_PM Case1Conclusion:APatientWithMassivePEHowDidWeTreat CasePresenter:VikasAggarwal

TCTENDOVASCULAR:EVAR/TEVARDEEPDIVE

SUNDAY,SEPTEMBER23,2018

2:00PM-4:00PM

Room30D-E,UpperLevel

2:00PM-3:20PM

SessionI.LatestEVARandTEVARStrategies

Moderators:RobertA.Lookstein,VirendraIPatel

Discussants:J.MichaelBacharach,DanielleBajakian,SomjotS.Brar,BryanT.Fisher,PatrickT.O'Gara,HirooTakayama

2:00_PM OperativeManagementofAcuteTypeAAorticDissection Lecturers:HirooTakayama

2:10_PM MedicalTreatmentandLongtermManagementofAcuteTypeBAorticDissection:LessonsfromIRADandBeyond Lecturers:PatrickT.O'Gara

2:20_PM InterventionalTreatmentOptionsforAcuteTypeBAorticDissection Lecturers:ChristophA.Nienaber

2:30_PM AorticArchAneurysm:ManagementandTreatmentOptionsWithCaseExamples Lecturers:NimeshDesai

Page 131: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:131

2:40_PM BranchedandFenestratedGraftsintheTreatmentofThoracoabdominalAorticAneurysms Lecturers:BernardoCMendes

2:50_PM ChimneysSnorkelsandPeriscopesfortheTreatmentofJuxtaRenalAbdominalAorticAneurysms:AreThereAnyDatatoSupportThem Lecturers:RobertA.Lookstein

3:00_PM FenestratedStentGraftsintheTreatmentofComplexAbdominalAorticAneurysms Lecturers:DanielleBajakian

3:10_PM DecisionmakingandTreatmentSelectionforPatientsWithComplexAbdominalAorticAneurysms Lecturers:VirendraIPatel

3:20PM-4:00PM

SessionII.SpecialSituationsandCasePresentations

Moderators:RobertA.Lookstein,VirendraIPatel

Discussants:J.MichaelBacharach,SomjotS.Brar,PatrickT.O'Gara,DarrenBSchneider,HirooTakayama

3:20_PM EndograftinginWomen:AreThereGenderDifferencesinTechniqueorOutcomesWithCaseExamples Lecturers:DanielleBajakian

3:28_PM EndograftinginTypeADissectionWithCaseExamples Lecturers:HirooTakayama

3:36_PM ImaginginTypeBDissectionEndografting:IVUSAssistedTechniquesWithCaseExamples Lecturers:VirendraIPatel

3:44_PM EndovascularAorticRepairs:HistoricalPerspectives Lecturers:DarrenBSchneider

3:52_PM RoundtableDiscussionWhatAretheUnmetNeedsinEndografting

REGIONALSNAPSHOTSESSION:THEBESTOFINTERVENTIONFROMTHEMIDDLEEASTANDAFRICA-STRATEGIESFORCOMPLEXPATIENTS

SUNDAY,SEPTEMBER23,2018

2:00PM-4:00PM

Room31B-C,UpperLevel

2:00PM-2:40PM

SessionI.ChallengesofLeftMain/BifurcationInterventions

Moderators:RanKornowski,MohamedAhmedSobhy

Discussants:MagdyAbdelhamid,SamirAhnia,KaisBattikh,LeorPerl

2:00_PM ApproachtoLeftMainCoronaryBifurcationDiseasein2018 Lecturers:HanyRagy

2:10_PM Case1:OstialLeftMainInterventionTheValueofImaging CasePresenter:LeorPerl

2:17_PM Case2:ADistalLeftMainLesionWithChallenges CasePresenter:NabilFarag

2:24_PM RoundtableDiscussionWithAudienceQA

2:40PM-3:20PM

SessionII:AdvancedCTOApproaches

Moderators:MirvatAlasnag,GrahamA.Cassel,AliOto

Discussants:WaqarH.Ahmed,ShereenAl-Shaikh,HossamHassan,MohamedJeilan,AhmedVachiat

2:40_PM Case3:AntegradeStrategy CasePresenter:ShereenAl-Shaikh

2:47_PM ABCsofAntegrade:ToolsandTechnique Lecturers:WaqarH.Ahmed

2:54_PM RoundtableDiscussionWithAudienceQA

3:00_PM Case4:RetrogradeStrategy CasePresenter:AhmedVachiat

3:07_PM ABCsofRetrograde:ToolsandTechnique Lecturers:AhmedVachiat

3:14_PM RoundtableDiscussionWithAudienceQA

3:20PM-4:00PM

Page 132: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:132

SessionIII:StructuralHeartDisease

Moderators:HabibGamra,E.MuratTuzcu

Discussants:HadiAbu-Hantash,DhakerLahidheb,ChaimS.Lotan

3:20_PM LAAClosure1:Stateoftheart Lecturers:E.MuratTuzcu

3:30_PM LAAClosure2:Stepbystep Lecturers:HazemKhamis

3:37_PM LAAClosure3:PreventionandManagementofComplications Lecturers:HabibGamra

3:44_PM RoundtableDiscussionWithAudienceQA

HOTTOPICLUNCH:CHRONICKIDNEYDISEASE-PREVENTINGANDTREATINGCONTRASTNEPHROPATHY

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Room23B-C,UpperLevel

12:15PM-1:45PM

ChronicKidneyDisease:PreventingandTreatingContrastNephropathy

Moderators:SripalBangalore,SomjotS.Brar

Discussants:CarloBriguori,GrahamA.Cassel,JosedeRibamarCostaJr,HitinderS.Gurm,NavinK.Kapur,RoxanaMehran

12:15_PM Topic1:PrognosticSignificanceofAcuteKidneyInjuryAfterTAVR Lecturers:StevenR.Bailey

12:25_PM RoundtableDiscussionWithAudienceQA

12:30_PM Topic2:ZeroContrastPCI Lecturers:ZiadA.Ali

12:40_PM RoundtableDiscussionWithAudienceQA

12:45_PM Topic3:RevascularizationStrategiesPCICABGvsMedicalTherapyinAdvancedCKD Lecturers:SripalBangalore

12:55_PM RoundtableDiscussionWithAudienceQA

1:00_PM Topic4:CINRiskPredictionandOutcomes Lecturers:HitinderS.Gurm

1:10_PM RoundtableDiscussionWithAudienceQA

1:15_PM Topic5:CINPreventionStrategies Lecturers:RoxanaMehran

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM Topic6:RadialAccessandAKIWhatDoWeKnow Lecturers:SomjotS.Brar

1:40_PM RoundtableDiscussionWithAudienceQA

HOTTOPICLUNCH:CTIMAGINGFORTHECORONARYANDSTRUCTURALHEARTDISEASEINTERVENTIONALIST(SPONSOREDBYTHESOCIETYOF

CARDIOVASCULARCOMPUTEDTOMOGRAPHY)

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Room24A-B,UpperLevel

12:15PM-1:45PM

CTImagingfortheCoronaryandStructuralHeartDiseaseInterventionalist(SponsoredbytheSocietyofCardiovascularComputedTomography)

Moderators:JamesK.Min,ToddC.Villines

Discussants:VictoriaDelgado,HasanJilaihawi,OmarK.Khalique,PaulKnaapen,JonathonA.Leipsic,StephenH.Little

12:15_PM ImagingandBeyondforLAAOcclusion:EchoCTand3DPrinting Lecturers:StephenH.Little

12:25_PM RoundtableDiscussionWithAudienceQA

Page 133: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:133

12:30_PM IsPostTAVRCTImagingJustasImportantasPreTAVRCTImagingFocusonHALT Lecturers:HasanJilaihawi

12:40_PM RoundtableDiscussionWithAudienceQA

12:45_PM NewCTInsightsforTMVR:TheNeoLVOTandSkirtNeoLVOTConcept Lecturers:VictoriaDelgado

12:55_PM RoundtableDiscussionWithAudienceQA

1:00_PM CTasFirstlineTestforEveryoneWithSuspectedCAD:RationaleBehindtheNICEGuidelines Lecturers:JamesK.Min

1:10_PM RoundtableDiscussionWithAudienceQA

1:15_PM FFRCT:AnEvidenceBasedAppraisal Lecturers:ToddC.Villines

1:25_PM RoundtableDiscussionWithAudienceQA

1:30_PM TheVulnerablePlaqueandPatientRevisited:WholeHeartQuantitationandCharacterizationofAtherosclerosisbyCT Lecturers:PaulKnaapen

1:40_PM RoundtableDiscussionWithAudienceQA

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-ACUTEINFARCTANGIOPLASTYANDCARDIOGENICSHOCK

SUNDAY,SEPTEMBER23,2018

12:15PM-1:51PM

Room26A-B,UpperLevel

12:15PM-1:51PM

AcuteInfarctAngioplastyandCardiogenicShock

Moderators:DavidA.Cox,TimothyD.Henry

Discussants:PawelE.Buszman,WarrenJ.Cantor,StevenP.Marso,SandeepNathan,SheilaSahni,NirUriel

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:DavidA.Cox

12:18_PM Case1:HowWeTreatedAHemodynamicallyStableSTEMIPatientWithSevereMultivesselDisease CasePresenter:SanjitS.Jolly

12:26_PM Case2:ACaseinWhichPrimaryPCIResultedinSevereNoReflow CasePresenter:ThomasD.Stuckey

12:34_PM Case3:ACaseofSTEMIandMassiveThrombusBurden CasePresenter:CarlosE.Uribe

12:42_PM Case4:APatientWithSTEMIDuetoaSeverelyDegeneratedSaphenousVeinGraft CasePresenter:JohnS.DouglasJr

12:50_PM Case5:APatientWithaDefiniteSTEMIandApparentlyMinimallyDiseasedCoronaryArteriesNotTakoTsubo CasePresenter:PetrKala

12:58_PM Case6:PrimaryPCIWithDoubleStentThrombosis CasePresenter:MohamedAhmedSobhy

1:06_PM Case7:ACaseofCardiogenicShockDuetoanOccludedLeftMainThatWeTreatedWithImpella CasePresenter:MichaelS.Lee

1:14_PM Case8:ACaseofCardiogenicShockThatWeTreatedWithECMO CasePresenter:A.ReshadGaran

1:22_PM Case9:ACaseofCardiogenicShockThatWeTreatedWithBiventricularSupport CasePresenter:SanjogKalra

1:30_PM Case10:AVeryElderlyPatientWithCardiogenicShock:HowAggressiveIsTooAggressive CasePresenter:JoseM.delaTorreHernandez

1:38_PM Case11:ACaseofOutofHospitalCardiacArrestWithoutSTSegmentElevationThatWeTooktotheCathLab CasePresenter:GrahamNichol

1:46_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:TimothyD.Henry

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-COMPLEXTAVRCASES

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Page 134: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:134

Room28D-E,UpperLevel

12:15PM-1:45PM

ComplexTAVRCases

Moderators:PhilippeGenereux,JosepRodés-Cabau

Discussants:SuzanneV.Arnold,WayneB.Batchelor,IsaacGeorge,TullioPalmerini,ShigeruSaito,TobiasTichelbäcker

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:JosepRodés-Cabau

12:20_PM Case1:AComplexTAVRDecision:ProhibitiveSurgicalRiskvsTheTypeCPatient CasePresenter:AnthonyA.Bavry

12:30_PM Case2:ACaseofEmbolicProtectioninDifficultCerebralAnatomy CasePresenter:JochenWöhrle

12:40_PM Case3:EvaluationandTreatmentofLowFlowLowGradientAorticStenosis CasePresenter:PhilippePibarot

12:50_PM Case4:ACaseofMinimalistTAVRWithSingleFemoralAccess CasePresenter:BernardR.Chevalier

1:00_PM Case5:ACaseinWhichWePushedtheEnvelopetoCompleteaTransfemoralTAVR CasePresenter:GraysonH.Wheatley

1:10_PM Case6:TransCarotidTAVRStepbyStep CasePresenter:KeithB.Allen

1:20_PM Case7:ACaseofPureNonCalcificAorticInsufficiencyTreatedWithTAVR CasePresenter:Wei-HsianYin

1:30_PM Case8:ACaseofAsymptomaticLeafletThrombosis:ManagementStrategies CasePresenter:PhilippBlanke

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:PhilippeGenereux

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-CTORETROGRADETECHNIQUES

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Room25A-B,UpperLevel

12:15PM-1:45PM

CTORetrogradeTechniques

Moderators:MasahikoOchiai,GeorgiosSianos

Discussants:TonyJ.DeMartini,KefeiDou,OmerGoktekin,WilliamNicholson,JasonWollmuth,R.MichaelWyman

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:MasahikoOchiai

12:20_PM Case1:RetrogradeCTOTechnique:ACaseEmphasizingCollateralSelection CasePresenter:AlfredoR.Galassi

12:30_PM Case2:RetrogradeCTOTechnique:ACaseEmphasizingHowtoConnectTheWires CasePresenter:PaulHsien-LiKao

12:40_PM Case3:UsingIVUSDuringRetrogradeCTOPCI CasePresenter:SatoruSumitsuji

12:50_PM Case4:StepByStepTroubleShootingDuringRetrogradeCTOPCI CasePresenter:PaulKnaapen

1:00_PM Case5:ACaseUsingEpicardialCollateralsDuringRetrogradeCTO CasePresenter:MasahisaYamane

1:10_PM Case6:ACaseofChannelInjuryDuringtheRetrogradeApproach CasePresenter:SudhirRathore

1:20_PM Case7:ACaseofSevereIschemiaandThrombosisDuringRetrogradeCTO CasePresenter:LeiGe

1:30_PM Case8:ManagingaLargePerforationDuringaRetrogradeCTOPCI CasePresenter:EmmanouilS.Brilakis

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:GeorgiosSianos

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-INTERVENTIONAL�RICHEMOTIONALEXPERIENCES�(AKACOMPLICATIONS)II:STRUCTURAL

Page 135: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:135

SUNDAY,SEPTEMBER23,2018

12:15PM-1:47PM

Room28A-B,UpperLevel

12:15PM-1:47PM

Interventional�RichEmotionalExperiences�(AKAComplications)II:Structural

Moderators:SamirR.Kapadia,BernardPrendergast

Discussants:EricEeckhout,GaneshManoharan,ChristopherU.Meduri,JohnC.Messenger,BernhardReimers,PaulSorajja

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:BernardPrendergast

12:18_PM Case1:AFrighteningVascularComplicationAfterTAVR CasePresenter:EthanCKorngold

12:25_PM Case2:ACaseofCoronaryObstructionAfterTAVR CasePresenter:JohnK.Forrest

12:32_PM Case3:ManagementofanEmbolizedTAVRBioprosthesisIntotheLeftVentricle CasePresenter:GoravAilawadi

12:39_PM Case4:ClinicallySignificantTAVRLeafletThrombosis CasePresenter:RajMakkar

12:46_PM Case5:ManagingaSevereParavalvularLeakAfterTAVRUsingFusionImaging CasePresenter:TorstenP.Vahl

12:53_PM Case6:AorticRuptureDuringTAVR CasePresenter:MarcoBarbanti

1:00_PM Case7:ACaseofLateOutofHospitalHeartBlockAfterTAVR CasePresenter:DannyDvir

1:07_PM Case8:RetrievalofanEmbolizedPFOClosureDevice CasePresenter:JacquelineSaw

1:14_PM Case9:ManagementofAcuteLVOutflowTractObstructionDuringTMVR CasePresenter:HowardC.Herrmann

1:21_PM Case10:StepbyStepClosureofaLargeMitralParavalvularLeak CasePresenter:EustaquioMariaOnorato

1:28_PM Case11:AnUnexpectedComplicationDuringLAAClosure CasePresenter:RamonQuesada

1:35_PM Case12:AHarrowingComplicationDuringaComplexCongenitalProcedure CasePresenter:JohnP.Breinholt

1:42_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:SamirR.Kapadia

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-LAAOCCLUSION:DECISIONS,TIPS,ANDTRICKS

SUNDAY,SEPTEMBER23,2018

12:15PM-1:59PM

Room27A-B,UpperLevel

12:15PM-1:59PM

LAAOcclusion:Decisions,Tips,andTricks

Moderators:MauriceBuchbinder,VivekY.Reddy

Discussants:HabibGamra,AaronV.Kaplan,UlfLandmesser,PetrNeuzil,Jai-WunPark,KoljaSievert

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:VivekY.Reddy

12:18_PM Case1:AcuteLAAClosureDeviceEmbolizationWithChallengingRetrieval Lecturers:MauriceBuchbinder

12:26_PM Case2:ADifficultTransseptalPunctureforanLAAOcclusionProcedure CasePresenter:MeganCoylewright

12:34_PM Case3:ACaseWhereProceduralGuidanceWithTEEMadealltheDifference CasePresenter:RamonQuesada

12:42_PM Case4:ACaseDemonstratingWhyIPreferICEOverTEEforLAAOcclusion CasePresenter:JacquelineSaw

12:42_PM Case5:ACaseofImageFusionTechnologytoGuideLAAExclusion CasePresenter:CarlosE.Ruiz

12:50_PM Case6:ClosingtheWideMouthedMultilobedLAA

Page 136: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:136

CasePresenter:StefanC.Bertog1:03_PM Case7:ClosingtheLAAWhentheDeviceWontFit

CasePresenter:RedaIbrahim1:06_PM Case8:TwoQuickCases:OneinWhichIPreferredWatchmanOneinWhichIPreferredAmplatzer

CasePresenter:AshishPershad1:14_PM Case9:ManagementofaPersistentLeakAfterLAAClosure

CasePresenter:GeorgeS.Hanzel1:22_PM Case10:ReclosingaReopenedLAAAfterSurgicalLigation

CasePresenter:PeterB.Sick1:30_PM Case11:MajorComplicationofanLAAClosureProcedureinaFrailElderlyPatient

CasePresenter:DavidHildick-Smith1:38_PM Case12:AnLAAExclusionProcedureGuidedbyPersonalizedComputerModeling

CasePresenter:PhilippeGarot1:46_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases

Lecturers:MauriceBuchbinder

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-LEFTMAINANDBIFURCATIONINTERVENTION:TECHNIQUEANDOUTCOMES

SUNDAY,SEPTEMBER23,2018

12:15PM-1:45PM

Room29A-B,UpperLevel

12:15PM-1:45PM

LeftMainandBifurcationIntervention:TechniqueandOutcomes

Moderators:DavideCapodanno,JeanFajadet

Discussants:AndrejsErglis,TimA.Fischell,AnnapoornaKini,AlfredoE.Rodriguez,CorradoTamburino,ChrisKwokYiuWong

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:DavideCapodanno

12:20_PM Case1:AnOstialLeftMainLesion:HowtoNailtheOstium CasePresenter:AfzalurRahman

12:28_PM Case2:AComplexLeftMainBifurcation:IsLesionPreparationNecessary CasePresenter:NiratBeohar

12:36_PM Case3:AComplexLeftMainBifurcation:IChoseProvisionalTheAcuteandorLateResultsWereUnexpected CasePresenter:JeanFajadet

12:44_PM Case4:AComplexLeftMainBifurcation:IChoseSKSTheAcuteandorLateResultsWereUnexpected CasePresenter:SaminK.Sharma

12:52_PM Case5:AComplexLeftMainBifurcation:IChoseCulotteTheAcuteandorLateResultsWereUnexpected CasePresenter:MiroslawFerenc

1:00_PM Case6:AComplexLeftMainBifurcation:IChoseDKCrushTheAcuteandorLateResultsWereUnexpected CasePresenter:JunjieZhang

1:08_PM Case7:ALeftMainDistalBifurcationPCIinWhichIntravascularImagingMarkedlyChangedMyTreatment CasePresenter:JacekLegutko

1:16_PM Case8:ALeftMainDistalBifurcationPCIinWhichPhysiologicGuidanceMarkedlyChangedMyTreatment CasePresenter:Jung-MinAhn

1:24_PM Case9:AComplexLeftMainTrifurcation:HeresHowIDidIt CasePresenter:VinayK.Bahl

1:32_PM Case10:LongitudinalStentDeformationDuringLeftMainStenting CasePresenter:YvesR.Louvard

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:JeanFajadet

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-PHYSIOLOGICGUIDANCE-FFR,IFR,CFRANDIMR

SUNDAY,SEPTEMBER23,2018

12:15PM-1:47PM

Room33B-C,UpperLevel

12:15PM-1:47PM

PhysiologicGuidanceintheCathLab:FFR,iFRandMore

Moderators:JavierEscaned,MortonJ.Kern

Page 137: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:137

Discussants:FelixBohm,MichalisHamilos,NielsR.Holm,ErickSchampaert,AdhirShroff

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:JavierEscaned

12:18_PM Case1:ACaseinWhich3VesselFFRMarkedlyChangedMyTreatment CasePresenter:Seung-JungPark

12:25_PM Case2:ACaseinWhichFFROfAMildLesionLedMeToStent CasePresenter:ValerianFernandes

12:32_PM Case3:ACaseinWhichPostStentFFRAssessmentChangedMyTreatment CasePresenter:RobertoDiletti

12:39_PM Case4:ACaseofiFRCoRegistrationToIdentifyFocalTreatableDisease CasePresenter:JustinE.Davies

12:46_PM Case5:ACaseWithMarkedDiscordanceBetweenFFRandiFRWhichtoBelieve CasePresenter:ArnoldSeto

12:53_PM Case6:ACaseofFFRandiFRintheLeftMainWhichToBelieve CasePresenter:RobertJ.Gil

1:00_PM Case7:ACaseofCulpritandNonCulpritLesionAssessmentinACS:FFRiFRBothorNither CasePresenter:EricVanBelle

1:07_PM Case8:ACaseofPhysiologicalAssessmentofaMyocardialBridge CasePresenter:AmirLerman

1:14_PM Case9:ACaseinWhichitWasPreferableToMeasureCoronaryFlowNotPressure CasePresenter:JanJ.Piek

1:21_PM Case10:ACaseDemonstratingtheRestingFullCycleRatioRFR CasePresenter:ZiadA.Ali

1:28_PM Case11:ACaseofDemonstratingthePotentialUtilityofvFFR CasePresenter:JoostDaemen

1:35_PM Case12:ACaseDemonstratingthePotentialUtilityofQFR CasePresenter:ShengxianTu

1:42_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:MortonJ.Kern

SPECIAL@TCTSESSION:CACI@TCT

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

Room25A-B,UpperLevel

2:00PM-3:30PM

CACIAtTCT2018.PCIInStableAngina:WhyIsORBITANottheLastNailForCoronaryAngioplasty?

Moderators:AnibalA.Damonte,DiegoDGrinfeld,AlfredoE.Rodriguez

2:00_PM IntroductionandSessionObjectives Lecturers:AnibalA.Damonte

2:03_PM RoleofPCIInStableAnginaPatients

2:13_PM RoundtableDiscussionWithAudienceQA

2:18_PM CasePresentation1:PCIinStableAngina CasePresenter:GuillermoMigliaro

2:23_PM RoundtableDiscussionWithAudienceQA

2:26_PM WhatAretheLastingClinicalImplicationsOftheORBITATrial Lecturers:JohnA.Ambrose

2:36_PM RoundtableDiscussionWithAudienceQA

2:41_PM CasePresentation2:PCIinStableAngina Lecturers:RubenA.Piraino

2:46_PM RoundtableDiscussionWithAudienceQA

2:49_PM SCAIPositionStatementsOnTheRoleOfPCIInStableAnginaAfterORBITA Lecturers:DavidA.Cox

2:59_PM RoundtableDiscussionWithAudienceQA

3:04_PM CasePresentation3:PCIInStableAngina CasePresenter:AntonioAPocovi

Page 138: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:138

3:09_PM RoundtableDiscussionWithAudienceQA

3:22_PM SessionSummaryandTakeHomeMessages Lecturers:AlfredoE.Rodriguez

SPECIALSESSION:30THTCTANNIVERSARYCELEBRATORYKEYNOTE

SUNDAY,SEPTEMBER23,2018

2:00PM-2:30PM

Ballroom6A,UpperLevel

2:00PM-2:30PM

30thTCTAnniversaryCelebratoryKeynote

Moderators:RichardA.Schatz,PatrickW.Serruys

Discussants:RafaelBeyar,PeterC.Block,JeanFajadet,GeorgeW.Vetrovec

2:00_PM TheLegacyofAndreasGruentzigTheFatherofInterventionalCardiology Lecturers:PhilippeE.Gaspard

2:20_PM RoundtableDiscussion

SPECIALSESSION:HEMODYNAMICBRAINTEASERSFROMTHECATHLAB

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

Room23B-C,UpperLevel

2:00PM-3:30PM

SpecialSession:HemodynamicBrainTeasersFromtheCathLab

Moderators:MortonJ.Kern,HolgerThiele

Discussants:AnthonyA.Bavry,JosephP.CarrozzaJr,HolgerM.Nef,GerhardC.Schuler

2:00_PM LowFlowLowGradientAorticStenosisHemodynamicPitfalls Lecturers:HowardC.Herrmann

2:08_PM RoundtableDiscussionWithAudienceQA

2:18_PM HypertrophicCardiomyopathyBrockenbroughPhenomenonandMore Lecturers:AnthonyA.Bavry

2:26_PM RoundtableDiscussionWithAudienceQA

2:36_PM ConstrictivePericarditisorRestrictiveCardiomyopathyHemodynamicOldSchool Lecturers:GerhardC.Schuler

2:44_PM RoundtableDiscussionWithAudienceQA

2:54_PM PulmonaryHypertensionHowtoAssess

3:02_PM RoundtableDiscussionWithAudienceQA

3:12_PM ShuntAssessmentVSDASDTypicalPitfalls Lecturers:HolgerM.Nef

3:20_PM RoundtableDiscussionWithAudienceQA

FASCINATINGLECTURESII:ARTIFICIALINTELLIGENCE,MACHINELEARNING,ANDADVANCEDIMAGING

SUNDAY,SEPTEMBER23,2018

2:30PM-3:45PM

Ballroom6A,UpperLevel

2:30PM-3:45PM

ArtificialIntelligence,MachineLearning,andAdvancedImaging

Moderators:MayraGuerrero,JamesK.Min

Discussants:AnthonyN.DeMaria,KishoreJ.Harjai,PeterH.Stone,DarrenL.Walters,RobertL.Wilensky

2:30_PM TheFutureofSTEMICare:TheImpactofDisruptiveTechnology

Page 139: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:139

Lecturers:JamesFlaherty2:40_PM FascinatingQA

2:45_PM ArtificialIntelligenceandtheFutureofInterventionalCardiology Lecturers:ParthaSardar

2:55_PM FascinatingQA

3:00_PM InteractiveVirtualRealityImagingforStructuralHeartProceduralPlanning Lecturers:SaurabhSanon

3:10_PM FascinatingQA

3:15_PM PatientSpecificComputerSimulationofTAVRinBicuspidAorticValveMorphology Lecturers:CameronDowling

3:25_PM FascinatingQA

3:30_PM From3DPrintingtoVirtualImplantation:AGuidetotheFutureofStructuralHeartInterventions Lecturers:JamesOtton

3:40_PM FascinatingQA

SPECIAL@TCTSESSION:GISE@TCT

SUNDAY,SEPTEMBER23,2018

2:30PM-4:00PM

Room24A-B,UpperLevel

2:30PM-4:00PM

GISE@TCT:Case-BasedDebatesinPatientsWithHigh-BleedingRiskUndergoingPCI

Moderators:GeorgeD.Dangas,GiuseppeTarantini

Discussants:StevenR.Bailey,GiovanniEsposito,JuanF.Granada,RoxanaMehran,FrancescoSaia

2:30_PM IntroductionAndSessionGoals Lecturers:GiuseppeTarantini

2:35_PM Case1Introduction:APatientWithChronicCADAtHighBleedingRiskRequiringPCI CasePresenter:GiulioStefanini

2:40_PM RoundtableDiscussionWithAudienceQA

2:50_PM HowWouldITreatThisPatient Lecturers:DominickJ.Angiolillo

2:55_PM HowWouldITreatThisPatient Lecturers:UgoLimbruno

3:00_PM Case1Conclusion:HowDidIActuallyTreatThisPatient CasePresenter:GiulioStefanini

3:10_PM Consensus:PCIConsiderationsInTheHighBleedingRiskPatientWithChronicCAD Lecturers:GiuseppeTarantini

3:17_PM Case2Introduction:AHighBleedingRiskPatientWithAfibAndACSRequiringPCIAndOralAnticoagulantTherapy CasePresenter:UsmanBaber

3:22_PM RoundtableDiscussionWithAudienceQA

3:32_PM HowWouldITreatThisPatient Lecturers:AlessioGLaManna

3:37_PM HowWouldITreatThisPatient Lecturers:GrzegorzL.Kaluza

3:42_PM Case2Conclusion:HowDidIActuallyTreatThisPatient CasePresenter:UsmanBaber

3:47_PM Consensus:ConsiderationsInTheHighBleedingRiskPatientRequiringPCIAndOralAnticoagulantTherapy Lecturers:RoxanaMehran

3:55_PM ConclusionsAndTakeHomeMessages Lecturers:GiuseppeTarantini

SPECIALSESSION:DISCUSSIONSWITHTHELATEBREAKINGTRIALPRINCIPALINVESTIGATORSII

SUNDAY,SEPTEMBER23,2018

3:45PM-5:00PM

Page 140: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:140

Ballroom6A,UpperLevel

3:45PM-5:00PM

DiscussionsWiththeLateBreakingTrialPrincipalInvestigatorsII

Moderators:AndreasBaumbach,StephanWindecker

Discussants:RobertJ.Gil,MitchellW.Krucoff,FrederickG.St.Goar

3:45_PM LEADERSFREEII:SummaryandClinicalImplications Lecturers:MitchellW.Krucoff

3:50_PM Discussion Discussants:MitchellW.Krucoff

4:00_PM SORTOUTIX:SummaryandClinicalImplications Lecturers:LisetteOkkelsJensen

4:05_PM Discussion Discussants:LisetteOkkelsJensen

4:15_PM SOLVETAVI:SummaryandClinicalImplications Lecturers:HolgerThiele

4:20_PM Discussion Discussants:HolgerThiele

4:30_PM REDUCEFMR:SummaryandClinicalImplications Lecturers:HorstSievert

4:35_PM Discussion Discussants:HorstSievert

4:45_PM COAPT:SummaryandClinicalImplications Lecturers:GreggW.Stone

4:50_PM Discussion Discussants:GreggW.Stone

PRESENTATIONTHEATERPROGRAM:ADVANCEDSOLUTIONSFORCOMPLEXPCI:XIENCESIERRA,OCTANDOUTCOMES(SPONSOREDBYABBOTT)

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

PresentationTheater5,ExhibitHall,GroundLevel

11:30AM-12:30PM

AdvancedSolutionsforComplexPCI:XIENCESierra,OCTandOutcomes

Faculty:JonathanM.Hill,AllenJeremias,AjayJ.Kirtane,JoseM.delaTorreHernandez

11:30_AM Welcome Lecturers:JoseM.delaTorreHernandez

11:34_AM LeftMainNEWEXCELDataandCaseReview Lecturers:JonathanM.Hill

11:53_AM DiffuseandCalcifiedLesions:TreatingChallengingSituations Lecturers:AjayJ.Kirtane

12:12_PM HowtoUseOCTtoGetPrecisePlacementforBifurcations:IntroductiontotheBOOMTechnique Lecturers:AllenJeremias

12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:FFRANDNHPR:STARTRIGHT,FINISHRIGHT(SPONSOREDBYOPSENSMEDICAL)

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

PresentationTheater4,ExhibitHall,GroundLevel

11:30AM-12:30PM

FFRandNHPR:StartRight,FinishRight

Chairs:MortonJ.Kern

Faculty:AllenJeremias,HitoshiMatsuo,ManishA.Parikh,BarryFUretsky

11:30_AM UsingOneFFRWireStarttoFinish

Page 141: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:141

Lecturers:MortonJ.Kern11:40_AM NHPRandFFRWhentoUseWhat

Lecturers:AllenJeremias11:50_AM ClinicalExperienceUsingOpsensdPR

Lecturers:HitoshiMatsuo12:00_PM UnderstandingtheImpactofDrift:TheDRIFTstudy

Lecturers:ManishA.Parikh12:10_PM PostPCIFFREndingonaHighNote

Lecturers:BarryFUretsky12:20_PM Discussion

Moderators:MortonJ.Kern

Discussants:AllenJeremias,HitoshiMatsuo,ManishA.Parikh,BarryFUretsky12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:THECOMINGOFAGEOFFFRCT:CLINICALUSEOFTHEHEARTFLOWFFRCTANALYSISTOGUIDETREATMENT

DECISIONMAKING(SPONSOREDBYHEARTFLOW)

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

PresentationTheater3,ExhibitHall,GroundLevel

11:30AM-12:30PM

TheComingofAgeofFFRCT:ClinicalUseoftheHeartFlowFFRCTAnalysistoGuideTreatmentDecisionMaking

Chairs:GreggW.Stone

Faculty:BernardDeBruyne,MD,PhD,PamelaS.Douglas,JonathonA.Leipsic,RobertD.Safian

11:30_AM WelcomeandIntroduction Lecturers:GreggW.Stone

11:35_AM OverviewoftheHeartFlowAnalysis Lecturers:BernardDeBruyne,MD,PhD

11:45_AM ReviewofLatestHeartFlowData Lecturers:JonathonA.Leipsic

11:55_AM IncorporatingHeartFlowintoDailyPractice Lecturers:RobertD.Safian

12:05_PM OntheHorizon:HeartFlowSponsoredRandomizedClinicalTrialsIPRECISE Lecturers:PamelaS.Douglas

12:10_PM OntheHorizon:HeartFlowSponsoredRandomizedClinicalTrialsIIDECISION Lecturers:GreggW.Stone

12:15_PM ModeratedDiscussion Moderators:GreggW.Stone

Lecturers:BernardDeBruyne,MD,PhD

Discussants:PamelaS.Douglas,JonathonA.Leipsic,RobertD.Safian

PRESENTATIONTHEATERPROGRAM:TMVR:PREPARINGFORTHENEXTREVOLUTION(SPONSOREDBYCRF,SUPPORTEDBYMEDTRONIC)

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

PresentationTheater1,HallB2,GroundLevel

11:30AM-12:30PM

TMVR:PreparingfortheNextRevolution

CoChairs:MartinB.Leon,ChristopherU.Meduri

Faculty:VinayakBapat,MichaelJ.Mack,VivekRajagopal,MD

11:30_AM TreatmentofMitralDiseasein2018CurrentState Lecturers:ChristopherU.Meduri

11:34_AM TranscatheterMitralValveReplacement:RationaleandTrialDesignConsiderations Lecturers:MartinB.Leon

11:44_AM DiscussionandAudienceInteraction

11:47_AM CTImagingandScreeningtheTranscatheterMitralValveReplacementPatient

11:57_AM DiscussionandAudienceInteraction

Page 142: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:142

12:00_PM OptimizingMedicalCarefortheTranscatheterMitralValveReplacementPatient Lecturers:VivekRajagopal,MD

12:10_PM DiscussionandAudienceInteraction

12:13_PM IntrepidTranscatheterMitralValveReplacementGlobalPilotStudyOutcomes:LessonsLearned Lecturers:VinayakBapat

12:23_PM DiscussionandAudienceInteraction

12:26_PM SessionEvaluationandKeyLearnings Lecturers:MartinB.Leon,ChristopherU.Meduri

12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:UNVEILINGTHEFUTUREOFBIORESORBABLECORONARYSCAFFOLDS:THETHIN-WALLEDHIGHMECHANICAL

PERFORMANCEAMARANTHMEDICALBRSPROGRAM(SPONSOREDBYAMARANTHMEDICAL,INC.)

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

PresentationTheater2,HallB2,GroundLevel

11:30AM-12:30PM

UnveilingtheFutureofBioresorbableCoronaryScaffolds:TheThin-WalledHighMechanicalPerformanceAmaranthMedicalBRSProgram

Chairs:AntonioColombo,MartinB.Leon

Faculty:AlaideChieffo,JuanF.Granada,AzeemLatib

11:30_AM WelcomeandSessionObjectives Lecturers:AntonioColombo

11:35_AM TechnologicalPlatformandExperimentalInsightsfromtheWorldsThinnest85mBRS Lecturers:JuanF.Granada

11:47_AM DiscussionandAudienceQuestions Moderators:AntonioColombo,MartinB.Leon

11:52_AM FORTITUDE150mandAPTITUDE115mBRS:2and3yearClinicalUpdates Lecturers:AlaideChieffo

12:04_PM DiscussionandAudienceQuestions Moderators:MartinB.Leon

12:09_PM MAGNITUDE98mBRS9monthFinalSafetyandImagingResults Lecturers:AzeemLatib

12:21_PM DiscussionandAudienceQuestions Moderators:MartinB.Leon

12:26_PM SessionEvaluationandSummary Lecturers:MartinB.Leon

PRESENTATIONTHEATERPROGRAM:CHALLENGINGPCIINHIGH-BLEEDINGRISKPATIENTS-ACASEBASEDAPPROACH(SPONSOREDBYMEDTRONIC)

SUNDAY,SEPTEMBER23,2018

1:00PM-2:00PM

PresentationTheater3,ExhibitHall,GroundLevel

1:00PM-2:00PM

ChallengingPCIinHigh-BleedingRiskPatients-ACaseBasedApproach

CoChairs:AjayJ.Kirtane,AzeemLatib

1:00_PM WelcomeandSessionObjectives

1:05_PM APatientOlderThan75Years

1:13_PM PanelDiscussionQA

1:22_PM APatientCurrentlyTakingAntiCoagulants

1:30_PM PanelDiscussionQA

1:39_PM APatientWithaHistoryofBleeding

1:47_PM PanelDiscussionQA

Page 143: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:143

1:56_PM SummaryandClose

PRESENTATIONTHEATERPROGRAM:CLINICALKALEIDOSCOPEOFNOVELINTERVENTIONALTECHNOLOGIES(MERILLIFESCIENCESPVT.LTD.)

SUNDAY,SEPTEMBER23,2018

1:00PM-2:00PM

PresentationTheater2,HallB2,GroundLevel

1:00PM-2:00PM

ClinicalKaleidoscopeofNovelInterventionalTechnologies

Chairs:TeguhSantoso,SaminK.Sharma

Faculty:AlexandreAbizaid,PierfrancescoAgostoni,AbdulRahmanAl-Mughairi,PraveenChandra,AlejandroCherro,EnricDomingo,MartinB.Leon,GabrielMaluenda,

ChenMao,SahilA.Parikh,RavinderSinghRao,Mohd.RiadSenoussaoui,AshokSeth,CorradoTamburino

1:00_PM OpeningRemarks Lecturers:MartinB.Leon

1:05_PM ScienceBehindMyValTHVClinicalUpdate Lecturers:AshokSeth

1:12_PM MyExperienceWithMyValTHVinComplexClinicalSituations Lecturers:RavinderSinghRao

1:19_PM NextGenerationBRSMeRes100ScienceClinicalUpdate Lecturers:PraveenChandra

1:26_PM ExtendingtheRoleofBRSinPADClinicalUpdate Lecturers:SahilA.Parikh

1:33_PM BioMimeThinnerStrutDESmeriTVRCTUpdate Lecturers:AlexandreAbizaid

1:40_PM ComplexCasesWithBioMimeFamilyofSES Lecturers:CorradoTamburino

1:47_PM PanelDiscussion

2:00_PM Adjourn

PRESENTATIONTHEATERPROGRAM:MOREOPTIONSANDMOREPOSSIBILITIESINTREATINGPATIENTSWITHMR(SPONSOREDBYABBOTT)

SUNDAY,SEPTEMBER23,2018

1:00PM-2:00PM

PresentationTheater5,ExhibitHall,GroundLevel

1:00PM-2:00PM

MoreOptionsandMorePossibilitiesinTreatingPatientswithMR

Faculty:WilliamT.Abraham,SaibalKar,JoAnnLindenfeld,MichaelJ.Mack,GreggW.Stone

1:00_PM Welcome Lecturers:MichaelJ.Mack

1:05_PM EmergingDataintheHeartFailurePatientwithMR Lecturers:GreggW.Stone

1:15_PM ImplicationstoPatientCare:WhenGuidedTherapyIsNotEnough Lecturers:WilliamT.Abraham

1:25_PM TheNewHeartTeam:AConversationwithyourHeartFailureSpecialist Lecturers:JoAnnLindenfeld

1:35_PM NewHorizonsinPatientOutcomeswithMitraClipNTRXTR:OnBehalfoftheEXPANDInvestigators Lecturers:SaibalKar

1:45_PM ClosingandRemarks Lecturers:WilliamT.Abraham,SaibalKar,JoAnnLindenfeld,MichaelJ.Mack

2:00_PM Adjourn

PRESENTATIONTHEATERPROGRAM:OPTIMIZINGPCI:NEWOPTIONSINCORONARYPHYSIOLOGY&HIGHDEFINITIONIVUS(SPONSOREDBYBOSTON

SCIENTIFICCORPORATION)

Page 144: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:144

SUNDAY,SEPTEMBER23,2018

1:00PM-2:00PM

PresentationTheater4,ExhibitHall,GroundLevel

1:00PM-2:00PM

OptimizingPCI:NewOptionsinCoronaryPhysiology&HighDefinitionIVUS

Chairs:MortonJ.Kern

Faculty:ZiadA.Ali,NilsJohnson,AkikoMaehara

1:00_PM CoronaryPhysiologyToolbox Lecturers:MortonJ.Kern

1:05_PM DFRMethodologyAnalysis Lecturers:NilsJohnson

1:15_PM PanelDiscussion Moderators:MortonJ.Kern

Discussants:ZiadA.Ali,NilsJohnson,AkikoMaehara1:20_PM WhentoUseWhatinCoronaryPhysiology

Lecturers:ZiadA.Ali1:30_PM PanelDiscussion

Moderators:MortonJ.Kern

Discussants:ZiadA.Ali,NilsJohnson,AkikoMaehara1:35_PM HDIVUSWhenPrecisionDepthMatter

Lecturers:AkikoMaehara1:50_PM PanelDiscussionQA

Moderators:MortonJ.Kern

Discussants:ZiadA.Ali,NilsJohnson,AkikoMaehara

PRESENTATIONTHEATERPROGRAM:OPTIMIZINGREVASCULARIZATIONINCOMPLEXPERIPHERALARTERIALLESIONS(SPONSOREDBYMEDTRONIC)

SUNDAY,SEPTEMBER23,2018

1:00PM-2:00PM

PresentationTheater1,HallB2,GroundLevel

1:00PM-2:00PM

OptimizingRevascularizationinComplexPeripheralArterialLesions

Chairs:KrishnaJ.Rocha-Singh

Faculty:BrianG.DeRubertis,JonC.George,MehdiH.Shishehbor

1:00_PM Introduction Lecturers:KrishnaJ.Rocha-Singh

1:10_PM DurabilityofDrugCoatedBalloons Lecturers:KrishnaJ.Rocha-Singh

1:25_PM VesselPreparationforOptimalOutcomes Lecturers:BrianG.DeRubertis

1:40_PM OptimalAngioplastyTechniquesBelowtheKnee Lecturers:JonC.George

1:55_PM ClosingRemarks Lecturers:KrishnaJ.Rocha-Singh

TRAINING:ABBOTTPAVILION#6-LARGEBOREACCESSTOCLOSE:WHATYOUWANT(ANDNEED!!)TOKNOW

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

LargeBoreAccesstoClose:WhatYouWant(andNeed!!)toKnow

InteractiveTrainingFaculty:PaulD.Mahoney,AdhirShroff

8:00_AM Introduction:AccessPlanningandManagementofComplicationsReview

8:20_AM HandsonDeviceDeployment

Page 145: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:145

TRAINING:BOSTONSCIENTIFICPAVILION#6-LAA:WATCHMAN

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

LAA:Watchman

InteractiveTrainingFaculty:ShephalDoshi,GeorgeS.Hanzel,SaibalKar

8:00_AM LatestWatchmanClinicalDataandProceduralTipsandTricks

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#5-CORONARYCALCIUMSOLUTIONS

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-8:45AM

RapidFireCasePresentations

8:00_AM WhenandHowtoUseCoronaryAtherectomyandTheImportanceofStentUnderexpansioninAdditiontoDeviceDelivery InteractiveTrainingFaculty:JasvindarSingh

8:10_AM TheUseofImagingtoAssistWithCalciumManagement InteractiveTrainingFaculty:RobertLeonardi

8:20_AM TipsandTrickstoGuideandExtensionManagement InteractiveTrainingFaculty:DimitriKarmpaliotis

8:35_AM CalciumComplicationsandBailoutSituations InteractiveTrainingFaculty:RamzanZakir

8:45AM-9:30AM

Hands-onRotationsBetweenBostonScientific,CSI,andAbiomed

8:45_AM Abiomed:ImpellaFamilyofDevices InteractiveTrainingFaculty:ThomGDahle,JustinLevisay

TRAINING:ENDOVASCULARPAVILION#5-SFAINTERVENTION,COMPLEXLESIONS,DEBULKING,ANDDEFINITIVETHERAPY

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

SFAIntervention:De-bulking,ComplexLesions,andDefinitiveTherapySessionI

InteractiveTrainingFaculty:S.HinanAhmed,DanielleBajakian,SubhashBanerjee,GeorgeSChrysant,MahirElder,BryanT.Fisher,BeauHawkins,VishalKapur,S.Jay

Mathews,CarlosI.Mena-Hurtado,PeterP.Monteleone,CraigM.Walker

8:00_AM VideoIntroduction:IntroducingUnmetNeedsComplexLesionsDefinitiveTreatmentOptionsandDebulking

8:10_AM Rotation1:DefinitiveTreatmentOptionsFeaturingAbbott InteractiveTrainingFaculty:DanielleBajakian,PeterMFarrugia,CraigM.Walker

8:30_AM Rotation2:DefinitiveTreatmentOptionsandDebulkingFeaturingBSC InteractiveTrainingFaculty:GeorgeSChrysant,BeauHawkins,S.JayMathews

8:50_AM Rotation3:DefinitiveTreatmentOptionsDebulkingandComplexLesionsFeaturingMedtronic InteractiveTrainingFaculty:S.HinanAhmed,SubhashBanerjee,PeterP.Monteleone

9:10_AM Rotation4:DebulkingFeaturingCSI InteractiveTrainingFaculty:MahirElder,BryanT.Fisher,VishalKapur

TRAINING:INTERVENTIONALIMAGINGPAVILION#5-FUSIONIMAGINGFORPARAVALVULARLEAK

Page 146: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:146

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

8:00AM-9:30AM

FusionImagingforParavalvularLeak

InteractiveTrainingFaculty:SameerGafoor,ChadKliger,PritiMehla,RahulSharma,GaganDSingh,TorstenP.Vahl,AlanVainrib

TRAINING:TAVRPAVILION#5-WHATMATTERSMOSTFORASPATIENTS

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

WhatMattersMostforASPatients

InteractiveTrainingFaculty:PhilippePibarot,MichaelJ.Rinaldi,VinodH.Thourani,NeilJ.Weissman

TRAINING:ABBOTTPAVILION#7-NOWTHATISEEIT,IKNOWHOWTOTREATIT!AHANDS-ONSKILLSLAB

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

NowThatISeeIt,IKnowHowtoTreatIt!AHands-onSkillsLab

InteractiveTrainingFaculty:ZiadA.Ali,HiramG.Bezerra,JonathanM.Hill,VamsiKrishsna,EvanShlofmitz,GabrielTensolRodriguesPereira,ArmandoVergara-Martel

10:00_AM OCT:NowthatIseeIt..Presentation

TRAINING:BOSTONSCIENTIFICPAVILION#7-LAA:WATCHMAN

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

LAA:Watchman

InteractiveTrainingFaculty:MeganCoylewright,ShephalDoshi,GeorgeS.Hanzel

10:00_AM LatestWatchmanClinicalDataandProceduralTipsandTricks

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#6-CORONARYCALCIUMSOLUTIONS

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-10:45AM

RapidFireCasePresentations

10:00_AM WhenandHowtoUseCoronaryAtherectomyandtheImportanceofStentUnderexpansioninAdditiontoDeviceDelivery InteractiveTrainingFaculty:RajeevNarayan

10:10_AM TheUseofImagingtoAssistWithCalciumManagement InteractiveTrainingFaculty:BinitaShah

10:20_AM TipsandTrickstoGuideandextensionManagement InteractiveTrainingFaculty:MarkC.Bieniarz

Page 147: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:147

10:30_AM CalciumComplicationsandBailoutSituations InteractiveTrainingFaculty:BrianPO'Neill

10:45AM-11:30AM

Hands-onRotationsBetweenBostonScientific,CSI,Abiomed

10:45_AM AbiomedFeaturedDevices:ImpellaFamilyofDevices InteractiveTrainingFaculty:ThomGDahle,JustinLevisay

TRAINING:ENDOVASCULARPAVILION#6-SFAINTERVENTION,COMPLEXLESIONS,DEBULKING,ANDDEFINITIVETHERAPY

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

SFAIntervention:De-bulking,ComplexLesions,andDefinitiveTherapySessionII

InteractiveTrainingFaculty:GeorgeLAdams,MohammadMehdiAnsari,EhrinJ.Armstrong,SubhashBanerjee,EricJ.Dippel,PeterMFarrugia,DmitriyN.Feldman,Bryan

T.Fisher,BeauHawkins,EthanCKorngold,CarlosI.Mena-Hurtado

10:00_AM VideoIntroduction:IntroducingUnmetNeedsDefinitiveTreatmentOptionsDebulkingandComplexLesions

10:10_AM Rotation1:DefinitiveTreatmentOptionsFeaturingAbbott InteractiveTrainingFaculty:MohammadMehdiAnsari,PeterMFarrugia,EthanCKorngold

10:30_AM Rotation2:DefinitiveTreatmentOptionsandDebulkingFeaturingBSC InteractiveTrainingFaculty:EhrinJ.Armstrong,BryanT.Fisher,SteveHenao

10:50_AM Rotation3:DefinitiveTreatmentOptionsDebulkingandComplexLesionsFeaturingMedtronic InteractiveTrainingFaculty:SubhashBanerjee,EricJ.Dippel,DmitriyN.Feldman

11:10_AM Rotation4:DebulkingFeaturingCSI InteractiveTrainingFaculty:GeorgeLAdams,BeauHawkins,CarlosI.Mena-Hurtado

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#6-CARDIOGENICSHOCK(NCSI)

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

CardiogenicShock:TheNationalCardiogenicShockInitiative

10:00_AM NCSI:ImprovingOutcomesinCardiogenicShock InteractiveTrainingFaculty:WilliamW.O'Neill

10:30_AM ICUManagement:PositioningTroubleshootingEscalation InteractiveTrainingFaculty:SalvatoreFMannino

11:00_AM TreatingtheShockPatient:ChoosingtheOptimalSupportDevice InteractiveTrainingFaculty:NavinK.Kapur

TRAINING:INTERVENTIONALIMAGINGPAVILION#6-FUSIONIMAGINGFORPARAVALVULARLEAK

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

10:00AM-11:30AM

FusionImagingforParavalvularLeak

InteractiveTrainingFaculty:OmarK.Khalique,ChadKliger,PritiMehla,RahulSharma,GaganDSingh,AlanVainrib

TRAINING:MEDTRONICPAVILION#6-STRUCTURALHEART:TAVRINBICUSPIDAORTICVALVETRAININGWORKSHOP

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

Page 148: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:148

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

StructuralHeart:TAVRinBicuspidAorticValveTrainingWorkshop

InteractiveTrainingFaculty:BaselRamlawi

10:00_AM Introduction

10:05_AM OverviewofBicuspidAorticValveDiseaseState

10:25_AM IdentificationandClassificationofBicuspidAorticValves

10:45_AM SizingmethodologycontroversiesandProceduralConsiderationsforPerformingTAVRinBicuspid

TRAINING:TAVRPAVILION#6-HOWTOAPPROACHAORTICANDMITRALVALVE-IN-VALVE

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

HowtoApproachAorticandMitralValve-in-Valve

InteractiveTrainingFaculty:VasilisBabaliaros,AdamB.Greenbaum,MayraGuerrero,PaulD.Mahoney

TRAINING:ABBOTTPAVILION#8-PFOCLOSURE:RECENTDATA,TECHNIQUES,ANDBESTPRACTICESFORMANAGINGPATIENTS

SUNDAY,SEPTEMBER23,2018

12:00PM-1:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

PFOClosure:RecentData,Techniques,andBestPracticesforManagingPatients

InteractiveTrainingFaculty:ZahidAmin,PatrickA.Calvert,JohnM.Lasala,IgalMoarof,RodrigoNieckeldaCosta,JensErikNielsen-Kudsk

12:00_PM Introduction

12:05_PM PFOClosure:RecentDataTechniquesandBestPracticesforManagingPatients

TRAINING:BOSTONSCIENTIFICPAVILION#8-LAA:WATCHMAN

SUNDAY,SEPTEMBER23,2018

12:00PM-1:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

LAA:Watchman

InteractiveTrainingFaculty:StevenL.Almany,ShephalDoshi,SaibalKar

12:00_PM LatestWatchmanClinicalDataandProceduralTipsandTricks

TRAINING:MEDTRONICPAVILION#7-STRUCTURALHEART:AORTICVIVTRAININGWORKSHOP

SUNDAY,SEPTEMBER23,2018

12:00PM-1:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

StructuralHeart:AorticViVTrainingWorkshop

Page 149: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:149

InteractiveTrainingFaculty:BaselRamlawi

12:00_PM Introduction

12:05_PM InteractiveCasePresentationViVinStentedSurgicalValves

12:35_PM Wetlab:SurgicalValveImplantConsiderations

1:10_PM DeviceRecaptureMitigationofCoronaryOcclusionand

TRAINING:ABBOTTPAVILION#9-MITRACLIPNTR&XTR:DEVICE&PROCEDURALTECHNIQUES

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

MitraClipNTR&XTR:Device&ProceduralTechniques

InteractiveTrainingFaculty:GoravAilawadi,AnitaAsgar,WayneB.Batchelor,BassemChehab,PaoloDenti,RodrigoEstevez-Loureiro,GeorgeGellert,JamesB.HermillerJr,

PaulD.Mahoney,MoodyMMakar,AhmedIMustafa,VivekRajagopal,MichaelJ.Rinaldi,DavidG.Rizik,JoshuaRovin,GaganDSingh,MaurizioTaramasso

2:00_PM Introduction

2:05_PM DidacticDeviceOverview

2:25_PM HandsOnDeviceDeployment

TRAINING:BOSTONSCIENTIFICPAVILION#9-INNOVATIONSINTAVR:LOTUSEDGE,ACURATENEO2,ANDSENTINELCEREBRALPROTECTIONSYSTEM

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

InnovationsinTAVR:LOTUSEdge,ACURATEneo2,andSentinelCerebralProtectionSystem

InteractiveTrainingFaculty:AlexandreAbizaid,VijayIyer,SaibKhogali

2:00_PM IntroductiontoLOTUSEdge:TechnologyandCaseReviews

2:15_PM QA

2:20_PM IntroductiontoACURATEneo2:TechnologyandCaseReviews

2:35_PM QA

2:40_PM IntroductiontoSentinelEmbolicProtectionDevice

2:50_PM QA

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#7-TEACHINGOLDDOGSNEWTRICKS

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-2:45PM

RapidFireCasePresentations

2:00_PM RadialTipsandTricks InteractiveTrainingFaculty:KinturSanghvi

2:10_PM CrossingandDeliveryIssues InteractiveTrainingFaculty:DimitriosBliagos

2:20_PM TroubleshootingCommonProblemsinComplexPCI:WhentheGuideWontEngageWhentheLesionorBranchCantBeWiredOpenVesselWhenthe

BalloonWontCrossWhentheStentDoesntExpandNonCoaxialandCoAxialAnchoring

Page 150: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:150

InteractiveTrainingFaculty:AnnapoornaKini2:32_PM ComplicationsManagement

InteractiveTrainingFaculty:MohanNair

2:45PM-3:30PM

Hands-onRotationsBetweenBostonScientific,Medtronic,andTBD

2:45_PM MedtronicInc.FeaturedDevice:RadialGuidesOnyxSimulatorandVideosforloops InteractiveTrainingFaculty:AzeemLatib,DuaneS.Pinto

TRAINING:ENDOVASCULARPAVILION#7-SFAINTERVENTION,COMPLEXLESIONS,DEBULKING,ANDDEFINITIVETHERAPY

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

SFAIntervention:De-bulking,ComplexLesions,andDefinitiveTherapySessionIII

InteractiveTrainingFaculty:SamerAbbas,GeorgeLAdams,MohammadMehdiAnsari,EhrinJ.Armstrong,AnvarBabaev,EricJ.Dippel,PeterMFarrugia,EthanCKorngold,

S.JayMathews,MitulPatel,MehdiH.Shishehbor,MitchellWeinberg

2:00_PM VideoIntroduction:IntroducingUnmetNeedsDefinitiveTreatmentOptionsDebulkingandComplexLesions

2:10_PM Rotation1:DefinitiveTreatmentOptionsFeaturingAbbott InteractiveTrainingFaculty:PeterMFarrugia,EthanCKorngold,MehdiH.Shishehbor

2:30_PM Rotation2:DefinitiveTreatmentOptionsandDebulkingFeaturingBSC InteractiveTrainingFaculty:MohammadMehdiAnsari,AnvarBabaev,S.JayMathews

2:50_PM Rotation3:DefinitiveTreatmentOptionsDebulkingandComplexLesionsFeaturingMedtronic InteractiveTrainingFaculty:SamerAbbas,MitulPatel,MitchellWeinberg

3:10_PM Rotation4:DefinitiveTreatmentOptionsandComplexLesionsFeaturingCook InteractiveTrainingFaculty:GeorgeLAdams,EhrinJ.Armstrong,EricJ.Dippel

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#7-HEMODYNAMICSOFSHOCKANDHIGHRISKPCI

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

IntroductiontoTEACH:TrainingandEducationinAdvancedCardiovascularHemodynamics

2:00_PM TrainingandEducationinAdvancedCardiovascularHemodynamics:TEACHIntro InteractiveTrainingFaculty:DanielBurkhoff

2:20_PM SimulatedcasesonHRPCIHandsOn InteractiveTrainingFaculty:DanielBurkhoff,JohnM.Lasala

3:00_PM SimulatedCasesonAMICGSHandsOn InteractiveTrainingFaculty:PerwaizM.Meraj

TRAINING:INTERVENTIONALIMAGINGPAVILION#7-ADVANCEDIMAGINGFORVALVE-IN-VALVE

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

2:00PM-3:30PM

AdvancedImagingforValve-in-Valve

InteractiveTrainingFaculty:OmarK.Khalique,ChadKliger,RahulSharma,TorstenP.Vahl

TRAINING:MEDTRONICPAVILION#8-STRUCTURALHEART:CONFRONTINGTHEPATIENTWITHCORONARYARTERYDISEASEANDAORTICSTENOSIS

Page 151: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:151

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

StructuralHeart:ConfrontingthePatientWithCoronaryArteryDiseaseandAorticStenosis

InteractiveTrainingFaculty:HaroldL.Dauerman

2:00_PM IntroductionWelcomeRemarks

2:05_PM AppropriatetreatmentpathwayforpatientspresentingwithbothCADandAS

2:05_PM CasebaseDiscussion

2:05_PM InitialTreatmentDecisionsandConsiderations

TRAINING:TAVRPAVILION#7-UNDERSTANDINGTHVHEMODYNAMICSANDDURABILITY

SUNDAY,SEPTEMBER23,2018

2:00PM-3:30PM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

UnderstandingTHVHemodynamicsandDurability

InteractiveTrainingFaculty:PamelaS.Douglas,DannyDvir,RebeccaT.Hahn,PhilippePibarot,VinodH.Thourani

TRAINING:ABBOTTPAVILION#10-GUIDEWIREDESIGNANDSELECTION:AHANDS-ONUSER'SGUIDETOGUIDEWIRETECHNOLOGY

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

GuidewireDesignandSelection:AHands-onUser'sGuidetoGuideWireTechnology

InteractiveTrainingFaculty:DavidDaniels,JackHall,AmirKaki,WilliamNicholson,RobertF.Riley

4:00_PM Introduction

4:05_PM DidacticonGuidewireBuildingBlocksandWHwires

4:15_PM HandsonWorkhorseWiresActivity

4:30_PM PolymerJacketedWiresOverviewandHandsonActivity

4:50_PM ExtraSupportSpecialtywiresOverviewandHandsonActivity

5:10_PM WigglewireOverviewandHandsonActivity

TRAINING:BOSTONSCIENTIFICPAVILION#10-INNOVATIONSINTAVR:LOTUSEDGE,ACURATENEO2,ANDSENTINELCEREBRALPROTECTION

SYSTEM

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

InnovationsinTAVR:LOTUSEdge,ACURATEneo2,andSentinelCerebralProtectionSystem

InteractiveTrainingFaculty:AlexandreAbizaid,DanielJ.Blackman,VijayIyer

4:00_PM IntroductiontoLOTUSEdge:TechnologyandCaseReviews

4:15_PM QA

Page 152: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:152

4:20_PM IntroductiontoACURATEneo2:TechnologyandCaseReviews

4:35_PM QA

4:40_PM IntroductiontoSentinelEmbolicProtectionDevice

4:50_PM QA

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#8-TEACHINGOLDDOGSNEWTRICKS

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-4:45PM

RapidFireCasePresentations

4:00_PM RadialTipsandTricks InteractiveTrainingFaculty:WilliamARollefson

4:10_PM CrossingandDeliveryIssues InteractiveTrainingFaculty:AshishPershad

4:20_PM TroubleshootingCommonProblemsinComplexPCI:WhentheGuideWontEngageWhentheLesionorBranchCantBeWiredOpenVesselWhenthe

BalloonWontCrossWhentheStentDoesntExpandNonCoaxialandCoAxialAnchoring InteractiveTrainingFaculty:PravinKGoel

4:32_PM ComplicationsManagement InteractiveTrainingFaculty:JunjieZhang

4:45PM-5:30PM

Hands-onRotationsBetweenBostonScientificCorporation,MedtronicInc.,andTDB

4:45_PM MedtronicInc.FeaturedDevice:RadialGuidesOnyxSimulatorandVideosforloops InteractiveTrainingFaculty:FaustoFeres,DuaneS.Pinto,JunjieZhang

TRAINING:ENDOVASCULARPAVILION#8-SFAINTERVENTION,COMPLEXLESIONS,DEBULKING,ANDDEFINITIVETHERAPY

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

SFAIntervention:De-bulking,ComplexLesions,andDefinitiveTherapySessionIV

InteractiveTrainingFaculty:SamerAbbas,MohammadMehdiAnsari,AnvarBabaev,GeorgeSChrysant,LawrenceA.Garcia,S.JayMathews,CarlosI.Mena-Hurtado,Mitul

Patel,MehdiH.Shishehbor,MitchellWeinberg,RamzanZakir

4:00_PM VideoIntroduction:IntroducingUnmetNeedsDefinitiveTreatmentOptionsDebulkingandComplexLesions

4:10_PM Rotation1:DefinitiveTreatmentOptionsFeaturingAbbott InteractiveTrainingFaculty:MohammadMehdiAnsari,MehdiH.Shishehbor,RamzanZakir

4:30_PM Rotation2:DefinitiveTreatmentOptionsandDebulkingFeaturingBSC InteractiveTrainingFaculty:GeorgeSChrysant,S.JayMathews

4:50_PM Rotation3:DefinitiveTreatmentOptionsDebulkingandComplexLesionsFeaturingMedtronic InteractiveTrainingFaculty:SamerAbbas,AnvarBabaev,MitchellWeinberg

5:10_PM Rotation4:DefinitiveTreatmentOptionsandComplexLesionsFeaturingCook InteractiveTrainingFaculty:LawrenceA.Garcia,CarlosI.Mena-Hurtado,VirendraIPatel

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#8-COMPLEXPROTECTEDPCI

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

Page 153: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:153

ComplexProtectedPCI

4:00_PM ComplexProtectedPCI:PatientIdentification InteractiveTrainingFaculty:HiramG.Bezerra

4:20_PM SimulatedCasesonHRPCISimulationHandsOn InteractiveTrainingFaculty:MauricioG.Cohen,DuaneS.Pinto

4:55_PM InsertionRepositioningHandsOn InteractiveTrainingFaculty:PaulD.Mahoney,AdhirShroff

TRAINING:INTERVENTIONALIMAGINGPAVILION#8-ADVANCEDIMAGINGFORVALVE-IN-VALVE

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

4:00PM-5:30PM

AdvancedImagingforValve-in-Valve

InteractiveTrainingFaculty:OmarK.Khalique,ChadKliger,RahulSharma,TorstenP.Vahl

TRAINING:MEDTRONICPAVILION#9-EV:IDENTIFYINGSUPERFICIALVENOUSDISEASEANDTREATMENTOPTIONS

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

EV:IdentifyingSuperficialVenousDiseaseandTreatmentOptions

InteractiveTrainingFaculty:RobertEFoster,JonC.George,MajaZaric

4:00_PM Introduction

4:05_PM DidacticPresentation:UnderstandingVenousDiseaseTreatmentOptionsforYourPatient

TRAINING:TAVRPAVILION#8-ADVANCINGEFFICIENCYINTAVR

SUNDAY,SEPTEMBER23,2018

4:00PM-5:30PM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

AdvancingEfficiencyinTAVR

InteractiveTrainingFaculty:AnitaAsgar,DavidJ.Cohen,JamesL.Velianou,DavidA.Wood

INTERNATIONALSESSION:APOTPOURRIOFHIGH-RISKANDCOMPLEXCASESOFCORONARY,PERIPHERAL,ANDSTRUCTURALHEARTDISEASE

INTERVENTION,PRESENTEDBYTSCI(TAIWANSOCIETYOFCARDIOVASCULARINTERVENTIONS),ISIC(INDONESIANSOCIETYOFINTERVENTIONAL

CARDIOLOGY),CIAT(CARDIOVASCULARINTERVENTIONASSOCIATIONOFTHAILAND),CVIT(JAPANESEASSOCIATIONOFCARDIOVASCULAR

INTERVENTIONANDTHERAPEUTICS)

SUNDAY,SEPTEMBER23,2018

8:30AM-10:00AM

Room27A-B,UpperLevel

8:30AM-9:11AM

SessionI.High-RiskandComplexInterventionPart1

Moderators:PaulHsien-LiKao,WasanUdayachalerm

Discussants:WacinBuddhari,Chi-JenChang,TakaharuNakayoshi,SodiqurRifqi,YoshitoYamamoto

8:30_AM IntroductionandSessionIGoals Lecturers:PaulHsien-LiKao

Page 154: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:154

8:31_AM ThailandPresents:ANightmareinCTOInterventionChasingtheRemnant CasePresenter:NattawutWongpraparut

8:39_AM IndonesiaPresents:PCIandTAVIinaHighRiskPatientWithACSCausedbyDiffuseLeftCoronaryArteryFullMetalJacketInStentStenosisWithSevere

AorticStenosis CasePresenter:TeguhSantoso

8:47_AM JapanPresents:EndovascularEntryClosureofAorticDissectionWithanAmplatzerVascularPlug2 CasePresenter:YosukeHata

8:55_AM TaiwanPresents:TaiwanTAVRRegistry Lecturers:Wei-HsianYin

9:03_AM RoundtableDiscussionWithAudienceQA

9:09_AM SessionIConclusionsandTakehomeMessages Lecturers:WasanUdayachalerm

9:11AM-10:00AM

SessionII.High-RiskandComplexInterventionPart2

Moderators:YutakaHikichi,TeguhSantoso

Discussants:Hsuan-LiHuang,WirashKehasukcharoen,Wen-LiengLee,SamuelSudanawidjaja,DamrasTresukosol

9:11_AM IntroductionandSessionIIGoals Lecturers:YutakaHikichi

9:12_AM TaiwanPresents:EndovascularRevascularizationofChronicCarotidArteryOcclusion CasePresenter:Ying-HsienChen

9:20_AM ThailandPresents:PercutaneousClosureofaHighFlowAcquiredRenalAVFistulaUsingAVP2inaPatientWithHeartFailureandPulmonary

Hypertension CasePresenter:KrissadaMeemook

9:28_AM JapanPresents:BRAVOTechniqueCompleteRevascularizationforHeavilyCalcifiedCommonFemoralArteryOcclusionWithoutSurgicalEndaterectomy CasePresenter:YoshitoYamamoto

9:36_AM IndonesiaPresents:APatientWithTotalOcclusionofBothSubclavianArteriesBothIliacArteriestheAbdominalAortaandLeftMainHowtoTreat CasePresenter:LindaLison

9:44_AM TaiwanPresents:ConquerALIExhaustAlltheWeaponsinTaiwan CasePresenter:Chung-HoHsu

9:52_AM RoundtableDiscussionWithAudienceQA

9:58_AM SessionIIConclusionsandTakehomeMessages Lecturers:TeguhSantoso

INTERNATIONALSESSION:TREATMENTDILEMMASINACUTECORONARYSYNDROMESPRESENTEDBYCARDIOLOGYSOCIETYOFSERBIAWORKING

GROUPONINTERVENTIONALCARDIOLOGY,FYRMACEDONIANSOCIETYOFCARDIOLOGY,HELLENICSOCIETYWORKINGGROUPONINTERVENTIONAL

CARDIOLOGY,CYPRUSSOCIETYOFCARDIOLOGYANDSLOVENIANWORKINGGROUPFORINTERVENTIONALCARDIOLOGY

SUNDAY,SEPTEMBER23,2018

9:00AM-10:30AM

Room24C,UpperLevel

9:00AM-10:30AM

TreatmentDilemmasinAcuteCoronarySyndromes

Moderators:MihaCercek,MichalisHamilos,MilanA.Nedeljkovic,EmmanouilISkalidis

Discussants:ChristosChristou,SaskoKedev,KonstantinosToutouzas

9:00_AM SloveniaPresents:LiteratureReviewandaCase:ACSinaPatientWithLargeThromboticBurden Lecturers:MihaCercek

9:13_AM RoundtableDiscussionWithAudienceQA

9:18_AM FYROMacedoniaPresents:LiteratureReviewandaCase:TransradialAccessforComplexLeftMainPCI Lecturers:SaskoKedev

9:31_AM RoundtableDiscussionWithAudienceQA

9:36_AM GreecePresents:LiteratureReviewandaCase:PCIforSpontaneousCoronaryArteryDissection Lecturers:MichalisHamilos

9:49_AM RoundtableDiscussionWithAudienceQA

9:54_AM CyprusPresents:LiteratureReviewandaCase:ComplexTransradialPrimaryPCIofanAneurysmalTortuousRightCoronaryArteryFilledWithThrombus Lecturers:ChristosChristou

10:07_AM RoundtableDiscussionWithAudienceQA

10:12_AM SerbiaPresents:LiteratureReviewandaCase:ToStentorNottoStentinaPatientWithECGChangesSuggestiveofIschemia

Page 155: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:155

Lecturers:MilanA.Nedeljkovic10:25_AM RoundtableDiscussionWithAudienceQA

INTERNATIONALSESSION:COMPLEXHIGH-RISKINDICATEDPATIENTS(CHIPPCI)PRESENTEDBYTHEBRITISHCARDIOVASCULARINTERVENTION

SOCIETY,RUSSIANSCIENTIFICSOCIETYOFENDOVASCULARTHERAPIES,SCOTTISHCARDIACSOCIETY,ANDTHEIRISHCARDIACSOCIETY

SUNDAY,SEPTEMBER23,2018

10:00AM-11:30AM

Room27A-B,UpperLevel

10:00AM-11:30AM

ComplexHigh-RiskIndicatedPatients(CHIPPCI)

Moderators:MargaretB.McEntegart,JamesNolan

Discussants:BagratAlekyan,RichardAAnderson,VladimirGanyukov,MamasMamas

10:00_AM ImpactofAgingonCHIPPCITechniqueandOutcomes Lecturers:RichardAAnderson

10:08_AM CasePresentation1:TheWisdomofCHIPPCIinaVeryElderlyPatient CasePresenter:KarimRatib

10:14_AM Case1Commentary:TheWisdomofCHIPPCIinaVeryElderlyPatientWhatWouldIHaveDoneWithThisPatient Lecturers:MamasMamas

10:20_AM CHIPPCIOutcomesinUKPractice:InsightFromtheBCISPCIRegistry Lecturers:TimKinnaird

10:28_AM VascularAccessManagementintheCHIPPatient Lecturers:SergeyA.Abugov

10:36_AM CasePresentation2:BenefitsandHazardsofDistalRadialAccessintheCHIPPatient CasePresenter:EvgenyV.Merkulov

10:42_AM Case2Commentary:BenefitsandHazardsofDistalRadialAccessintheCHIPPatientHowIWouldHaveDoneThisCase

10:48_AM ContemporaryAssessmentandManagementofCoronaryCalcium

10:56_AM CasePresentation3:ResistantCalcificLeftMainStemDisease

11:02_AM Case3Commentary:ResistantCalcificLeftMainStemDiseaseWhatDoestheLiteratureTellUs Lecturers:NickCurzen

11:08_AM MechanicalCirculatorySupportforCHIPPCI:IsThereAnyGoodData

11:16_AM CasePresentation4:MechanicalCirculatorySupportinCHIPPCI CasePresenter:AlexeyProtopopov

11:22_AM Case4Commentary:MechanicalCirculatorySupportinCHIPPCI:HowIWouldHaveManagedThisCase CasePresenter:DavidBurke

11:28_AM ConcludingRemarks Lecturers:MargaretB.McEntegart,JamesNolan

INTERNATIONALSESSION:STEMIPOTPOURRIPRESENTEDBYTHECANADIANASSOCIATIONOFINTERVENTIONALCARDIOLOGY;KOREANSOCIETYOF

INTERVENTIONALCARDIOLOGY;SWISSWORKINGGROUPINTERVENTIONALCARDIOLOGYANDACUTECORONARYSYNDROME;VIETNAMNATIONAL

HEARTASSOCIATION

SUNDAY,SEPTEMBER23,2018

10:30AM-12:00PM

Room24C,UpperLevel

10:30AM-12:00PM

STEMIPotpourriPresentedbyTheCanadianAssociationofInterventionalCardiology;KoreanSocietyofInterventionalCardiology;SwissWorkingGroupInterventional

CardiologyandAcuteCoronarySyndrome;VietnamNationalHeartAssociation

Moderators:AkshayBagai,StephenCook

Discussants:WarrenJ.Cantor,StephaneNoble,HungManhPham

10:30_AM CasePresentationFromCanada:FalseActivationandAlternativeDiagnoses CasePresenter:WarrenJ.Cantor

10:40_AM RoundtableDiscussionWithAudienceQA

10:45_AM CasePresentationFromSwitzerland:STEMIPostTAVI CasePresenter:StephaneNoble

Page 156: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:156

10:55_AM RoundtableDiscussionWithAudienceQA

11:00_AM CasePresentationFromS.Korea:CompleteVs.IRAonlyPCIAmongSTEMIPatientsWithMVD

11:10_AM RoundtableDiscussionWithAudienceQA

11:15_AM CasePresentationFromVietnam:PharmacoinvasiveStrategyIntheDevelopingWorld CasePresenter:QuangNgocNguyen

11:25_AM RoundtableDiscussionWithAudienceQA

11:30_AM UnsettledIssuesinSTEMIIntervention:TheGrandDiscussion Lecturers:AkshayBagai,StephenCook

INTERNATIONALSESSION:EXPLORINGTHEUNKNOWNOFINTERVENTIONALCARDIOLOGY�PCIANDSTRUCTURALINTERVENTIONSPRESENTEDBYTHEPORTUGUESEASSOCIATIONOFINTERVENTIONALCARDIOLOGY(APIC),SOCIEDADEBRASILEIRADEHEMODINâMICAECARDIOLOGíA

INTERVENCIONISTA(SBHCI),PHILIPPINEHEARTASSOCIATION,ANDTHESINGAPORECARDIACSOCIETY

SUNDAY,SEPTEMBER23,2018

1:30PM-3:30PM

Room24C,UpperLevel

1:30PM-3:30PM

ExploringtheUnknownofInterventionalCardiology:PCIandStructuralInterventions

Moderators:JoshuaP.Loh,JoãoASilveira

Discussants:AndresJrNBaysa,AlexandreSchaanQuadros

1:30_PM WelcomeandSessionObjectives Lecturers:JoãoASilveira

1:34_PM Case1:PercutaneousClosureofAnythingWithSomethingTheOffLabelUseofDevices.MitralLeakPostMIVSDAscendingAortaPseudoaneurysmLV

Pseudoaneurysm CasePresenter:AntonioFiarresga

1:44_PM RoundtableDiscussionWithAudienceQA

1:48_PM Case2:MultipleLongtermTAVIFailures:AUniqueCaseTreatedWithThreeDifferentDevices CasePresenter:RicardoA.Costa

1:58_PM RoundtableDiscussionWithAudienceQA

2:02_PM Case3:AnImprovisedFenestratedASDOccluderinSeverePulmonaryHypertension CasePresenter:RichardNicandroRTorres

2:12_PM RoundtableDiscussionWithAudienceQA

2:16_PM Case4:OCTFindingsandManagementofaDislodgedMagnesiumBasedBioresorbableScaffold Lecturers:CheeYangChin

2:26_PM RoundtableDiscussionWithAudienceQA

2:30_PM Case5:StentFailure:ISRHowtoTreat CasePresenter:PedrodeAraujoGoncalves

2:40_PM RoundtableDiscussionWithAudienceQA

2:44_PM Case6:ProvisionalReverseStentinginanOstialCircumflexLesion CasePresenter:AlexandreSchaanQuadros

2:54_PM RoundtableDiscussionWithAudienceQA

2:58_PM Case7:WhenCalciumHitsYouinTheFaceRotaSTEMIandOPNBalloonat4AM CasePresenter:FahimHaiderJafary

3:08_PM RoundtableDiscussionWithAudienceQA

3:12_PM Case8:AComplicatedEVAR CasePresenter:JohnSTan

3:22_PM RoundtableDiscussionWithAudienceQA

3:26_PM ClosingRemarks Lecturers:JoshuaP.Loh

INTERNATIONALSESSION:CARDIACINTERVENTIONSINTHESETTINGOFACUTEMYOCARDIALINFARCTION,ORGANIZEDBYTHESPANISHWORKING

GROUPONINTERVENTIONALCARDIOLOGY,TURKISHWORKINGGROUPOFINTERVENTIONALCARDIOLOGY,DUTCHWORKINGGROUP

INTERVENTIONALCARDIOLOGY,ANDTHECARDIACSOCIETYOFAUSTRALIAANDNEWZEALAND

Page 157: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:157

SUNDAY,SEPTEMBER23,2018

3:30PM-5:00PM

Room24C,UpperLevel

3:30PM-5:00PM

CardiacInterventionsintheSettingofAcuteMyocardialInfarction

Moderators:EnverAtalar,DavidW.M.Muller,ArmandoPerezdePrado,NielsvanRoyen

Discussants:NezihiBaris,RikHermanides,RaulMoreno,MarkW.I.Webster

3:30_PM Introduction Lecturers:ArmandoPerezdePrado

3:35_PM SpainPresents:HemodynamicSupportinaKillipIVClassPatientWithAcuteMyocardialInfarction CasePresenter:AnaBelenCidAlvarez

3:47_PM SpainDiscusses:HowWouldIApproachThisPatientandCardiogenicShockinGeneral Lecturers:RaulMoreno

3:54_PM TurkeyPresents:APatientWithCoronaryThrombusUndergoingPrimaryPCIforSTEMIIsStentingAlwaysaSolution CasePresenter:CemBarcin

4:06_PM TurkeyDiscusses:HowWouldIApproachThisPatientandCoronaryThrombusinGeneral Lecturers:NezihiBaris

4:13_PM TheNetherlandsPresents:TwoStepStentApproachtoCoronaryDissectionandVesselWallHematoma CasePresenter:RikHermanides

4:25_PM TheNetherlandsDiscusses:HowWouldIApproachThisPatientandMultivesselDiseaseinSTEMIinGeneral Lecturers:NielsvanRoyen

4:32_PM AustraliaPresents:APatientWithSpontaneousCoronaryArteryDissectionToTreatorNot CasePresenter:ScottHarding

4:44_PM AustraliaDiscusses:HowWouldIApproachThisPatientandSCADinGeneral Lecturers:MarkW.I.Webster

4:51_PM TakehomeMessages Lecturers:DavidW.M.Muller

INTERNATIONALSESSION:OCTGUIDANCEINLEFTMAINBIFURCATIONS,PRESENTEDBYTHENORDIC-BALTIC-BRITISHSTUDYGROUPFOR

INTERVENTIONALCARDIOLOGY

SUNDAY,SEPTEMBER23,2018

3:30PM-5:30PM

Room27A-B,UpperLevel

3:30PM-4:00PM

SessionI.�Simple�LeftMainBifurcationTreatmentGuidedbyOCT

Discussants:AndrejsErglis,NielsR.Holm

3:30_PM StructuredOCTGuidanceforLeftMainBifurcationStenting Lecturers:NielsR.Holm

3:40_PM Case1:OCTinSimpleLeftMainBifurcationStenting CasePresenter:IndulisKumsars

3:50_PM Case2:OCTGuidedProvisionalLeftMainStentingShouldIStentThisCircumflex CasePresenter:JohanRBennett

4:00PM-4:30PM

SessionII.OCTFindingsDuringComplexLeftMainBifurcationStenting

Moderators:EvaldH.Christiansen

Discussants:AndrejsErglis,NielsR.Holm

4:00_PM OCTintheLeftMainCoronaryArteryPracticalTipsandTricks Lecturers:FrancescoBurzotta

4:10_PM Case3:OCTasCosupervisorfortheYoungInterventionalistUndertakingLeftMainBifurcationStenting CasePresenter:KarlisGrikis

4:20_PM Case4:ComplexLeftMainStentingRequiresInvasiveImagingEveninExperiencedHands

4:30PM-5:00PM

SessionIII.OCT-GuidedTwo-StentTreatmentinLeftMainBifurcationLesions

Page 158: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:158

Discussants:AndrejsErglis,NielsR.Holm

4:30_PM OCTGuidedDKCrush:PracticalAspects Lecturers:LeneNAndreasen

4:40_PM Case5:OCTforDKCrushTheCriticalSteps

4:50_PM Case6:OCTforCulotteTheCriticalPoints CasePresenter:PaulKnaapen

5:00PM-5:30PM

SessionVI.OCT-GuidedPlaquePreparationinDistalLeftMainBifurcationStenting

Moderators:EvaldH.Christiansen

Discussants:AndrejsErglis,NielsR.Holm

5:00_PM OCTGuidedPlaquePreparationforCalcifiedDistalLeftMainLesions Lecturers:EvaldH.Christiansen

5:07_PM Case7:SeverelyCalcifiedDistalLeftMainBifurcationLesion CasePresenter:OlliA.Kajander

5:17_PM Case8:DiffuseDiseaseinDistalBranchesStentLengthbyAngiographyorOCT CasePresenter:StuartWatkins

5:27_PM SummaryandTakehomeMessages

INTERNATIONALSESSION:TCTINTERNATIONALFELLOWSSESSION

SUNDAY,SEPTEMBER23,2018

4:30PM-6:05PM

Room33B-C,UpperLevel

4:30PM-5:03PM

SessionI.TopThreeInternationalFellowsCases

Moderators:OriBen-Yehuda,MohamedAhmedSobhy

Discussants:MirvatAlasnag,CarlosCabreraArroyo,RabindraNathChakraborty,AfzalurRahman,WojtekWojakowski,PedrodeAraujoGoncalves

4:30_PM IntroductionofTop3Selectedwinners Lecturers:OriBen-Yehuda

4:35_PM FirstPlaceWinnerCaseTitle:CoronaryCompressionExclusionWithIntravascularUltrasoundDuringPercutaneousPulmonaryValveImplantation

SubsequentlyComplicatedByHomograftRupture CasePresenter:KarolZbronski

4:42_PM SecondPlaceWinnerCaseTitle:UtilityOfTheHybridApproachTreatingHighlySymptomaticPatientWithMultipleFailedPriorBypassSurgeriesAnd

Interventions CasePresenter:PeterTajti

4:49_PM ThirdPlaceWinnerCaseTitle:ThePointOfNoTurningBack CasePresenter:HeshamBahaaeldin

4:56_PM RoundtableDiscussionwithAudienceQA Moderators:OriBen-Yehuda

5:03PM-5:45PM

SessionII.FellowsGotTalent�CaseCompetition!

Moderators:WojtekWojakowski

Discussants:MirvatAlasnag,OriBen-Yehuda,CarlosCabreraArroyo,RabindraNathChakraborty,MohamedAhmedSobhy,PedrodeAraujoGoncalves

5:03_PM Case1A:LeftMainStemLMSPercutaneousCoronaryInterventionPCIWithHighSpeedRotationalAtherectomyHSRAPriorToTranscatheterAortic

ValveReplacementTAVR CasePresenter:NovaliaSidik

5:10_PM Case2B:ACalcifiedLadCoronaryPerforation CasePresenter:MesferAlfadhel

5:17_PM Case3C:LiverOrLetDie CasePresenter:MichaelMichail

5:24_PM Case4D:TreatmentOfCalcificCoronaryArteriesInTheSettingOfAcuteCoronarySyndromeInAnElderlyFrailPersonWithPoorPeripheralArterial

Access CasePresenter:MuhammadZia-Ul-Haq

5:31_PM VotingCommencesWinnerAnnouncedTCTPollAppPleasevoteonthecaseyoufoundmostchallenging.Options:ABCorD PollModerators:WojtekWojakowski

5:38_PM RoundtableDiscussionwithAudienceQA

Page 159: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:159

Moderators:WojtekWojakowski

5:45PM-6:05PM

SessionIII.MyMostChallengingCase-FellowsCommittee

Moderators:MirvatAlasnag,RabindraNathChakraborty

Discussants:OriBen-Yehuda,CarlosCabreraArroyo,AfzalurRahman,MohamedAhmedSobhy,WojtekWojakowski,PedrodeAraujoGoncalves

5:45_PM TAVIValveInValvePatientWithPreviousMitroflwWithBailoutStentingOfTheRCA CasePresenter:PedrodeAraujoGoncalves

5:52_PM ManagementOfAcuteCarotidStentThrombosis CasePresenter:CarlosCabreraArroyo

5:59_PM RoundtableDiscussionwithAudienceQA Moderators:AfzalurRahman

MODERATEDPOSTERSESSION:ASSESSMENTANDIMPACTOFAORTICREGURGITATION

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

8:30AM-9:30AM

AssessmentandImpactofAorticRegurgitation

Moderators:PhilippBlanke,RandolphP.Martin

Discussants:JiriMaly,KonstantinosSpargias

8:30_AM TCT443:QuantitativeAssessmentofAorticRegurgitationin7DifferentTypesofAorticValvesAfterTranscatheterAorticValveImplantationA

MulticenterAnalysisByAnIndependentCoreLabNotSponsoredBytheindustry Lecturers:PatrickW.Serruys

8:37_AM Discussion

8:42_AM TCT444:ComparisonofTransthoracicEchocardiogramWithQuantitativeAssessmentofAorticRegurgitationAfterTAVIWithVideodensitometryina

LargeRealWorldPopulation:SubAnalysisoftheRESPONDRegistry Lecturers:RodrigoModolo

8:49_AM Discussion

8:54_AM TCT445:FeasibilityofAnalysisofANovelQuantitativeMethodtoAssessAorticRegurgitationAfterTAVI:PreliminaryResultsoftheASSESS

REGURGEProtocoledQuantitativeASSESSmentofAorticRegurgitationUsingVideodensitometryinaMulticenterStudy Lecturers:MohamedAbdel-Wahab

9:01_AM Discussion

9:06_AM TCT446:FeasibilityStudyofaSingleSynchronizedDiastolicinjectionWithLowContrastVolumeforAortographyinaProgressiveAorticRegurgitation

PorcineModel Lecturers:RodrigoModolo

9:13_AM Discussion

9:18_AM TCT447:SeverityAssessmentofTranscatheterAorticValveParavalvularRegurgitationBasedontheLeakageMomentumFlux Lecturers:MohammadBarakat

9:25_AM Discussion

MODERATEDPOSTERSESSION:BESTOFMODERATEDTAVRPOSTERABSTRACTSII

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

8:30AM-9:18AM

BestofModeratedTAVRPosterAbstractsII

Moderators:StephenR.Ramee,DavidA.Wood

Discussants:RodrigoBagur,RobertJ.Gil,Jean-MichelParadis,EricVanBelle

8:30_AM TCT433:TheImpactofMultisliceComputedTomographyBasedAorticValveAnnularDimensionsonHemodynamicPerformanceofSelfExpanding

TranscatheterValvesComparedWithindividualSurgicalValveTypes Lecturers:G.MichaelDeeb

8:37_AM Discussion

Page 160: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:160

8:42_AM TCT434:AssessingNationalEstimatesof30ReadmissionRatesandAssociatedCostsWithTranscatheterandSurgicalAorticValveReplacementinthe

UnitedStates Lecturers:KimberlyMoore

8:49_AM Discussion

8:54_AM TCT435:TheOutcomesofBicuspidAorticValvePatientsUndergoingSurgicalvsTranscatheterAorticValveReplacement Lecturers:MohamadSoud

9:01_AM Discussion Lecturers:MarkHensey

9:06_AM TCT436:AldehydesPotentialDriversofValveLeafletThrombosisPostTranscatheterAorticValveReplacement Lecturers:MarkHensey

9:13_AM Discussion

MODERATEDPOSTERSESSION:CATHLABOFTHEFUTURE:TELEMEDICINEANDROBOTICS

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

8:30AM-9:30AM

CathLaboftheFuture:TelemedicineandRobotics

Moderators:GioraWeisz

Discussants:R.StefanKiesz,SaminK.Sharma

8:30_AM TCT438:TelemedicineIncreasestheAccesstoPrimaryPercutaneousCoronaryInterventionSavingCostsandLivesinSTElevationMyocardialInfarction

STEMIThreeYearAnalysisoftheLatinAmericaTelemedicineNetworkLATinPrograminSaoPauloEastZ Lecturers:SameerMehta

8:37_AM Discussion

8:42_AM TCT439:LongTermSavingsWithTelemedicineSTEMINetworks Lecturers:SameerMehta

8:49_AM Discussion

8:54_AM TCT440:RevascularizationOutcomesFinancialImpactandMortalityReductionEffectsofaTelemedicineGuidedStrategyonPopulationBasedAMI

Management Lecturers:SameerMehta

9:01_AM Discussion

9:06_AM TCT441:SOCIMELATin:PartnersforComprehensiveNationwideAMICareinMexico Lecturers:SameerMehta

9:13_AM Discussion

9:18_AM TCT442:RoboticPeripheralVascularInterventionWithDrugCoatedBalloonsIsFeasibleandReducesOperatorRadiationExposureResultsofthe

RoboticAssistedPeripheralInterventionforPeripheralArteryDiseaseRAPIDStudyII Lecturers:LawrenceAng

9:25_AM Discussion

MODERATEDPOSTERSESSION:HEMODYNAMICSUPPORTANDHIGHRISKPCI

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

8:30AM-9:30AM

HemodynamicSupportandHighRiskPCI

Moderators:MarvinJ.Slepian,ChristianM.Spaulding

Discussants:CarloBriguori,IanC.Gilchrist,MichaelA.Kutcher

8:30_AM TCT448:ImpactofClinicalindicationRiskStrataonOutcomesinPatientsSupportedWithImpellaMicroaxialHeartPumps Lecturers:EishaWali

8:37_AM Discussion

8:42_AM TCT449:TrendsinUtilizationandHospitalVariationintheUseofMechanicalCirculatorySupportDevicesinPatientsUndergoingPercutaneousCoronary

InterventioninMichigan:InsightsFromtheBlueCrossBlueShieldofMichiganCardiovascularConsortiu

Page 161: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:161

Lecturers:ThomasEarl8:49_AM Discussion

8:54_AM TCT450:CoronaryandMyocardialHaemodynamicEffectsofImpellaLVUnloadinginPatientsUndergoingHighRiskPercutaneousCoronaryIntervention Lecturers:NataliaBriceno

9:01_AM Discussion

9:06_AM TCT451:IncidenceCorrelatesandImpactofLeftVentricularEjectionFractionImprovementonShortandLongTermClinicalOutcomeofPatients

UndergoingHighRiskPercutaneousCoronaryInterventionaSingleCenterExperience Lecturers:SerdarFarhan

9:13_AM Discussion

9:18_AM TCT452:HemodynamicsandItsPredictorsDuringImpellaProtectedPCIinHighRiskPatientsWithReducedEjectionFraction Lecturers:GiulioRusso

9:25_AM Discussion

MODERATEDPOSTERSESSION:INTRACORONARYPHYSIOLOGYSTUDIESII

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

8:30AM-9:30AM

IntracoronaryPhysiologyStudiesII

Moderators:AmirLerman,NickE.J.West

Discussants:MiodragC.Ostojic,Seung-JungPark,ExpeditoEustáquioRibeiro,ShengxianTu

8:30_AM TCT463:InstabilityofCoronaryFlowVelocityandBasalMicrovascularResistanceDoesNotAffectReproducibilityofIFRPostPCI Lecturers:MuhammadAetesam-Ur-Rahman

8:37_AM Discussion

8:42_AM TCT464:DiagnosticClassificationoftheCoronaryFlowVelocityReserveandHyperemicStenosisResistanceIndexUsingContrastMedia Lecturers:MasafumiNakayama

8:49_AM Discussion

8:54_AM TCT465:DiagnosticAccuracyofMicrocatheterDerivedFractionalFlowReserveSystematicReviewWithLesionLevelAnalysis Lecturers:OzanDemir

9:01_AM Discussion

9:06_AM TCT466:ClinicalUtilityofaNovelMathematicalSolutionforAssessmentofIndividualLesionContributioninSerialCoronaryArteryDisease Lecturers:BhavikModi

9:13_AM Discussion

9:18_AM TCT467:AdenosineFreeIndexesvsFFRforFunctionalEvaluationASystematicMetaAnalysis Lecturers:AntonioMariaLeone

9:25_AM Discussion

MODERATEDPOSTERSESSION:MANAGEMENTOFIN-STENTRESTENOSISII

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

8:30AM-9:30AM

ManagementofIn-stentRestenosisII

Moderators:RamonQuesada,CarlL.Tommaso

Discussants:DanieleGiacoppo,JooMyungLee,YasunoriUeda,BoXu

8:30_AM TCT458:AdditionalDiagnosticValueofCTPerfusionOverCoronaryCTAngiographyinStentedPatientsWithSuspectedInStentRestenosisorCoronary

ArteryDiseaseProgressionADVANTAGEStudyPreliminaryResults Lecturers:DanieleAndreini

8:37_AM Discussion

8:42_AM TCT459:DrugElutingBalloonsvsNewGenerationDrugElutingStentsfortheManagementofInStentRestenosisAnUpdatedMetaAnalysisof

RandomizedStudies

Page 162: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:162

Lecturers:LeiGao8:49_AM Discussion

8:54_AM TCT460:PrognosticValueofIrregularProtrusionandSubsequentNeoatherosclerosisAfterSecondGenerationDrugElutingStentImplantationOptical

CoherenceTomographyStudy Lecturers:KounosukeInoue

9:01_AM Discussion

9:06_AM TCT461:AssociationBetweenInStentNeoatherosclerosisandRestenosisinPatientsWithAcuteMyocardialInfarctionat5YearsFollowUpAssessedBy

OpticalCoherencetomography Lecturers:MasaruKuroda

9:13_AM Discussion

9:18_AM TCT462:DrugElutingStentTherapyforRecurrentInStentRestenosisFollowingFailedVascularBrachyTherapy Lecturers:KyleBuchanan

9:25_AM Discussion

MODERATEDPOSTERSESSION:NEWERDESI

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

8:30AM-9:30AM

NewerDESI

Moderators:AndreasBaumbach,GiulioStefanini

Discussants:FrancescoPrati,BjornRedfors

8:30_AM TCT468:SequentialTechniquesofProvisionalStentinginCoronaryBifurcationWiththeXpositionSSelfApposingNitinolStentAComparativeBench

Study Lecturers:FrancoisDerimay

8:37_AM Discussion

8:42_AM TCT469:OneYearClinicalOutcomeofBiodegradablePolymerSirolimusElutingStentinPatientsWithAcuteCoronarySyndromeInsightFromtheULISSE

Registry Lecturers:ElisabettaMoscarella

8:49_AM Discussion

8:54_AM TCT470:WorldwideEverydayPracticeRegistryAssessingtheXpositionSSelfApposingStentinChallengingLesionsWithVesselDiameterVariance

SIZINGRegistry Lecturers:MarcusSiry

9:01_AM Discussion

9:06_AM TCT471:BIOVITESSEMulticenterProspectiveFirstinManStudyofaNewPolymerFreeDrugCoatedStentWithUltrathinStruts:OneMonthOptical

CoherenceTomographyResultsofCohort1 Lecturers:LorenzRaber

9:13_AM Discussion

9:18_AM TCT472:ACSvsNonACSAPredefinedSubStudyAnalysisofeCobra Lecturers:LucMaillard

9:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRRISKSTRATIFICATIONANDOUTCOMESII

SUNDAY,SEPTEMBER23,2018

8:30AM-9:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

8:30AM-9:30AM

TAVRRiskStratificationandOutcomesII

Moderators:GaneshManoharan,TamimNazif

Discussants:StefanC.Bertog,BruceBowers,JaffarMKhan,MarkusFlorianKrackhardt,RichardSmalling

8:30_AM TCT453:AppropriatenessofTranscatheterAorticValveReplacementInsightFromtheOceanTAVIRegistry Lecturers:TakuInohara

Page 163: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:163

8:37_AM Discussion

8:42_AM TCT454:MyocardialFibrosisImagingBySpeckleTrackingEchocardiographyImprovesRiskStratificationinSevereAorticStenosisAfterTranscatheter

AorticValveReplacement Lecturers:AhmadManshad

8:49_AM Discussion

8:54_AM TCT455:TransfemoralTAVIinPatientsWithUnfavorableConditionsforTAVIFollowingtheEuropeanGuidelinesofValvularHeartDisease Lecturers:LeireUnzue

9:01_AM Discussion

9:06_AM TCT456:AssociationofImmediateImprovementinRenalFunctionAfterTranscatheterAorticValveReplacementandPostOperativeOutcomesin

PatientsWithRenalDysfunction Lecturers:AlexisOkoh

9:13_AM Discussion

9:18_AM TCT457:ShortandLongTermChangesinLeftVentricularMassandGeometryPostTAVR Lecturers:MohammadThawabi

9:25_AM Discussion

MODERATEDPOSTERSESSION:BESTOFMODERATEDENDOVASCULARINTERVENTIONANDSTRUCTURALHEARTDISEASE

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

9:30AM-10:18AM

BestofModeratedEndovascularInterventionandStructuralHeartDisease

Moderators:TyroneJ.Collins,RogerJ.Laham

Discussants:SaurabhSanon,HendrikTreede,ApostolosTzikas

9:30_AM TCT483:PARADIGMEXTENDProspectiveAcademicTrialofCguardMicroNetCoveredSelfExpandableStentSysteminAllComerSymptomaticand

IncreasedStrokeRiskAsymptomaticCarotidStenosisCumulative3YearClinicalandDuplexUltrasoundEvidenceforS Lecturers:PiotrMusialek

9:37_AM Discussion

9:42_AM TCT484:ElectrosurgicalLacerationofAlfieriStitchELASTICtoFacilitateTranscatheterMitralValveReplacementFirstinHumanReport Lecturers:JaffarMKhan

9:49_AM Discussion

9:54_AM TCT486:PatentforamenOvaleClosurevsMedicalTherapyforCryptogenicStrokeAnUpdatedSystematicReviewandMetaAnalysis Lecturers:SunnyGoel

10:01_AM Discussion

10:06_AM TCT487:AnalysisofOutcomesofDrugCoatingBalloonUseforofSymptomaticFemoropoplitealArterialDiseaseTreatment Lecturers:DanielGarcia

10:13_AM Discussion

MODERATEDPOSTERSESSION:CARDIOGENICSHOCKANDVENTRICULARASSISTII

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

9:30AM-10:30AM

CardiogenicShockandVentricularAssistII

Moderators:MassimoNapodano,TanveerRab

Discussants:ThomasD.Stuckey,Li-WahTam,KengoTanabe,NirUriel,MarcoV.Wainstein

9:30_AM TCT488:RiskofMortalityAssociatedWithUseofMechanicalSupportDevicesAmongComatoseCardiacArrestPatients Lecturers:AbhishekDutta

9:37_AM Discussion

9:42_AM TCT489:UseofaPercutaneousLeftVentricularAssistDeviceforPatientsWithCardiogenicShock Lecturers:WaqasMalick

Page 164: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:164

9:49_AM Discussion

9:54_AM TCT490:RightAtrialPressurePredictsMortalityinCardiogenicShockInsightsFromtheCardiogenicShockWorkingGroupRegistry Lecturers:KevinMorine

10:01_AM Discussion

10:06_AM TCT491:PostImpellaImplantMortalityDeterminantsandAssociatedLactateLevelsinCardiogenicShockPatientsASingleCenterExperience Lecturers:YongJi

10:13_AM Discussion

10:18_AM TCT492:MultimodalityManagementofCardiogenicShockintheUnitedStatesInsightsFromtheCardiogenicShockWorkingGroupRegistry Lecturers:KevinMorine

10:25_AM Discussion

MODERATEDPOSTERSESSION:INTRAVASCULARIMAGINGANDINCOMPLETESTENTAPPOSITION

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

9:30AM-10:30AM

IntravascularImagingandIncompleteStentApposition

Moderators:MartinW.Bergmann,Robert-JanvanGeuns

Discussants:DanielH.Berrocal,AdrianoCaixeta,BoXu

9:30_AM TCT503:CutoffValueofStrutVesselDistanceonResolutionofAcuteincompleteStentAppositionAtOneMonthUsingSerialOpticalCoherence

tomographyAfterCobaltChromiumEverolimusElutingStentImplantationinPatientsWithStableCoronaryArtery Lecturers:HidetoOda

9:37_AM Discussion

9:42_AM TCT504:incidenceandNaturalCourseofincompleteStentAppositioninHeavilyCalcifiedLesionsRequiringRotationalAthereCTOmyPriortoStenting:

AnOpticalCoherencetomographyStudy Lecturers:AtsushiKyodo

9:49_AM Discussion

9:54_AM TCT505:TemporalChangesofStentAppositionImmediatelyAfterStentDeploymentUsingOpticalCoherencetomography Lecturers:HyuckJunYoon

10:01_AM Discussion

10:06_AM TCT506:CutoffValueofMalappositionVolumeonResolutionofAcuteincompleteStentAppositionAtOneMonthUsingSerialOpticalCoherence

tomographyAfterCobaltChromiumEverolimusElutingStentImplantationinPatientsWithStableCoronaryArteryD Lecturers:YoheiUchimura

10:13_AM Discussion

10:18_AM TCT507:IncreaseofCoronaryLumenAreaWithImprovedStentAppositionAfterSelfExpandableStentinginTotalOcclusions:ResultsoftheSPACIOUS

PilotStudy Lecturers:SelinaVlieger

10:25_AM Discussion

MODERATEDPOSTERSESSION:NEWERDESII

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

9:30AM-10:30AM

NewerDESII

Moderators:PetrKala,DanielI.Simon

Discussants:NicolasFoin,PhilippeGarot,IoannisIakovou

9:30_AM TCT508:TrackingTissueDistributionandRetentionofSirolimusandAnalogDeliveredFromPolymerFreeDrugCoatedStents Lecturers:AbrahamTzafriri

9:37_AM Discussion

9:42_AM TCT509:EighteenMonthResultsofHighRiskPatientsTreatedWithUltrathinStrutBiodegradablePolymerOrsiroDEStheBioflowIIISatelliteItaly

Page 165: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:165

SubgroupsAnalysis Lecturers:StefanoGalli

9:49_AM Discussion

9:54_AM TCT510:DutchMulticenterExperienceUsingtheSTENTYSXpositionSSelfExpandingStentinComplexCoronaryLesions Lecturers:SelinaVlieger

10:01_AM Discussion

10:06_AM TCT511:TwoYearClinicalResultsWiththeAngioliteDrugElutingStent:TheANCHORStudy Lecturers:RishiPuri

10:13_AM Discussion

10:18_AM TCT512:APolymerFreeBiolimusCoatedStentfortheManagementofRealWorldPatientsWithCoronaryArteryDisease Lecturers:AlfonsoIelasi

10:25_AM Discussion

MODERATEDPOSTERSESSION:OPTIMALDIAGNOSISANDTREATMENTOFPATIENTSWITHSTEMIORNSTEMIII

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

9:30AM-10:30AM

OptimalDiagnosisandTreatmentofPatientswithSTEMIorNSTEMIII

Moderators:TayoA.Addo,ChristianW.Hamm

Discussants:MChadiAlraies,UsmanBaber,OtavioBerwanger,PawelE.Buszman,Jun-JackCheng

9:30_AM TCT498:TissueProtrusionAfterCoronaryStentingisAssociatedWithPoorClinicalOutcomesinPatientsWithSTSegmentElevationMyocardial

Infarction Lecturers:YoshiyukiOkuya

9:37_AM Discussion

9:42_AM TCT499:PrognosticImplicationsofPreProceduralTIMIFlowinPatientsWithSTEMIUndergoingPCIWithDrugElutingStentImplantation Lecturers:RafalWolny

9:49_AM Discussion

9:54_AM TCT500:PrognosticImplicationsofReducedPreProceduralTIMIFlowinPatientsWithNonStSegmentElevationAcuteCoronarySyndromesUndergoing

PCI Lecturers:RafalWolny

10:01_AM Discussion

10:06_AM TCT501:Profilin1ConcentrationIsAMarkerofSymptomDurationinMyocardialInfarction Lecturers:ElzbietaPaszek

10:13_AM Discussion

10:18_AM TCT502:ArePharmacoinvasiveTherapyResultsAfter6HoursofSymptomsOnsetAdequateHowDotheyCompareWithThoseTreatedWithLessThan

6Hours Lecturers:GuilhermeCintra

10:25_AM Discussion

MODERATEDPOSTERSESSION:SELECTEDEARLYINNOVATIVETECHNIQUES

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

9:30AM-10:30AM

SelectedEarlyInnovativeTechniques

Moderators:LouisA.Cannon,PeterJ.Fitzgerald

Discussants:MarkC.Bates,StevenJ.Yakubov

9:30_AM TCT478:InVivoPerformanceofANovelPermanentlyImplantedLeftAtrialPressureMonitoringSystem Lecturers:LeorPerl

9:37_AM Discussion

Page 166: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:166

9:42_AM TCT479:NovelApproachforLeftAtrialAppendageOcclusionAFeasibilityStudyofCatheterDeliveredExpandableFoam Lecturers:GilbertoMelnick

9:49_AM Discussion

9:54_AM TCT480:CellularResolutionIntravascularOpticalCoherenceTomographyforHumanCoronaryArteryImaging Lecturers:BiweiYin

10:01_AM Discussion

10:06_AM TCT481:DiastolicFunctioninPatientsUndergoingCoronarySinusReducerImplantationASingleCenterExperience Lecturers:YishaySzekely

10:13_AM Discussion

10:18_AM TCT482:TrabecularCuttingANovelSurgicalTherapyforHeartFailureWithPreservedEjectionFraction Lecturers:MeaganOglesby

10:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRANDCONDUCTIONANDRHYTHMDISTURBANCES

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

9:30AM-10:30AM

TAVRandConductionandRhythmDisturbances

Moderators:MichaelMooney,AlexandreC.Zago

Discussants:JamesCockburn,AnibalA.Damonte,NimeshDesai,ChandanDevireddy,ManuelPan

9:30_AM TCT473:LeftBundleBranchBlockAfterTAVIWithEdwardsSapien3SystemInfluenceoftheValveDepth Lecturers:LeireUnzue

9:37_AM Discussion

9:42_AM TCT475:PacemakerDependencyat2monthFollowupAfterPermanentPacemakerImplantationCausedbyTranscatheterAorticValveImplantation

inducedConductionDisturbances Lecturers:MartinvanMourik

9:49_AM Discussion

9:54_AM TCT476:NewOnsetAtrialFibrillationinPatientsUndergoingTransfemoralTranscatheterAorticValveReplacementRiskFactorsandOutcome Lecturers:FelixWoitek

10:01_AM Discussion

10:06_AM TCT477:PrevalenceandClinicalImpactofBaselineQRSDurationinPatientsWithSevereAorticStenosisTwoYearsAfterAorticValveReplacementin

thePARTNERIITrial Lecturers:LeonGustavoMacedo

10:13_AM Discussion

MODERATEDPOSTERSESSION:TAVRTECHNIQUESANDOUTCOMESII

SUNDAY,SEPTEMBER23,2018

9:30AM-10:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

9:30AM-10:30AM

TAVRTechniquesandOutcomesII

Moderators:ReginaldI.Low,MichaelJ.Mullen

Discussants:JosephP.CarrozzaJr,AntoineLafont,SimonCheung-chiLam,JohnM.Lasala

9:30_AM TCT493:LongTermPatientSatisfactionAfterTAVRShouldTreatingPhysiciansBeLessWorriedAboutSymptomsasOutcomeMeasure Lecturers:JeroenVendrik

9:37_AM Discussion

9:42_AM TCT494:InfluenceofHighDevicePositioningonOutcomesAfterTranscatheterAorticValveReplacementWithContemporarySelfExpandingValves Lecturers:Zhen-GangZhao

9:49_AM Discussion

9:54_AM TCT495:ComparisonofaNovelDirect3DWithTraditionalPlanimetricBasedMethodsforDeterminationofOptimalAngiographicViewforTAVR

Page 167: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:167

Procedures Lecturers:NilsPetri

10:01_AM Discussion

10:06_AM TCT496:OutcomesAfterTranscatheterAorticValveReplacementWiththeSAPIEN3TheVARC2CompositeEndpointsatOneYear Lecturers:CostanzaPellegrini

10:13_AM Discussion

10:18_AM TCT184:30DayOutcomesFollowingTranscatheterAorticValveReplacementwiththeEvolutPROValveinCommercialUse:ReportfromtheSTSACC

TVTRegistry Lecturers:JohnK.Forrest

10:25_AM Discussion

MODERATEDPOSTERSESSION:CATHETER-BASEDTREATMENTOFPERIPHERALVASCULARDISEASEIII

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

10:30AM-11:30AM

Catheter-basedTreatmentofPeripheralVascularDiseaseIII

Moderators:JeffreyG.Carr,RobertD.Safian

Discussants:JulieLogan,MahmoodK.Razavi,MehdiH.Shishehbor

10:30_AM TCT523:RVOTAoRatioonComputedTomographyBetterPredictsRVDysfunctionandInvasiveHemodynamicAbnormalitiesasComparedtoRVLVRatio

inPatientsWithPulmonaryEmbolism Lecturers:AlexandruMarginean

10:37_AM Discussion

10:42_AM TCT524:ResultsofSelfExpandingNitinolStentsPostDilatedWithDrugCoatedBallooninTreatmentofFemoropoplitialDisease Lecturers:AdilWani

10:49_AM Discussion

10:54_AM TCT525:FirstReportofthe12MonthOutcomesofSELUTIonTrial:ANovelSirolimusCoatedDCBTechnologyEvaluatedinSFA Lecturers:KlausBrechtel

11:01_AM Discussion

11:06_AM TCT526:LongTermBiocompatibilityofANovelBioresorbableScaffoldforPeripheralArteries:APreliminaryStudyinYucatanMiniswine Lecturers:MarcoFerrone

11:13_AM Discussion

MODERATEDPOSTERSESSION:CTOFOLLOW-UPWITHMEDICALTHERAPY

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

10:30AM-11:18AM

CTOfollow-upwithMedicalTherapy

Moderators:StefanHarb,JenniferA.Tremmel

Discussants:RaviS.Hira,WaleedYKadro,JaikirshanKhatri,IosifXenogiannis,MasatokiYoshida

10:30_AM TCT528:ImpactofRevascularizationvsMedicalTherapyAlOneforChronicTotalOcclusionManagementinElderlyPatients Lecturers:EduardoFlores

10:37_AM Discussion

10:42_AM TCT168:DevelopmentofaHumanLikeCoronaryChronicTotalOcclusionModelUsingHumanAtheroscleroticTissue Lecturers:GilbertoMelnick

10:49_AM Discussion

10:54_AM TCT530:LongTermClinicalOutcomesinPatientsWithCoronaryChronicTotalOcclusionUndergoingOptimalMedicalTherapy Lecturers:EuihongKo

11:01_AM Discussion

11:06_AM TCT531:PercutaneousCoronaryInterventionvsOptimalMedicalTreatmentforChronicTotalOcclusion:AMetaAnalysis

Page 168: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:168

Lecturers:MuhammadKhalid11:13_AM Discussion

MODERATEDPOSTERSESSION:INTRACORONARYPHYSIOLOGYSTUDIESIII

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

10:30AM-11:30AM

IntracoronaryPhysiologyStudiesIII

Moderators:AllenJeremias,TimP.VandeHoef

Discussants:RashaAl-Lamee,RobertoDiletti,VincentJ.Pompili,AfzalurRahman,GeraldS.Werner,AlanC.Yeung

10:30_AM TCT542:ComparisonofSodiumNitroprussideandAdenosineforFractionalFlowReserveAssessment:ASystematicReviewandMetaAnalysis Lecturers:RaulSolerno

10:37_AM Discussion

10:42_AM TCT543:ResidualIschemiaisFrequentintheVesselUndergoingPercutaneousCoronaryIntervention:ResultsofAProspectiveRegistry Lecturers:BarryUretsky

10:49_AM Discussion

10:54_AM TCT544:ANovelPhysiologicalAssessmentofMyocardialMassVolume Lecturers:TadashiMurai

11:01_AM Discussion

11:06_AM TCT545:DefiningCoronaryRespondersofintraAorticBalloonPumpCounterpulsation Lecturers:NatalieBriceno

11:13_AM Discussion

11:18_AM TCT546:MicrovascularDysfunctionAfterImmediatevsDeferredStentinginPatientsWithAcuteMyocardialInfarction Lecturers:HyunjongLee

11:25_AM Discussion

MODERATEDPOSTERSESSION:MISCELLANEOUSTAVRCOMPLICATIONSII

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

10:30AM-11:30AM

MiscellaneousTAVRComplicationsII

Moderators:MauricioG.Cohen,PieterR.Stella

Discussants:RobertJ.Applegate,LarryS.Dean,DavidW.M.Muller,RamonQuesada

10:30_AM TCT532:ReducedLeftVentricularEjectionFractionAfterTranscatheterAorticValveReplacement Lecturers:PaigeCraig

10:37_AM Discussion

10:42_AM TCT533:PredictorsofHighHospitalCostAfterTranscatheterAorticValveReplacementintheUnitedStates:AnalysisofNationwideinpatientSample

Database Lecturers:TomoAndo

10:49_AM Discussion

10:54_AM TCT534:ClinicalImpactsofPeriproceduralMyocardialInjuryAfterTranscatheterAorticValveReplacement Lecturers:HanbitPark

11:01_AM Discussion

11:06_AM TCT535:LeftVentricularDiastolicFunctionandCardiovascularMortalityAfterTranscatheterAorticValveReplacement Lecturers:SangYongOm

11:13_AM Discussion

11:18_AM TCT536:ImpactofAorticValveGradientandLeftVentricularEjectionFractionUponOutcomesFollowingTranscatheterAorticValveImplantation Lecturers:JohnSchindler

Page 169: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:169

11:25_AM Discussion

MODERATEDPOSTERSESSION:NEWERDESIII

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

10:30AM-11:30AM

NewerDESIII

Moderators:KennethChin,SigmundSilber

Discussants:Hyeon-CheolGwon,JoãoASilveira,SCWong,MasahisaYamane

10:30_AM TCT547:initialExperienceWithUltrathinStrutBiodegradablePolymerCoatedEverolimusElutingCoronaryStentinCoronaryArteryDiseasePatients Lecturers:K.Sivaprasad

10:37_AM Discussion

10:42_AM TCT548:PredictorsofClinicalOutcomesAfterPolymerFreeAmphilimusandBiolimusElutingStents:TheFREEFUTUREStudy Lecturers:MauroChiarito

10:49_AM Discussion

10:54_AM TCT549:LongTermClinicalOutcomesAfterImplantationofNovelAbluminalCoatedSirolimusElutingStentinRealWorldUnselectedPopulation:

UpdateFromenABlERegistry Lecturers:LucaTesta

11:01_AM Discussion

11:06_AM TCT550:SafetyandEfficacyofUltraThinBiodegradablePolymerCoatedEverolimusElutingStentinRealWorldPatientsWithCoronaryArteryDisease

OneYearOutcomesofIndianMultiCentricStudy Lecturers:ManjinderSandhu

11:13_AM Discussion

11:18_AM TCT551:ExtremelyEarlyOpticalCoHerencetOmogRaphyComparativeStudyAmongDrugElutingStentsWithPersistentaBsorbableOrWithout

PolymERHORSEPOWERStudy Lecturers:BeatrizVaquerizo

11:25_AM Discussion

MODERATEDPOSTERSESSION:PCIINHIGHBLEEDINGRISK(HBR)PATIENTSII

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

10:30AM-11:30AM

PCIinHighBleedingRisk(HBR)PatientsII

Moderators:MichelR.LeMay,MichelleO'Donoghue

Discussants:TeresaL.Carman,KurtHuber,PiotrJankowski,GiulioStefanini,ClemensvonBirgelen

10:30_AM TCT537:ImpactofConcomitantAnticoagulantDrugonLongTermThromboticandBleedingEventandAfterEverolimusElutingStentImplantation Lecturers:KatsuyaMiura

10:37_AM Discussion

10:42_AM TCT538:BleedingOutcomesinPatientsUndergoingCombinedTAVRPCI:TimeforAnAdjustmenttotheCathPCIBleedingModel Lecturers:AakritiGupta

10:49_AM Discussion

10:54_AM TCT539:ClinicalOutcomesinHighBleedingRiskPatientsUndergoingComplexPCIWiththeXienceEverolimusElutingStent:APatientLevelPooled

AnalysisFromFourXiencePostApprovalTrials Lecturers:BirgitVogel

11:01_AM Discussion

11:06_AM TCT540:IncidencePredictorsandImpactofPostDischargeGastrointestinalBleedingAfterCoronaryDrugElutingStentsImplantation:TheADAPTDES

Study Lecturers:GennaroGiustino

11:13_AM Discussion

Page 170: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:170

11:18_AM TCT541:TheValidityofPRECISEDAPTScoreforthePredictingBleedingComplicationinPatientsTreatedWithDualAntiplateletTherapy Lecturers:MooHyunKim

11:25_AM Discussion

MODERATEDPOSTERSESSION:PCIINPATIENTSWITHPREVIOUSCABG

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

10:30AM-11:30AM

PCIinPatientsWithPreviousCABG

Moderators:J.DawnAbbott,JohnS.DouglasJr

Discussants:TakW.Kwan,FaisalLatif,ParthaSardar

10:30_AM TCT518:DrugElutingStentsvsBareMetalStentsinSaphenousVeinGraftInterventions:MetaAnalysisofRandomizedControlledTrials Lecturers:JaiParekh

10:37_AM Discussion

10:42_AM TCT519:AComprehensiveMetaAnalysisofRandomizedControlledTrialsComparingDrugElutingStentsWithBareMetalStentsinSaphenousVein

GraftInterventions Lecturers:KirstinHesterberg

10:49_AM Discussion

10:54_AM TCT520:LongTermOutcomesofSaphenousVeinGraftPercutaneousCoronaryIntervention Lecturers:NovaliaSidik

11:01_AM Discussion

11:06_AM TCT521:LongTermCardiovascularOutcomesWithDrugElutingStentsvsBareMetalStentsinSaphenousVeinGraftInterventions:InsightsFromAn

UpdatedMetaAnalysisofRandomizedControlledTrials Lecturers:AmartyaKundu

11:13_AM Discussion

11:18_AM TCT522:LongTermOutcomesWithSaphenousVeinGraftvsNativeCoronaryArteryInterventioninPatientsWithCoronaryArteryBypassGrafting:

EvidenceFromMetaAnalysisandMetaRegression Lecturers:MarwanSaad

11:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRVSTAVRANDTAVRVSSAVRI

SUNDAY,SEPTEMBER23,2018

10:30AM-11:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

10:30AM-11:30AM

TAVRvsTAVRandTAVRvsSAVRI

Moderators:WilliamF.Fearon,WilsonY.Szeto

Discussants:AnitaAsgar,NiratBeohar,AmitN.Patel,PinakB.Shah

10:30_AM TCT513:TranscathetervsSurgicalAorticValveReplacementinLowRiskSurgicalPatients:AMetaAnalysisofRandomizedClinicalTrials Lecturers:BabikirKheiri

10:37_AM Discussion

10:42_AM TCT514:BalloonExpandableSapien329mmvsSelfExpandableEvolutR34mminTAVRPatientsWithALargeAnnulus:IsthereADifferencein

PerformanceandRiskofCerebralEmbolization Lecturers:ChristinaBrinkmann

10:49_AM Discussion

10:54_AM TCT515:SAVRVsTAVRinPatientsWithPreviousMyocardialInfarction:ANationwidePropensityMatchedAnalysis Lecturers:BhrugeshShah

11:01_AM Discussion

11:06_AM TCT516:theOutcomeofTranscatheterAorticValveReplacementComparedtoSurgicalAorticValveReplacementinPatientsWithHeartFailureWith

ReducedEjectionFraction Lecturers:YasserAl-Khadra

Page 171: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:171

11:13_AM Discussion

11:18_AM TCT517:OutcomeofTranscatheterAorticValveReplacementvsSurgicalAorticValveReplacementinPatientsWithPeripheralArterialDisease Lecturers:AmrIdris

11:25_AM Discussion

MODERATEDPOSTERSESSION:ASDANDPFOCLOSUREII

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters1,ExhibitHall,GroundLevel

11:30AM-12:18PM

ASDandPFOClosureII

Moderators:PeterC.Block,SrihariS.Naidu

Discussants:ParagBarwad,MarekGrygier,MichaelJ.Mullen,CarmeloPanetta,SanjeevanPasupati

11:30_AM TCT552:ImpactofOccluderDeviceonLongtermOutcomeAfterPercutaneousClosureofPatentforamenOvaleinPatientWithCryptogenicCerebral

IschemicEvents Lecturers:JuliaSeeger

11:37_AM Discussion

11:42_AM TCT553:PatentforamenOvaleClosureandCryptogenicStrokeTimetoUpdateGuidelines Lecturers:MaheshAnanthaNarayanan

11:49_AM Discussion

11:54_AM TCT554:ComparisonofTranscatheterandSurgicalRepairofAtrialSeptalDefect:AnalysisFromNationwideinpatientSample Lecturers:YashwantAgrawal

12:01_PM Discussion

12:06_PM TCT555:FeasibilityandSafetyEfficacyProfileofthePercutaneousPatentforamenClosure:NoblestitchElvsOtherDevices Lecturers:FedericoDeMarco

12:13_PM Discussion

MODERATEDPOSTERSESSION:CATHLABOFTHEFUTURE:STRATEGIESTOCONTROLRADIATIONEXPOSUREII

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters2,ExhibitHall,GroundLevel

11:30AM-12:30PM

CathLaboftheFuture:StrategiestoControlRadiationExposureII

Moderators:AndrewJ.Einstein,RyanD.Madder

Discussants:StevenL.Almany,LloydW.Klein,BoXu

11:30_AM TCT556:ComparisonofRadiationExposureinPCIBetweenRadialandFemoralApproachUsingNanodotDosimetersonPatientsandDirectReadout

PocketMiniDosimeteronOperators Lecturers:ArulShanmugam

11:37_AM Discussion

11:42_AM TCT557:ImpactofaSuspendedLeadSuitonPhysicianRadiationDosesAcrossPatientBMICategoriesDuringCoronaryAngiography Lecturers:LahdanRefahiyat

11:49_AM Discussion

11:54_AM TCT558:EfficacyofDisposableLeadFreeRadiationProtectionDrapeRadpadDuringDiagnosticandInterventionalProcedres Lecturers:HungNgo

12:01_PM Discussion

12:06_PM TCT559:PrevalenceofEyeLesionsinInterventionalCardiologyStaffinMexico:EstudioiCataratas Lecturers:JoseAzpir-Lopez

12:13_PM Discussion

MODERATEDPOSTERSESSION:COMPUTATIONALFLUIDDYNAMICS(CT-FFR,QFR,INTRAVASCULARIMAGING-FFR,ANDOTHERS)III

Page 172: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:172

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters7,ExhibitHall,GroundLevel

11:30AM-12:30PM

ComputationalFluidDynamics(CT-FFR,QFR,IntravascularImaging-FFR,andothers)III

Moderators:StephanAchenbach,NilsJohnson

Discussants:TakashiKubo,JamesE.Udelson,NealG.Uren,ZhaoWang

11:30_AM TCT578:AssessmentofLesionSpecificIschemiaUsingFractionalFlowReserveFFRProfilesDerivedFromCoronaryComputedtomographyAngiography

FFRCTandinvasiveMeasurementsFFRINV:ImportanceoftheSiteofMeasurementandImplicationsforPatie Lecturers:ElvisCami

11:37_AM Discussion

11:42_AM TCT579:EvaluationoftheDiagnosticPerformanceoftheQuantitativeFlowRatioQFRAccordingtotheInterindividualVariationsintheAdenosine

ResponseDuringFractionalFlowReserveFFRMeasurement Lecturers:HernanMejia-Renteria

11:49_AM Discussion

11:54_AM TCT580:RelationshipBetweenAdversePlaqueCharacteristicsandWallShearStressAssessedByComputationalFluidDynamics Lecturers:YouJeongKi

12:01_PM Discussion

12:06_PM TCT581:DiagnosticValueofLongitudinalFlowGradientforthePresenceofHemodynamicallySignificantCoronaryArteryDisease Lecturers:MichielBom

12:13_PM Discussion

12:18_PM TCT582:NetworkMetaAnalysisofDiagnosticTestAccuracyStudiesonNoninvasiveImagingforCoronaryArteryDisease:Evidenceon13IsolatedOr

HybridTests661Studiesand97173Patients Lecturers:GiuseppeBiondi-Zoccai

12:25_PM Discussion

MODERATEDPOSTERSESSION:MANAGEMENTOFIN-STENTRESTENOSISIII

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters6,ExhibitHall,GroundLevel

11:30AM-12:18PM

ManagementofIn-StentRestenosisIII

Moderators:JamesB.HermillerJr,RichardShlofmitz

Discussants:TayoA.Addo,MohamedAliElsalamony,RunlinGao,DanieleGiacoppo,JasvindarSingh

11:30_AM TCT574:CirculatingAngiostatinPredictingtheRiskofRepeatTargetLesionRevascularizationinCADPatientsSufferedinStentRestenosisAfterCoronary

Intervention Lecturers:ZhangweiChen

11:37_AM Discussion

11:42_AM TCT575:LongTermOutcomesAfterPercutaneousTreatmentofSecondGenerationDrugElutingStentRestenosisAccordingtotheRestenosisPattern

andManagement Lecturers:MarceloAbud

11:49_AM Discussion

11:54_AM TCT576:LongTermOutcomeofPatientsWithRecurrentDrugElutingStentRestenosis Lecturers:GouthamRavipati

12:01_PM Discussion

12:06_PM TCT577:ImpactofAngiographicPatternsofinStentRestenosison5YearsClinicalOutcomesinPatientsTreatedWithCobaltChromiumEverolimus

ElutingStent Lecturers:TakashiHiromasa

12:13_PM Discussion

MODERATEDPOSTERSESSION:NEWERDESIV

Page 173: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:173

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters8,ExhibitHall,GroundLevel

11:30AM-12:30PM

NewerDESIV

Moderators:SundeepMishra,ManelSabate

Discussants:AlexandreAbizaid,SalvatoreBrugaletta,JosephP.CarrozzaJr,SalvatoreCassese,GrzegorzL.Kaluza

11:30_AM TCT583:Final5YearResultsinUnselectedPatientsImplantedWithaThinStrutPlatinumChromiumEverolimusElutingStent:ThePROMUSElement

PlusUSPostApprovalStudy Lecturers:DavidE.Kandzari

11:37_AM Discussion

11:42_AM TCT584:LongTermImpactofImprovingDrugElutingStentTechnologyinPatientsUndergoingMultilesionIntervention:APatientLevelAnalysisof19

RandomizedTrials Lecturers:PaulGuedeney

11:49_AM Discussion

11:54_AM TCT586:LongTermPerformanceoftheDualTherapyCOMBOStent:ResultsFromtheREMEDEERegistry Lecturers:LauraKerkmeijer

12:01_PM Discussion

12:06_PM TCT585:FirstinManStudyoftheNewDedicatedBifurcationBiOSSLIMC:9MonthinterimResultsWithOCTAnalysis Lecturers:RobertJ.Gil

12:13_PM Discussion

MODERATEDPOSTERSESSION:NON-ELECTIVETAVRORBALLOONVALVULOPLASTY

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters5,ExhibitHall,GroundLevel

11:30AM-12:18PM

Non-electiveTAVRorBalloonValvuloplasty

Moderators:IgorF.Palacios,ChristianSpies

Discussants:SimonRedwood,FrancescoSaia,MollySzerlip,AlanZajarias

11:30_AM TCT570:inHospitalOutcomesofTranscatheterAorticValveReplacementAfterNonElectiveAdmissioninComparisonWithElectiveAdmission Lecturers:TomoAndo

11:37_AM Discussion

11:42_AM TCT571:OutcomesofPercutaneousBalloonAorticValvuloplastyforSevereAorticStenosisinPatientsPresentingWithCardiogenicShock Lecturers:OzanDemir

11:49_AM Discussion

11:54_AM TCT572:MechanicalCirculatorySupportUtilizationinTranscatheterAorticValveReplacementintheUnitedStates Lecturers:AhmadAlkhalil

12:01_PM Discussion

12:06_PM TCT573:interHospitalTransferofTAVRPatientsIsAssociatedWithIndexComplicationsButNotReadmissionOutcomes Lecturers:HanningXing

12:13_PM Discussion

MODERATEDPOSTERSESSION:PHARMACOLOGY:TRADITIONALVSNEWERANTIPLATELETAGENTSI

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters4,ExhibitHall,GroundLevel

11:30AM-12:30PM

Pharmacology:TraditionalvsNewerAntiplateletAgentsI

Page 174: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:174

Moderators:DimitriosAlexopoulos,DominickJ.Angiolillo

Discussants:FrederickFeit,EfrainGaxiola,SanjayKaul

11:30_AM TCT565:AComparisonofClopidogrelvsNewerP2Y12AntagonistsforPercutaneousCoronaryInterventioninPatientsWithOutofHospitalCardiac

ArrestManagedWiththerapeuticHypothermia:AMetaAnalysis Lecturers:AymanElbadawi

11:37_AM Discussion

11:42_AM TCT566:ClinicalUseofCangrelor:RealWorldDataFromtheSwedishCoronaryAngiographyandAngioplastyRegistrySCAAR Lecturers:PerGrimfjard

11:49_AM Discussion

11:54_AM TCT567:CangrelorinCardiogenicShock:AGlobalMulticenterMatchedAnalysisWithOralP2Y12InhibitionFromtheIABPSHOCKIITrial Lecturers:MichalDroppa

12:01_PM Discussion

12:06_PM TCT568:RealWorldEvaluationofAntiplateletSwitchingStrategyforCoronaryInterventions Lecturers:NikolaosKakouros

12:13_PM Discussion

12:18_PM TCT569:LowerMortalityAfterClinicallySignificantBleedinginPatientsTreatedWithReversibleP2Y12AgentTicagrelor:AComparativeAllComers

Prospective2YearFollowUpStudyinPatientsTreatedWithinvasiveStrategyAfterAcuteCoronarySynd Lecturers:GirishViswanathan

12:25_PM Discussion

MODERATEDPOSTERSESSION:RENALDENERVATION

SUNDAY,SEPTEMBER23,2018

11:30AM-12:30PM

ModeratedPosters3,ExhibitHall,GroundLevel

11:30AM-12:30PM

RenalDenervation

Moderators:HerbertD.Aronow,KrishnaJ.Rocha-Singh

Discussants:MelvinD.Lobo,FarrellO.Mendelsohn,C.VenkataS.Ram,PaulA.Sobotka,StephenC.Textor

11:30_AM TCT560:SympatheticRenalDenervationAfterAcuteMyocardialInfarctionResultsinIncreasedMyocardialSalvageinPigs Lecturers:LuigiEmilioPastormerlo

11:37_AM Discussion

11:42_AM TCT561:SplenicArteryDenervation:RationaleFeasibilityandEarlyPreClinicalExperienceinAPorcineModelofInflammatoryArthritis Lecturers:MazenAlbaghdadi

11:49_AM Discussion

11:54_AM TCT562:ChemicalRenalDenervationWithAlcoholthePostMarketStudyDataandtheTargetBPProgram Lecturers:FelixMahfoud

12:01_PM Discussion

12:06_PM TCT563:SuperiorandProximalNervesinPorcineRenalArteriesAreLeastAccessibletoRadiofrequencyAblationDuetoShieldingByPeriArterialBlood

VesselsandLymphNodes Lecturers:AbrahamTzafriri

12:13_PM Discussion

12:18_PM TCT564:theEffectofRenalSympatheticDenervationonEndogenousCatecholaminesandReninAngiotensinAldosterOneSystem Lecturers:LidaFeyz

12:25_PM Discussion

MODERATEDPOSTERSESSION:ACUTEKIDNEYINJURYDURINGPERCUTANEOUSINTERVENTIONS(PCIORTAVR)II

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

Page 175: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:175

12:45PM-1:45PM

AcuteKidneyInjuryDuringPercutaneousInterventions(PCIorTAVR)II

Moderators:HaroldL.Dauerman,CharlesJ.Davidson

Discussants:ShmuelBanai,JuliaBaron,WolfgangBocksch,DanieleGiacoppo,LloydW.Klein,KyungWoo(KW)Park,AsifQasim,GireeshWarwadekar

12:45_PM TCT592:RemoteIschemicConditioninginAcuteSTElevationMyocardialInfarctionDoesNotProtectAgainstAcuteKidneyInjury Lecturers:IlianaHurtadoRendon

12:52_PM Discussion

12:57_PM TCT593:PredictingAcuteKidneyInjuryinPatientsUndergoingTranscatheterAorticValveReplacement:TestingtheMehranContrastInduced

NephropathyScore Lecturers:MalikMurtaza

1:04_PM Discussion

1:09_PM TCT594:RotationalAthereCTOmyandtheRiskforContrastInducedNephropathy Lecturers:OzanDemir

1:16_PM Discussion

1:21_PM TCT595:UltraLowContrastPercutaneousCoronaryInterventiontoMinimizetheRiskforContrastInducedAcuteKidneyInjuryinPatientsWithSevere

ChronicKidneyDisease Lecturers:LorenzoAzzalini

1:28_PM Discussion

1:33_PM TCT596:WorsenedRenalFunctionAfterTranscatheterAorticValveReplacementIncreasesLongTermMortality Lecturers:RicardoCigarroa

1:40_PM Discussion

MODERATEDPOSTERSESSION:COMORBIDITIESINCADII

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

12:45PM-1:45PM

ComorbiditiesinCADII

Moderators:JohnA.Ambrose,SorinJ.Brener

Discussants:WacinBuddhari,JooMyungLee,GiampaoloNiccoli,JanJ.Piek,ExpeditoEustáquioRibeiro,PeterWenaweser

12:45_PM TCT612:PhysicianPredictionofMortalityOutcomesintheCardiacCathLab:ComparisonstoAValidatedRiskScore Lecturers:KiranSarathy

12:52_PM Discussion

12:57_PM TCT613:IsYoungerTrulyBetterClinicalCharacteristicsandinHospitalOutcomesofPercutaneousCoronaryInterventionPerformedinPatients45Years

OldOrYounger Lecturers:MartaBande

1:04_PM Discussion

1:09_PM TCT614:theObesityParadoxRevisited:BodyMassIndexandLongTermOutcomesAfterPCIFromALargePooledPatientLevelDatabase Lecturers:RafalWolny

1:16_PM Discussion

1:21_PM TCT615:PercutaneousCoronaryInterventionforPatientsWithIschemicCardiomyopathyIsAssociatedWithLowMortalityandImprovesEjection

Fraction:AMetaAnalysisof3844Patients Lecturers:AmeeraAhmed

1:28_PM Discussion

1:33_PM TCT616:ImpactofGeneralCardiologyFollowUponOptimalCardiovascularRiskFactorManagementPostRevascularization:OutcomesinA

NationalizedHealthcareSystem Lecturers:RichardJung

1:40_PM Discussion

MODERATEDPOSTERSESSION:COMPUTATIONALFLUIDDYNAMICS(CT-FFR,QFR,INTRAVASCULARIMAGING-FFR,ANDOTHERS)IV

SUNDAY,SEPTEMBER23,2018

Page 176: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:176

12:45PM-1:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

12:45PM-1:45PM

ComputationalFluidDynamics(CT-FFR,QFR,IntravascularImaging-FFR,andothers)IV

Moderators:JohnMcB.Hodgson,EvelynRegar

Discussants:PatrickDupouy,MarcD.Feldman,JonathanM.Hill,Young-HakKim,YasunoriUeda

12:45_PM TCT617:DiagnosticAccuracyof3Dimensionaland2DimensionalQuantitativeCoronaryAngiographyforPredictingPhysiologicalSignificanceof

CoronaryStenosis Lecturers:JunqingYang

12:52_PM Discussion

12:57_PM TCT618:AngiogramBasedFractionalFlowReserveinPatientsWithMultiVesselDisease Lecturers:HiroyukiOmori

1:04_PM Discussion

1:09_PM TCT619:ComparisonofOneDimensional1DandThreeDimensional3DModelsfortheEstimationofCoronaryFractionalFlowReserveThrough

CardiovascularImaging Lecturers:CristianoGuedesBezerra

1:16_PM Discussion

1:21_PM TCT620:influenceofDiabetesMellitusandChronicKidneyDiseaseonDiagnosticAccuracyofQuantitativeFlowRatioQFR Lecturers:JakubMaksym

1:28_PM Discussion

1:33_PM TCT621:ComparisonofQuantitativeFlowRatioandinstantaneousWaveFreeRatioforImmediateAssessmentofNonCulpritLesionsinPatientsWith

STSegmentElevationMyocardialInfarctionaniSTEMISubstudy Lecturers:MartinSejrHansen

1:40_PM Discussion

MODERATEDPOSTERSESSION:DESVSDESII

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

12:45PM-1:45PM

DESvsDESII

Moderators:GiuseppeBiondi-Zoccai,EvaldH.Christiansen

Discussants:MamasMamas,EdwardJ.McNulty,AshokSeth,PhilipM.Urban

12:45_PM TCT622:ComparativeSafetyandEffectivenessofPolymerFreeBiolimusElutingStentsvsPermanentPolymerEverolimusElutingStentsinRoutine

ClinicalPractice Lecturers:GiuseppeBiondi-Zoccai

12:52_PM Discussion

12:57_PM TCT623:12MonthsOutcomesofANonInferiorityRandomizedClinicalTrialComparingtheEfficacyandSafetyofAngioliteVsXienceinPatientsWith

PCIIndication Lecturers:ArmandoPerezdePrado

1:04_PM Discussion

1:09_PM TCT624:AProspectiveMulticenterRandomizedPostMarketTrialEvaluatingANovelCobaltChromeRapamycinDrugElutingStent:SubgroupAnalysisof

theTARGETAllComersTrial Lecturers:AlexandraJ.Lansky

1:16_PM Discussion

1:21_PM TCT625:FiveYearClinicalOutcomesofNOBORIBiolimusElutingStentvsXIENCEEverolimusElutingStentinDiabeticPatients Lecturers:YuichiTanaka

1:28_PM Discussion

1:33_PM TCT626:ComparativeEffectivenessofDifferentTypesofContemporaryDrugElutingStentsinPatientsWithDeNovoLongCoronaryArteryLesions Lecturers:Do-YoonKang

1:40_PM Discussion

Page 177: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:177

MODERATEDPOSTERSESSION:INTERVENTIONTHERAPIESINPATIENTSWITHDIABETESMELLITUSI

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

12:45PM-1:45PM

InterventionTherapiesinPatientswithDiabetesMellitusI

Moderators:FrederickFeit,NormanE.Lepor

Discussants:AngelesAlonsoGarcia,MichaelP.Flaherty,EfrainGaxiola,CindyL.Grines,MiodragC.Ostojic

12:45_PM TCT597:GLP1DoesNotProtectAgainstRightVentricularStunningorCumulativeIschemicDysfunctionFollowingRightCoronaryArteryBalloon

OcclusioninHumans Lecturers:JoelGiblett

12:52_PM Discussion

12:57_PM TCT598:PrediabetesandItsImpactonClinicalOutcomeAfterCoronaryInterventioninChinesePatients Lecturers:Huan-HuanWang

1:04_PM Discussion

1:09_PM TCT599:TheGlucagOnLikePeptide1LoadingDuringPCIGOLDPCITrial:12MonthClinicalOutcomes Lecturers:JoelGiblett

1:16_PM Discussion

1:21_PM TCT600:theImpactofDiabetesMellitusontheLongTermRiskforHeartFailureinPatientsWhoUnderwentCoronaryRevascularization Lecturers:YasuakiTakeji

1:28_PM Discussion

1:33_PM TCT601:ResultsofPercutaneousCoronaryInterventionWithSecondGenerationPaclitaxelCoatedBalloonsinDiabeticPatientsAtALongTermFollow

Up Lecturers:IgnacioSanchez-Perez

1:40_PM Discussion

MODERATEDPOSTERSESSION:RACIALANDGENDERDISPARITIESINCORONARYARTERYDISEASEANDINTERVENTIONI

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters4,ExhibitHall,GroundLevel

12:45PM-1:45PM

RacialandGenderDisparitiesinCoronaryArteryDiseaseandInterventionI

Moderators:PatriciaJ.Best,AnthonyN.DeMaria

Discussants:TayoA.Addo,YalingHan,LisetteOkkelsJensen,WaleedYKadro,MargaretB.McEntegart,A.J.ConradC.Smith

12:45_PM TCT602:GenderBasedDifferencesinOutcomesofPercutaneousCoronaryInterventionvsCoronaryArteryBypassGraftingforMultivesselDiseaseA

MetaAnalysisofRandomizedControlledTrials Lecturers:KhagendraDahal

12:52_PM Discussion

12:57_PM TCT603:DirectStentingStrategyIsAssociatedWithImprovedSurvivalinWomenUndergoingPrimaryPercutaneousCoronaryInterventionforST

ElevationMyocardialInfarction:APropensityScoreMatchedComparativeStudy Lecturers:IvanBessonov

1:04_PM Discussion

1:09_PM TCT604:OutcomeofHighRiskPercutaneousCoronaryIntervention:GenderBasedAnalysis Lecturers:MChadiAlraies

1:16_PM Discussion

1:21_PM TCT605:SexBasedDifferencesininHospitalOutcomesofPatientsWithCardiogenicShockTreatedWithPercutaneousMechanicalCirculatorySupport

intheUnitedStates Lecturers:PedroVillablanca

1:28_PM Discussion

1:33_PM TCT606:GenderDifferencesinFractionalFlowReserveAfterPercutaneousCoronaryIntervention Lecturers:LaurensZandvoort

Page 178: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:178

1:40_PM Discussion

MODERATEDPOSTERSESSION:TAVR,STROKE,ANDEMBOLICPROTECTIONII

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters1,ExhibitHall,GroundLevel

12:45PM-1:45PM

TAVR,Stroke,andEmbolicProtectionII

Moderators:LuigiSalemme,E.MuratTuzcu

Discussants:StephanBaldus,JosephE.Bavaria,DanielH.Berrocal,CameronDowling,RandolphP.Martin

12:45_PM TCT587:theSizeoftheImplantedValveDuringTranscatheterAorticValveImplantationPredictstheIncreaseinCerebralBloodFlowVelocitySizeDoes

Matter Lecturers:WienekeVlastra

12:52_PM Discussion

12:57_PM TCT588:HavePatientsWithAHistoryofCerebralEventsAHigherRiskofPeriproceduralStrokeDuringProtectedTransfemoralAorticValve

ImplantationWithUseofADoubleFilterCerebralEmbolicProtectionDeviceResultsofALargeAllComersPopulatio Lecturers:JuliaSeeger

1:04_PM Discussion

1:09_PM TCT589:ClinicalOutcomesoftheSentinelCerebralProtectionSysteminPatientsUndergoingTranscatheterAorticValveReplacement:AMetaAnalysis Lecturers:ZaherFanari

1:16_PM Discussion

1:21_PM TCT590:PilotEvaluationofCognitiveFunctionAfterSurgicalandTranscatheterAorticValveReplacement Lecturers:SantiagoGarcia

1:28_PM Discussion

1:33_PM TCT591:HypoalbuminemiaIncreasesPeriproceduralStrokeinTranscatheterAorticValveReplacement:ARetrospectiveSingleCenterCaseControl

Analysis Lecturers:DominiqueMonlezun

1:40_PM Discussion

MODERATEDPOSTERSESSION:TAVRINFRAILPATIENTSANDPATIENTSWITHAHISTORYOFMALIGNANCY

SUNDAY,SEPTEMBER23,2018

12:45PM-1:45PM

ModeratedPosters5,ExhibitHall,GroundLevel

12:45PM-1:45PM

TAVRinFrailPatientsandPatientswithaHistoryofMalignancy

Moderators:AdrianoCaixeta,RuedigerS.Lange

Discussants:BiswajitKar,LuisNombela-Franco

12:45_PM TCT607:ProteinCaloricMalnutritionIsAssociatedWithAdverseOutcomesFollowingTAVR Lecturers:SarahRudasill

12:52_PM Discussion

12:57_PM TCT608:EffectofChronicLiverDiseaseontheOutcomesReadmissionsLengthofStayandCostofTranscatheterAorticValveReplacementandSurgical

AorticValveReplacement Lecturers:HabibKhoury

1:04_PM Discussion

1:09_PM TCT609:ChoosingBetweenTranscatheterSurgicalandMedicalManagementinCancerPatientsWithSevereAorticStenosis Lecturers:DinuBalanescu

1:16_PM Discussion

1:21_PM TCT610:OutcomesofTranscatheterAorticValveReplacementComparedtoSurgicalAorticValveReplacementinPatientsWithPriorChestRadiation Lecturers:YohanChacko

1:28_PM Discussion

1:33_PM TCT611:PrognosticImpactofUnderweightinPatientsWithSevereAorticValveStenosisUndergoingTranscatheterAorticValveImplantationOrSurgical

Page 179: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:179

AorticValveReplacementProspectiveDataFromtheGermanAorticValveRegistryGARY Lecturers:LisaVoigtländer

1:40_PM Discuss

MODERATEDPOSTERSESSION:CORONARYCALCIFICATIONII

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

1:45PM-2:45PM

CoronaryCalcificationII

Moderators:PrashantKaul,SunilV.Rao

Discussants:ChristianFrerker,CareyD.Kimmelstiel,PerwaizM.Meraj,NattawutWongpraparut

1:45_PM TCT652:CoronaryArteryCalciumScoreinPredictingPeriproceduralMyocardialInfarctioninPatientsUndergoingElectivePercutaneousCoronary

Intervention Lecturers:MinGyuKang

1:52_PM Discussion

1:57_PM TCT653:AcuteMidTermResultsofDrugCoatedBalloonFollowingRotationalAthereCTOmy Lecturers:TaitoNagai

2:04_PM Discussion

2:09_PM TCT654:CoronaryLesionCalcificationandtheTwoYearOutcomeAfterPercutaneousCoronaryIntervention Lecturers:YinZhang

2:16_PM Discussion

2:21_PM TCT655:PrevalencePredictorsPrognosticSignificanceandEffectofTechniquesonOutcomesofCoronaryLesionCalcificationFollowingImplantationof

DrugElutingStents:APatientLevelPooledAnalysisofStentSpecificMultiCenterProspectiveIRI Lecturers:CheolHyunLee

2:28_PM Discussion

2:33_PM TCT656:theCoatingPerformanceofDesintortuousandCalcifiedLesions:thePreliminaryResultofBenchmarkStudy Lecturers:YiLi

2:40_PM Discussion

MODERATEDPOSTERSESSION:DESVSDESIII

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

1:45PM-2:45PM

DESvsDESIII

Moderators:AlaideChieffo,MichaelA.Kutcher

Discussants:ArifAlNooryani,JaikirshanKhatri,AlexanderGrigorievichOsiev

1:45_PM TCT662:AngioscopicFollowUpAfterDrugElutingStentsImplantationforStableCoronaryArteryDiseases Lecturers:SoichiroHiramatsu

1:52_PM Discussion

1:57_PM TCT663:ComparisonofConformabilityandWallShearStressBetweenResoluteintegrityZotarolimusElutingStentandtheXIENCEXpeditionEverolimus

ElutingStentinAngulatedVessels:AninterimAnalysisoftheSHEARSTENTRandomizedControlledStudy Lecturers:ArnavKumar

2:04_PM Discussion

2:09_PM TCT665:UnselectedUseofUltrathinStrutBiodegradablePolymerSirolimusElutingStentvsDurablePolymerEverolimusElutingStentforCoronary

Revascularization Lecturers:KyoheiYamaji

2:16_PM Discussion

2:21_PM TCT664:TwelveMonthClinicalOutcomesComparingBiodegradablePolymerSirolimusElutingStentvsDurablePolymerEverolimusElutingCoronary

StentsinPatientsWithDeNovoNativeCoronaryArteryLesions:ThemeriTVRandomizedTrial Lecturers:RicardoA.Costa

Page 180: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:180

2:28_PM Discussion

2:33_PM TCT666:SafetyEvaluationoftheBiodegradablePolymerBasedSirolimusElutingStentWithFasterDrugElutingRateandPolymerAbsorptionKineticsin

ComplexPatientandLesionSubgroupofthePANDAIIITrial Lecturers:SidaJia

2:40_PM Discussion

MODERATEDPOSTERSESSION:NON-ATHEROSCLEROSISCORONARYARTERYDISEASEII

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

1:45PM-2:45PM

Non-atherosclerosisCoronaryArteryDiseaseII

Moderators:FrancescoPelliccia,RenuVirmani

Discussants:ValerianFernandes,YujiIkari,SaskoKedev

1:45_PM TCT632:MechanismsofMyocardialInfarctioninPatientsWithNonobstructiveCoronaryArteryDisease:ResultsFromtheOpticalCoherence

tomographyStudy Lecturers:MaksymilianOpolski

1:52_PM Discussion

1:57_PM TCT633:PrognosticValveofinitialintravascularUltrasoundWithoutARoutineEarlyBaselineStudyintheEvaluationofCardiacTransplantVasculopathy Lecturers:MohammadRezaMovahed

2:04_PM Discussion

2:09_PM TCT634:PercutaneousCoronaryInterventionWithDrugElutingStentsfortheTreatmentofCardiacAllograftVasculopathyandtheImpactof

intravascularUltrasoundandStentCharacteristicsonLesionPatency:4YearOutcomes Lecturers:RichardCheng

2:16_PM Discussion

2:21_PM TCT635:UnmaskingMyocardialBridgeRelatedIschemiaByintracoronaryFunctionalEvaluation Lecturers:AlbertoBarioli

2:28_PM Discussion

2:33_PM TCT636:internationalExperienceWithImpellaMechanicalCirculatorySupportforTakotsuboSyndromeWithShock Lecturers:LChristianNapp

2:40_PM Discussion

MODERATEDPOSTERSESSION:PCIVOLUMESANDOUTCOMESI

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

1:45PM-2:45PM

PCIVolumesandOutcomesI

Moderators:DavidP.Faxon,SigmundSilber

Discussants:LorenzoAzzalini,Jun-JackCheng,JohnS.DouglasJr,SaminK.Sharma

1:45_PM TCT657:TemporalTrendsinthePracticeoftheTransRadialApproachPCIinALargeTertiaryCenterMoreIsBetter Lecturers:LeorPerl

1:52_PM Discussion

1:57_PM TCT658:ComplexHighandIndicatedPercutaneousCoronaryindication:DoesOperatorVolumeinfluencePatientOutcome Lecturers:TimKinnaird

2:04_PM Discussion

2:09_PM TCT659:RatesofSelectionofRevascularizationStrategyPCIvsCABGDoNotinfluenceinHospitalMortalityinAcuteCoronarySyndromesACS Lecturers:AshrafAbugroun

2:16_PM Discussion

2:21_PM TCT660:PrevalenceTreatmentOptionsandinfluenceofATrainingProgramonClinicalOutcomeinPatientsWithSTElevationMyocardialInfarction

Between1999and2016inChina:theProspectiveMulticenterRegistryMOODYTrial

Page 181: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:181

Lecturers:Shao-LiangChen2:28_PM Discussion

2:33_PM TCT661:TheInfluenceofCatheterizationLaboratoryVolumeandHospitalTeachingStatusontheAcuteMyocardialInfarctionOutcomes Lecturers:TariqEnezate

2:40_PM Discussion

MODERATEDPOSTERSESSION:PERCUTANEOUSINTERVENTIONS(PCIORTAV)INDIALYSISPATIENTSORPATIENTSWITHCHRONICKIDNEYDISEASE

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

1:45PM-2:45PM

PercutaneousInterventions(PCIorTAV)inDialysisPatientsorPatientswithChronicKidneyDisease

Moderators:ZiadA.Ali,StephenCook

Discussants:UsmanBaber,JuliaBaron,GianniDall'Ara,OliverHusser,RobertM.Schainfeld

1:45_PM TCT637:AMetaAnalysisofClinicalOutcomesofTranscatheterAorticValveReplacementinPatientsWithEndStageRenalDisease Lecturers:JavierAmioneGuerra

1:52_PM Discussion

1:57_PM TCT638:ClinicalOutcomesofHemodialysisPatientsWithCoronaryArteryDiseaseAfterNewerGenerationDrugElutingStentImplantation Lecturers:ShotaOkuno

2:04_PM Discussion

2:09_PM TCT639:ComparisonofPatientsWithandWithoutDialysisPriortoTAVIin2000ConsecutiveImplantationsWithA3YearFollowUp Lecturers:GerhardSchymik

2:16_PM Discussion

2:21_PM TCT640:TranscatheterAorticValveReplacementvsSurgicalAorticValveReplacementOutcomesinPatientsonDialysis:SystematicReviewandMeta

Analysis Lecturers:ZaherFanari

2:28_PM Discussion

2:33_PM TCT641:TranscatheterAorticValveReplacementOutcomesinPatientsWithEndStageRenalDisease:SystematicReviewandMetaAnalysis Lecturers:ZaherFanari

2:40_PM Discussion

MODERATEDPOSTERSESSION:PHARMACOLOGY:TRADITIONALVSNEWERANTIPLATELETAGENTSII

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters4,ExhibitHall,GroundLevel

1:45PM-2:45PM

Pharmacology:TraditionalvsNewerAntiplateletAgentsII

Moderators:GermanoDiSciascio,FaustoFeres

Discussants:DmitriyN.Feldman,Hyeon-CheolGwon,MinaMadan

1:45_PM TCT642:theComparativeEffectivenessandSafetyofCangrelorvsInLabGlycoproteinIIbIIIaInhibitorGPIinPatientsUndergoingPercutaneousCoronary

Intervention:InsightsFromtheBlueCrossBlueShieldofMichiganCardiovascularConsortiumBMC2 Lecturers:SaifullahSiddiqui

1:52_PM Discussion

1:57_PM TCT643:AntiplateletTherapyWithCangrelorinPatientsUndergoingSurgeryAfterCoronaryStentImplantation:ARealWorldBridgingProtocol

Experience Lecturers:GiuliaMasiero

2:04_PM Discussion

2:09_PM TCT644:UseofNewThienopyridinesinPatientsWithCoronaryArteryDiseaseTreatedWithPercutaneousCoronaryInterventionsinArgentinaResults

FromARealWorldMulticenterRegistry Lecturers:AlfredoRodriguezGranillo

2:16_PM Discussion

Page 182: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:182

2:21_PM TCT645:AssessmentofAngiographicOutcomesAfterCangrelorinAcuteCoronarySyndromePatientsWithTimiGradeFlow0Or1andThrombus

ComparedtoGlycoproteinIIbIIIaInhibitors Lecturers:AlexandreHideo-Kajita

2:28_PM Discussion

2:33_PM TCT646:PlatelettoRedCellDistributionWidthRatioPredictsHighonClopidogrelPlateletReactivityinPatientsWithPercutaneousCoronary

Intervention Lecturers:MariuszTomaniak

2:40_PM Discussion

MODERATEDPOSTERSESSION:TAVRLEAFLETTHROMBOSISANDDURABILITY

SUNDAY,SEPTEMBER23,2018

1:45PM-2:45PM

ModeratedPosters5,ExhibitHall,GroundLevel

1:45PM-2:45PM

TAVRLeafletThrombosisandDurability

Moderators:Duk-WooPark,LarsSondergaard

Discussants:EvaldH.Christiansen,GeorgeD.Dangas,HansR.Figulla,GeorgeS.Hanzel

1:45_PM TCT647:HemodynamicValveDeteriorationFollowingTranscatheterAorticValveImplantation:PrevalenceandPredictorsofElevatedTransvalvular

Gradients Lecturers:TobiasRheude

1:52_PM Discussion

1:57_PM TCT648:ThePrevalenceofComputedTomographyDefinedLeafletThrombosisinIntravsSupraAnnularTranscatheterAorticValveProstheses Lecturers:HashrulRashid

2:04_PM Discussion

2:09_PM TCT649:ImpactofPostdilatationonLongTermOutcomeandValveDurabilityinTAVRPatients Lecturers:StephanHaussig

2:16_PM Discussion

2:21_PM TCT650:ClinicalPresentationManagementandOutcomesofPatientsWhoDevelopedPostTranscatheterAorticValveReplacementThrombosis:Global

CaseSeries Lecturers:DanielGarcia

2:28_PM Discussion

2:33_PM TCT651:NovelPreclinicalModelofAorticBandingforEvaluationofImplantationFeasibilityandLongTermDurabilityofTranscatheterAorticValves Lecturers:PawelE.Buszman

2:40_PM Discussion

MODERATEDPOSTERSESSION:METALLICBIORESORBABLEVASCULARSCAFFOLDSII

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

2:45PM-3:45PM

MetallicBioresorbableVascularScaffoldsII

Moderators:StephanAchenbach,BernardoCortese

Discussants:VasimFarooq,YasuhiroHonda

2:45_PM TCT700:initialExperienceofMagnesiumBioresorbableScaffoldImplantationinAcuteCoronarySyndrome Lecturers:MagdalenaLanocha,MD

2:52_PM Discussion

2:57_PM TCT701:ConsecutiveintravascularImagingAssessmentUpto3YearsFollowingImplantationofResorbableMagnesiumScaffolds Lecturers:HimanshuRai,MD

3:04_PM Discussion

3:09_PM TCT702:MagnesiumMetallicBioabsorbableScaffoldMagmarisLongTermResultsAnalysisFromPooledMulticentreItalianExperience Lecturers:StefanoGalli,MD

Page 183: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:183

3:16_PM Discussion

3:21_PM TCT703:EarlyResultsFollowingMagnesiumBioresorbableVascularScaffoldImplantationinPatientsWithAcuteMyocardialInfarction Lecturers:AlfonsoIelasi,MD

3:28_PM Dicsussion

3:33_PM TCT704:FeasibilityofOverlappedMagnesiumMadeBioresorbableScaffoldImplantationinLongLesionsResultsFromtheMulticenterItalianRegistry

MAGIC Lecturers:FrancescoTomassini,MD

3:40_PM Discussion

MODERATEDPOSTERSESSION:OUTCOMESAFTERPCITREATMENTOFCTOLESIONS

SUNDAY,SEPTEMBER23,2018

2:45PM-4:15PM

ModeratedPosters4,ExhibitHall,GroundLevel

2:45PM-4:15PM

OutcomesAfterPCITreatmentofCTOLesionsI

Moderators:J.AaronGrantham,HabibSamady

Discussants:ParagBarwad,AndreaGagnor,JJGoy,LuizFYbarra,Chih-FanYeh

2:45_PM TCT683:LongTermPrognosisofCompletePercutaneousCoronaryRevascularizationinPatientsWithChronicTotalOcclusion:AComparisonBetween

PreservedandImpairedRenalFunction Lecturers:RenatoValenti

2:52_PM Discussion

2:57_PM TCT684:PredictorsofTargetVesselFailureinLongTermFollowUpWithChronicTotalOcclusionPatientsAfterSuccessfulPercutaneousCoronary

Intervention Lecturers:KyusupLee

3:04_PM Discussion

3:09_PM TCT685:theImprovementofLeftVentricularFunctionAfterCTORevascularizationAStrainEchocardiographyBasedStudy Lecturers:ChunKaiChen

3:16_PM Discussion

3:21_PM TCT715:EvaluationoftheImpactofPercutaneousCoronaryInterventionofChronicTotalOcclusiononRegionalMyocardialFunctionUsingStrain

Echocardiography Lecturers:MohamedElGowelly

3:28_PM Discussion

3:33_PM TCT716:OverTenYearsFollowUpofChronicTotalCoronaryOcclusionAngioplasty Lecturers:KoheiYoneda

3:40_PM Discussion

3:45_PM TCT717:ImpactofPercutaneousCoronaryInterventionforChronicTotalOcclusiononLongTermOutcomesofPatientsWithStableCoronaryArtery

DiseaseAccompaniedByLeftVentricularDysfunction Lecturers:RyosukeMurai

3:52_PM Discussion

3:57_PM TCT718:AMetaAnalysisofLongTermClinicalOutcomesFollowingSuccessfulPercutaneousCoronaryInterventionWithDrugElutingStentsforChronic

TotalOcclusions Lecturers:AravdeepJhand

4:04_PM Discussion

MODERATEDPOSTERSESSION:PCIINTHEELDERLYI

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

2:45PM-3:45PM

PCIintheElderlyI

Moderators:HenningKelbæk,RichardA.Schatz

Page 184: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:184

Discussants:FrancescoBedogni,RichardR.Heuser,AaronV.Kaplan,MaheshVMadhavan,FazilaT.Malik,BonnieH.Weiner

2:45_PM TCT690:IncrementalAgeRelated1YearMACCEAfterAcuteMyocardialInfarctionintheDrugElutingStentEraFromKAMIRNIHRegistry Lecturers:SeongHyeonBu

2:52_PM Discussion

2:57_PM TCT691:NationalTrendsofPercutaneousCoronaryInterventionfortheElderly Lecturers:AymanElbadawi,MD

3:04_PM Discussion

3:09_PM TCT692:ImpactofDrugElutingStentGenerationinElderlyPatientsUndergoingPCI:FiveYearFollowUpFromAPatientLevelAnalysisof19Randomized

Trials Lecturers:PaulGuedeney,MD

3:16_PM Discussion

3:21_PM TCT693:OutcomesofPercutaneousCoronaryInterventioninOctogenarianPatientsAnAnalysisoftheNationalInpatientSample Lecturers:AmrIdris,MD

3:28_PM Discussion

3:33_PM TCT694:OutcomeofHighRiskPercutaneousCoronaryInterventioninOctogenarians:InsightFromtheFromthecVADRegistry Lecturers:MChadiAlraies

3:40_PM Discussion

MODERATEDPOSTERSESSION:STEMIANDMULTIVESSELDISEASE

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

2:45PM-3:33PM

STEMIandMultivesselDisease

Moderators:SanjitS.Jolly,PieterC.Smits

Discussants:BimmerE.Claessen,WaleedYKadro,MichaelMaeng,NadiaRSutton

2:45_PM TCT677:MultivesselvsCulpritLesiononlyPercutaneousCoronaryInterventioninAcuteMyocardialInfarctionComplicatedByCardiogenicShock:An

UpdatedMetaAnalysis Lecturers:AmartyaKundu

2:52_PM Discussion

2:57_PM TCT679:theImpactofCompleteRevascularizationinSTEMIPatientsWithLeftVentricularDysfunction Lecturers:JeehoonKang

3:04_PM Discussion

3:09_PM TCT680:TrendsandPredictorsofEarlyReadmissioninSTEMIPatientsUndergoingMultivesselPercutaneousCoronaryIntervention Lecturers:ByomeshTripathi

3:16_PM Discussant

3:21_PM TCT681:CulpritVesselonlyvsMultivesselPercutaneousCoronaryInterventioninAcuteStElevationMyocardialInfarctionWithCardiogenicShock:A

ComprehensiveUpdatedMetaAnalysis Lecturers:MuhammadKhalid

3:28_PM Discussion

MODERATEDPOSTERSESSION:SURGICALTREATMENTOFAORTICORMVDISEASE

SUNDAY,SEPTEMBER23,2018

2:45PM-3:57PM

ModeratedPosters1,ExhibitHall,GroundLevel

2:45PM-3:57PM

SurgicalTreatmentofAorticorMVDisease

Moderators:GregoryP.Fontana,IsaacGeorge

Discussants:StephanM.Ensminger,MathewWilliams

2:45_PM TCT667:CausesandClinicalOutcomesofPatientsWithMitralRegurgitationWhoAreineligibleforTranscatheterMitralValveReplacement

Page 185: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:185

Lecturers:HirokiNiikura2:52_PM Discussion

2:57_PM TCT668:ThirtyDayReadmissionsAfterTranscatheterMitralValveRepairVsSurgicalMitralValveRepair:Analysisofthe20142015Nationwide

ReadmissionsDatabases Lecturers:FabioLima

3:04_PM Discussion

3:09_PM TCT669:ContemporaryOutcomesofIsolatedBioprothesticMitralValveReplacementforMitralRegurgitation Lecturers:ChalakBerzingi

3:16_PM Discussion

3:21_PM TCT670:DifferenceinPostSAVRInpatientOutcomesBetweenTAVRandNonTAVRPerformingHospitals Lecturers:GodlyJack

3:28_PM Discussion

3:33_PM TCT671:ASystematicReviewandMetaAnalysisofPermanentPacemakerImplantationandParavalvularLeakRatesAfterSuturelessAorticValve

Operations Lecturers:LukeSeibolt

3:40_PM Discussion

3:45_PM TCT672:TrendsinUtilizationofSurgicalandTranscatheterMitralValveRepairintheUnitedStates Lecturers:TanushGupta

3:52_PM Discussion

MODERATEDPOSTERSESSION:SYNTAXSCOREANDSYNTAXTRIALSTUDIESII

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

2:45PM-3:45PM

SYNTAXScoreandSYNTAXTrialStudiesII

Moderators:DavidR.HolmesJr.,CorradoTamburino

Discussants:PatrickJGoleski,TalibMajwal,SheilaSahni

2:45_PM TCT673:TwoYearsClinicalOutcomesWiththeStateoftheArtPCIfortheTreatmentofBifurcationLesions:ASubAnalysisoftheSYNTAXIIStudy Lecturers:RodrigoModolo

2:52_PM Discussion

2:57_PM TCT674:ImpactofCoronaryCalcificationontheAgreementBetweenCoronaryCtaandConventionalAngiographyintheSyntaxScoreTreatment

Decision Lecturers:SaimaMushtaq

3:04_PM Discussion

3:09_PM TCT675:SitevsCoreLaboratorySYNTAXScoreVariability Lecturers:CarlosCollet

3:16_PM Discussion

3:21_PM TCT676:CouldtheLogisticClinicalSYNTAXScoreHavePredictedtheAllCauseMortalityintheGlobalLeadersTrialAPredictionPriortotheUnblinding

oftheTrial Lecturers:PlyChichareon

3:28_PM Discussion

MODERATEDPOSTERSESSION:TAVRANDCADII

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters1,ExhibitHall,GroundLevel

2:45PM-3:45PM

TAVRandCADII

Moderators:BernardR.Chevalier,JunboGe

Discussants:PaulHsien-LiKao,PoonamVelagapudi

Page 186: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:186

2:45_PM TCT627:ImpactofCoronaryRevascularizationinPatientsUndergoingTranscatheterAorticValveImplantation Lecturers:DiegoLopezOtero

2:52_PM Discussion

2:57_PM TCT628:ImpactofPrestagedPercutaneousCoronaryInterventiononOutcomeinCoronaryArteryDiseasePatientsUndergoingTransfemoralAortic

ValveReplacement Lecturers:JuliaSeeger

3:04_PM Discussion

3:09_PM TCT629:TroponinRisePredictsThirtyDaysOutcomeinCoronaryArteryDiseasePatientsUndergoingTransfemoralAorticValveReplacementforSevere

AorticStenosis Lecturers:JuliaSeeger

3:16_PM Discussion

3:21_PM TCT630:NewIndexesforPredictingCoronaryObstructionAfterBalloonExpandableTranscatheterAorticValveReplacement Lecturers:YasushiFuku

3:28_PM Discussion

3:33_PM TCT631:DILEMMAScorePredicts1YearMortalityinPatientsWithCoronaryArteryDiseaseUndergoingTranscatheterAorticValveReplacement Lecturers:MichaelMichail

3:40_PM Discussion

MODERATEDPOSTERSESSION:TAVRRISKSTRATIFICATIONANDOUTCOMESIII

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters5,ExhibitHall,GroundLevel

2:45PM-3:45PM

TAVRRiskStratificationandOutcomesIII

Moderators:JoseLuisNavia,HendrikTreede

Discussants:DanielJ.Blackman,ThomasModine,WojtekWojakowski,SCWong,YuejinYang

2:45_PM TCT686:MixedAorticValveDisease:ImpactonOutcomeAfterTranscatheterAorticValveImplantation Lecturers:KonstantinosStathogiannis,MD

2:52_PM Discussion

2:57_PM TCT687:ParavalvularLeakintheRESPONDPostMarketStudyPredictorsandImpacton2YearClinicalOutcomesFollowingTAVRWithAFully

RepositionableandRetrievableAorticValveinRoutineClinicalPractice Lecturers:JochenWöhrle

3:04_PM Discussion

3:09_PM TCT688:EffectofReninAngiotensinSystemBlockadeinLongTermOutcomesFollowingTranscatheterAorticValveImplantationResultsFromthe

RetrospectiveCohortoftheRASTAVIStudy Lecturers:IgnacioAmat-Santos

3:16_PM Discussion

3:21_PM TCT689:ComparisonofTranscatheterAorticValvesStentandLeafletStressesofSAPIENvsCorevalve Lecturers:YueXuan,MD

3:28_PM Discussion

MODERATEDPOSTERSESSION:USEOFEXTRACORPOREALMEMBRANEOXYGENATION(ECMO)

SUNDAY,SEPTEMBER23,2018

2:45PM-3:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

2:45PM-3:45PM

UseofExtracorporealMembraneOxygenation(ECMO)

Moderators:A.ReshadGaran,MichaelMooney

Discussants:VladimirGanyukov,NavinK.Kapur,SrihariS.Naidu,NirUriel

2:45_PM TCT695:ComparingVenoArterialExtracorporealMembraneOxygenationECMOandImpellainCardiogenicShockPatients Lecturers:ThongNguyen,MD

Page 187: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:187

2:52_PM Discussion

2:57_PM TCT696:RealWorldExperienceWithExtracorporealCardiopulmonaryResuscitationECPR Lecturers:LucasMarinacci,MD

3:04_PM Discussion

3:09_PM TCT697:LeftVentricularDecompressionDuringExtracorporealMembraneOxygenationforCardiogenicShockASystematicReviewandMetaAnalysis Lecturers:JuanRusso,MD

3:16_PM Discussion

3:21_PM TCT698:VAECMOfortheTreatmentofCardiogenicShockinPrimaryPCIforSTEMIAMultiCentrePerspective Lecturers:FlorisVanDenBrink,MD

3:28_PM Discussion

3:33_PM TCT699:OutcomesofVenoarterialExtracorporealMembraneOxygenationVAECMOSupportforCardiogenicShockinALargeTertiaryCareAdvanced

HeartFailureandTransplantReferralCenterFrom20132017 Lecturers:ColinHirst,MD

3:40_PM Discussion

MODERATEDPOSTERSESSION:BESTOFMODERATEDPCIPOSTERABSTRACTSII

SUNDAY,SEPTEMBER23,2018

3:45PM-4:45PM

ModeratedPosters2,ExhibitHall,GroundLevel

3:45PM-4:45PM

BestofModeratedPCIPosterAbstractsII

Moderators:KennethChin,HolgerM.Nef

Discussants:MohammadAl-Mutairi,MartaBande,AshokDutta,HadleyWilson,BernhardWitzenbichler

3:45_PM TCT705:CurrentTreatmentStrategiesforInStentRestenosisintheEraofDrugElutingStentsAMetaAnalysis Lecturers:KleanthisTheodoropoulos,MD

3:52_PM Discussion

3:57_PM TCT707:AProspectiveRandomizedMulticenterStudytoAssesstheSafetyandEffectivenessoftheOrsiroSirolimusElutingStentintheTreatmentof

SubjectsWithUptoTwoDeNovoCoronaryArteryLesionsBIOFLOWIV3YearClinicalResults Lecturers:TonSlagboom,MD

4:04_PM Discussion

4:09_PM TCT708:InfluenceofHospitalCharacteristicsontheManagementandOutcomesofCardiogenicShockComplicatingAcuteMyocardialInfarctionA15

YearNationalStudy Lecturers:SaraschandraVallabhajosyula,MD

4:16_PM Discussion

4:21_PM TCT709:ClinicalImportanceofintraProceduralThromboticEventsAVALIDATESWEDEHEARTSubstudy Lecturers:SofiaKarlsson,MD

4:28_PM Discussion

4:33_PM TCT706:CardiovascularandNonCardiovascularDeathAfterPCIInsightsFrom32882PatientsEnrolledin21RandomizedTrials Lecturers:SorinJ.Brener

4:40_PM Discussion

MODERATEDPOSTERSESSION:MISCELLANEOUSPHARMACOTHERAPYSTUDIES

SUNDAY,SEPTEMBER23,2018

3:45PM-4:45PM

ModeratedPosters6,ExhibitHall,GroundLevel

3:45PM-4:45PM

MiscellaneousPharmacotherapyStudies

Moderators:JohnA.Ambrose,DharamJ.Kumbhani

Discussants:KelleyRBranch,HuayCheemTan,JamesE.Udelson

3:45_PM TCT725:NormalizationofTestosteroneAfterTestosteroneReplacementTherapyIsNotAssociatedWithIncreasedIncidenceofRecurrentMyocardial

InfarctioninPatientsWithAHistoryofPreviousMyocardialInfarction

Page 188: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:188

Lecturers:Mohammad-AliJazayeri,MD3:52_PM Discussion

3:57_PM TCT726:EarlyintravenousBetaBlockersinPatientsUndergoingPrimaryPercutaneousCoronaryInterventionforSTSegmentElevationMyocardial

InfarctionAPatientPooledMetaAnalysisofRandomisedClinicalTrials Lecturers:PeterDamman,MD

4:04_PM Discussion

4:09_PM TCT727:RelevanceofTypeandDoseofBetaBlockersinPrognosisAmongPatientsWithIschemicHeartDiseaseDataFromGRANDDESRegistry Lecturers:JiesuckPark,MD

4:16_PM Discussion

4:21_PM TCT728:LongTermMedicationAdherenceandPrognosisAfterSuccessfulPercutaneousCoronaryInterventioninPatientsWithAcuteMyocardial

InfarctionExperiencesFromtheKoreanMulticenterRegistry Lecturers:JuhanKim,MD

4:28_PM Discussion

MODERATEDPOSTERSESSION:PHARMACOLOGY:STATINSANDLIPIDS

SUNDAY,SEPTEMBER23,2018

3:45PM-4:45PM

ModeratedPosters3,ExhibitHall,GroundLevel

3:45PM-4:45PM

Pharmacology:StatinsandLipids

Moderators:NormanE.Lepor,EvanA.Stein

Discussants:TizianaClaudiaAranzulla,WolfgangBocksch,FrederickFeit

3:45_PM TCT710:EffectsofBorassusAetiopiumBreadonMetabolicRiskParametersofGhanaianCardiovascularDiseaseOutpatientsAPilotInterventionStudy Lecturers:OdeafoAsamoah-Boakye,MD

3:52_PM Discussion

3:57_PM TCT711:AchievingTargetLDLFollowingPercutaneousCoronaryRevascularizationContemporaryResultsinANationalizedHealthCareSystem Lecturers:TrevorSimard,MD

4:04_PM Discussion

4:09_PM TCT712:MetabolicParametersAsIndependentMarkersforCoronaryEndothelialDysfunctioninHumans Lecturers:JongwookYu,MD

4:16_PM Discussion

4:21_PM TCT713:ImpactofStatinsPreloadingBeforePCIonPeriproceduralMyocardialInfarctionAmongStableAnginaPeCTOrisPatientsUndergoing

PercutaneousCoronaryIntervention:AMetaAnalysisofRandomizedControlledTrials Lecturers:MohamadSoud,MD

4:28_PM Discussion

4:33_PM TCT714:AssociationofStatinandMortalityAfterTranscatheterAorticValveReplacement Lecturers:PoghniPeri-Okonny,MD

4:40_PM Discussion

MODERATEDPOSTERSESSION:STENTORSCAFFOLDTHROMBOSIS

SUNDAY,SEPTEMBER23,2018

3:45PM-4:45PM

ModeratedPosters8,ExhibitHall,GroundLevel

3:45PM-4:45PM

StentorScaffoldThrombosis

Moderators:MaurizioMenichelli,DavidG.Rizik

Discussants:SalvatoreBrugaletta,DemetriusLopes,KyungWoo(KW)Park

3:45_PM TCT734:ComparisonofThromboresistanceBetweenEverolimusElutingFluoropolymerStentandELuNIRRidaforolimusElutingCoronary

StentRidaforolimusElutingStentinAnExVivoSwineShuntModel Lecturers:HiroyukiJinnouchi,MD

3:52_PM Discussion

Page 189: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:189

3:57_PM TCT735:ClinicalUtilityofCombinedOpticalCoherencetomographyandNearinfraredSpectroscopyforAssessingtheMechanismofVeryLateStent

Thrombosis Lecturers:YasushiIno,MD

4:04_PM Discussion

4:09_PM TCT736:PrevalenceandImpactofBleedingDeterminantsonRisksforOutofHospitalBleedingandCoronaryThrombosisinPatientsUndergoing

PercutaneousCoronaryIntervention:ResultsFromALargeSingleCenterPCIRegistry Lecturers:SabatoSorrentino,MD

4:16_PM Discussion

4:21_PM TCT737:VeryLateStentThrombosisAfterRevascularizationWithBiodegradablePolymerDrugElutingStentsFromtheSORTOUTVIITrial Lecturers:LisetteOkkelsJensen

4:28_PM Discussion

4:33_PM TCT738:incidenceandPredictorsofOutcomesAfterFirstDefiniteStentThrombosisEvent Lecturers:MariaTovarForero,MD

4:40_PM Discussion

MODERATEDPOSTERSESSION:TAVRINPATIENTSWITHPULMONARYHYPERTENSIONORRVFAILURE

SUNDAY,SEPTEMBER23,2018

3:45PM-4:33PM

ModeratedPosters5,ExhibitHall,GroundLevel

3:45PM-4:33PM

TAVRinPatientswithPulmonaryHypertensionorRVFailure

Moderators:HelgeMöllmann,JeffreyJ.Popma

Discussants:JanKovac,UlrichSchäfer

3:45_PM TCT719:ClinicalImpactofBaselineRightBundleBranchBlockinPatientsUndergoingTranscatheterAorticValveReplacement Lecturers:EuihongKo,MD

3:52_PM Discussion

3:57_PM TCT720:RightVentricularFunctionAsAPredictorforMortalityinTAVIPatients Lecturers:ZisisDimitriadis,MD

4:04_PM Discussion

4:09_PM TCT722:PreExistingPulmonaryHypertensioninPatientsUndergoingAorticValveReplacementEffectoninHospitalMortalityandProcedural

Complications Lecturers:KonstantinosVoudris,MD

4:16_PM Discussion

4:21_PM TCT723:PulmonaryArterialProportionalPulsePressure:AHemodynamicPredictorofRightVentricularDysfunctionandEarlyOutcomesFollowing

TranscatheterAorticValveReplacement Lecturers:MartinMiguelAmor,MD

4:28_PM Discussion

MODERATEDPOSTERSESSION:VASCULARACCESSDURINGPCII

SUNDAY,SEPTEMBER23,2018

3:45PM-4:45PM

ModeratedPosters7,ExhibitHall,GroundLevel

3:45PM-4:45PM

VascularAccessDuringPCII

Moderators:RobertJ.Applegate,ZazaKavteladze

Discussants:MazenAbu-Fadel,ItshacItsikBen-dor,ChristopherPyne,EufracinoSandoval,YaderSandoval

3:45_PM TCT729:ProceduralOutcomesofPercutaneousCoronaryInterventionsforChronicTotalOcclusionsViatheRadialApproachInsightFromAn

internationalCTORegistry Lecturers:PeterTajti

3:52_PM Discussion

3:57_PM TCT730:DistalTransradialAccessintheAnatomicalSnuffboxforCoronaryAngiographyAsAnAlternativeAccessSiteforFasterHemostasisASingle

CenterRegistry

Page 190: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:190

Lecturers:ShunsukeAoi,MD4:04_PM Discussion

4:09_PM TCT731:PotentialBenefitsofModifiedShortAxisViewandLongAxisViewUseinUltrasoundGuidedRadialArteryCatheterizationASystematicReview

andMetaAnalysisofRandomizedControlledTrials Lecturers:MChadiAlraies

4:16_PM Discussion

4:21_PM TCT732:ReadmissionandMortalityinPatientsUndergoingPercutaneousCoronaryInterventionStratifiedByAccessSiteAdjustedandPropensityScore

MatchedAnalyses Lecturers:AhmadMasri,MD

4:28_PM Discussion

4:33_PM TCT733:ComparisionofVascularClosureDeviceWithTransFemoralApproachvsTransRadialApproachAnUpdatedMetaAnalysis Lecturers:SisirSiddamsetti,MD

4:40_PM Discussion

CARDIOVASCULARPROFESSIONALS(CVP)COURSE:27THANNUALCARDIOVASCULARNURSEANDTECHNOLOGISTSYMPOSIUM:HOTTOPICS

SUNDAY,SEPTEMBER23,2018

2:00PM-4:15PM

Room28D-E,UpperLevel

2:00PM-2:30PM

SessionI.PFOClosureProcedure

Moderators:PatriciaKeegan

Discussants:SrihariS.Naidu,MartinaKellySpeight

2:00_PM PFOClosurePharmacologyandProcedure Lecturers:PatriciaKeegan

2:10_PM PFOClosureComplications Lecturers:SrihariS.Naidu

2:20_PM RoundtableDiscussionwithAudienceQA

2:30PM-3:25PM

SessionII.TranscatheterMitralValveRepair

Moderators:ElizabethM.Perpetua

Discussants:JulieLogan,JasonH.Rogers,MartinaKellySpeight

2:30_PM MitralValveDisease101TodayandTomorrow Lecturers:JulieLogan

2:45_PM AnatomicalAssessmentfortheMitraClip Lecturers:ElizabethM.Perpetua

3:00_PM MitraClipProcedureandComplications Lecturers:JasonH.Rogers

3:15_PM RoundtableDiscussionwithAudienceQA

3:25PM-4:15PM

SessionIII.TranscatheterAorticValveTherapies

Moderators:MartinaKellySpeight

Discussants:MarianC.Hawkey,PatriciaKeegan,VivekRajagopal

3:25_PM DAPTandAnticoagulationPostTAVR:WhatistheStandardofCare Lecturers:PatriciaKeegan

3:35_PM ConductionAbnormalitiesAfterTAVR:ManagementRecommendations Lecturers:MarianC.Hawkey

3:45_PM ClinicalImpactofValveThrombosisAfterTAVR Lecturers:MartinaKellySpeight

3:55_PM DiagnosingandManagingPerivalvularLeakinPostTAVRPatients Lecturers:VivekRajagopal

4:05_PM RoundtablediscussionwithaudienceQA

Page 191: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:191

EVENINGPROGRAM:THEAPPROACHTOTHEHIGHBLEEDINGRISKPATIENT(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,BOSTONSCIENTIFIC

CORPORATION,BIOSENSORS,CELONOVABIOSCIENCES,MEDTRONIC,ANDORBUSNEICH)

SUNDAY,SEPTEMBER23,2018

6:00PM-8:00PM

PacificBallroom14-17,LevelOne

6:00PM-6:30PM

Check-In&Reception

6:30PM-8:00PM

TheApproachtotheHighBleedingRiskPatient

CoChairs:RoxanaMehran,Marie-ClaudeMorice,PhilipM.Urban

Faculty:DominickJ.Angiolillo,RobertA.Byrne,BimmerE.Claessen,GiuseppeDeLuca,C.MichaelGibson,AjayJ.Kirtane,MitchellW.Krucoff,MartinB.Leon,GreggW.

Stone,MarcoValgimigli,MD,RobertW.Yeh

6:30_PM WelcomeandIntroductions Lecturers:PhilipM.Urban

6:32_PM CasePresentationAPatientatHighBleedingRiskandCADRealManagementDilemmas CasePresenter:BimmerE.Claessen

6:37_PM BleedingRiskScores:WhichOneIdentifiestheRiskBest CasePresenter:DominickJ.Angiolillo

6:42_PM BalancingtheRiskofBleedingv.Ischemia:TheTRADEOFFScore CasePresenter:PhilipM.Urban

6:47_PM LeadersPrograms Lecturers:MitchellW.Krucoff

6:52_PM OnyxShortDAPTPrograms Lecturers:GreggW.Stone

6:57_PM XienceShortDAPTPrograms Lecturers:MarcoValgimigli,MD

7:02_PM EVOLVEShortDAPTPrograms Lecturers:AjayJ.Kirtane

7:07_PM COBRAREDUCE Lecturers:RobertA.Byrne

7:12_PM COMBOREDUCE Lecturers:GiuseppeDeLuca

7:17_PM PanelDiscussion7:26_PM DropASA

Lecturers:C.MichaelGibson7:31_PM ReduceDuration

Lecturers:RobertW.Yeh7:36_PM SwitchTherapies

Lecturers:DominickJ.Angiolillo7:41_PM UseNOACs

Lecturers:C.MichaelGibson7:46_PM DefiningtheHighBleedingRiskPatientTheARCHBR

Lecturers:MitchellW.Krucoff7:51_PM Panel8:00_PM Adjourn

EVENINGPROGRAM:ULTRATHINORSIRODES:NOVELTECHNOLOGY,EYE-CATCHINGCASESANDROBUSTEVIDENCE(SPONSOREDBYBIOTRONIK)

SUNDAY,SEPTEMBER23,2018

6:00PM-8:00PM

PacificBallroom23-26,LevelOne

6:00PM-8:00PM

UltrathinOrsiroDES:Noveltechnology,eye-catchingcasesandrobustevidence

Chairs:DavidE.Kandzari

Page 192: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:192

Faculty:SripalBangalore,DavidA.Cox,JamesB.HermillerJr,ThomasPilgrim,DavidG.Rizik,RonWaksman,StevenJ.Yakubov,ClemensvonBirgelen

6:00_PM DinnerReception

6:30_PM MeetBIOTRONIKVI Lecturers:RonWaksman

6:40_PM Productanddataoverview Lecturers:DavidE.Kandzari

6:50_PM WhatsthedealwithultrathinstrutsThefacts. Lecturers:SripalBangalore

7:05_PM Discussion

7:10_PM WhatsthedealwithultrathinstrutsBiocompatibility. Lecturers:ThomasPilgrim

7:25_PM Discussion

7:30_PM WhatsthedealwithultrathinstrutsEffectiveendothelialization. Lecturers:ClemensvonBirgelen

7:45_PM Discussion

7:50_PM Keylearningsandtakeaway Moderators:DavidE.Kandzari

Discussants:DavidA.Cox,JamesB.HermillerJr,DavidG.Rizik,RonWaksman,StevenJ.Yakubov8:00_PM Adjourn

FDATOWNHALLMEETINGPART2:HOTTOPICS

SUNDAY,SEPTEMBER23,2018

2:00PM-6:00PM

Room29A-B,UpperLevel

2:00PM-2:52PM

SessionI.ShamControlledStudies:Regulatory,Clinical,andIndustryPerspectives

Moderators:KennethJ.CavanaughJr,RoxanaMehran

Discussants:JeroenJ.Bax,AnthonyH.Gershlick,StevenL.Goldberg,DavidE.Kandzari,AjayJ.Kirtane,LauraMauri,HirenMistry,MarkReisman,ChuckSimonton,GreggW.

Stone

2:00_PM ORBITAOneYearLater:WhatWouldIDoDifferentlyIfAnything Lecturers:RashaAl-Lamee

2:08_PM ShamControlsinRenalDenervationStudies:NeedtoHavevsNicetoHave Lecturers:LauraMauri

2:16_PM FDAPerspectivesonShamControlledTrials Lecturers:HirenMistry

2:24_PM PatientPerspectivesonShamControlledTrials Lecturers:DebbeMcCall

2:32_PM RoundtableDiscussionwithAudienceQA:ProsAndConsofShamControlledTrials

2:52PM-3:25PM

SessionII.�Accessory�DevicesforTAVR:CaseStudy�CerebralEmbolicProtectionDevices

Moderators:JeffreyJ.Popma,ChangfuWu

Discussants:OriBen-Yehuda,KennethJ.CavanaughJr,HemalGada,PhilippeGenereux,SamirR.Kapadia,A.PieterKappetein,AlexandraJ.Lansky,JohnCLaschinger,

ShawnMcCarthy,StevenJ.Yakubov

2:52_PM CerebralEmbolicProtectionforTAVRProcedures:ACriticalAppraisal Lecturers:SamirR.Kapadia

3:00_PM CerebralEmbolicProtection:RegulatoryPerspectives Lecturers:KennethJ.CavanaughJr

3:08_PM RoundtableDiscussionwithAudienceQA:SafetyandEffectivenessConsiderations

3:25PM-4:01PM

SessionIII.MitralRepair/ReplacementDevices

Moderators:MichaelJ.Mack,ChangfuWu

Page 193: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:193

Discussants:HowardC.Herrmann,JohnCLaschinger,GidonYehudaPerlman,JaimeRaben,HorstSievert,GreggW.Stone,EricVang,BernardVasseur

3:25_PM PivotalTranscatheterFMRDeviceTrials:COAPTMITRA.frReduceFMRACTIVEandMore Lecturers:GreggW.Stone

3:33_PM TranscatheterMitralValveReplacement:TrialDesignConsiderations Lecturers:JohnCLaschinger

3:41_PM RoundtableDiscussionWithAudienceQA:HowMayRecentTrialsAffecttheLandscape

4:01PM-4:37PM

SessionIV.TricuspidRepair/ReplacementDevices

Moderators:JaimeRaben,JosepRodés-Cabau

Discussants:VinayakBapat,RickGeoffrion,StephenH.Little,BrijMaini,ChristopherU.Meduri,StantonJ.Rowe,MaurizioTaramasso,YanTopilsky,BernardVasseur,

BernardZovighian

4:01_PM TranscatheterTricuspidValveTherapies:ChallengingTechnologiesandClinicalTrialPathways Lecturers:JosepRodés-Cabau

4:09_PM RegulatoryConsiderationsforTranscatheterTricuspidValveTherapies Lecturers:BernardVasseur

4:17_PM RoundtableDiscussionwithAudienceQA:DemonstratingsafetyandEfficacyforTRReductionTherapies

4:37PM-5:13PM

SessionV.PercutaneousCirculatorySupportDevices:ClinicalNeeds,PayerConsiderations,andRegulatoryChallenges

Moderators:NicoleIbrahim,DavidE.Kandzari

Discussants:DanielBurkhoff,UlrichP.Jorde,NavinK.Kapur,JohnCLaschinger,MichaelRMinogue,WilliamW.O'Neill,IleanaL.Pina,HolgerThiele,NirUriel

4:37_PM AreRandomizedTrialsFeasibleforPercutaneousMechanicalSupportDevices Lecturers:HolgerThiele

4:45_PM PercutaneousMechanicalSupportDevicesforShockandPreShock:ClinicalandRegulatoryConsiderations Lecturers:JohnCLaschinger

4:53_PM RoundtableDiscussionWithAudienceQA:ReimbursementandRegulatoryChallengesforPercutaneousCirculatorySupportDevices

5:13PM-6:00PM

SessionVI:Drug-CoatedBalloons:CoronaryandPeripheralIndications

Moderators:JuanF.Granada,MichaelC.John

Discussants:BernardoCortese,DonaldCutlip,AlokeV.Finn,AlexandraJ.Lansky,P.F.AdrianMagee,JeffMirviss,SemihOktay,SahilA.Parikh,BrunoScheller,RobertS.

Schwartz,EleniWhatley

5:13_PM DCBforBTK:ClinicalChallengesandLessonsLearned Lecturers:SahilA.Parikh

5:21_PM DCBforCoronaryArteryDisease:InStentRestenosisNSTEMIandSmallVessels Lecturers:BrunoScheller

5:29_PM FDAPerspectivesonDCBinCoronaryandPeripheralInterventions Lecturers:P.F.AdrianMagee

5:37_PM RoundtableDiscussionwithAudienceQA:LeastBurdensomeTrialstoDemonstrateDCBSafetyandEffectiveness

EDITEDTAPEDCASES

SUNDAY,SEPTEMBER23,2018

2:30PM-4:40PM

PresentationTheater3,ExhibitHall,GroundLevel

2:30PM-4:40PM

EditedTapedCases

Moderators:StefanHarb,ChetRihal

Discussants:MatthewJDaniels,AdamJanas,SimonCheung-chiLam,JorgePalazuelos

2:30_PM IntravascularLithotripsyforaSeverelyUnderexpandedCoronaryStent CasePresenter:StuartWatkins

2:42_PM DiscussionandQA

2:50_PM AxillaryArteryAccessforMechanicalCirculatorySupportinPatientswithProhibitivePeripheralArterialDiseaseUndergoingHighriskPCI

Page 194: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|SUNDAY,SEPTEMBER23,2018

LastUpdated09/10/2018Page:194

CasePresenter:AmirKaki3:02_PM Discussion

3:10_PM SelfpositioningTransspetalPunctureandGuidanceSystem CasePresenter:FrancescoMaisano

3:22_PM Discussion

3:30_PM PercutaneousMitralValveinvalveImplanationwithSapien3ProstehsisinFailedMosaicSurgicalValveUsingtheTranseptalApproach CasePresenter:CaterinaGandolfo

3:42_PM Discussion

3:50_PM AltaValveTMVR CasePresenter:AnitaAsgar

4:02_PM Discussion

4:10_PM ModerateSedationLeftAtrialAppendageOcclusion CasePresenter:MohamadAdnanAlkhouli

4:30_PM Discussion

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#5-LARGEBOREACCESSANDCLOSURE

SUNDAY,SEPTEMBER23,2018

8:00AM-9:30AM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

LargeBoreAccessandClosure

8:00_AM PercutaneousAxillaryAccessLargeBoreAccessandClosure:Overview InteractiveTrainingFaculty:AmirKaki,JamesM.McCabe,RajivTayal

8:10_AM HandsonPercutaneousAxillaryAccessLargeBoreAccessandClosure

Page 195: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:195

MONDAY,SEPTEMBER24,2018-

BREAKFASTPROGRAM:CBCECINITIATIVE(SPONSOREDBYCBCEC)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

26A-B

BREAKFASTPROGRAM:CHAT-WITH-EXPERTS:DAPTSTRATEGIESFORMANAGINGHIGH-BLEEDINGRISKDESPATIENTS(SPONSOREDBYABBOTT)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

Room30D-E,UpperLevel

6:30AM-8:00AM

Chat-With-Experts:DAPTStrategiesforManagingHigh-BleedingRiskDESPatients

Faculty:AlokeV.Finn,RoxanaMehran,StephanWindecker

6:30_AM CheckinBreakfast

7:00_AM Welcome Lecturers:RoxanaMehran

7:05_AM CurrentChallengesinManagingHBRPatientsandtheRoleofDES Lecturers:StephanWindecker

7:10_AM ImpactofDESDesignonShortDAPTDuration Lecturers:AlokeV.Finn

7:15_AM LiveQAwithPanelFaculty Lecturers:AlokeV.Finn,RoxanaMehran,StephanWindecker

7:55_AM ClosingRemarks Lecturers:RoxanaMehran

BREAKFASTPROGRAM:CORONARYDRUGCOATEDBALLOONS:EMERGINGCLINICALUSESANDFUTUREDIRECTIONS(SPONSOREDBYCRF,

SUPPORTEDBYB.BRAUNINTERVENTIONALSYSTEMS,INC.)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

Room24A-B,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

CoronaryDrugCoatedBalloons:EmergingClinicalUsesandFutureDirections

CoChairs:JuanF.Granada,BrunoScheller

Faculty:FernandoAlfonso,AntonioColombo,BernardoCortese,RabanJeger,MD

7:00_AM DCBforTreatmentofCoronaryISR:ReviewofLiteratureinComparisonWithDES Lecturers:FernandoAlfonso

7:08_AM DCBOnlyApplicationinSVD:InsightFromtheBASKETSMALL2Trial Lecturers:RabanJeger,MD

7:16_AM DCBOnlyApplicationinHighBleedingRiskDEBUTandACSPEPCADNSTEMI Lecturers:BrunoScheller

7:24_AM ModeratedDiscussion

7:32_AM DCBCoronaryintheUS:ChallengesandOpportunities

7:40_AM InnovationsinLocalDrugandDedicatedDeliveryTechnologies Lecturers:JuanF.Granada

7:48_AM ModeratedDiscussion

8:00_AM Adjourn

Page 196: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:196

BREAKFASTPROGRAM:INTERVENTIONALTHERAPIESFORHYPERTENSION-CURRENTEVIDENCEANDCONTROVERSIES(SPONSOREDBYCRF,

SUPPORTEDBYMEDTRONIC)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

Room23B-C,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

InterventionalTherapiesforHypertension:CurrentEvidenceandControversies

CoChairs:JuanF.Granada,AjayJ.Kirtane,MartinB.Leon

Faculty:DavidE.Kandzari,FelixMahfoud,MichaelA.Weber,MD

7:00_AM WelcomeandIntroductions Lecturers:MartinB.Leon

7:02_AM PreclinicalAdvancesintheUnderstandingofInterventionalHypertensionTherapies Lecturers:FelixMahfoud

7:14_AM ModeratedDiscussion

7:19_AM InCaseYouMissedIt:WhatsHappenedSoVeryRecentlyinRenalDenervation Lecturers:AjayJ.Kirtane

7:31_AM OnMedsorOffMeds:WhatistheSweetSpotforDeviceBasedHypertensionTherapies Lecturers:MichaelA.Weber,MD

7:42_AM RegulatoryandReimbursementChallengesforHypertensionTherapies:MyCrystalBallfortheNext510years Lecturers:DavidE.Kandzari

7:54_AM ModeratedDiscussion

8:00_AM Adjourn

BREAKFASTPROGRAM:LEFTMAINSYMPOSIUM(SPONSOREDBYINDIAMEDTRONIC)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

Room28D-E,UpperLevel

6:30AM-8:00AM

LeftMainSymposium

Faculty:AntonioColombo,GaryS.Mintz

6:30_AM CheckinBreakfast

7:00_AM LeadingtheWayinLeftMain:SymposiumObjective Lecturers:AntonioColombo

7:03_AM LeftMainBifurcation:Wherearewetodayin2018 Moderators:GaryS.Mintz

Discussants:AntonioColombo7:13_AM ImpactofStentDesignonLMBifurcation

Moderators:GaryS.Mintz

Discussants:AntonioColombo7:23_AM Case:LeftMainBifurcationProvisionalStentingTechnique

Moderators:GaryS.Mintz

Discussants:AntonioColombo7:31_AM Case:ImagingGuidedLeftMainPCI

Moderators:GaryS.Mintz

Discussants:AntonioColombo7:39_AM Case:LeftMainTrifurcation

Moderators:GaryS.Mintz7:47_AM Case:RotablationInLeftMain

Moderators:GaryS.Mintz

Discussants:AntonioColombo7:55_AM ConclusionClosingRemarks

Page 197: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:197

BREAKFASTPROGRAM:THECARILLONMITRALCONTOURSYSTEM:RESHAPINGTHECOURSEOFFMR(SPONSOREDBYCARDIACDIMENSIONS)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

Room28A-B,UpperLevel

6:30AM-8:00AM

TheCarillonMitralContourSystem:ReshapingtheCourseofFMR

Chairs:HorstSievert

Faculty:StevenL.Goldberg,SamirR.Kapadia,MartinB.Leon,KlausWitte,MBBS,MRCP,MD,FESC,FACC

6:30_AM CheckinBreakfast

7:00_AM HighlightsfromLateBreakingClinicalTrials:FMRStudies Lecturers:HorstSievert

7:10_AM AHeartFailurePhysiciansPerspectiveonFMR Lecturers:KlausWitte,MBBS,MRCP,MD,FESC,FACC

7:25_AM InsightsontheREDUCEFMRTrial:ARandomizedShamControlledTrial Lecturers:HorstSievert

7:45_AM TheCARILLONTrial:ARandomizedShamcontrolledIDETrial Lecturers:SamirR.Kapadia

7:55_AM SummaryofFMRTrials Lecturers:StevenL.Goldberg

BREAKFASTPROGRAM:UNDERSTANDINGTHECROWDEDLANDSCAPEOFPERCUTANEOUSMITRALINTERVENTIONS(SPONSOREDBYCRF,

SUPPORTEDBYABBOTT)

MONDAY,SEPTEMBER24,2018

6:30AM-8:00AM

Room25A-B,UpperLevel

6:30AM-7:00AM

Check-In&Breakfast

7:00AM-8:00AM

UnderstandingtheCrowdedLandscapeofPercutaneousMitralInterventions

Chairs:TedFeldman

Faculty:WilliamT.Abraham,PaulSorajja

7:00_AM Welcome Lecturers:TedFeldman

7:05_AM StatusofMitraClipTherapyinUSPractice:RealWorldPracticeandOutcomes Lecturers:PaulSorajja

7:20_AM COAPTMitraFranceandReshape:LatestTrialResultsforTranscatheterRepairforFMR Lecturers:WilliamT.Abraham

7:35_AM FutureDirections:ImpactofTrialResultsonPatientSelectionNextGenRepairDevicesandRoleofMitralReplacement Lecturers:TedFeldman

7:50_AM RoundtableDiscussionwithAudienceQA

8:00_AM Adjourn

MAINARENAIII,MONDAY,SEPT.24

MONDAY,SEPTEMBER24,2018

8:00AM-1:05PM

MainArena,HallF,GroundLevel

8:00AM-9:30AM

LiveCases#5

LiveCaseModerators:MartinB.Leon

Page 198: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:198

LiveCaseCoModerators:SaibalKar

LiveCaseDiscussants:SaifAnwaruddin,NiratBeohar,AnthonyN.DeMaria,JonathanM.Hill,AmirKaki,AzeemLatib,RobertJ.Lederman,BrijMaini,Jean-FrancoisObadia

FactoidFaculty:ChristineJ.Chung,AmiraliMasoumi,MeghaPrasad,SabatoSorrentino,EisukeUsui

8:00_AM HeartCenterBonnUniversityHospitalBonnGermany LiveCaseOperators:EberhardGrube,GeorgNickenig

8:45_AM St.PaulsHospitalVancouverBC LiveCaseOperators:JohnG.Webb,DavidA.Wood

9:30AM-10:00AM

RapidFireCaseControversies:Endovascular

Moderators:SahilA.Parikh,ChristopherJ.White

Discussants:HerbertD.Aronow,BrianG.DeRubertis,OsamuIida,D.ChristopherMetzger,VirendraIPatel,MahmoodK.Razavi,PeterA.Soukas

9:30_AM TheOtherTypeOfAorticStenosis:ComplexAortoiliacOcclusiveDisease CasePresenter:EhrinJ.Armstrong

9:40_AM LongCalcifiedSFAChronicOcclusion CasePresenter:LawrenceA.Garcia

9:50_AM ComplexMultilevelCriticalLimbIschemia CasePresenter:CarlosI.Mena-Hurtado

10:00AM-10:15AM

TCT2018LinnemeierYoungInvestigatorAward

AwardPresenters:GreggW.Stone

Discussants:LorenzoAzzalini,SalvatoreBrugaletta,PhilippLurz,LuisNombela-Franco

10:00_AM TCT2018LinnemeierYoungInvestigatorAward Lecturers:GreggW.Stone

10:15AM-10:20AM

TCT2018SharkTankWinner

AwardPresenters:JuanF.Granada,RobertS.Schwartz

10:15_AM SharkTankWinnerPresentation Lecturers:JuanF.Granada

10:20AM-11:20AM

Late-BreakingTrials4

Moderators:GreggW.Stone

CoModerator:C.MichaelGibson

Discussants:TakashiAkasaka,JohnA.Ambrose,DeepakL.Bhatt,DavidErlinge,JohnMcB.Hodgson,RyanD.Madder,GaryS.Mintz,JamesE.Muller,FreekW.A.Verheugt

10:20_AM ULTIMATE:ARandomizedTrialofIntravascularUltrasoundGuidanceofCoronaryDrugElutingStentImplantationinanAllComersPatientPopulation Lecturers:JunjieZhang

10:32_AM RoundtableDiscussion

10:40_AM LRP:AssessmentofCoronaryNearInfraredSpectroscopyImagingtoDetectVulnerablePlaquesandVulnerablePatients Lecturers:RonWaksman

10:52_AM RoundtableDiscussion

11:00_AM OACALONE:ARandomizedTrialofOralAnticoagulationWithvsWithoutSingleAntiplateletTherapyinPatientsWithAtrialFibrillationBeyondOneYear

AfterCoronaryStentImplantation Lecturers:YukikoNakano

11:12_AM RoundtableDiscussion

11:20AM-12:05PM

LiveCases#6

LiveCaseModerators:GreggW.Stone

LiveCaseCoModerators:DavidH.Adams

LiveCaseDiscussants:JonathonA.Leipsic,ScottLim,RandolphP.Martin,DavidW.M.Muller,MichaelJ.Reardon,RobertJ.Siegel,HorstSievert,PaulSorajja,Mathew

Williams

FactoidFaculty:ChristineJ.Chung,AmiraliMasoumi,MeghaPrasad,SabatoSorrentino,EisukeUsui

11:20_AM NYPHColumbiaUniversityMedicalCenterNewYorkNY LiveCaseOperators:MichaelCollins,RebeccaT.Hahn,DimitriKarmpaliotis,SusheelK.Kodali,NicholasJ.Lembo,ManishA.Parikh

12:05PM-1:05PM

Page 199: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:199

Late-BreakingClinicalScience2,Co-SponsoredbyTheEuropeanHeartJournal

Moderators:ThomasF.Luscher

CoModerator:JeroenJ.Bax

Discussants:PawelE.Buszman,JeffChambers,StephenG.Ellis,BernardJ.Gersh,StuartJ.Head,NielsR.Holm,RanKornowski,UlfLandmesser,AlexandraJ.Lansky,Perwaiz

M.Meraj

12:05_PM FASTFFR:AccuracyofFractionalFlowReserveDerivedFromCoronaryAngiography Lecturers:WilliamF.Fearon

12:15_PM RoundtableDiscussion

12:20_PM SYNTAXES:TenYearFollowupFromaRandomizedTrialofDrugElutingStentsvsBypassSurgeryinPatientsWithLeftMainandTripleVesselDisease Lecturers:DanielJ.F.M.Thuijs

12:30_PM RoundtableDiscussion

12:35_PM MAINCOMPARE:TenYearFollowupFromaNonrandomizedTrialofDrugElutingStentsvsBypassSurgeryinPatientsWithLeftMainDisease Lecturers:Seung-JungPark

12:45_PM RoundtableDiscussion

12:50_PM PREPARECALC:ARandomizedTrialofHighspeedRotationalAtherectomyPriortoDrugElutingStentImplantationinSeverelyCalcifiedCoronaryLesions Lecturers:GertRichardt

1:00_PM RoundtableDiscussion

KEYNOTEINTERVENTIONALSTUDIESVII:STRUCTURALHEARTINTERVENTIONSII

MONDAY,SEPTEMBER24,2018

8:00AM-9:00AM

Ballroom6A,UpperLevel

8:00AM-9:00AM

KeynoteInterventionalStudiesVII:StructuralHeartInterventionsII

Moderators:CharlesJ.Davidson,FrancescoMaisano

Discussants:StephanBaldus,AnthonyA.Bavry,PeterC.Block,JosephP.CarrozzaJr,HowardC.Herrmann,VinodH.Thourani,E.MuratTuzcu,MathewWilliams

8:00_AM TENDYNETranscatheterMitralProsthesis:LongtermResultsFromtheFirst100PatientsEnrolledintheGlobalFeasibilityStudy Lecturers:PaulSorajja

8:10_AM Discussion

8:15_AM SAPIENM3TranscatheterMitralValveReplacementSystem:30DayOutcomesFromtheUSEarlyFeasibilityStudy Lecturers:RajMakkar

8:25_AM Discussion

8:30_AM DIRECT:ARandomizedTrialEvaluatingPredilatationPriortoImplantationofaSelfExpandingTranscatheterHeartValveinPatientsWithSevereAortic

Stenosis Lecturers:KonstantinosToutouzas

8:40_AM Discussion

8:45_AM CENTERCollaborationII:IncidencePredictorsandOutcomesofStrokeinPatientsUndergoingTranscatheterHeartValveImplantationforSevereAortic

Stenosis Lecturers:WienekeVlastra

8:55_AM Discussion

KEYNOTEINTERVENTIONALSTUDIESVIII:PHARMACOTHERAPYTRIALSANDHIGHBLEEDINGRISKPATIENTS

MONDAY,SEPTEMBER24,2018

9:00AM-10:15AM

Ballroom6A,UpperLevel

9:00AM-10:15AM

KeynoteInterventionalStudiesVIII:PharmacotherapyTrialsandHighBleedingRiskPatients

Moderators:DominickJ.Angiolillo,NealS.Kleiman

Discussants:StephanAchenbach,TayoA.Addo,DimitriosAlexopoulos,DmitriyN.Feldman,Hyeon-CheolGwon,KurtHuber,NormanE.Lepor,ThomasD.Stuckey

9:00_AM GLOBALLEADERS:ARandomizedTrialofTicagrelorMonotherapyAfterPCIPatientOrientedClinicalOutcomesandNetAdverseCardiovascularEvents Lecturers:PatrickW.Serruys

Page 200: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:200

9:10_AM Discussion

9:15_AM GLOBALLEADERS:FirstReportoftheResultsinACSandNonACSSubgroups Lecturers:PascalVranckx

9:25_AM Discussion

9:30_AM HEALINGAMI:ARandomizedTrialofTicagrelortoImproveLeftVentricularRemodelinginSTSegmentElevationMyocardialInfarction Lecturers:YongwhiPark

9:40_AM Discussion

9:45_AM SECUREPCI:ImpactofTimingofAtorvastatinLoadingDoseinPatientsUndergoingPCIforAcuteCoronarySyndromes Lecturers:RenatoD.Lopes

9:55_AM Discussion

10:00_AM EVOLVESHORTDAPT:ThreeMonthOutcomesonDualAntiplateletTherapyinaHighBleedingRiskPopulationTreatedWithaBioresorbablePolymer

BasedDrugElutingStent Lecturers:AjayJ.Kirtane

10:10_AM Discussion

KEYNOTEINTERVENTIONALSTUDIESIX:FOURFASCINATINGANDVERYDIFFERENTSTUDIES

MONDAY,SEPTEMBER24,2018

1:00PM-2:00PM

Ballroom6A,UpperLevel

1:00PM-2:00PM

KeynoteInterventionalStudiesIX:FourFascinatingandVeryDifferentStudies

1:00_PM REDUCEHTN:REINFORCE:AShamControlledOffMedRandomizedTrialofRenalDenervationforTreatmentofHypertension Lecturers:MichaelA.Weber

1:10_PM Discussion

1:15_PM ARCUS:ComprehensiveAssessmentofUpperExtremityFunctionAfterTransradialPCI Lecturers:A.J.J.IJsselmuiden

1:25_PM Discussion

1:30_PM TAKOTSUBOSWEDEHEART:EffectsofPharmacologicalInterventionsonMortalityinPatientsWithTakotsuboSyndrome Lecturers:ElmirOmerovic

1:40_PM Discussion

1:45_PM CEREBRIA1:MachineLearningvsExpertHumanOpiniontoDeterminePhysiologicallyOptimizedCoronaryRevascularizationStrategies Lecturers:JustinE.Davies

1:55_PM Discussion

DIDACTICSESSION:PHYSIOLOGICLESIONASSESSMENTANDINTERVENTIONALPLANNING

MONDAY,SEPTEMBER24,2018

8:00AM-12:00PM

Room2,UpperLevel

8:00AM-9:00AM

SessionI.Non-invasiveImagingtoGuideRevascularization

Moderators:PamelaS.Douglas,JavierEscaned

Discussants:ColinBerry,NickCurzen,PaulKnaapen,RanKornowski,MichaelMooney

8:00_AM PhysiologyCaseVignette1:PullingtheFFRCTRIPCORD CasePresenter:NickCurzen

8:05_AM RelativeDiagnosticperformanceofNonInvasiveTestsVersusFFR:ThePACIPICStudy. Lecturers:PaulKnaapen

8:13_AM FFRCT:FromPLATFORMtoPRECISE Lecturers:PamelaS.Douglas

8:21_AM FFRCT:InteractiveVirtualStentingandDECISION Lecturers:GreggW.Stone

8:29_AM FFRCTinEverydayPracticeTODAY:AHowtoGuide

Page 201: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:201

Lecturers:MichaelMooney8:37_AM CardiacMRIasPhysiologicGatekeeper:TheMRINFORMTrial

Lecturers:ColinBerry8:45_AM PhysiologyCaseVignette2:AngiographyDerivedFFR

CasePresenter:RanKornowski8:50_AM RoundtableDiscussionWithAudienceQA

9:00AM-10:00AM

SessionII.FractionalFlowReserve(FFR)toGuideRevascularization

Moderators:WilliamF.Fearon,NilsJohnson

Discussants:Jung-MinAhn,ThomasEngstrøm,OleFröbert,HabibSamady,EricVanBelle,FrederikM.Zimmermann

9:00_AM PhysiologyCaseVignette3:FFRGuidanceinMultivesselDisease CasePresenter:EricVanBelle

9:05_AM CanFFRGuidedPCIReduceDeathandMI Lecturers:FrederikM.Zimmermann

9:15_AM FFRArtifactsFailuresandTroubleshooting Lecturers:ThomasEngstrøm

9:25_AM PhysiologyCaseVignette4:FFRAssessmentofaNonACSCulpritLesion CasePresenter:NielsvanRoyen

9:30_AM FFRinNonCulpritACSLesions:WhatToDoBeforeFULLREVASC Lecturers:FelixBohm

9:40_AM FFRAfterPCI:ShouldWeREACT Lecturers:ZsoltPiroth

9:50_AM RoundtableDiscussionWithAudienceQA

10:00AM-11:00AM

SessionIII.RestingPhysiologytoGuideRevascularization

Moderators:JustinE.Davies

Discussants:MichalisHamilos,LeandroILasave,SamerMansour,SukhjinderSNijjer,Seung-JungPark,AndrewSharp

10:00_AM PhysiologyCaseVignette5:UtilizationofiFRinComplexPCI CasePresenter:Seung-JungPark

10:05_AM IsiFRGuidedRevascularizationEffectiveandCostSaving

10:15_AM DiastolicPressureRatiosdPR:ImplicationsforPhysiologyandPractice Lecturers:NilsJohnson

10:25_AM PhysiologyCaseVignette6:TandemLesions Lecturers:AndrewSharp

10:30_AM PullbackAssessmentAtRest:SpottheProblem Lecturers:JustinE.Davies

10:40_AM ClinicalConundrum:WhenRestingandHyperemicPressureIndicesDisagree Lecturers:TimP.VandeHoef

10:50_AM RoundtableDiscussionWithAudienceQA

11:00AM-12:00PM

SessionIV.InvasiveFlowAssessmenttoGuideRevascularization

Moderators:MortonJ.Kern,JanJ.Piek

Discussants:RashaAl-Lamee,GiuseppeDeLuca,OleFröbert,ZsoltPiroth,AfzalurRahman,TimP.VandeHoef

11:00_AM PhysiologyCaseVignette7:CombinedPressureFlowinPractice CasePresenter:MortonJ.Kern

11:05_AM WhenPressureandFlowDisagree:TheDEFINEFLOWTrial. Lecturers:JanJ.Piek

11:15_AM AbsoluteFlowandResistanceasanEverydayTool:TechniqueandApplications

11:25_AM PhysiologyCaseVignette8:IMRMadetheDiagnosis CasePresenter:AfzalurRahman

11:30_AM UtilityofIMRinStableAnginaandinSTEMICulprits Lecturers:WilliamF.Fearon

11:40_AM AssessingChestPainWithInvasivePhysiology:LessonsFromOrbitaandOtherStudies Lecturers:RashaAl-Lamee

Page 202: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:202

11:50_AM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:THECTOSUMMIT,PART1:EVIDENCE.TECHNIQUE,ANDPROGRAMBUILDING

MONDAY,SEPTEMBER24,2018

8:00AM-12:00PM

Room5,UpperLevel

8:00AM-9:00AM

SessionI.CTOPCIin2018:ControversialDataandDebates

Moderators:JohnA.Spertus,RobertW.Yeh

Discussants:EvaldH.Christiansen,CarloDiMario,J.AaronGrantham,Seung-HwanLee,BarryD.Rutherford,GeraldS.Werner

8:00_AM DataAnalysis:TheBigThreeTrialsDecisionCTOEUROCTOOPENCTO Lecturers:AjayJ.Kirtane

9:00AM-10:30AM

SessionII.ProceduralBasics

Moderators:AlfredoR.Galassi,R.MichaelWyman

Discussants:RaviS.Hira,UngiImre,ArunKalyanasundaram,ArasiMaran,MitulPatel,JuliaSeeger,MasahisaYamane

9:00_AM The2018EssentialToolboxforCTOPCI:WiresMicroCathetersandOtherAncillaryDevices Lecturers:RobertF.Riley

9:10_AM InnovationinCTOPCI:WhyAreWeGettingBetter Lecturers:MasahisaYamane

9:20_AM RoundtableDiscussionWithAudienceQA

9:30_AM BasicPrinciplesofWireManipulation Lecturers:WilliamL.Lombardi

9:40_AM RoundtableDiscussionWithAudienceQA

9:45_AM AngiogramPerformanceandEvaluationfortheCTOOperator:ProximalCapDistalCapLesionLengthandCollateralAssessment Lecturers:MargaretB.McEntegart

9:55_AM RoundtableDiscussionWithAudienceQA

10:00_AM ContemporaryAntegradeDissectionandReEntry:StepbyStepTechnique Lecturers:AshishPershad

10:10_AM RoundtableDiscussionWithAudienceQA

10:15_AM TheRetrogradeApproach:StepbyStepInstructions Lecturers:WilliamNicholson

10:25_AM RoundtableDiscussionWithAudienceQA

10:30AM-12:00PM

SessionIII.CTOTroubleShootingandAlgorithmsforSuccess

Moderators:JavierEscaned,GeraldS.Werner

Discussants:MauroCarlino,OmerGoktekin,SanjogKalra,VincentOn-HingKwok,SCWong,LuizFYbarra

10:30_AM WireCrossesProximalCapbuttheProximalorDistalCapisUncrossableorUndilatable:WhatNow

10:40_AM RoundtableDiscussionWithAudienceQA

10:45_AM ADRisnotWorking:WhatNow Lecturers:TonyJ.DeMartini

10:55_AM RoundtableDiscussionWithAudienceQA

11:00_AM TheWireHasCrossedtheCollateralbuttheMicrocatheterWont:NextSteps Lecturers:AshishPershad

11:10_AM RoundtableDiscussionWithAudienceQA

11:15_AM TheREVERSECARTisNotWorking:WhatNow Lecturers:MasahisaYamane

11:25_AM RoundtableDiscussionWithAudienceQA

11:30_AM HemodynamicSupportforCTOPCI:WhoWhenandHow Lecturers:JamesM.McCabe

Page 203: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:203

11:40_AM RoundtableDiscussionWithAudienceQA

11:45_AM FailingwithStyle:TheConceptoftheSubIntimalPlaqueModificationSPMandSTARWithDeferredStenting Lecturers:PatrickJGoleski

11:55_AM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:TRANSCATHETERMITRALVALVETHERAPIES,PART2-TRANSCATHETERMITRALVALVEREPLACEMENT(TMVR)

MONDAY,SEPTEMBER24,2018

8:00AM-12:15PM

Room1,UpperLevel

8:00AM-8:57AM

SessionI.TMVRPatientSelection/TrialDesign

Moderators:DavidH.Adams,ShmuelBanai

Discussants:AnitaAsgar,StevenF.Bolling,TedFeldman,AlexanderLauten,RajMakkar,AllanSchwartz,RalphStephanvonBardeleben

8:00_AM TMVRforSecondaryMR:WhyEliminationofMRCanBeBeneficial Lecturers:WilliamT.Abraham

8:07_AM WhyTMVRforSecondaryMRMayNotBeEnough:ItsaDiseaseoftheLeftVentricleNottheMitralValve Lecturers:JoAnnLindenfeld

8:14_AM TheEssentialsofCTImagingforTMVR Lecturers:JonathonA.Leipsic

8:21_AM AdverseOutcomesinEarlyFeasibilityTMVRStudies:IsitthePatienttheDeviceortheImplantTechnique

8:28_AM TranscatheterRepairorReplacementforSecondaryMRRiskBenefitAnalysis Lecturers:JasonH.Rogers

8:35_AM ShouldandWillCOAPTAffectTMVRTrialDesignandPatientRecruitment Lecturers:MichaelJ.Mack

8:42_AM RoundtableDiscussionWithAudienceQA

8:57AM-10:34AM

SessionII.EarlyTMVRFeasibilityandPivotalTrials

Moderators:MichaelJ.Mack,DavidW.M.Muller

Discussants:GregoryP.Fontana,RajMakkar,BernardPrendergast,JasonH.Rogers,PaulSorajja,RashmiYadav

8:57_AM Intrepid:DeviceAttributesImplantProcedureClinicalResultsandAPOLLODesignandStatus Lecturers:MichaelJ.Reardon

9:07_AM Tendyne:DeviceAttributesImplantProcedureClinicalResultsandSUMMITDesignandStatus Lecturers:GoravAilawadi

9:17_AM Tiara:DeviceAttributesImplantProcedureandClinicalResults Lecturers:ShmuelBanai

9:25_AM HighLife:DeviceAttributesImplantProcedureandClinicalResults Lecturers:RuedigerS.Lange

9:33_AM Cephea:DeviceAttributesImplantProcedureandFirstinHuman Lecturers:JuanF.Granada

9:41_AM CardiAQ:DeviceAttributesImplantProcedureandEarlyResults Lecturers:MollySzerlip

9:49_AM SapienM3:DeviceAttributesImplantProcedureandEarlyResults Lecturers:RajMakkar

9:57_AM Caisson:DeviceAttributesImplantProcedureandEarlyResults Lecturers:MathewWilliams

10:05_AM CardioValve:DeviceAttributesImplantProcedureandEarlyResults Lecturers:FrancescoMaisano

10:12_AM ALTAValve:DeviceAttributesImplantProcedureandFirstinHuman Lecturers:PhilippeGenereux

10:19_AM RoundtableDiscussionWithAudienceQA

10:34AM-11:27AM

SessionIII.ComplicationsofTMVR:WhatCanGoWrong?

Moderators:JamesB.HermillerJr,WilsonY.Szeto

Page 204: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:204

Discussants:KhalilFattouch,SameerGafoor,AdamB.Greenbaum,RogerJ.Laham,RuedigerS.Lange,Jean-FrancoisObadia

10:34_AM ThePanoramaofExpectedandUnexpectedComplicationsofTMVR Lecturers:PaulSorajja

10:44_AM CasePresentation:ParavalvularLeakWithHemolysis CasePresenter:RogerJ.Laham

10:52_AM CasePresentation:DeteriorationofLVSystolicFunctionWorsenedHeartFailureDespiteSuccessfulTMVR CasePresenter:AlfredoTrento

11:00_AM CasePresentation:LeftVentricularOutflowTractObstruction CasePresenter:JaffarMKhan

11:08_AM TheLAMPOONProcedure:DescriptionandClinicalOutcomes Lecturers:RobertJ.Lederman

11:15_AM RoundtableDiscussionWithAudienceQA

11:27AM-12:15PM

SessionIV.TMVRPotpourriandFutureDirections

Moderators:HowardC.Herrmann,VinodH.Thourani

Discussants:AndreaColli,JanKovac,ThomasModine,MaurizioTaramasso,HendrikTreede,AlfredoTrento

11:27_AM MovingFromTransapicaltoTransseptalImplantation:WhatAretheTechnicalandAnatomicChallengesandWillWeGetThere Lecturers:JasonH.Rogers

11:34_AM AddressingtheHurdles:EmergingDevicesandNovelValveDesigns Lecturers:VinodH.Thourani

11:42_AM ApproachestoSevereMitralAnnularCalcification:TranscatheterRepairorReplacement Lecturers:MayraGuerrero

11:52_AM UpdateonValveinValveandValveinRingOutcomes Lecturers:DannyDvir

12:02_PM RoundtableDiscussionandWrapUp

DIDACTICSESSION:VASCULARACCESSANDINTERVENTION:RADIALACCESSANDBEYOND

MONDAY,SEPTEMBER24,2018

8:00AM-12:00PM

Room6D,UpperLevel

8:00AM-9:00AM

SessionI.StepbyStepFundamentals�RadialandUlnarApproachModerators:OlivierF.Bertrand,SunilV.Rao

Discussants:MirvatAlasnag,JayBagai,BinitaShah,AdhirShroff,JenniferA.Tremmel,MladenI.Vidovich

8:00_AM RadialAccessTechniquesIncludingLDTRAandEmergingLargeBore Lecturers:RajivGulati

8:12_AM DistalRadialvsTransradialAccessSuccessandComplications:TheD.A.T.A.Study Lecturers:SanjayKumarChugh

8:20_AM StrategiestoTraversetheArmandChestVessels Lecturers:RobertJ.Applegate

8:28_AM RadialAccessandCHIP:AreTheyCompatible Lecturers:PrashantKaul

8:36_AM SpecialPopulationsforRadialAccess:PostmastectomyESRDandShock Lecturers:IanC.Gilchrist

8:44_AM UlnarAccess:WhyWhenandHow Lecturers:SunilV.Rao

8:52_AM RoundtableDiscussionWithAudienceQA

9:00AM-10:00AM

SessionII.FemoralandAlternativeAccess

Moderators:JamesM.McCabe,TobyRogers

Discussants:RobertJ.Applegate,AdamB.Greenbaum,CindyL.Grines,ZacharySteinberg,JenniferA.Tremmel,ZoltanG.Turi

9:00_AM PrimeronUltrasoundGuidedArterialAccessRadialUlnarLDTRAFemoralandPedal:APrimer Lecturers:KathleenE.Kearney

Page 205: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:205

9:10_AM LargeBoreFemoralAccessandPreClosure Lecturers:CurtissT.Stinis

9:20_AM PrimeronTranscavalAccess Lecturers:JaffarMKhan

9:30_AM PrimeronPercutaneousAxillary Lecturers:RajivTayal

9:40_AM AddressingtheAchillesHeelofEachAlternativeAccessMethod Lecturers:JamesM.McCabe

9:50_AM RoundtableDiscussionWithAudienceQA

10:00AM-11:00AM

SessionIII.BleedingandClosure

Moderators:KimberlyA.Skelding,RobertW.Yeh

Discussants:MirvatAlasnag,RodrigoBagur,PerwaizM.Meraj,ChristopherPyne,SunilV.Rao,JeffreyM.Schussler

10:00_AM RadialHemostasisandPreservingRadialPatency Lecturers:SamirB.Pancholy

10:10_AM CurrentGenerationClosureDevicesHowDoTheyWorkAreThereAnyDatatoCompareThem Lecturers:ZoltanG.Turi

10:20_AM ClosureDevicesvs.ManualPressureforStandardSheathsRadialandFemoralWhatAretheData Lecturers:RobertW.Yeh

10:30_AM UpdateonNextGenerationClosureDevices Lecturers:ItshacItsikBen-dor

10:40_AM DoFemoralSkillsSufferatHighVolumeRadialCenters Lecturers:PinakB.Shah

10:50_AM RoundtableDiscussionWithAudienceQA

11:00AM-12:00PM

SessionIV.AccessSiteComplications:TipsandTricks

Moderators:FernandaNunez,BinitaShah

Discussants:KeithB.Allen,UsmanBaber,YujiIkari,DuaneS.Pinto,SheilaSahni,YaderSandoval

11:00_AM FemoralAccessNightmares:DealingWithComplications Lecturers:ItshacItsikBen-dor

11:10_AM IHaveLargeBoreFemoralAccessButthePatientHasNoDistalPerfusion Lecturers:AmirKaki

11:20_AM DealingWithRadialandUlnarAccessSiteComplications Lecturers:MauricioG.Cohen

11:30_AM MyClosureDeviceDidntWorkWhatNow Lecturers:KhaldoonAlaswad

11:40_AM CanIPutaCoveredStentAcrossThisJointSpaceorDoINeedtoCallaSurgeon Lecturers:EhrinJ.Armstrong

11:50_AM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:INTERVENTIONALTHERAPIESFORARTERIALHYPERTENSION-RENALDENERVATIONANDBEYOND

MONDAY,SEPTEMBER24,2018

2:00PM-6:15PM

Room6D,UpperLevel

2:00PM-2:50PM

SessionI.Hypertension2018Update

Moderators:VasiliosPapademetriou,PaulA.Sobotka

Discussants:CheeTangChin,GerardoPayro,C.VenkataS.Ram,KinturSanghvi,StephenC.Textor,MitchellWeinberg

2:00_PM Hypertension2018Update:FromAmbulatoryMonitoringtoDefinitionalControversiesandMore Lecturers:MichaelA.Weber

2:10_PM 2018EuropeanGuidelinesandPerspectivesonHypertension Lecturers:AdamWitkowski

2:17_PM HavetheNewU.S.HypertensionGuidelinesandTreatmentTargetsMeaningfullyChangedCarePathwaysandPractice Lecturers:PaulA.Sobotka

Page 206: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:206

2:24_PM UncontrolledHypertensionorNonCompliantPatientAssessmentScopeoftheProblemandImplications Lecturers:C.VenkataS.Ram

2:31_PM ClinicallyEffectiveStrategiesforBloodPressureControlin2018

2:38_PM RoundtableDiscussionWithAudienceQA

2:50PM-3:30PM

SessionII.ManagementofHypertension:TreatmentOptions

Moderators:MarkC.Bates,BernardJ.Gersh

Discussants:HerbertD.Aronow,JoostDaemen,JustinE.Davies,FranzX.Kleber,MelvinD.Lobo,FarrellO.Mendelsohn

2:50_PM PotentialInterventionsforHypertensivePatientsWithHFpEF Lecturers:FranzX.Kleber

3:30PM-5:20PM

SessionIII.RenalDenervationin2018:WhatHaveWeLearned?

Moderators:ThomasF.Luscher,FelixMahfoud

Discussants:IvoPetrov,KrishnaJ.Rocha-Singh,RobertL.Wilensky,AdamWitkowski,WojtekWojakowski

3:30_PM ResultsandUpdateFromtheSPYRALHypertensionProgramOFFMEDandONMEDTrials Lecturers:DavidE.Kandzari

3:41_PM ResultsandUpdateFromtheParadiseHypertensionProgramOFFMEDandONMEDStudies Lecturers:AjayJ.Kirtane

3:52_PM ResultsandUpdateFromtheVessixREINFORCEProgram Lecturers:MartinB.Leon

4:03_PM AlcoholMediatedRenalDenervationCurrentStatusandUSPivotalTrialPlans Lecturers:FelixMahfoud

4:10_PM ClinicalTrialsAllLookPositive:IsRenalDenervationReadyforClinicalPracticeNow Lecturers:ChandanDevireddy

4:17_PM RoundtableDiscussionWithAudienceQA

4:30_PM TrialsinRenalDenervation:HowMuchBloodPressureReductionisEnough Lecturers:ThomasF.Luscher

4:37_PM WhoaretheIdealCandidatesforRenalDenervation Lecturers:AndrewSharp

4:44_PM PredictingRespondersvsNonRespondersHowtoSolvetheUnmetNeed Lecturers:JustinE.Davies

4:51_PM SensingRenalNerveActivityBeforeDuringandAfterDenervation:Autonomix Lecturers:RobertS.Schwartz

4:58_PM SensingRenalNerveActivityBeforeDuringandAfterDenervation:SyMap Lecturers:JieWang

5:05_PM RoundtableDiscussionWithAudienceQA

5:20PM-6:15PM

SessionIV.Device-BasedHypertensionTherapiesBeyondRenalDenervation

Moderators:MarkC.Bates,FarrellO.Mendelsohn

Discussants:StevenL.Almany,StefanC.Bertog,DanielBurkhoff,JoostDaemen,PiotrJankowski,ChristianUkena

5:20_PM TargetsforDeviceBasedHypertensionTreatmentsBeyondtheKidneys:PhysiologyRevisited Lecturers:FarrellO.Mendelsohn

5:28_PM CarotidBodyEndovascularBaroreflexAmplificationVascularDynamicsMobiusHD:CurrentStatus Lecturers:GreggW.Stone

5:36_PM TranscatheterCarotidBodyDenervationCibiem:ExtendedFollowUpandFutureDirections Lecturers:FelixMahfoud

5:44_PM AVFistulaCreationROXCoupler:EfficacyandSafetyResults Lecturers:KrishnaJ.Rocha-Singh

5:52_PM PacemakerMediatedHypertensionTreatmentBackBeat:FirstinManResultsandOngoingPlans Lecturers:DanielBurkhoff

6:00_PM RoundtableDiscussionWithAudienceQA

DIDACTICSESSION:LEFTATRIALAPPENDAGECLOSUREINNONVALVULARATRIALFIBRILLATION

Page 207: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:207

MONDAY,SEPTEMBER24,2018

2:00PM-6:00PM

Room2,UpperLevel

2:00PM-3:20PM

Session1:DecisionsandPracticalConsiderations

Moderators:JamesB.HermillerJr,DavidHildick-Smith

Lecturers:KishoreJ.Harjai

Discussants:StefanC.Bertog,PatrickA.Calvert,TedFeldman,SameerGafoor,HabibGamra,PetrNeuzil

2:00_PM StrokeEtiologyLAAClosureandtheTherapeuticLandscape:ANeurologistsPerspective Lecturers:DavidE.Thaler

2:10_PM Debate:IsLAAClosureaValidAlternativeforPatientsWithNoorMildContraindicationstoAnticoagulantsNoNOACsAreStronglyPreferredtoLAA

Closure Lecturers:FreekW.A.Verheugt

2:18_PM Debate:IsLAAClosureaValidAlternativeforPatientswithNoorMildContraindicationstoAnticoagulantsYesLAAClosureReducesHemorrhagicStroke

andMortalityAndNearlyEveryoneHasaReasonNottoTakeOralAnticoagulants Lecturers:DavidR.HolmesJr.

2:26_PM SharedDecisionmakinginNVAF:ThePatientsPerspective Lecturers:MeganCoylewright

2:34_PM RoundtableDiscussionWithAudienceQA

2:44_PM EssentialofPreproceduralImagingandIntraproceduralGuidance Lecturers:JacquelineSaw

2:54_PM AdjunctivePharmacologyFollowingLAAClosureinAnticoagulantIndicatedandContraindicatedPatients Lecturers:MartinW.Bergmann

3:02_PM ManagingaBusyLAAClosureProgram:PatientSelectionEducationConsentScreeningandPeriproceduralCare Lecturers:GeorgeS.Hanzel

3:10_PM RoundtableDiscussionWithAudienceQA

3:20PM-4:36PM

Session2:OngoingInvestigationsinLAAClosure

Moderators:VivekY.Reddy,BrianK.Whisenant

Discussants:StevenR.Bailey,MauriceBuchbinder,UlfLandmesser,RandallJ.Lee,MatthewJ.Price,MichaelJ.Rinaldi

3:20_PM TheLAAORegistry:OverviewDataAdjudicationandEmergingInsights Lecturers:PaulD.Varosy

3:30_PM RealWorldWatchmanExperience:SafetyandOutcomesFromTheLAAORegistry Lecturers:ZoltanG.Turi

3:40_PM FDAPerspectivesonNewDevicesandIndicationsforLAAClosure Lecturers:AndrewFarb

3:50_PM TheWatchmanPlatformASAPTooandFlex:RationaleDeviceandOverviewoftheTrials Lecturers:VivekY.Reddy

4:00_PM TheAmuletPlatformExperienceandUSPivotalTrial Lecturers:ApostolosTzikas

4:10_PM TheWaveCrestDeviceandUSPivotalTrial Lecturers:GreggW.Stone

4:18_PM TheWatchTAVRTrial:RationaleDesignandStatus Lecturers:SamirR.Kapadia

4:26_PM RoundtableDiscussionWithAudienceQA

4:36PM-6:00PM

Session3:EstablishedandEmergingDevices

Moderators:SaibalKar,HorstSievert

Discussants:PhilippeGarot,JanKovac,AshishPershad,RamonQuesada,PeterB.Sick,BrianK.Whisenant

4:36_PM OptimalTechniqueandTipsforWatchmanImplantation Lecturers:SaibalKar

4:46_PM OptimalTechniqueandTipsforAmuletImplantation Lecturers:HorstSievert

4:56_PM Cardia:DifferentiatingFeaturesTechniqueandOutcomes Lecturers:RedaIbrahim

5:06_PM SeaLA:DifferentiatingFeaturesTechniqueandOutcomes

Page 208: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:208

Lecturers:KoljaSievert5:16_PM EpicardialLAAclosure:FromSurgicalResultstoTranspericardialApplications

Lecturers:KrzysztofBartus5:26_PM TheBigPicture:ChoosingtheRightDevicefortheRightAnatomy

Lecturers:HorstSievert5:36_PM LAAClosure:ChallengingCaseVignettes

CasePresenter:RedaIbrahim5:46_PM RoundtableDiscussionwithAudienceQA

DIDACTICSESSION:STEMI,CARDIACARREST,ANDCARDIOGENICSHOCK

MONDAY,SEPTEMBER24,2018

2:00PM-6:08PM

Room1,UpperLevel

2:00PM-2:57PM

SessionI.CoronaryFlow:NoReflowandInfarctSizeInSTEMI

Moderators:MortonJ.Kern,GrahamNichol

Discussants:SorinJ.Brener,RajivGulati,NealS.Kleiman,DharamJ.Kumbhani,AmirLerman,DivakaPerera

2:00_PM DeviceVersusDrugBasedApproachestoLimitNoReflowInSTEMI Lecturers:MauricioG.Cohen

2:07_PM TheRoleofFFRiFRiMRandWIAInEvaluatingCulpritLesionandVesselFlowInSTEMI Lecturers:KalpaDeSilva

2:14_PM RecognitionDiagnosisandManagementofSpontaneousCoronaryArteryDissection Lecturers:JacquelineSaw

2:21_PM CasePresentation1:NoReflowAfterPrimaryPCI CasePresenter:NimaAghili

2:28_PM DevicestoReduceInfarctSizeinSTEMI Lecturers:GreggW.Stone

2:38_PM MechanismsandTreatmentOptionsforMINOCA Lecturers:FrancescoPelliccia

2:45_PM RoundtableDiscussionwithAudienceQA

2:57PM-3:49PM

SessionII.MultivesselPCIinSTEMI

Moderators:AnthonyH.Gershlick,PieterC.Smits

Discussants:BernardoKremerDinizGonçalves,CindyL.Grines,SanjitS.Jolly,RanKornowski,MohamedAhmedSobhy,JacquelineE.Tamis-Holland

2:57_PM RationaleandDataforMultivesselPCIinSTEMI Lecturers:PieterC.Smits

3:04_PM ManagementofNonCulpritCTOinSTEMI Lecturers:EmmanouilS.Brilakis

3:11_PM TheRoleofFFRiFRandiMRinAssessingNonCulpritLesionsandVesselsinSTEMI Lecturers:JooMyungLee

3:18_PM FlashDebate1:BasedonWhatWeKnowRoutineMultivesselRevascularizationAcuteorDelayedIsthePreferredStrategy Lecturers:ThomasEngstrøm

3:24_PM FlashDebate1:BasedonWhatWeDontKnowCulpritLesionOnlyPCIWithaConservativeApproachIsthePreferredStrategy Lecturers:DeepakL.Bhatt

3:30_PM CasePresentation2:AHighRiskComplexPatientWithSTEMIandMultivesselDisease Lecturers:MarwanF.Jumean

3:37_PM RoundtableDiscussionwithAudienceQA

3:49PM-5:22PM

SessionIII.CardiogenicShock

Moderators:VladimirDzavik,RichardSmalling

Discussants:RameshK.Adiraju,NicolaCorvaja,VasimFarooq,SanjogKalra,SimonRedwood,BarryD.Rutherford

3:49_PM DefiningCardiogenicShockfor2018andtheFuture:HemodynamicvsHemometabolicShock Lecturers:NavinK.Kapur

3:57_PM HemodynamicSupport:WhichDeviceforWhichPatientandWhy

Page 209: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:209

Lecturers:DanielBurkhoff4:05_PM UsingHemodynamicstoGuideDecisionMakinginCardiogenicShock

Lecturers:SalvatoreFMannino4:13_PM DoortoSupport:TheNewMetricforSuccessWithCardiogenicShock

Lecturers:WilliamW.O'Neill4:21_PM HubandSpokeStrategiesforCardiogenicShock:WhataretheEssentialElements

Lecturers:HolgerThiele4:29_PM FlashDebate2:VAECMOIstheOptimalSupportPlatformforCardiogenicShock

Lecturers:MichaelMooney4:36_PM FlashDebate2:ImpellaIstheOptimalSupportPlatformforCardiogenicShock

Lecturers:PerwaizM.Meraj4:43_PM PostCathLabManagementofShock:WhatstheRoleoftheInterventionalist

Lecturers:MichaelJ.Lim4:51_PM CasePresentation3:STEMIWithCardiogenicShockandNoSimpleOptionsforMCS

CasePresenter:BiswajitKar4:59_PM EssentialElementsforaContemporaryShockTrial

Lecturers:JamesE.Udelson5:07_PM RoundtableDiscussionwithAudienceQA

5:22PM-6:08PM

SessionIV.CardiacArrest

Moderators:NavinK.Kapur

Discussants:DavidABaran,JasonNeilKatz,MichelR.LeMay,RobertT.Pyo,IvanC.Rokos,ChristianM.Spaulding

5:22_PM ToCathorNottoCathinOHCA:DataandDecisionMakingCriteria Lecturers:ChristianM.Spaulding

5:29_PM HemodynamicSupportandHypothermiaStrategiesforCardiacArrest Lecturers:MichaelMooney

5:37_PM FlashDebate3:VAECMOIsBestImplementedbytheInterventionalist Lecturers:SandeepNathan

5:43_PM FlashDebate3:VAECMOIsBestImplementedbytheCardiacSurgeon Lecturers:HirooTakayama

5:49_PM CasePresentation4:OHCAWithUncertainNeurologicStatus CasePresenter:TanveerRab

5:56_PM RoundtableDiscussionwithAudienceQA

DIDACTICSESSION:THECTOSUMMIT,PART2:COMPLICATIONS

MONDAY,SEPTEMBER24,2018

2:00PM-6:00PM

Room5,UpperLevel

2:00PM-2:30PM

SessionI.HowtoHandleDisaster

Moderators:JonathanM.Hill,WilliamL.Lombardi

Discussants:LeszekBryniarski,M.NicholasBurke,LeiGe,PaulHsien-LiKao,WilliamNicholson

2:00_PM ComplicationLessonsFromthePROGRESSCTORegistry Lecturers:IosifXenogiannis

2:10_PM RoundtableDiscussionWithAudienceQA

2:15_PM ComplicationLessonsFromOPENCTO Lecturers:AdamC.Salisbury

2:25_PM RoundtableDiscussionWithAudienceQA

2:30PM-4:00PM

SessionII.ComplicationManagement

Moderators:JaikirshanKhatri,GeorgiosSianos

Discussants:WissamJaber,VincentOn-HingKwok,SudhirRathore,SatoruSumitsuji,LingTao,MinhN.Vo

2:30_PM ManagingPerforationsI:AntegradeWireorDeviceExitHowtoRecognizeandOptionsforManagement Lecturers:KhaldoonAlaswad

Page 210: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:210

2:40_PM RoundtableDiscussionWithAudienceQA

2:45_PM ManagingPerforationsII:PerforationoftheTargetVesselHowtoAvoidandManage Lecturers:FaroucAJaffer

2:55_PM RoundtableDiscussionWithAudienceQA

3:00_PM ManagingPerforationsIII:RetrogradeCollateralRupturesHowtoAvoidandManage Lecturers:SanjogKalra

3:10_PM RoundtableDiscussionWithAudienceQA

3:15_PM ManagingPerforationsIV:SeptalandFreeWallAdventuresHowtoRecognizeAvoidandManage Lecturers:ScottHarding

3:25_PM RoundtableDiscussionWithAudienceQA

3:30_PM ManagingPerforationsV:ThePostCABGPatient Lecturers:RobertF.Riley

3:40_PM RoundtableDiscussionWithAudienceQA

3:45_PM DonorVesselDissectionandorThrombosis:HowtoRecognizeAvoidandManage Lecturers:DarshanDoshi

3:55_PM RoundtableDiscussionWithAudienceQA

4:00PM-5:00PM

SessionIII.Case-BasedComplicationManagement:LearningFromOthers

Moderators:PaulKnaapen,YuejinYang

Discussants:KevinJ.Croce,MargaretB.McEntegart,LamprosK.Michalis,GennaroSardella,HadleyWilson

4:00_PM MyWorst2ComplicationsandWhatILearned CasePresenter:KathleenE.Kearney

4:15_PM RoundtableDiscussionWithAudienceQA

4:20_PM MyWorst2ComplicationsandWhatILearned CasePresenter:AndreaGagnor

4:35_PM RoundtableDiscussionWithAudienceQA

4:40_PM MyWorst2ComplicationsandWhatILearned CasePresenter:GeraldS.Werner

4:55_PM RoundtableDiscussionWithAudienceQA

5:00PM-6:00PM

SessionIV.MoreCase-BasedComplications

Moderators:M.NicholasBurke,MauroCarlino

Discussants:KefeiDou,AhmedElghamaz,ScottHarding,MasatoNakamura,AlexanderGrigorievichOsiev,BinZhang

5:00_PM MyWorst2ComplicationThatWerePreventable CasePresenter:R.MichaelWyman

5:15_PM RoundtableDiscussionWithAudienceQA

5:20_PM MyWorst2ComplicationsthatISaved CasePresenter:TonyJ.DeMartini

5:35_PM RoundtableDiscussionWithAudienceQA

5:40_PM MyWorst2ComplicationsThatThePatientCouldntRecoverFrom CasePresenter:StevenP.Marso

5:55_PM RoundtableDiscussionWithAudienceQA

TCTENDOVASCULAR:EXPERTCASEREVIEWS-COMPLICATIONSOFENDOVASCULARINTERVENTIONS

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room28D-E,UpperLevel

12:15PM-1:45PM

ComplicationsofEndovascularInterventions

Moderators:SahilA.Parikh,VirendraIPatel

Page 211: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:211

Discussants:HerbertD.Aronow,J.MichaelBacharach,RobertM.Bersin,JeffreyG.Carr,EthanCKorngold,D.ChristopherMetzger

12:15_PM Case1:AortoIliacPerforation CasePresenter:EhrinJ.Armstrong

12:25_PM Case2:LookOutBelow:EmbolicShowers CasePresenter:D.ChristopherMetzger

12:35_PM Case3:AcuteOcclusionandDissection

12:45_PM Case4:WorstEndoleakEver CasePresenter:VirendraIPatel

12:55_PM Case5:CarotidStentThrombosis CasePresenter:HerbertD.Aronow

1:05_PM Case6:IVCFilterEmbolization CasePresenter:J.StephenJenkins

1:15_PM Case7:TEVARTooFar CasePresenter:SomjotS.Brar

1:25_PM Case8:TheWorstAccessDisaster CasePresenter:J.MichaelBacharach

1:35_PM Case9:CLITurnsIntoALI CasePresenter:CarlosI.Mena-Hurtado

TCTENDOVASCULAR:EXPERTCASEREVIEWS-DEEPANDSUPERFICIALVENOUSINTERVENTIONS

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room30D-E,UpperLevel

12:15PM-12:55PM

SessionI:ManagementofDeepVenousDisease

Moderators:BrianG.DeRubertis,MahmoodK.Razavi

Discussants:TeresaL.Carman,AnthonyJ.Comerota,RaghuKolluri,RobertA.Lookstein,S.JayMathews,JohnMoriarty

12:15_PM ChronicIVCFilterOcclusion:AggressiveRetrievalTechniquesvsRecanalizationWithCaseReviews Lecturers:BrianG.DeRubertis

12:25_PM HowITreatFemoralVeinOcclusionsWithCaseReviews Lecturers:JohnMoriarty

12:35_PM CentralVenousStents:WhenWhichOnesAndHowWithCaseReviews Lecturers:MahmoodK.Razavi

12:45_PM ChoiceandDurationofAntiplateletandAnticoagulationTherapyAfterVenousInterventionsWithCaseReviews Lecturers:AnthonyJ.Comerota

12:55PM-1:45PM

SessionII:SuperficialVenousDisease,VenousAblation,PelvicVenousDisorders

Moderators:RaghuKolluri,SanjivLakhanpal

Discussants:TeresaL.Carman,AnthonyJ.Comerota,RobertA.Lookstein,NickMorrison,SanjumSSethi

12:55_PM EndothermalVenousAblation:StepByStepApproachandAvoidingPitfallsWithCaseReviews Lecturers:SanjivLakhanpal

1:05_PM NonThermalAblationofSuperficialAxialVeinsWithCaseReviews Lecturers:RaghuKolluri

1:15_PM ManagementofPelvicCongestionSyndromeWithCaseReviews Lecturers:BrianG.DeRubertis

1:25_PM DuplexEvaluationofVenousReflux:SimpletoComplexCaseExamples Lecturers:TeresaL.Carman

1:35_PM VenousUlcerManagementAfterVenousAblationWithCaseReviews Lecturers:RaghuKolluri

TCTENDOVASCULAR:PE/VTETHERAPIES

MONDAY,SEPTEMBER24,2018

2:00PM-4:00PM

Room30D-E,UpperLevel

Page 212: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:212

2:00PM-3:00PM

SessionI.AcutePulmonaryEmbolism

Moderators:RobertA.Lookstein,VictorF.Tapson

Discussants:JohnMoriarty,RahulS.Patel,MahmoodK.Razavi,KennethRosenfield,MehdiH.Shishehbor,AkhileshK.Sista

2:00_PM AcutePulmonaryEmbolism:HowBigIstheProblemandHowtoStartaPERT Lecturers:TeresaL.Carman

2:10_PM DataforLyticTherapyinMassiveandSubmassivePulmonaryEmbolism Lecturers:AkhileshK.Sista

2:20_PM EmergingCatheterBasedTechniquestoTreatAcutePulmonaryEmbolism Lecturers:RobertA.Lookstein

2:30_PM WhentoEmployAdvancedTherapiesinPE Lecturers:JayS.Giri

2:40_PM SpecialTopic:WhatIstheRoleofBalloonPulmonaryAngioplastyforTreatmentofCTEPH Lecturers:EhtishamMahmud

2:50_PM RoundtableDiscussionWithAudienceQA

3:00PM-4:00PM

SessionII.InferiorVenaCavaFilters

Moderators:JayS.Giri,AkhileshK.Sista

Discussants:RiyazBashir,TeresaL.Carman,JohnMoriarty,RahulS.Patel,EricASecemsky

3:00_PM WhoShouldGetanIVCFilterReviewoftheGuidelines Lecturers:AkhileshK.Sista

3:10_PM OverviewofCurrentandFutureIVCFilterDevices Lecturers:RahulS.Patel

3:20_PM ComplicationsofIVCFilters:SpectrumFrequencyTreatmentandAvoidanceStrategies Lecturers:EricASecemsky

3:30_PM TipsandTricksforToughIVCFilterRetrievals Lecturers:JohnMoriarty

3:40_PM SpecialTopic:WhatisHappeningNationallyandWhatistheFutureofIVCFilters Lecturers:RobertA.Lookstein

3:50_PM RoundtableDiscussionwithAudienceQA

HOTTOPICLUNCH:FROMVALVESTOLIMBS...APARADIGMFORPARITY(SPONSOREDBYTHEASSOCIATIONOFBLACKCARDIOLOGISTS)

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room23B-C,UpperLevel

12:15PM-1:45PM

FromValvestoLimbs...AParadigmforParity

Moderators:WayneB.Batchelor,AaronHorne,Jr.

Discussants:SeunAlli,FolusoFakorede,UzomaIbebuogu,LeeKirksey

12:15_PM WelcomeandOpeningRemarks Lecturers:WayneB.Batchelor

12:20_PM DiversityintheInterventionalWorkplace:CurrentChallengesandOpportunities Lecturers:RoxanaMehran

12:30_PM TAVR:WhereAreWeHeaded Lecturers:SeunAlli

12:40_PM ShouldWeExpandTAVRtoNonTraditionalCenters Lecturers:UzomaIbebuogu

12:50_PM PAD:OverviewofCurrentManagementStrategiesCanWeDoBetter Lecturers:FolusoFakorede

1:00_PM ShouldThereBeRegionalizationofCLImanagement Lecturers:LeeKirksey

1:10_PM ClinicalResearch101:HowtoBuildaSuccessfulResearchPrograminPrivatePractice Lecturers:WayneB.Batchelor

1:20_PM RoundtableDiscussionwithAudienceQA

1:40_PM ClosingRemarksandTakeHomeMessages

Page 213: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:213

Lecturers:WayneB.Batchelor

HOTTOPICLUNCH:RADIATIONMANAGEMENTINTHEINTERVENTIONALENVIRONMENT

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room24A-B,UpperLevel

12:15PM-1:45PM

RadiationManagementintheInterventionalEnvironment

Moderators:StephenBalter,SanjogKalra

Discussants:PatriciaAbrams,KishoreJ.Harjai,EdwinM.Leidholdt,Jr.,RyanD.Madder,GlennVanLangenhove,BonnieH.Weiner

12:15_PM Introduction:RadiationSafeforYouandYourPatients Lecturers:StephenBalter

12:25_PM StaffRiskManagement:PhysicianConcerns Lecturers:SanjogKalra

12:35_PM StaffRiskManagement:PhysicistResponses Lecturers:EdwinM.Leidholdt,Jr.

12:45_PM RoundtableDiscussionWithAudienceQA

12:55_PM PatientRadiationManagement:PhysicianConcerns Lecturers:SanjogKalra

1:05_PM PatientRadiationManagement:PhysicistResponses Lecturers:StephenBalter

1:15_PM RadiationManagement:LessonsLearned Lecturers:EdwinM.Leidholdt,Jr.

1:25_PM TheFuture:RoboticPCISuspendedLeadSuitsandOtherApproachestoReduceRadiationExposureinTheCathLab Lecturers:RyanD.Madder

1:35_PM RoundtableDiscussionWithAudienceQA

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-DIAGNOSISANDMANAGEMENTOFHEAVILYCALCIFIEDLESIONS

MONDAY,SEPTEMBER24,2018

12:15PM-2:00PM

Room26A-B,UpperLevel

12:15PM-2:00PM

DiagnosisandManagementofHeavilyCalcifiedLesions

Moderators:PhilippeGenereux,AjayJ.Kirtane

Discussants:AlaideChieffo,CarloDiMario,KarelT.Koch,RichardA.Schatz,SigmundSilber,GioraWeisz

12:15_PM Introduction:WhatDoWeHopetoLearnFromtheseCases Lecturers:AjayJ.Kirtane

12:19_PM Case1:ACaseofthatTypifiesRotoregret CasePresenter:FazilaT.Malik

12:27_PM Case2:ACaseDemonstratingtheCalcifiedLesionforWhichaCuttingorScoringBalloonisSufficient CasePresenter:SheilaSahni

12:35_PM Case3:TwoQuickCasesinWhichIntravascularImaging1LedmetoChooseAtherectomyand2DirectedmeAwayFromAtherectomy CasePresenter:JohnMcB.Hodgson

12:43_PM Case4:AStepbystepCaseofOCTguidedAtherectomy CasePresenter:TakashiAkasaka

12:51_PM Case5:ACaseofAtherectomyinSeverelyTortuousAnatomy CasePresenter:RamonQuesada

12:59_PM Case6:AtherectomyinaComplexCalcifiedLeftMainTrifurcation CasePresenter:AfzalurRahman

1:07_PM Case7:ASurprisingCaseofIntravascularLithotripsy CasePresenter:JonathanM.Hill

1:15_PM Case8:ACaseofaStuckBurrWithaNovelSolution CasePresenter:GertRichardt

1:23_PM Case9:ACaseofaMassiveRotablatorPerforation CasePresenter:EvanShlofmitz

Page 214: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:214

1:31_PM Case10:ACaseofOrbitalAtherectomyforaDiffuselyDiseaseVessel CasePresenter:JeffChambers

1:39_PM Case11:APerforationfromOrbitalAtherectomy CasePresenter:MichaelS.Lee

1:47_PM Case12:ACaseofInStentRestenosisDuetoaMarkedlyUnderexpandedStentinaSeverelyCalcifiedLesion CasePresenter:AzeemLatib

1:55_PM TakehomeMessage:WhatDidWeLearnFromtheseCases

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-HYPERTROPHICCARDIOMYOPATHYANDSEPTALABLATION

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room33B-C,UpperLevel

12:15PM-1:45PM

HypertrophicCardiomyopathyandSeptalAblation

Moderators:SherifF.Nagueh,HubertSeggewiss

Discussants:JohnS.DouglasJr,ValerianFernandes,VijayIyer,SrihariS.Naidu,NishPatel,AlexandreC.Zago

12:15_PM Introduction:WhatDoWeHopetoLearnFromtheseCases Lecturers:HubertSeggewiss

12:20_PM Case1:SevereLVOTObstructioninaSymptomatic20YearOldMaleDespiteMaximizedMedicalTreatment CasePresenter:CareyD.Kimmelstiel

12:30_PM Case2:SeptalArteryRuptureWithSeptalInfarctionandReliefofLVOTObstruction CasePresenter:FrancescoPelliccia

12:40_PM Case3:ThirdDegreeAVBlockAfterAblationRequiringUpgradefromVVItoDualChamberPacing CasePresenter:MichaelA.Fifer

12:50_PM Case4:SevereDyspneainaPatientWithObstructiveHCMandaProximalLADStent CasePresenter:JorgeGaspar

1:00_PM Case5:SevereDyspneainaPatientWithHCMandMidCavitaryObstruction CasePresenter:AlexanderGrigorievichOsiev

1:10_PM Case6:ACaseofLADOcclusionDuringAlcoholSeptalAblation CasePresenter:KoljaSievert

1:20_PM Case7:SeptalBranchCollateralizationNotedDuringtheCourseofAlcoholSeptalAblation CasePresenter:AntoineLafont

1:30_PM Case8:SevereObstructiveHCMinaSymptomaticPatientDespiteMaximizedMedicalTherapyandSeptalThicknessof13mm. CasePresenter:RabindraNathChakraborty

1:40_PM TakeHomeMessages:WhatDidYouLearnFromtheseCases Lecturers:SherifF.Nagueh

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-INTRAVASCULARIMAGING�IVUS,OCTANDNIRS

MONDAY,SEPTEMBER24,2018

12:15PM-1:51PM

Room28A-B,UpperLevel

12:15PM-1:51PM

IntravascularImaging�IVUS,OCTandNIRSModerators:DavidErlinge,GaryS.Mintz

Discussants:MartinW.Bergmann,MarcD.Feldman,MargaretB.McEntegart,YasunoriUeda,CarloZivelonghi,Robert-JanvanGeuns

12:15_PM Introduction:WhatDoWeHopetoLearnFromtheseCases Lecturers:GaryS.Mintz

12:18_PM Case1:ACaseinWhichPreandPostinterventionalIVUSChangedtheNumberLengthandorDiametersofStentsUsed CasePresenter:MassoudA.Leesar

12:26_PM Case2:ACaseinWhichPreandPostinterventionalOCTChangedtheNumberLengthandorDiametersofStentsUsed CasePresenter:EvelynRegar

12:34_PM Case3:ACaseinWhichIntravascularImagingChangedMyPrestentPlaqueModificationStrategy CasePresenter:YunDaiChen

12:42_PM Case4:ACaseinWhichNIRSIVUSwasUsefultoGuideStenting CasePresenter:JamesA.Goldstein

Page 215: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:215

12:50_PM Case5:ACaseinWhichIUsedOCTtoReduceDAPTDuration CasePresenter:WojtekWojakowski

12:58_PM Case6:ACaseinWhichOCTFoundtheHiddenCulpritLesioninACS CasePresenter:RajeshM.Dave

1:06_PM Case7:ACaseofIntravascularImagingtoDiagnoseandGuideTreatmentofaSpontaneousCoronaryArteryDissection CasePresenter:FernandoAlfonso

1:14_PM Case8:ICaseinWhich3DOCTImagingChangedHowITreatedaBifurcation CasePresenter:TakashiAkasaka

1:22_PM Case9:ACaseinWhichIntravascularImagingDemonstratedaSurprisingCauseandGuidedTreatmentofStentThrombosis CasePresenter:IoannisIakovou

1:30_PM Case10:ACaseinWhichIntravascularImagingDemonstratedaSurprisingCauseandGuidedTreatmentofInstentRestenosis CasePresenter:HiramG.Bezerra

1:38_PM Case11:ACaseinWhichIntravascularImagingDemonstratedtheCauseofAcuteVesselClosure CasePresenter:AshishShah

1:46_PM TakehomeMessage:WhatDidWeLearnFromtheseCases

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-MITRALVALVULOPLASTY

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room27A-B,UpperLevel

12:15PM-1:45PM

MitralValvuloplasty

Moderators:WilliamW.O'Neill

Discussants:VinayK.Bahl,RobertoJCubeddu,EduardoDeMarchena,DavidR.HolmesJr.,AlexanderLlanos,RahulSakhuja,ChristianF.Witzke

12:15_PM Introduction:WhatDoWeHopetoLearnFromTheseCases Lecturers:IgorF.Palacios

12:20_PM Case1:InouevsDoubleBalloonMitralValvuloplastyinOptimalPatients CasePresenter:RahulSakhuja

12:30_PM Case2:MitralValvuloplastyWith3DandICEImaging Lecturers:HowardC.Herrmann

12:40_PM Case3:InoueTechniqueMitralValvuloplastyIsNotAlwaysStraightForward Lecturers:AlexanderLlanos

12:50_PM Case4:MitralValvuloplastyComplicatedbySevereMitralRegurgitationinaPatientWithRheumaticMitralStenosis CasePresenter:ChristianF.Witzke

1:00_PM Case5:MitralValvuloplastyinaPatientWithSevereMitralStenosisFromMitralAnnularCalcification CasePresenter:RobertoJCubeddu

1:10_PM Case6:MitralValveinValveforaPatientWithSevereMitralAnnularCalcificationandStenosis CasePresenter:WilliamW.O'Neill

1:20_PM Case7:AnUnusualComplicationofMitralValvuloplastyinaPatientWithSevereCalcificMitralStenosis CasePresenter:DavidR.HolmesJr.

1:30_PM Case8:MitralValvuloplastyandTAVRinaPatientWithMitralandAorticStenosis CasePresenter:EduardoDeMarchena

1:40_PM TakeHomeMessages:WhatDidWeLearnFromTheseCases Lecturers:IgorF.Palacios

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-PARAVALVULARLEAKCLOSURE

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room25A-B,UpperLevel

12:15PM-1:45PM

ParavalvularLeakClosure

Moderators:AnitaAsgar,ChetRihal

Discussants:KhalidAmber,GeorgeS.Hanzel,MassimoNapodano,ManuelPan,PhilippePibarot,TorstenP.Vahl

12:15_PM Introduction:WhatDoWeHopetoLearnFromtheseCases Lecturers:AnitaAsgar

Page 216: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:216

12:20_PM Case1:ACaseofAorticParavalvularLeak:RetrogradeClosureTechnique CasePresenter:RogerJ.Laham

12:30_PM Case2:ACaseofParavalvularLeakPostTAVR CasePresenter:JohnK.Forrest

12:40_PM Case3:ACaseofMitralParavalvularLeak:AntegradeClosureRequiringMultipleDevices CasePresenter:MohamedAbdel-Wahab

12:50_PM Case4:AComplexMitralParavalvularLeak Lecturers:StephenR.Ramee

1:00_PM Case5:TechnicalChallengesandAdvancedTechniquesforParavalvularLeakClosure:DifficultAorticParavalvularLeakClosure CasePresenter:ChetRihal

1:10_PM Case6:ClosingRightSidedParavalvularLeaks:ACaseofTricuspidPVLClosure

1:20_PM Case7:ManagingComplications1:PlugEmbolizationandRetrieval CasePresenter:WojtekWojakowski

1:30_PM Case8:Managingcomplications2:ACaseofaComplicatedMitralParavalvularLeak CasePresenter:RedaIbrahim

1:40_PM TakehomeMessages:WhatDidWeLearnFromtheseCases Lecturers:ChetRihal

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-PFOCLOSURECASESTUDIES

MONDAY,SEPTEMBER24,2018

12:15PM-1:47PM

Room32A-B,UpperLevel

12:15PM-1:05PM

SessionI:PFOTechniquesandStrategies

Moderators:MichaelJ.Mullen,RobertJ.Sommer

Discussants:SuzanneJ.Baron,AsimCheema,HansR.Figulla,SachinS.Goel,StevenL.Goldberg

12:15_PM WhatWeHopetoLearnFromTheseCases Lecturers:RobertJ.Sommer

12:17_PM ACaseThatFavorsCardioformDevice CasePresenter:AsimCheema

12:25_PM ACaseThatFavorstheAmplatzerPFODevice CasePresenter:MeganCoylewright

12:33_PM APFOWithaSignificantAtrialSeptalAneurysm CasePresenter:ZacharySteinberg

12:41_PM APFOWithaLipomatousAtrialSeptum

12:49_PM APFOWithEustachianValveAttachmentsNeartheDefect CasePresenter:MichaelJ.Mullen

12:57_PM APFOWithLongWellAttachedPFOTunnel CasePresenter:AmarKrishnaswamy

1:05PM-1:47PM

SessionII:PFOClinicalConundrums

Moderators:ZahidAmin,RobertJ.Sommer

Discussants:PeterC.Block,JohnP.Breinholt,CraigEFleishman,HarsimranSachdevaSingh,PaulVermeersch

1:05_PM APatientWithMigraineWithAuraMimickingTIA:IsPFOClosureAppropriate CasePresenter:AshishShah

1:13_PM APatientWithaPFOandCryptogenicStrokeOutsidetheRecommendedAgeRange:IsPFOClosureAppropriate CasePresenter:DavidE.Thaler

1:21_PM APatientWithAtrialFibrillationCryptogenicStrokeandPFO:WatchmanDespiteOAC CasePresenter:SaibalKar

1:29_PM APatientWithDVTPulmonaryEmbolusandPFO:CloseonOAC CasePresenter:HarsimranSachdevaSingh

1:37_PM APatientRequiringSurgeryWithaPFOandaHighRiskofVTEParadoxicalEmbolization:CloseforPrimaryStrokePrevention CasePresenter:ZahidAmin

1:45_PM ConclusionsandTakehomeMessages Lecturers:RobertJ.Sommer

Page 217: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:217

COMPLEXINTERVENTIONS:EXPERTCASEREVIEWS-TRANSRADIALACCESSTECHNIQUEPEARLSANDCOMPLICATIONS

MONDAY,SEPTEMBER24,2018

12:15PM-1:45PM

Room29A-B,UpperLevel

12:15PM-1:45PM

TransradialAccessTechniquePearlsandComplications

Moderators:OlivierF.Bertrand,SamirB.Pancholy

Discussants:RichardAAnderson,StephenP.Hoole,SanjitS.Jolly,YvesR.Louvard,MarcelloSena,KimberlyA.Skelding

12:15_PM Introduction:WhatDoWeHopetoLearnFromtheseCases Lecturers:SamirB.Pancholy

12:19_PM Case1:AHeavilyCalcifiedRadialArteryinCKD CasePresenter:BinitaShah

12:28_PM Case2:ComplexSlenderPCI:SmallisBeautiful CasePresenter:YujiIkari

12:37_PM Case3:RecognitionofanAberrantRightSubclavianArteryAccessandNavigationOptions CasePresenter:MichaelA.Kutcher

12:46_PM Case4:RadialArteryDissectionandPerforation CasePresenter:ScottHarding

12:55_PM Case5:UlnarAccesswhentheRadialArteryisOccluded CasePresenter:SaskoKedev

1:04_PM Case6:RightHeartCatheterizationUsingRadialistSkills CasePresenter:MladenI.Vidovich

1:13_PM Case7:AComplexRadialLoop CasePresenter:SCWong

1:22_PM Case8:DualRadialAccessandCTO CasePresenter:JamesNolan

1:31_PM Case9:ADifficultRightMammaryArteryCannulationFromRadialAccess CasePresenter:WilliamMSuh

1:40_PM TakehomeMessages:WhatDidWeLearnFromtheseCases Lecturers:OlivierF.Bertrand

SPECIALSESSION:CAPABILITYBUILDINGANDCONTINUINGEDUCATIONALCOMMITTEEINCARDIOLOGY(CBCEC)ATTCT:HOWTOTREATLEFTMAIN

ANDCORONARYBIFURCATIONLESIONS

MONDAY,SEPTEMBER24,2018

7:00AM-8:00AM

Room26A-B,UpperLevel

7:00AM-8:00AM

HowtoTreatLeftMainandCoronaryBifurcationLesions

Moderators:Shao-LiangChen,YalingHan,TanveerRab,ImadSheiban,GreggW.Stone,Yi-DaTang

Discussants:JamesB.HermillerJr,ChunguangQiu,FeiYe

7:00_AM Case1:ALeftMainBifurcationInterventioninSTEMIPPCI CasePresenter:LilyLi

7:04_AM HowWouldITreatThisCase Lecturers:NingGuo

7:08_AM HowWouldITreatThisCase Lecturers:KaiXu

7:12_AM HowWouldITreatThisCase Lecturers:YanLi

7:16_AM HowWouldITreatThisCase Lecturers:YongXia

7:20_AM RoundtableDiscussionWithAudienceQA

7:26_AM HowDidITreatThisCase CasePresenter:LilyLi

7:30_AM Case2:ADistalLMLADD1BifurcationPCICase CasePresenter:JunjieZhang

Page 218: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:218

7:34_AM HowwouldItreatthiscase Lecturers:ZeningJin

7:38_AM HowwouldItreatthiscase Lecturers:JingboHou

7:42_AM HowWouldITreatThisCase Lecturers:NingTan

7:46_AM HowWouldITreatThisCase Lecturers:Rong-ChongHuang

7:50_AM RoundtableDiscussionWithAudienceQA

7:56_AM HowDidITreatThisCase CasePresenter:JunjieZhang

SPECIALSESSION:BESTPRACTICEOFCONTEMPORARYPCIINCHINA

MONDAY,SEPTEMBER24,2018

9:00AM-11:00AM

Room28A-B,UpperLevel

9:00AM-11:00AM

BestPracticeofContemporaryPCIinChina

9:00_AM Introduction Lecturers:BenHe

9:05_AM BestPracticeofContemporaryPCIinChina Lecturers:JianfangLuo

MyTopLearninginCTO

Discussants:ZeningJin,XiantaoSong

9:20_AM MyTopLearninginCTO CasePresenter:LeiGe

9:30_AM Discussion9:33_AM MyTopLearninginCTO

CasePresenter:LeiSong9:43_AM Discussion9:46_AM MyTopLearninginCTO

CasePresenter:YanLi9:56_AM Discussion

MyTopLearninginImaging

Discussants:XueboLiu,RuqiongNie

10:00_AM MyTopLearninginImaging CasePresenter:JunPu

10:10_AM Discussion10:13_AM MyTopLearninginImaging

CasePresenter:BingchenLiu10:23_AM Discussion10:26_AM MyTopLearninginImaging

CasePresenter:GuoJun10:36_AM Discussion10:40_AM UpdateonTreatmentsandTechniquesofCoronaryCalcium

Lecturers:FeiYe

MyTopLearninginCTO

Discussants:ZeningJin,XiantaoSong

9:20_AM MyTopLearninginCTO CasePresenter:LeiGe

9:30_AM Discussion9:33_AM MyTopLearninginCTO

CasePresenter:LeiSong9:43_AM Discussion9:46_AM MyTopLearninginCTO

Page 219: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:219

CasePresenter:YanLi9:56_AM Discussion

MyTopLearninginImaging

Discussants:XueboLiu,RuqiongNie

10:00_AM MyTopLearninginImaging CasePresenter:JunPu

10:10_AM Discussion10:13_AM MyTopLearninginImaging

CasePresenter:BingchenLiu10:23_AM Discussion10:26_AM MyTopLearninginImaging

CasePresenter:GuoJun10:36_AM Discussion10:55_AM Closing

Lecturers:BenHe

SPECIALSESSION:SCAICATHLABLEADERSHIPBOOTCAMP

MONDAY,SEPTEMBER24,2018

1:00PM-5:00PM

Room30A-C,UpperLevel

1:00PM-2:00PM

BootcampI:EssentialCathLabManagementSkills

Moderators:PrashantKaul,DanielM.Kolansky

Discussants:RobertJ.Applegate,SamirR.Kapadia,DuaneS.Pinto,ArnoldSeto,BernadetteS.Speiser,HadleyWilson

1:00_PM WelcomeandIntroduction Lecturers:DanielM.Kolansky

1:05_PM TheCathLabMedicalDirector:KeystoSuccess Lecturers:DuaneS.Pinto

1:15_PM TheCathLabManager:KeystoSuccess Lecturers:BernadetteS.Speiser

1:25_PM EstablishingaSafetyCultureintheCathLab Lecturers:ArnoldSeto

1:35_PM ManagingCathLabConflicts:SchedulingPersonalitiesCantWeAllJustGetAlong Lecturers:HadleyWilson

1:45_PM RoundtableDiscussionWithAudienceQA

2:00PM-3:00PM

BootcampII:CathLabEconomics-MovetoValue-BasedPayments

Moderators:PeterLDuffy,TimothyD.Henry

Discussants:SamirR.Kapadia,DanielM.Kolansky,JohnA.Spertus

2:00_PM CathLabEconomics:WhereDoWeStandWithMACRAandMIPS Lecturers:DanielM.Kolansky

2:10_PM CMSStrategyandtheMovetoValue Lecturers:JohnA.Spertus

2:20_PM ValueBasedSTEMICare:SavingMoneyDuringMITreatment Lecturers:TimothyD.Henry

2:30_PM CathLabEfficiency:SavingTimeandMoneyWhileReducingStress Lecturers:SamirR.Kapadia

2:40_PM RoundtableDiscussionWithAudienceQA

3:00PM-4:00PM

BootcampIII:AchievingQualityObjectivesintheCathLab

Moderators:SunilV.Rao

Discussants:J.DawnAbbott,AdnanK.Chhatriwalla,JepthaP.Curtis,MichaelA.Kutcher,DuaneS.Pinto,AdhirShroff

3:00_PM TheTop10QualityMetricsforYourCathLab Lecturers:MichaelA.Kutcher

Page 220: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:220

3:10_PM UsingSCAIAUCandPCIRiskAppstoOptimizeCareinYourCathLab Lecturers:SunilV.Rao

3:20_PM TrackingPerformance:UpdatesonNCDRReporting Lecturers:J.DawnAbbott

3:30_PM UPDATEonPublicReportingintheCathLab Lecturers:JepthaP.Curtis

3:40_PM RoundtableDiscussionWithAudienceQA

4:00PM-5:00PM

BootcampIV:UsingProtocolsandPathwaystoOptimizeCareStandardization

Moderators:DavidA.Cox,DmitriyN.Feldman

Discussants:JayBagai,MauricioG.Cohen,JamesA.Goldstein,CindyL.Grines,NavinK.Kapur,PrashantKaul,FaisalLatif,SrihariS.Naidu,BinitaShah,JenniferA.Tremmel

4:00_PM STEMICare:YourSTEMIProtocolin2018 Lecturers:CindyL.Grines

4:10_PM RadialAccess:ReducingBleedingandImprovingPatientSatisfaction Lecturers:BinitaShah

4:20_PM PathwaysforSameDayPCIDischarge Lecturers:MauricioG.Cohen

4:30_PM ShockintheCathLab:DevelopingaTeamBasedProtocol Lecturers:EmmanouilS.Brilakis

4:40_PM ReducingRadiationExposureintheCathLab Lecturers:JayBagai

4:50_PM RoundtableDiscussionWithAudienceQA

FASCINATINGLECTURESIII:SOCIALMEDIA,DIGITALHEALTH,ANDCOMMUNICATIONSKILLS

MONDAY,SEPTEMBER24,2018

2:00PM-4:00PM

Ballroom6A,UpperLevel

2:00PM-3:45PM

SocialMedia,DigitalHealth,andCommunicationSkills

Moderators:C.MichaelGibson,MamasMamas

Discussants:MirvatAlasnag,MChadiAlraies,ElianoPioNavarese,SheilaSahni,ChuckSimonton,WilliamMSuh

2:00_PM TheDosandDontsofSocialMediainPractice Lecturers:PoonamVelagapudi

2:10_PM FascinatingQA

2:15_PM TheInterventionalCardiologyTweetorial:UseofSocialMediaasanEducationalToolforTeachingInterventionalTechniques Lecturers:MichaelPSavage

2:25_PM FascinatingQA

2:30_PM TweetbookCardiovascularInterventions:ANewOnlineCommunityforSharing Lecturers:DavidLFischman

2:40_PM FascinatingQA

2:45_PM SocialMediaandPCI:FromStableAnginatoCTOs Lecturers:AsifQasim

2:55_PM FascinatingQA

3:00_PM RiseofthePlanetoftheApps:TheWorldofMobileApplicationsforCardiovascularEducation Lecturers:AnnapoornaKini

3:10_PM FascinatingQA

3:15_PM AdvancesinDigitalHealthMayHelpPreventCardiovascularDiseases:EPrevention Lecturers:MohammadElTahlawi

3:25_PM FascinatingQA

3:30_PM TheArtofPresentation:AFundamentalSkillforCardiologistsintheContemporaryEra Lecturers:AbdallahElSabbagh

3:40_PM FascinatingQA

Page 221: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:221

SPECIALSESSION:DISCUSSIONSWITHTHELATEBREAKINGTRIALPRINCIPALINVESTIGATORSIII

MONDAY,SEPTEMBER24,2018

4:00PM-5:00PM

Ballroom6A,UpperLevel

4:00PM-5:00PM

DiscussionsWiththeLateBreakingTrialPrincipalInvestigatorsIII

Moderators:JohnA.Bittl,DavidErlinge,TakashiKubo

Discussants:DánielAradi,MichaelMaeng,YukikoNakano,MichaelPSavage,RonWaksman,BernhardWitzenbichler,JunjieZhang

4:00_PM ULTIMATE:SummaryandClinicalImplications Lecturers:JunjieZhang

4:05_PM Discussion Discussants:JunjieZhang

4:15_PM LRP:SummaryandClinicalImplications Lecturers:RonWaksman

4:20_PM Discussion Discussants:RonWaksman

4:30_PM OACALONE:SummaryandClinicalImplications Lecturers:YukikoNakano

4:35_PM Discussion Discussants:YukikoNakano

PRESENTATIONTHEATERPROGRAM:CEREBRALEMBOLICPROTECTIONWITHSENTINELINTAVR:SHIFTINGTHEPARADIGMTOWARDSTANDARDOF

CARE(SPONSOREDBYBOSTONSCIENTIFICCORPORATION)

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

PresentationTheater3,ExhibitHall,GroundLevel

11:30AM-12:30PM

CerebralEmbolicProtectionwithSentinelinTAVR:ShiftingtheParadigmTowardStandardofCare

Chairs:MartinB.Leon,RajMakkar

Faculty:HemalGada,LarsSondergaard,JochenWöhrle

11:30_AM ImpactofCEPinPractice:CathLabIntegrationtheRealWorldOutcomes Lecturers:RajMakkar

11:40_AM AContemporaryReviewoftheDataSupportingtheUseofSentinelinTAVR Lecturers:JochenWöhrle

11:50_AM StrokeEconomicstheRoleofSentineltoGrowyourTAVRProgram Lecturers:HemalGada

12:00_PM TheRoleofCerebalProtectionintheAgeofMinimalistApproachtoTAVR Lecturers:LarsSondergaard

12:10_PM FutureConsiderations:TheRoleofSharedDecisionMakingandAdoptionofCerebralEmbolicProtectioninPractice Lecturers:MartinB.Leon

12:20_PM PanelDiscussion Moderators:MartinB.Leon,RajMakkar

Discussants:HemalGada,LarsSondergaard

PRESENTATIONTHEATERPROGRAM:MYEXPERIENCEWITHBALLOONEXPANDABLEANDSELF-EXPANDINGSTENTGRAFTSINTREATINGAORTOILIAC

OCCLUSIVEDISEASE(SPONSOREDBYGORE&ASSOCIATES)

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

PresentationTheater4,ExhibitHall,GroundLevel

11:30AM-12:30PM

MyExperiencewithBalloonExpandableandSelf-ExpandingStentGraftsinTreatingAortoiliacOcclusiveDisease

Faculty:EhrinJ.Armstrong

Page 222: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:222

PRESENTATIONTHEATERPROGRAM:SCAITRANSITIONFORVALUE:ACASE-ANDDEBATE-BASEDDISCUSSIONOFTHEVALUEOFTRANSRADIALCPCI

(SPONSOREDBYSOCIETYFORCARDIOVASCULARANGIOGRAPHYANDINTERVENTIONS,SUPPORTEDBYMEDTRONIC)

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

PresentationTheater1,HallB2,GroundLevel

11:30AM-12:30PM

SCAITRAnsitionforVALUE:ACase-andDebate-basedDiscussionoftheValueofTransradialcPCI

Chairs:AdhirShroff

Faculty:J.DawnAbbott,ElliottM.Groves,RajivGulati,ArasiMaran,ArnoldSeto

11:30_AM SCAIsTRAnsitionforVALUEandHowitAppliestoComplexPCIcPCI Lecturers:AdhirShroff

11:38_AM FemoraltoRadial101:FocusoncPCI Lecturers:RajivGulati

11:46_AM SCAIsLengthofStayExpertConsensusDocument:ACasebasedApplicationtoTRAcPCI Lecturers:ArnoldSeto

11:56_AM CasePresentation:ComplexTRALeftMainPCIMiniDebate Lecturers:J.DawnAbbott

12:04_PM LeftMainPCI:TransfemoralShouldbetheDefaultAccessSite Lecturers:ArasiMaran

12:12_PM LeftMainPCI:TransradialShouldbetheDefaultAccessSite Lecturers:ElliottM.Groves

12:20_PM DiscussionandKeyTakeaways Discussants:J.DawnAbbott,ElliottM.Groves,RajivGulati,ArasiMaran,ArnoldSeto,AdhirShroff

12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:THENEWFRONTIER:CANWEFINALLYPREDICTANDSTARTTREATINGVULNERABLEPLAQUE?(SPONSOREDBY

INFRAREDX,INC.)

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

PresentationTheater5,ExhibitHall,GroundLevel

11:30AM-12:30PM

TheNewFrontier:CanWeFinallyPredictandStartTreatingVulnerablePlaque?

Chairs:RonWaksman

Faculty:DavidErlinge,JohnMcB.Hodgson,RyanD.Madder,RobertL.Wilensky

11:30_AM Introduction Lecturers:RonWaksman

11:35_AM IVUSNIRSTechnologyOverviewandEarlyClinicalTrials Lecturers:RyanD.Madder

11:43_AM CurrentClinicalUsesofIVUSNIRS Lecturers:JohnMcB.Hodgson

11:51_AM OngoingClinicaltrialsandFutureTreatmentStrategiesforVulnerablePlaque Lecturers:DavidErlinge

11:59_AM NewApplicationsofNIRS:CollagenDeficientCapDetection Lecturers:RobertL.Wilensky

12:07_PM LRPStudyResultsImpactonYourPractice Lecturers:RonWaksman

12:15_PM PanelDiscussionandQA

PRESENTATIONTHEATERPROGRAM:TRANSCATHETERTRICUSPIDVALVEINTERVENTIONS(SPONSOREDBYCRF,SUPPORTEDBYEDWARDS

LIFESCIENCES)

MONDAY,SEPTEMBER24,2018

Page 223: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:223

11:30AM-12:30PM

PresentationTheater2,HallB2,GroundLevel

11:30AM-12:30PM

TranscatheterTricuspidValveInterventions

Chairs:MichaelJ.Mack

Faculty:WilliamA.Gray,JoAnnLindenfeld,ChetRihal,MauriceE.Sarano

11:30_AM TricuspidValveDiseasein2018:WhatAretheChallenges Lecturers:MauriceE.Sarano

11:37_AM TranscatheterAnnularReductionforFTR Lecturers:WilliamA.Gray

11:44_AM OtherTranscatheterApproachestoTRReduction Lecturers:ChetRihal

11:51_AM TheSurgeonPerspectiveofTRTreatment:Surgeryvs.TranscatheterTherapy

11:58_AM TheHeartFailureSpecialistPerspectiveofTRManagement Lecturers:JoAnnLindenfeld

12:05_PM FocusedDiscussion:IsthereenoughintheToolboxIsThereanOpportunityforEarlierInterventionwithTranscatheterTherapy

12:30_PM Adjourn

PRESENTATIONTHEATERPROGRAM:ABILITYTOTRANSFORM:DEDICATEDDESTOTREATDIABETICPATIENTSANDSIROLIMUSCOATEDBALLOON

FORCAD(SPONSOREDBYENVISIONSCIENTIFICPVT.LTD.ANDCONCEPTMEDICALPVT.LTD.)

MONDAY,SEPTEMBER24,2018

1:00PM-2:00PM

PresentationTheater4,ExhibitHall,GroundLevel

1:00PM-2:00PM

ABILITYtoTRANSFORM:DedicatedDEStotreatDiabeticPatientsandSirolimusCoatedBalloonforCAD

Chairs:AlexandreAbizaid,AntonioColombo,PatrickW.Serruys

Faculty:OriBen-Yehuda,BernardoCortese,SameerDaniMD,DM,AzeemLatib,MartinB.Leon,RoxanaMehran,AshokSeth,LucaTesta,MD,PhD

1:00_PM FromConcepttoUSAIDETrialDesign Lecturers:OriBen-Yehuda

1:08_PM EuropeanExperienceandClinicalProgramme Lecturers:BernardoCortese

1:16_PM WhyshouldIuseAbluminusforDiabeticPatients Lecturers:RoxanaMehran

1:24_PM SpecialFeaturesandClinicalExperience Lecturers:AzeemLatib

1:32_PM ChallengingCaseswithImaging Lecturers:SameerDani

1:40_PM OverallExperienceofAbluminusDESinRealWorldandDedicateGlobalClinicalRegistry Lecturers:LucaTesta

PRESENTATIONTHEATERPROGRAM:COMPLEXPCIIN2018:ECLIPSE-INGTHESTANDARDOFCONVENTIONALANGIOPLASTY(SPONSOREDBYCRF,

SUPPORTEDBYCARDIOVASCULARSYSTEMS,INC.)

MONDAY,SEPTEMBER24,2018

1:00PM-2:00PM

PresentationTheater1,HallB2,GroundLevel

1:00PM-2:00PM

ComplexPCIin2018:ECLIPSE-ingtheStandardofConventionalAngioplasty

CoChairs:AjayJ.Kirtane,JeffreyW.Moses

Faculty:EhrinJ.Armstrong,JonathanM.Hill,JasvindarSingh

1:00_PM WhyWeDontSeeTypeALesionsAnymoreandWhatWeNeedtoPrepareforthisChange Lecturers:JeffreyW.Moses

1:10_PM DoWeUnderutilizeCoronaryAtherectomyRationaleandUpdateontheECLIPSETrial

Page 224: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:224

Lecturers:AjayJ.Kirtane1:20_PM Discussion

1:25_PM PlatformUpdates:NewToolsToCombattheToughestLesions Lecturers:JasvindarSingh

1:35_PM TipsandTricks:AStepByStepPracticumfortheTreatmentofSeverelyCalcifiedLesions Lecturers:JonathanM.Hill

1:45_PM CrossingtheUncrossable:ComplexCaseReviewwithTipsandTricksforSuccess Lecturers:EhrinJ.Armstrong

1:55_PM Discussion

2:00_PM Adjourn

PRESENTATIONTHEATERPROGRAM:FFRANGIOFORPCIGUIDANCE:ACLINICALREVIEW(SPONSOREDBYCATHWORKSLTD.)

MONDAY,SEPTEMBER24,2018

1:00PM-2:00PM

PresentationTheater5,ExhibitHall,GroundLevel

1:00PM-2:00PM

FFRangioforPCIGuidance:AClinicalReview

Chairs:MortonJ.Kern,RanKornowski

Faculty:WilliamF.Fearon,PeterJ.Fitzgerald,NilsJohnson,HitoshiMatsuo

1:00_PM GreetingsandIntroduction Lecturers:MortonJ.Kern

1:05_PM IndepthReviewoftheFASTFFRPivotalTrialResults CasePresenter:WilliamF.Fearon

1:20_PM DeepDiveIntoFASTFFR:SubgroupsandSecondaryEndpoints Lecturers:NilsJohnson

1:32_PM TheBenefitsofFFRangioinMultivesselDisease Lecturers:HitoshiMatsuo

1:42_PM HowDailyUseofFFRangioCanChangeClinicalPracticeintheFuture Lecturers:PeterJ.Fitzgerald

1:54_PM QuestionsandConcludingRemarks Lecturers:MortonJ.Kern

2:00_PM Adjourn Lecturers:MortonJ.Kern

PRESENTATIONTHEATERPROGRAM:TRANSCATHETERMITRALVALVEINTERVENTIONS(SPONSOREDBYCRF,SUPPORTEDBYEDWARDS

LIFESCIENCES)

MONDAY,SEPTEMBER24,2018

1:00PM-2:00PM

PresentationTheater2,HallB2,GroundLevel

1:00PM-2:00PM

TranscatheterMitralValveInterventions

Chairs:JeffreyJ.Popma

Faculty:WilliamT.Abraham,TedFeldman,HowardC.Herrmann,MarkReisman,BrianK.Whisenant

1:00_PM AnatomicalConsiderationsforMitralValveRepairReplacement:InsightsfromtheCenterforCardiovascularInnovation Lecturers:MarkReisman

1:07_PM TranscatheterAnnularReductionforFMR Lecturers:BrianK.Whisenant

1:14_PM DifferentApproachestoTranscatheterLeafletRepair Lecturers:TedFeldman

1:21_PM AdvancesinTransseptalTranscatheterMitralValveReplacement Lecturers:HowardC.Herrmann

1:28_PM TheHeartFailurePerspective Lecturers:WilliamT.Abraham

1:38_PM FocusedDiscussion:IsThereEnoughintheToolbox

Page 225: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:225

1:48_PM FocusedDiscussion:IsThereanOpportunityForEarlierInterventionwithTranscatheterTherapies

2:00_PM Adjourn

PRESENTATIONTHEATERPROGRAM:TREATINGPATIENTSATHIGHBLEEDINGRISK(HBR):THELEADERSFREEEXPERIENCE(SPONSOREDBY

BIOSENSORS)

MONDAY,SEPTEMBER24,2018

1:00PM-2:00PM

PresentationTheater3,ExhibitHall,GroundLevel

1:00PM-2:00PM

TreatingPatientsatHighBleedingRisk(HBR):TheLEADERSFREEExperience

CoChairs:MitchellW.Krucoff,MartinB.Leon

Faculty:RoxanaMehran,PhilipM.Urban,RenuVirmani

1:00_PM SessionOpening Lecturers:MitchellW.Krucoff

1:05_PM FromLEADERSFREEtoLEADERSFREEII Lecturers:PhilipM.Urban

1:17_PM LEADERSFREEII:1YearClinicalOutcomes Lecturers:MitchellW.Krucoff

1:29_PM HowBA9StentsHeal:PreClinicalPathologyData Lecturers:RenuVirmani

1:41_PM TheNeedforaConsensusDefinitionofHBRPatients Lecturers:RoxanaMehran

1:53_PM ClosingRemarks Lecturers:MartinB.Leon

2:00_PM Adjourn

TRAINING:ABBOTTPAVILION#11-GUIDEWIREDESIGNANDSELECTION:AHANDS-ONUSER'SGUIDETOGUIDEWIRETECHNOLOGY

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

GuidewireDesignandSelection:AHands-onUser'sGuidetoGWTechnology

InteractiveTrainingFaculty:DavidDaniels,JackHall,AmirKaki,EthanCKorngold,WilliamNicholson

8:00_AM Introduction

8:05_AM DidacticonGuidewireBuildingBlocksandWHwires

8:15_AM HandsonWorkhorseWiresActivity

8:30_AM PolymerJacketedWiresOverviewandHandsonActivity

8:50_AM ExtraSupportSpecialtywiresOverviewandHandsonActivity

9:10_AM WigglewireOverviewandHandsonActivity

TRAINING:BOSTONSCIENTIFICPAVILION#11-IMAGING/PHYSIOLOGY:OPTIMIZEPCI-NEWPHYSIOLOGICINDICESANDHIGHDEFINITIONIVUS

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

Imaging/Physiology:OptimizePCI-NewPhysiologicIndicesandHighDefinitionIVUS

InteractiveTrainingFaculty:YiannisSChatzizisis,JonathanM.Hill,NilsJohnson,MortonJ.Kern,DavidP.Lee,ArnoldSeto

Page 226: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:226

8:00_AM WelcomeRemarks

8:05_AM CoronaryphysiologytoolboxandnewoptionsinnonhyperemicpressureratiosNHPR

8:12_AM Whentousewhatincoronaryphysiology

8:19_AM FFRbestpracticesandcommonartifacts

8:26_AM HDIVUSincomplexcases

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#9-LEARNOPTIMALSTEP-BY-STEPTECHNIQUESFORBIFURCATIONS:PROVISIONAL,TAP,

ANDDKCRUSHTECHNIQUES

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-8:45AM

RapidFireCasePresentations

8:00_AM BifurcationTechniquesVideosVisibleHeart InteractiveTrainingFaculty:FrancescoBurzotta

8:12_AM OptimalApproachestoBifurcationswithstepbystep InteractiveTrainingFaculty:KirtiPunamiya

8:24_AM 1vs2Stents:PlaqueDistributionandRoleofImaging InteractiveTrainingFaculty:KefeiDou

8:34_AM WhentoSendtoSurgeryHowtoBuildaComplexLMCABifurcationPCIPractice InteractiveTrainingFaculty:DevangMaheshchandraDesai

8:45AM-9:30AM

Hands-onRotationsBetweenCordis,Medtronic/Opsens,AndAbbott

8:45_AM MedtronicOpsensFeaturedDevicesRadialStentModelsSimulatorVHFootagetoLoopandOnyx InteractiveTrainingFaculty:AdrianP.Banning,JensFlenstedLassen,AzeemLatib

TRAINING:ENDOVASCULARPAVILION#9-DEEPVEININTERVENTION:DVT,PE,ANDIVUS

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:25AM

DeepVeinIntervention:DVT,PE,andIVUSSessionI

InteractiveTrainingFaculty:RiyazBashir,TeresaL.Carman,RaghuKolluri,SanjivLakhanpal,RobertA.Lookstein,RahulS.Patel,SanjumSSethi

8:00_AM VideoIntroduction:NeedforInvasiveTreatmentofDeepVeinInterventionPEandVenousCompression

8:10_AM Rotation1:DVTFeaturingBostonScientific InteractiveTrainingFaculty:RobertA.Lookstein,RahulS.Patel

8:35_AM Rotation2:PE InteractiveTrainingFaculty:RiyazBashir,TeresaL.Carman,SanjumSSethi

9:00_AM Rotation3:VenousCompressionFeaturingPhilips InteractiveTrainingFaculty:RaghuKolluri,SanjivLakhanpal

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#9-EXTRACORPOREALLIFESUPPORT(ECLS)

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

ExtracorporealLifeSupport(ECLS)

8:00_AM ExtracorporealLifeSupportECLS:Overview

Page 227: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:227

Lecturers:A.ReshadGaran

TRAINING:INTERVENTIONALIMAGINGPAVILION#9-CORONARYCT:DIAGNOSIS,PLANNING,ANDINTERVENTIONALGUIDANCE

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

8:00AM-9:30AM

CoronaryCT:Diagnosis,Planning,andInterventionalGuidance

InteractiveTrainingFaculty:JoãoLCavalcante,FaroucAJaffer,HasanJilaihawi,MichaelC.C.Kim

TRAINING:TAVRPAVILION#9-IMPROVINGTAVRSAFETY&AMBULATIONWITHTHETEMPO®TEMPORARYPACINGLEAD

MONDAY,SEPTEMBER24,2018

8:00AM-9:30AM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

8:00AM-9:30AM

ImprovingTAVRSafety&AmbulationwiththeTempo®TemporaryPacingLead

InteractiveTrainingFaculty:StanleyJ.Chetcuti,GeorgeS.Hanzel,NikolaosKakouros,AmarKrishnaswamy,JohnC.Messenger,SanjeevanPasupati,CarlosESanchez,Mark

W.I.Webster,BrianK.Whisenant,StevenJ.Yakubov

8:00_AM Introduction

8:05_AM TempoLeadTechnologyOverview

8:11_AM TempoLeadClinicalResults

8:21_AM TheTempoLeadsRoleinReducingTAVRLengthofStayLOS

TRAINING:ABBOTTPAVILION#12-NOWTHATISEEIT,IKNOWHOWTOTREATIT!-AHANDS-ONSKILLSLAB

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

NowThatISeeIt,IKnowHowtoTreatIt!-AHands-onSkillsLab

InteractiveTrainingFaculty:HiramG.Bezerra,JonathanM.Hill,VamsiKrishsna,EvanShlofmitz,GabrielTensolRodriguesPereira,ArmandoVergara-Martel

10:00_AM OCT:NowthatIseeIt..Presentation

TRAINING:BOSTONSCIENTIFICPAVILION#12-ROTAPROPLAQUEMODIFICATION/VESSELPREP

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

RotaProPlaqueModification/VesselPrep

InteractiveTrainingFaculty:EmmanouilS.Brilakis,WilliamL.Lombardi,RobertF.Riley,DanielH.Steinberg

10:00_AM WelcomeRemarks

10:05_AM DidacticPresentation:ROTAPRORotationalAtherectomySystem25yearsofprovenclinicalsafetyandefficacy

10:35_AM HandsOnRotationsX5ROTAPROWetHeartModelsConsoles

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#10-LEARNOPTIMALSTEP-BY-STEPTECHNIQUESFORBIFURCATIONS:PROVISIONAL,TAP,

Page 228: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:228

ANDDKCRUSHTECHNIQUES

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-10:45AM

RapidFireCasePresentations

10:00_AM BifurcationTechniquesVideosVisibleHeart InteractiveTrainingFaculty:FrancescoBurzotta

10:12_AM OptimalApproachestoBifurcationswithstepbystep InteractiveTrainingFaculty:EmmanouilS.Brilakis

10:24_AM 1vs2Stents:PlaqueDistributionandRoleofImaging InteractiveTrainingFaculty:KefeiDou

10:34_AM WhentoSendtoSurgeryHowtoBuildaComplexLMCABifurcationPCIPractice InteractiveTrainingFaculty:RajMakkar

10:45AM-11:30AM

Hands-onRotationsBetweenCordis,Medtronic/Opsens,andAbbottOCT

10:45_AM MedtronicOpsensFeaturedDevicesRadialStentModelsSimulatorVHFootagetoLoopandOnyx InteractiveTrainingFaculty:FaustoFeres,JensFlenstedLassen,AzeemLatib

TRAINING:ENDOVASCULARPAVILION#10-DEEPVEININTERVENTION:DVT,PE,ANDIVUS

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:25AM

DeepVeinIntervention:DVT,PE,andIVUSSessionII

InteractiveTrainingFaculty:JayS.Giri,SanjivLakhanpal,GregoryPiazza,SanjumSSethi,VictorF.Tapson

10:00_AM VideoIntroduction:NeedforInvasiveTreatmentofDeepVeinInterventionPEandVenousCompression

10:10_AM Rotation1:DVTFeaturingBostonScientific InteractiveTrainingFaculty:MehdiH.Shishehbor,AkhileshK.Sista

10:35_AM Rotation2:PE InteractiveTrainingFaculty:JayS.Giri,GregoryPiazza,VictorF.Tapson

11:00_AM Rotation3:VenousCompressionFeaturingPhilips InteractiveTrainingFaculty:S.JayMathews,MitchellWeinberg

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#10-EXTRACORPOREALLIFESUPPORT(ECLS)

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

ExtracorporealLifeSupport(ECLS)

10:00_AM ExtracorporealLifeSupportECLS:Overview InteractiveTrainingFaculty:A.ReshadGaran

TRAINING:INTERVENTIONALIMAGINGPAVILION#10-CORONARYCT:DIAGNOSIS,PLANNING,ANDINTERVENTIONALGUIDANCE

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

Page 229: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:229

10:00AM-11:30AM

CoronaryCT:Diagnosis,Planning,andInterventionalGuidance

InteractiveTrainingFaculty:JoãoLCavalcante,FaroucAJaffer,HasanJilaihawi

TRAINING:MEDTRONICPAVILION#10-CORONARY:OPTIMIZINGOUTCOMESINPATIENTSWITHBIFURCATIONLESIONS

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

Coronary:OptimizingOutcomesinPatientsWithBifurcationLesions

InteractiveTrainingFaculty:FrancescoBurzotta,DavidHildick-Smith,AzeemLatib

10:00_AM Introduction

10:05_AM BifurcationsaComplexLesionSubset

10:30_AM BifurcationTreatmentTechniques

11:00_AM TheLeftMain

11:15_AM CaseDiscussionsQA

TRAINING:TAVRPAVILION#10-IMPROVINGTAVRSAFETY&AMBULATIONWITHTHETEMPO®TEMPORARYPACINGLEAD

MONDAY,SEPTEMBER24,2018

10:00AM-11:30AM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

10:00AM-11:30AM

ImprovingTAVRSafety&AmbulationwiththeTempo®TemporaryPacingLead

InteractiveTrainingFaculty:StanleyJ.Chetcuti,GeorgeS.Hanzel,NikolaosKakouros,AmarKrishnaswamy,JohnC.Messenger,SanjeevanPasupati,CarlosESanchez,Mark

W.I.Webster,BrianK.Whisenant

10:00_AM Introduction

10:05_AM TempoLeadTechnologyOverview

10:11_AM TempoLeadClinicalResults

10:21_AM TheTempoLeadsRoleinReducingTAVRLengthofStayLOS

TRAINING:ABBOTTPAVILION#13-MITRACLIPNTR&XTR:DEVICE&PROCEDURALTECHNIQUES

MONDAY,SEPTEMBER24,2018

12:00PM-1:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

MitraClipNTR&XTR:Device&ProceduralTechniques

InteractiveTrainingFaculty:BassemChehab,PaoloDenti,RodrigoEstevez-Loureiro,GeorgeGellert,JamesB.HermillerJr,ScottLim,PaulD.Mahoney,MoodyMMakar,

AhmedIMustafa,MichaelJ.Rinaldi,DavidG.Rizik,JoshuaRovin,GaganDSingh

12:00_PM Introduction

12:05_PM Didactic

12:25_PM HandsonSession

TRAINING:BOSTONSCIENTIFICPAVILION#13-ROTAPROPLAQUEMODIFICATION/VESSELPREP

Page 230: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:230

MONDAY,SEPTEMBER24,2018

12:00PM-1:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

RotaProPlaqueModification/VesselPrep

InteractiveTrainingFaculty:EmmanouilS.Brilakis,TonyJ.DeMartini,RobertF.Riley,DanielH.Steinberg

12:00_PM WelcomeRemarks

12:05_PM DidacticPresentation:ROTAPRORotationalAtherectomySystem25yearsofprovenclinicalsafetyandefficacy

12:35_PM HandsOnRotationsX5ROTAPROWetHeartModelsConsoles

TRAINING:MEDTRONICPAVILION#11-STRUCTURALHEART:FUNDAMENTALSOFCARDIACANATOMYANDIMAGINGCORRELATION

MONDAY,SEPTEMBER24,2018

12:00PM-1:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

12:00PM-1:30PM

StructuralHeart:FundamentalsofCardiacAnatomyandImagingCorrelation

InteractiveTrainingFaculty:JoãoLCavalcante,MichaelJ.Reardon

12:00_PM Introduction

12:05_PM AnatomyOverviewusingVariousImagingModalitiesforStructuralHeartProcedures

TRAINING:ABBOTTPAVILION#14-SAVETHATSIDEBRANCH!PRESERVINGSIDEBRANCHACCESS:AHANDS-ONPRACTICALSKILLSLAB

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

SaveThatSideBranch!PreservingSideBranchAccess:AHands-onPracticalSkillsLab

InteractiveTrainingFaculty:EmmanouilS.Brilakis,Jean-FrançoisTanguay,NickE.J.West,JasonWollmuth

2:00_PM Introduction

2:05_PM DidacticonFirstSBATechniqueandHandOnGuidedSessionTechnique1

2:45_PM DidacticonSecondSBATechniqueandHandOnGuidedSessionTechnique2

3:25_PM Wrapup

TRAINING:BOSTONSCIENTIFICPAVILION#14-ROTAPROPLAQUEMODIFICATION/VESSELPREP

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

RotaProPlaqueModification/VesselPrep

InteractiveTrainingFaculty:TonyJ.DeMartini,MichaelC.C.Kim,JamesM.McCabe,DanielH.Steinberg

2:00_PM WelcomeRemarks

2:05_PM DidacticPresentation:ROTAPRORotationalAtherectomySystem25yearsofprovenclinicalsafetyandefficacy

2:35_PM HandsOnRotationsX5ROTAPROWetHeartModelsConsoles

Page 231: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:231

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#11-CTOSKILLS101:HOWTOAPPROACHTHESELESIONS

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-2:45PM

RapidFireCasePresentations

2:45PM-3:30PM

Hands-onRotationsBetweenAbbottCTO,AsahiCTO,andBostonScientificCTO

2:45_PM AsahiCTODevices

TRAINING:ENDOVASCULARPAVILION#11-SUPERFICIALVENOUSDISEASE:DIAGNOSISANDTREATMENTOPTIONS

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

VenousInterventionSessionIII:SuperficialVeinIntervention

InteractiveTrainingFaculty:RobertEFoster,JonC.George,MajaZaric

2:00_PM VideoIntroduction:SuperficialVeinIntervention

2:10_PM HandsonFeaturingDevicesFromMedtronic

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#11-EXTRACORPOREALLIFESUPPORT(ECLS)

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

ExtracorporealLifeSupport(ECLS)

2:00_PM ExtracorporealLifeSupportECLS:Overview InteractiveTrainingFaculty:MaximilianHalbe

TRAINING:INTERVENTIONALIMAGINGPAVILION#11-CTANALYSISFORTAVRPROCEDURES:PLANNINGANDINTERVENTIONALGUIDANCE

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

2:00PM-3:30PM

CTAnalysisforTAVRProcedures:PlanningandInterventionalGuidance

InteractiveTrainingFaculty:PhilippBlanke,JoãoLCavalcante,ChadKliger,JonathonA.Leipsic,MichaelJ.Reardon,RahulSharma,DeeDeeWang

TRAINING:MEDTRONICPAVILION#12-CORONARY:DOSIZEANDSHAPEMATTER?HOWTOCHOOSETHE�RIGHT�DIAGNOSTICANDGUIDECATHETERS?

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

MEDTRONICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

Page 232: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:232

2:00PM-3:30PM

Coronary:DoSizeandShapeMatter?HowtoChoosethe�Right�DiagnosticandGuideCatheters?InteractiveTrainingFaculty:MitchellW.Krucoff

2:00_PM Introduction

2:05_PM CaseBasedLearning

2:45_PM QAandSimulatorHandson

TRAINING:TAVRPAVILION#11-INNOVATIONSINTAVR:LOTUSEDGE,ACURATENEO2,ANDSENTINELCEREBRALPROTECTIONSYSTEM

MONDAY,SEPTEMBER24,2018

2:00PM-3:30PM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

2:00PM-3:30PM

InnovationsinTAVR:LOTUSEdge,ACURATEneo2,andSentinelCerebralProtectionSystem

InteractiveTrainingFaculty:AlexandreAbizaid,VijayIyer,SaibKhogali

2:00_PM IntroductiontoLOTUSEdge:TechnologyandCaseReviews

2:15_PM QA

2:20_PM IntroductiontoACURATEneo2:TechnologyandCaseReviews

2:35_PM QA

2:40_PM IntroductiontoSentinelEmbolicProtectionDevice

2:50_PM QA

TRAINING:ABBOTTPAVILION#15-PFOCLOSURE:RECENTDATA,TECHNIQUES,ANDBESTPRACTICESFORMANAGINGPATIENTS

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

ABBOTTPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

PFOClosure:RecentData,Techniques,andBestPracticesforManagingPatients

InteractiveTrainingFaculty:ZahidAmin,PatrickA.Calvert,IgalMoarof,RodrigoNieckeldaCosta,JensErikNielsen-Kudsk

4:00_PM Introduction

4:05_PM PFOClosure:RecentDataTechniquesandBestPracticesforManagingPatients

TRAINING:BOSTONSCIENTIFICPAVILION#15-ROTAPROPLAQUEMODIFICATION/VESSELPREP

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

BOSTONSCIENTIFICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

RotaProPlaqueModification/VesselPrep

InteractiveTrainingFaculty:KhaldoonAlaswad,WilliamL.Lombardi,RobertF.Riley,DanielH.Steinberg

4:00_PM WelcomeRemarks

4:05_PM DidacticPresentation:ROTAPRORotationalAtherectomySystem25yearsofprovenclinicalsafetyandefficacy

4:35_PM HandsOnRotationsX5ROTAPROWetHeartModelsConsoles

Page 233: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:233

TRAINING:CHIP-ADVANCEDPCITECHNIQUESPAVILION#12-CTOSKILLS101:HOWTOAPPROACHTHESELESIONS

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

CHIPPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-4:45PM

RapidFireCasePresentations

4:45PM-5:30PM

Hands-onRotationsBetweenAbbottCTO,AsahiCTO,BostonScientificCTO

4:45_PM AsahiCTODevices

TRAINING:ENDOVASCULARPAVILION#12-SUPERFICIALVENOUSDISEASE:DIAGNOSISANDTREATMENTOPTIONS

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

ENDOVASCULARPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

VenousInterventionSessionIV:SuperficialVeinIntervention

InteractiveTrainingFaculty:RobertEFoster,RaghuKolluri,MajaZaric

4:00_PM VideoIntroduction:SuperficialVeinIntervention

4:10_PM HandsonFeaturingDevicesFromMedtronic

TRAINING:HEMODYNAMICSUPPORTANDPATIENTMANAGEMENTPAVILION#12-EXTRACORPOREALLIFESUPPORT(ECLS)

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

HEMODYNAMICPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

4:00PM-5:30PM

ExtracorporealLifeSupport(ECLS)

4:00_PM ExtracorporealLifeSupportECLS:Overview InteractiveTrainingFaculty:FrancescoMaisano

TRAINING:INTERVENTIONALIMAGINGPAVILION#12-CTANALYSISFORTAVRPROCEDURES:PLANNINGANDINTERVENTIONALGUIDANCE

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

InterventionalImagingPavilion,InteractiveTrainingWorkshop,UpperLevel

4:00PM-5:30PM

CTAnalysisforTAVRProcedures:PlanningandInterventionalGuidance

InteractiveTrainingFaculty:PhilippBlanke,JoãoLCavalcante,ChadKliger,JonathonA.Leipsic,MichaelJ.Reardon,RahulSharma,DeeDeeWang

TRAINING:TAVRPAVILION#12-INNOVATIONSINTAVR:LOTUSEDGE,ACURATENEO2,ANDSENTINELCEREBRALPROTECTIONSYSTEM

MONDAY,SEPTEMBER24,2018

4:00PM-5:30PM

TAVRPAVILION,InteractiveTrainingWorkshops(SailsPavilion),UpperLevel

Page 234: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:234

4:00PM-5:30PM

InnovationsinTAVR:LOTUSEdge,ACURATEneo2,andSentinelCerebralProtectionSystem

InteractiveTrainingFaculty:AlexandreAbizaid,DanielJ.Blackman,VijayIyer

4:00_PM IntroductiontoLOTUSEdge:TechnologyandCaseReviews

4:15_PM QA

4:20_PM IntroductiontoACURATEneo2:TechnologyandCaseReviews

4:35_PM QA

4:40_PM IntroductiontoSentinelEmbolicProtectionDevice

4:50_PM QA

INTERNATIONALSESSION:COMPLEXANDCOMPLICATEDCORONARYANDSTRUCTURALINTERVENTIONSPRESENTEDBYCOLEGIOARGENTINODE

CARDIOANGIóLOGOSINTERVENCIONISTAS(CACI),VENEZUELANSOCIETYOFCARDIOLOGY,SAUDIARABIANCARDIACINTERVENTIONALSOCIETY

(SACIS),MEXICANSOCIETYOFINTERVENTIONALCARDIOLOGY(SOCIME)

MONDAY,SEPTEMBER24,2018

10:30AM-12:00PM

Room24C,UpperLevel

10:30AM-12:00PM

ComplexandComplicatedCoronaryandStructuralInterventions

Moderators:JuanF.Granada,OscarA.Mendiz

Discussants:CarlosCabreraArroyo,CarlosDCalderas,AnibalA.Damonte,NabeelIsmaeil

10:30_AM Introduction Lecturers:JuanF.Granada

10:35_AM Case1FromArgentina:ComplexParavalvularLeakClosure CasePresenter:GustavoAlejandroLev

10:43_AM PanelDiscussion

10:50_AM Case2FromMexico:TitleTBD

10:57_AM RoundtableDiscussionwithAudienceQA

11:04_AM Case3FromSaudiArabia:STEMIAirShockandEmbolism CasePresenter:MostafaAlShamiari

11:12_AM RoundtableDiscussionwithAudienceQA

11:19_AM Case4FromVenezuela:IsEndovascularTreatmentStillanOptionWhenEVARFails CasePresenter:CarlosDCalderas

11:27_AM RoundtableDiscussionwithAudienceQA

11:34_AM Case5FromArgentina:TransfemoralTAVRComplicatedbyStuckDeliverySystemAfterDeployment CasePresenter:MiguelABallarino

11:42_AM RoundtableDiscussionwithAudienceQA

11:49_AM Case6FromSaudiArabia:TranscavalTAVRComplicatedbyDoubleTrouble CasePresenter:WaleedAlharbi

11:57_AM RoundtableDiscussionwithAudienceQA

INTERNATIONALSESSION:HEMODYNAMICFUNCTIONALASSESSMENTOFCORONARYSTENOSISINDAILYPRACTICEPRESENTEDBYGROUPE

ATHEROMEETCARDIOLOGIEINTERVENTIONNELLE(GACI)ANDCOLEGIOARGENTINOCARDIOANGIOLOGOSINTERVENCIONISTAS(CACI)

MONDAY,SEPTEMBER24,2018

1:30PM-3:30PM

Room24C,UpperLevel

1:30PM-3:30PM

HemodynamicFunctionalAssessmentofCoronaryStenosisinDailyPractice

Moderators:AnibalA.Damonte,JacquesMonsegu

Page 235: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:235

Discussants:AlejandroCherro,DiegoDGrinfeld,BrahimHarboui,AlejandroO.Palacios,AntoinePy

1:30_PM IntroductionandSessionGoals Lecturers:AnibalA.Damonte

1:35_PM HowtoPerformaHemodynamicFunctionalAssessmentandItsPitfalls Lecturers:RaulSolerno

1:48_PM ProFFR Lecturers:DanielH.Berrocal

2:01_PM ProiFR Lecturers:JacquesMonsegu

2:14_PM RoundtableDiscussionWithAudienceQA2:29_PM MultivesselDisease:ShouldInvasivePhysiologyChangeMyStrategy

Lecturers:EricVanBelle1:48_PM ProFFR

Lecturers:DanielH.Berrocal2:01_PM ProiFR

Lecturers:JacquesMonsegu2:14_PM RoundtableDiscussionWithAudienceQA2:42_PM HowtoUseInvasivePhysiologyinAssessingandTreatingLeftMainDisease

Lecturers:LeandroILasave1:48_PM ProFFR

Lecturers:DanielH.Berrocal2:01_PM ProiFR

Lecturers:JacquesMonsegu2:14_PM RoundtableDiscussionWithAudienceQA2:55_PM IsThereaRoleforInvasivePhysiologyinAcuteCoronarySyndromes

Lecturers:PatrickDupouy1:48_PM ProFFR

Lecturers:DanielH.Berrocal2:01_PM ProiFR

Lecturers:JacquesMonsegu2:14_PM RoundtableDiscussionWithAudienceQA3:08_PM RoundtableDiscussionWithAudienceQA

1:48_PM ProFFR

Lecturers:DanielH.Berrocal2:01_PM ProiFR

Lecturers:JacquesMonsegu2:14_PM RoundtableDiscussionWithAudienceQA

3:24_PM ConclusionsandTakehomeMessages Lecturers:JacquesMonsegu

INTERNATIONALSESSION:COMPLEXPRIMARYPCIANDCOMPLICATIONSINSTEMIPRESENTEDBYBULGARIANWORKINGGROUPOF

INTERVENTIONALCARDIOLOGY,HUNGARIANWORKINGGROUPOFINTERVENTIONALCARDIOLOGY,HONGKONGSOCIETYOFTRANSCATHETER

ENDOCARDIOVASCULARTHERAPEUTICS(HKSTENT),ANDROMANIANWORKINGGROUPOFINTERVENTIONALCARDIOLOGY

MONDAY,SEPTEMBER24,2018

3:30PM-5:00PM

Room27A-B,UpperLevel

3:30PM-4:15PM

SessionI:ComplexPrimaryPCIinSTEMI

Moderators:MichaelKang-YinLee,IvoPetrov,MarinPostu,ZoltanRuzsa

Discussants:ValeriLjubenovGelev,StefanMot,ZsoltPiroth,LucianMariusPredescu,Li-WahTam

3:30_PM IsMultivesselRevascularizationDuringPrimaryPCIinSTEMINecessaryDesirableorContraindicated Lecturers:StefanMot

3:35_PM CaseIntroduction:MyMostComplexSTEMIPCI CasePresenter:IstvanF.Edes

3:40_PM HowWouldITreatThisPatient Lecturers:MarinPostu

Page 236: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:236

3:45_PM CaseConclusion:HowITreatedThisPatient CasePresenter:IstvanF.Edes

3:50_PM WhatInterventionalistShouldKnowAboutUsingECMOAssistedCoronaryInterventioninCardiogenicShock Lecturers:ZoltanRuzsa

3:55_PM CaseIntroduction:MyMostComplexSTEMIPCI CasePresenter:LucianMariusPredescu

4:00_PM HowWouldITreatThisPatient Lecturers:ZsoltPiroth

4:05_PM CaseConclusion:HowITreatedThisPatient CasePresenter:LucianMariusPredescu

4:10_PM RoundtableDiscussionWithAudienceQA

4:15PM-5:00PM

SessionII:ComplexandComplicatedPrimaryPCI

Moderators:MichaelKang-YinLee,IvoPetrov,MarinPostu,ZoltanRuzsa

Discussants:ValeriLjubenovGelev,StefanMot,ZsoltPiroth,LucianMariusPredescu,Li-WahTam

4:15_PM SurprisesinPrimaryPCI Lecturers:Li-WahTam

4:20_PM CaseIntroduction:NoReflowDuringPrimaryPCI CasePresenter:YuHoChan

4:25_PM HowWouldITreatThisPatient Lecturers:IvajlaZhivkovaZheleva

4:30_PM CaseConclusion:HowITreatedThisPatient CasePresenter:YuHoChan

4:35_PM LeftMainPCIinPatientsWithSTEMI Lecturers:ValeriLjubenovGelev

4:40_PM CaseIntroduction:STEMIPatientWithLMOcclusionandSubtotalAortoostialStenosisoftheLADGraft CasePresenter:IvoPetrov

4:45_PM HowWouldITreatThisPatient Lecturers:AngusShing-FungChui

4:50_PM CaseConclusion:HowITreatedThisPatient CasePresenter:IvoPetrov

4:55_PM RoundtableDiscussionWithAudienceQA

INTERNATIONALSESSION:COMPLICATIONSMANAGEMENT�CHALLENGINGSAVESANDMISSESTHATTEACHUSHOWTOBEBETTERPRESENTEDBY

THECARDIOLOGYSOCIETYOFINDIA/NATIONALINTERVENTIONALCOUNCILOFINDIA

MONDAY,SEPTEMBER24,2018

3:30PM-5:00PM

Room24C,UpperLevel

3:30PM-5:00PM

ComplicationsManagement:ChallengingSavesandMissesThatTeachUsHowtoBeBetter

Moderators:SreenivasKumarArramraju,SreenivasArramrajuKumar,SahilA.Parikh

Discussants:ManojKumarAgarwala,SubhashBanerjee,RaghuCherukupalli,ManotoshPanja,GokulM.Reddy

3:30_PM IntroductionandSessionGoals Lecturers:SreenivasArramrajuKumar

3:35_PM HowtoAvoidComplicationsintheCathLabWithCaseExamples Lecturers:SundeepMishra

3:50_PM RoundtableDiscussionWithAudienceQA

3:55_PM CHIP:SuccessandRegretCases CasePresenter:PrathapKumar

4:10_PM RoundtableDiscussionWithAudienceQA

4:15_PM AcuteMIandACSCases:MortalityandFortunateSaves CasePresenter:SreenivasArramrajuKumar

4:30_PM IntravascularImaginginComplicationsManagement:ASeriesofCases

4:42_PM RoundtableDiscussionWithAudienceQA

Page 237: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:237

4:45_PM AorticAneurysmandDissectionCases:DifficultSavesandComplications CasePresenter:NarendaN.Khanna

4:57_PM RoundtableDiscussionWithAudienceQA

MODERATEDPOSTERSESSION:CARDIOGENICSHOCKANDVENTRICULARASSISTIII

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

8:30AM-9:30AM

CardiogenicShockandVentricularAssistIII

Moderators:TimothyD.Henry,AjayJ.Kirtane

Discussants:MohamadAdnanAlkhouli,HiramG.Bezerra,PhilippeGarot,ItaloPorto,GokulM.Reddy

8:30_AM TCT754:PredictorsofMortalityandClinicalOutcomesofAcuteSevereCardiogenicShockTreatedWiththeImpellaDevice Lecturers:CharleneRohm

8:37_AM Discussion

8:42_AM TCT755:ImpellaforCardiogenicShock:ATertiaryCareCenterExperience20112017 Lecturers:BenjaminSeguy

8:49_AM Discussion

8:54_AM TCT756:AcuteMechanicalUnloadingoftheLeftVentricleIncreasesFunctionalPerfusionoftheAreaatRiskbyEnhancingtheCollateralFlowIndexPrior

toReperfusion Lecturers:NataliaBriceno

9:01_AM Discussion

9:06_AM TCT757:AxillaryArteryAccessforMechanicalCirculatorySupportDevicesinPatientswithProhibitivePeripheralArterialDiseasePresentingwith

CardiogenicShock Lecturers:MChadiAlraies

9:13_AM Discussion

9:18_AM TCT758:TheFutureofHeartPumptechnology:HemodynamicMonitoringofPatientsonTemporaryMCSWithoutAdditionalInvasiveCatheters Lecturers:MirBasir

9:25_AM Discussion

MODERATEDPOSTERSESSION:NEWAPPROACHESTOISCHEMICORDILATEDCARDIOMYPATHY

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

8:30AM-9:30AM

NewApproachestoIschemicorDilatedCardiomypathy

Moderators:IleanaL.Pina,JamesE.Udelson

Discussants:DavidABaran,PeterCarson,VictoriaDelgado

8:30_AM TCT744:AxillaryintraaorticBalloonPumpsReducesTimetoAmbulationAfterVentricularAssistDeviceOrTransplantforAdvancedHeartFailure Lecturers:VinodChainani,MD

8:37_AM Discussion

8:42_AM TCT745:EarlyResultsofReviventProcedureintheTreatmentofPatientsWithLeftVentricularDilatationandHeartFailureDuetoIschemic

Cardiomyopathy Lecturers:YanWang,MD

8:49_AM Discussion

8:54_AM TCT746:CanCardiacMRIViabilityAssessmentGuideRevascularizationDecisionsinPatientsWithIschemicCardiomyopathy Lecturers:DemetriosDoukas,MD

9:01_AM Discussion

9:06_AM TCT747:theCardiAMPHeartFailureStudy:FirstResultsFromUnblindedRollinPhase Lecturers:PeterJohnston

9:13_AM Discussion

Page 238: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:238

9:18_AM TCT748:PerformanceofHelixTransendocardialBiotherapeuticDeliverySystemAfter300Cases Lecturers:EricDuckers,MD

9:25_AM Discussion

MODERATEDPOSTERSESSION:PCITECHNIQUESANDOUTCOMES

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

8:30AM-9:30AM

PCITechniquesandOutcomes

Moderators:TimA.Fischell,AlfredoE.Rodriguez

Discussants:KhaldoonAlaswad,AntonioColombo,EliasSanidas,JoãoASilveira,BernhardWitzenbichler

8:30_AM TCT764:LongtermFollowupofCoveredStentImplantation Lecturers:DaisukeHahcinohe

8:37_AM Discussion

8:42_AM TCT765:EffectofPSPandOtherElementsofTechniqueon3YearOutcomesAmongMetallicEverolimusElutingStentTreatedPatientsintheAbsorb

Trials Lecturers:StephenG.Ellis

8:49_AM Discussion

8:54_AM TCT766:CoronaryPerforationComplicatingPercutaneousCoronaryInterventioninPatientsPresentingWithAnAcuteCoronarySyndrome:AnAnalysis

of1013PerforationCasesFromtheBritishCardiovascularInterventionSocietyDatabase Lecturers:TimKinnaird

9:01_AM Discussion

9:06_AM TCT767:CoronaryArteryAneurysmAfterDrugElutingStentingIncidencePredictorsandOutcomeASingleCenteredStudy Lecturers:PuneetAggarwal,MD

9:13_AM Discussion

9:18_AM TCT768:ImpactofPSPTechniqueonClinicalOutcomesFollowingMetallicDrugElutingStentImplantations Lecturers:XueyanZhao,MD

9:25_AM Discussion

MODERATEDPOSTERSESSION:PCIVOLUMESANDOUTCOMESII

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

8:30AM-9:30AM

PCIVolumesandOutcomesII

Moderators:LloydW.Klein,GeorgeW.Vetrovec

Discussants:DavidA.Cox,LarryS.Dean,HitinderS.Gurm,JuyingQian,AnandMRao

8:30_AM TCT769:ImplementationofASameDayDischargeProgramAfterPercutaneousCoronaryInterventioninPatientsWithIncreasedRisk Lecturers:GerardoNau

8:37_AM Discussion

8:42_AM TCT770:ContemporaryTrendsReadmissionRatesandCostsofSameDayDischargeAmongPatientsUndergoingElectivePercutaneousCoronary

Intervention:DepartmentofVeteransAffairs20082016 Lecturers:JenniferRymer,MD

8:49_AM Discussion

8:54_AM TCT771:TemporalTrendsinRiskProfilesofPatientsReceivingPercutaneousCoronaryInterventionandCoronaryArteryBypassGrafting:InsightsFrom

theWashingtonStateClinicalOutcomesAssessmentProgramCoap Lecturers:AkashKataruka,MD

9:01_AM Discussion

9:06_AM TCT772:PracticeLevelVariationininitialTreatmentStrategyinPatientsWithNonStSegmentElevationMyocardialInfarctionAMultiLevel

MethodologicalApproach Lecturers:YoonJungPark,MD

Page 239: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:239

9:13_AM Discussion

9:18_AM TCT773:ProceduralVolumeandOutcomeWithRadialOrFemoralAccessforPercutaneousCoronaryInterventioninPatientsWithStSegmentElevation

MyocardialInfarction Lecturers:NamKyunKim,MD

9:25_AM Discussion

MODERATEDPOSTERSESSION:PHARMACOLOGY:DUALANDTRIPLEANTI-PLATELETTHERAPYI

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

8:30AM-9:30AM

Pharmacology:DualandTripleAnti-PlateletTherapyI

Moderators:FaustoFeres,MatthewT.Roe

Discussants:AndreaAbizaid,MassoudA.Leesar,KyungWoo(KW)Park

8:30_AM TCT774:DurationofDualAntiplateletTherapyinElectiveDrugCoatedBalloonAngioplasty Lecturers:NatashaCorballis,MD

8:37_AM Discussion

8:42_AM TCT775:ASystematicReviewofRandomizedandNonRandomizedStudiesComparingDualTherapyWithTripleTherapyinPatientsWithAtrial

FibrillationUndergoingPercutaneousCoronaryIntervention Lecturers:AlexanderSullivan,MD

8:49_AM Discussion

8:54_AM TCT776:DurationofDualAntiplateletTherapyAfterDrugCoatedBalloonImplantation Lecturers:FranzKleber,MD

9:01_AM Discussion

9:06_AM TCT777:GuidedDeEscalationofDAPTinAcuteCoronarySyndromePatientsUndergoingPercutaneousCoronaryInterventionWithBvsImplantationA

PostHocAnalysisFromtheRandomizedTROPICALACSTrial Lecturers:LukaszKoltowski,MD

9:13_AM Discussion

9:18_AM TCT778:ImpactofTicagrelorandAspirinvsClopidogrelandAspirininSymptomaticPatientsWithPeripheralArterialDisease:ThrombusBurden

AssessedbyOpticalCoherenceTomography Lecturers:MehmetCilingiroglu,MD

9:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRANDMVDISEASEORLAACLOSURE

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

8:30AM-9:30AM

TAVRandMVDiseaseorLAAClosure

Moderators:PaulA.Grayburn,Karl-HeinzKuck

Discussants:KrzysztofBartus,MeganCoylewright,MatthewJDaniels,JamesB.HermillerJr

8:30_AM TCT739:PotentialRoleofEmergingPercutaneousMitralTechnologiesinPatientsUndergoingTAVR Lecturers:AndrewElbardissi,MD

8:37_AM Discussion

8:42_AM TCT740:ImpactofCalcificMitralStenosisonSurvivalinPatientsWithAorticStenosisTreatedWithTAVR Lecturers:AnnaSannino,MD

8:49_AM Discussion

8:54_AM TCT741:ImpactofTranscatheterAorticValveReplacementonMitralValveGradients Lecturers:AnnaSannino,MD

9:01_AM Discussion

9:06_AM TCT742:PercutaneousLeftAtrialAppendageClosureFollowingTranscatheterAorticValveReplacement:ResultsFromtheAttractiveStudy

Page 240: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:240

Lecturers:LiesbethRosseel,MD9:13_AM Discussion

9:18_AM TCT743:TheMultivalvularScoreonlineAppfortheAssessmentofPatientsWithConcomitantMitralandAorticValveDiseaseCandidatesto

TranscatheterAorticValveImplantation:ProspectiveValidation Lecturers:IgnacioAmat-Santos,MD

9:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRSIZING

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

8:30AM-9:18AM

TAVRSizing

Moderators:DuaneS.Pinto,JoachimSchofer

Discussants:FayazShawl,RobertJ.Siegel,WilliamMSuh,GiuseppeTarantini,KonstantinosToutouzas

8:30_AM TCT759:ValveSizeAsAPredictorofPermanentPacemakerImplantationinEdwardsSAPIEN3TAVRValvesASingleCenterExperience Lecturers:MansoorAhmad,MD

8:37_AM Discussion

8:42_AM TCT761:ReproducibilityofAorticAnnularAreainterpretationforTranscatheterAorticValveReplacementAmongindustryRepresentativesand

PhysiciansUsingMultideteCTOrComputedtomography Lecturers:RaveenChawla

8:49_AM Discussion

8:54_AM TCT762:LowincidenceofProsthesisPatientMismatchFollowingExtremelySmallTranscatherterAorticValveReplacementWith20MmSAPIEN3 Lecturers:KazueOkajima,MD

9:01_AM Discussion

9:06_AM TCT763:ComparativeAnalysisEvaluatingImagingModalitiesforAorticAnnulusSizingandAProposedNewTechniqueUtilizingThreeDimensionalTrans

EsophagealEchocardiography:AProspectiveBlindedStudy Lecturers:GeorgeGellert,MD

9:13_AM Discussion

MODERATEDPOSTERSESSION:TRANRADIALACCESSCOMPLICATIONS

MONDAY,SEPTEMBER24,2018

8:30AM-9:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

8:30AM-9:30AM

TranradialAccessComplications

Moderators:RonaldCaputo

Discussants:MazenAbu-Fadel,MartaBande,WarrenJ.Cantor,VladimirDzavik,AlejandroGoldsmit,EufracinoSandoval,YaderSandoval

8:30_AM TCT749:RealWorldRegistryonRadialArteryOcclusionPostCardiacCatheterizationByArterialDuplexUltrasound Lecturers:WahWahHtun,MD

8:37_AM Discussion

8:42_AM TCT750:RadialArteryOcclusionIncidencePredictorsandLongTermOutcomeAfterTransradialCatheterization:ClinicoDopplerUltrasoundBased

StudyRAILTRACStudy Lecturers:PuneeetAggarwal,MD

8:49_AM Discussion

8:54_AM TCT751:EffectofPigtailAssistedTrackingPATofGuideCatheterDuringTransradialCoronaryAngioplastyonforearmComplications:AProspective

RandomizedTrial Lecturers:NaveenGarg,MD

9:01_AM Discussion

9:06_AM TCT752:TransradialAccessisAssociatedWithanIncreasedofRiskCatheterInducedCoronaryArteryDissectionComparedWithTransfemoralAccess Lecturers:PaulBoland,MD

Page 241: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:241

9:13_AM Discussion

9:18_AM TCT753:IncidenceofCompartmentSyndromeAfterCardiacCatheterizationViaTransradialApproach Lecturers:MichaelBode,MD

9:25_AM Discussion

MODERATEDPOSTERSESSION:INTERVENTIONTHERAPIESINPATIENTSWITHDIABETESMELLITUSII

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

9:30AM-10:18AM

InterventionTherapiesinPatientswithDiabetesMellitusII

Moderators:DonaldCutlip,MichaelE.Farkouh

Discussants:JayaChandrasekhar,FazilaT.Malik,StevenP.Marso,ExpeditoEustáquioRibeiro,BinitaShah,ClemensvonBirgelen

9:30_AM TCT789:OutcomesAfterPCIWithNovelSirolimusElutingStentWithUniqueFusionCoatinginPatientsWithDiabetesMellitus Lecturers:LucaTesta

9:37_AM Discussion

9:42_AM TCT790:EfficacyandSafetyoftheUltrathinBioresorbablePolymerSirolimusElutingStentsvsThinDurablePolymerEverolimusElutingStentsfor

TreatmentofPatientsWithDiabetesMellitus Lecturers:RonWaksman

9:49_AM Discussion

9:54_AM TCT792:EverolimusElutingvsBiolimusElutingStentImplantationinUnselectedPatientsWithandWithoutDiabetes:ASORTOUTVIIISubstudy Lecturers:MichaelMaeng

10:01_AM Discussion

10:06_AM TCT793:10YearOutcomesinPatientsWithandWithoutDiabetesTreatedWithFirstGenerationZotarolimusElutingandSirolimusElutingStents:The

SORTOUTIIIStudy Lecturers:KevinKrisWarnakulaOlesen

10:13_AM Discussion

MODERATEDPOSTERSESSION:MIDEFINITIONS

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters2,ExhibitHall,GroundLevel

9:30AM-10:30AM

MIDefinitions

Moderators:HectorM.Garcia-Garcia,PascalVranckx

Discussants:SripalBangalore,MiroslawFerenc,IssamD.Moussa,Duk-WooPark

9:30_AM TCT784:RelationshipBetweenEnzymaticInfarctSizeandTotalPlateletAggregabilityDuringPrimaryPercutaneousCoronaryInterventioninPatients

WithSTElevationMyocardialInfarction Lecturers:ShinnosukeKikuchi

9:37_AM Discussion

9:42_AM TCT785:MisclassificationofType2MyocardialInfarctionanditsImplicationonOutcomes Lecturers:AmerHawatmeh

9:49_AM Discussion

9:54_AM TCT786:ClinicalFeaturesofSubacuteMyocardialInfarctionMulticenterRegistryFromTokyoCCUNetworkDatabase Lecturers:RyosukeIto

10:01_AM Discussion

10:06_AM TCT787:HighSensitiveCardiacTroponinPredicts2YearsMortalityinPatientsWithCoronaryArteryDiseaseSubanalysisoftheGlobalLeadersTrial Lecturers:ChunChinChang

10:13_AM Discussion

10:18_AM TCT788:RelationshipBetweenTotalCKCKMBSCAIandUniversalDefinitioninDeterminingPeriPCIMyocardialInfarction:AnalysisFromthe

RandomizedBionICSTrial

Page 242: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:242

Lecturers:OriBen-Yehuda10:25_AM Discussion

MODERATEDPOSTERSESSION:OPTIMALDIAGNOSISANDTREATMENTOFPATIENTSWITHSTEMIORNSTEMIIII

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

9:30AM-10:30AM

OptimalDiagnosisandTreatmentofPatientswithSTEMIorNSTEMIIII

Moderators:WalterDesmet,BillFrench

Discussants:YunDaiChen,SimonP.Hoerstrup,EduardoInfantedeOliveira,SreenivasArramrajuKumar

9:30_AM TCT804:ComparativeValidationoftheALPHAScoreANovelRiskModelIncludingVascularAccessSiteforPredicting30DayMortalityinPatients

TreatedWithPrimaryPCI Lecturers:IstvanHizoh

9:37_AM Discussion

9:42_AM TCT805:TemporalTrendsandOutcomesofPercutaneousVentricularSeptalRuptureClosureinSTElevationMyocardialInfarctionintheUnitedStates Lecturers:SrikanthYandrapalli

9:49_AM Discussion

9:54_AM TCT806:OneYearClinicalOutcomesofIntensityBasedvsAttainedLowDensityCholesterolBasedStatinTherapyinPatientsWithAcuteMyocardial

Infarction Lecturers:Jung-HeeLee

10:01_AM Discussion

10:06_AM TCT807:PostProceduralintracoronaryPhysiologyPredictsFinalMyocardialInjuryAfterSTEMIInsightsFromtheOxAMIStudy Lecturers:RobertoScarsini

10:13_AM Discussion

10:18_AM TCT808:ComparisonBetweenClopidogrelandtheNewOralP2Y12InhibitorsintheTreatmentofPatientsWithSTEMIUndergoingPrimary

PercutaneousCoronaryIntervention Lecturers:MartinoPepe

10:25_AM Discussion

MODERATEDPOSTERSESSION:PHARMACOLOGY:DUALANDTRIPLEANTI-PLATELETTHERAPYII

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

9:30AM-10:30AM

Pharmacology:DualandTripleAnti-PlateletTherapyII

Moderators:TullioPalmerini

Discussants:UsmanBaber,PiotrJankowski,ElianoPioNavarese

9:30_AM TCT814:MetaAnalysisofEffectsofShortvsLongTermDualAntiPlateletTherapyAfterDrugElutingStentImplantationinPatientsWithCoronary

ArteryDisease Lecturers:HammadRahman

9:37_AM Discussion

9:42_AM TCT815:MetaAnalysisofSafetyandEfficacyofProtonPumpInhibitorsWithDualAntiplateletTherapyforCoronaryArteryDisease Lecturers:SafiKhan

9:49_AM Discussion

9:54_AM TCT816:PretreatmentWithDualAntiPlateletTherapy:FindingsFromDedicatedRCTsPostHocAnalysesandObservationalStudies Lecturers:BrandonKai

10:01_AM Discussion

10:06_AM TCT817:BestDurationofDualAntiplateletTherapyAfterDrugElutingStentImplantationANetworkMetaAnalysisofRandomizedControlledTrials Lecturers:MahmoudBarbarawi

10:13_AM Discussion

Page 243: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:243

10:18_AM TCT818:SafetyandEfficacyof3MonthDualAntiplateletTherapyAfterDrugElutingStentANetworkBayesanMetaAnalysisofRandomisedClinical

Trials Lecturers:GiuseppeFerrante

10:25_AM Discussion

MODERATEDPOSTERSESSION:RACIALANDGENDERDISPARITIESINCORONARYARTERYDISEASEANDINTERVENTIONII

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

9:30AM-10:30AM

RacialandGenderDisparitiesinCoronaryArteryDiseaseandInterventionII

Moderators:AmishaPatel,BonnieH.Weiner

Discussants:WaleedYKadro,ChristopherKim,NadiaRSutton

9:30_AM TCT794:EffectofAtrialFibrillationinAsianPatientsWithAnginaUndergoingPercutaneousCoronaryInterventionWithDrugElutingStents:ResultsFrom

aKoreanNationwideStudy Lecturers:YongGiunKim

9:37_AM Discussion

9:42_AM TCT795:PrognosticImpactofRaceinPatientsUndergoingPCI:Analysisof22638PatientsFrom10RandomizedCoronaryStentTrials Lecturers:BjornRedfors

9:49_AM Discussion

9:54_AM TCT796:AParadoxinSexSpecificClinicalOutcomesAfterBioresorbableScaffoldImplantation:2YearResultsFromtheAIDATrial Lecturers:LauraKerkmeijer

10:01_AM Discussion

10:06_AM TCT797:SexandRacialDisparitiesinOutcomesforPatientsUndergoingPercutaneousInterventionDataFromaLargeTertiaryCenter Lecturers:MicaelaIantorno

10:13_AM Discussion

10:18_AM TCT798:EvaluationofSexDifferencesinOneYearClinicalOutcomesAmongPatientsTreatedWiththeDualTherapyComboStentFromtheCombo

Collaboration Lecturers:JayaChandrasekhar

10:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRVSTAVRANDTAVRVSSAVRII

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

9:30AM-10:30AM

TAVRvsTAVRandTAVRvsSAVRII

Moderators:Jean-ClaudeLaborde,HelgeMöllmann

Discussants:AndreaColli,KhalilFattouch,NealSawlani

9:30_AM TCT779:QualityofLifeAfterSurgicalandTranscatheterAorticValveReplacementinPatientsandTheirInformalCaregivers:RealWorldData

ContributingtoEstablishValueBasedMedicineinEastDenmark Lecturers:LiesbethRosseel

9:37_AM Discussion

9:42_AM TCT780:FirstDirectComparisonoftheSelfExpandablePorticovstheBalloonExpandableSAPIEN3DeviceforTransCatheterAorticValveReplacement:

ACaseMatchedCohortStudy Lecturers:MariucaVasa-Nicotera

9:49_AM Discussion

9:54_AM TCT781:PatientsWithVonWillebrandFactorAbnormalitiesBleedLessFrequentlyAfterTranscatheterThanSurgicalAorticValveReplacement Lecturers:KajetanGrodecki

10:01_AM Discussion

10:06_AM TCT782:EarlyOutcomesComparisonofTAVIUsingThreeDifferentSecondGenerationProsthesesEdwardsSAPIEN3MedtronicEvolutRSymetis

ACURATENeoTF

Page 244: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:244

Lecturers:GiulianoCosta10:13_AM Discussion

10:18_AM TCT783:ProceduralandClinicalOutcomesofNewerGenerationTranscatheterAorticValvesvsFirstGenerationTranscatheterAorticValves Lecturers:CarlosGiuliani

10:25_AM Discussion

MODERATEDPOSTERSESSION:TRANSCATHETERTREATMENTOFMVANDTVDISEASEI

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

9:30AM-10:30AM

TranscatheterTreatmentofMVandTVDiseaseI

Moderators:JeroenJ.Bax,ScottLim

Discussants:SammyElmariah,ChristianFrerker,TsuyoshiKaneko,SaurabhSanon

9:30_AM TCT799:TheImportanceofEmergingTranscatheterMitralValveTechnologiesinCostEffectivenessandPostProcedureOutcomes Lecturers:AndrewElbardissi

9:37_AM Discussion

9:42_AM TCT800:ImmediateandLongTermPredictorScoreofSuccessAfterPercutaneousMitralBalloonValvoplasty Lecturers:RafaelAlexandreMeneguz-Moreno

9:49_AM Discussion

9:54_AM TCT801:PredictorsofImmediateSuccessandLongTermClinicalOutcomesAfterPercutaneousMitralBalloonValvuloplastyinPatientsWithRheumatic

MitralStenosis Lecturers:RafaelAlexandreMeneguz-Moreno

10:01_AM Discussion

10:06_AM TCT802:EffectsofPulmonaryHypertensiononTranscatheterMitralValveRepairOutcomes:AnalysisoftheSTSACCTVTRegistry Lecturers:RashaAl-Bawardy

10:13_AM Discussion

10:18_AM TCT803:MitralValveRepairWithaNovelTransseptalNeochordalSystem:FirstinManExperience Lecturers:AlbertoWeber

10:25_AM Discussion

MODERATEDPOSTERSESSION:VASCULARACCESSDURINGPCIII

MONDAY,SEPTEMBER24,2018

9:30AM-10:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

9:30AM-10:30AM

VascularAccessDuringPCIII

Moderators:GaryGershony,MichaelA.Kutcher

Discussants:YuBo,JamesCockburn,MauricioG.Cohen,YujiIkari,MichaelC.C.Kim,EthanCKorngold

9:30_AM TCT809:RadialArterytoSheathSizeRatioinanAmericanPopulationImplicationsastoWhyRealTimeUltrasoundGuidedRadialAccessMayDecrease

FailureCrossoverRates Lecturers:JonathanRoberts

9:37_AM Discussion

9:42_AM TCT810:NovelDistalTransradialApproachforCoronaryandPeripheralInterventions Lecturers:AvtandilBabunashvili

9:49_AM Discussion

9:54_AM TCT811:ThumbArterialFlowAssessmentAfterRadialArteryCompressionintheAnatomicalSnuffboxComparedtoWristLevel Lecturers:GregorySgueglia

10:01_AM Discussion

10:06_AM TCT812:TheDistalLeftRadialArteryforCoronaryAngiographyandInterventionAUsExperience Lecturers:KarimAl-Azizi

Page 245: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:245

10:13_AM Discussion Lecturers:JasonRoss

10:18_AM TCT813:AssessingRelativeImportanceforAttributesofRadialandFemoralArteryPCIAmongstHealthyOnlineRecruitedVolunteers Lecturers:JasonRoss

10:25_AM Discussion

MODERATEDPOSTERSESSION:ASDANDPFOCLOSUREIII

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters1,ExhibitHall,GroundLevel

10:30AM-11:30AM

ASDandPFOClosureIII

Moderators:EustaquioMariaOnorato,HarsimranSachdevaSingh

Discussants:SachinS.Goel,UzomaIbebuogu,Kee-SikKim,JorgePalazuelos,FrancescoPelliccia

10:30_AM TCT819:PatentForamenOvaleClosurevsMedicalTherapyAfterCryptogenicStrokeASystematicReviewandMetaAnalysis Lecturers:SafiKhan

10:37_AM Discussion

10:42_AM TCT820:ImpactofAtrialSeptalShuntinPatientsWithPatentForamenOvaleandCryptogenicCerebralIschemicEventsonAcuteandLongtermOutcome

AfterPercutaneousClosure Lecturers:JuliaSeeger

10:49_AM Discussion

10:54_AM TCT821:PatentForamenOvaleClosureinPatientsWithCryptogenicStroke:MetaAnalysisofRandomizedControlledTrials Lecturers:FahedDarmoch

11:01_AM Discussion

11:06_AM TCT822:PatentForamenOvalePFOClosureComparedtoMedicalTherapyforPreventionofStrokeRecurrenceinCryptogenicStrokePopulation

SystematicReviewandMetaAnalysis Lecturers:KaisHyasat

11:13_AM Discussion

MODERATEDPOSTERSESSION:CATHLABOFTHEFUTURE:STRATEGIESTOCONTROLRADIATIONEXPOSUREIII

MONDAY,SEPTEMBER24,2018

10:30AM-11:18AM

ModeratedPosters2,ExhibitHall,GroundLevel

10:30AM-11:18AM

StrategiestoControlRadiationExposureIII

Moderators:ToddJ.Brinton,LouisA.Cannon

Discussants:MarkC.Bates,JamesA.Goldstein,RamonLVarcoe

10:30_AM TCT823:IdentificationofPatientandProceduralCharacteristicsAssociatedWithHighRadiationUseDuringTAVI Lecturers:WienekeVlastra

10:37_AM Discussion

10:42_AM TCT824:StatewideVariabilityinRadiationDosesExceeding5GyDuringPercutaneousCoronaryInterventionDataFromtheBlueCrossBlueShieldof

MichiganCardiovascularCollaborativeBMC2Registry Lecturers:RyanMadder

10:49_AM Discussion

10:54_AM TCT825:TheRightRadialAccessforCoronaryAngiographyReducesRadiationExposureComparedtoOtherApproachesTheExperienceFromaHigh

VolumeCenter Lecturers:WojciechZajdel

11:01_AM Discussion

11:06_AM TCT826:EffectofAlluraXpefFD10ECOXRayImageProcessingonRadiationReductionDuringCardiacCatheterizationASingleCenter717Case

Experience Lecturers:J.R.ExequielPineda

Page 246: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:246

11:13_AM Discussion

MODERATEDPOSTERSESSION:HOCMORALCOHOLSEPTALABLATION

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters3,ExhibitHall,GroundLevel

10:30AM-11:18AM

HOCMorAlcoholSeptalAblation

Moderators:JohnS.DouglasJr,SrihariS.Naidu

Discussants:MichaelA.Fifer,AlexanderGrigorievichOsiev,IgorF.Palacios,KoljaSievert,QiZhang

10:30_AM TCT827:SeptalAlcoholAblationvsMyectomyforSymptomaticHypertrophicObstructiveCardiomyopathyAnUpdatedMetaAnalysisforLongTerm

Outcomes Lecturers:MohammedOsman

10:37_AM Discussion

10:42_AM TCT828:ClinicalOutcomesFollowingFocalAblationANewTechniqueforthePerformanceofAlcoholSeptalAblation Lecturers:YoussefRahban

10:49_AM Discussion

10:54_AM TCT830:OutcomesofAcuteMyocardialInfarctioninHypertrophicObstructiveCardiomyopathy Lecturers:ObaiAbdullah

11:01_AM Discussion

11:06_AM TCT831:DifferencesinShortTermOutcomesandCostBetweenAlcoholSeptalAblationandSeptalMyectomyforHypertrophicCardiomyopathyinthe

UnitedStates Lecturers:SrikanthYandrapalli

11:13_AM Discussion

MODERATEDPOSTERSESSION:LMCADISEASEANDINTERVENTIONIII

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters4,ExhibitHall,GroundLevel

10:30AM-11:30AM

LMCADiseaseandInterventionIII

Moderators:AndrejsErglis,LeifThuesen

Discussants:AlaideChieffo,NicolasFoin,RobertJ.Gil,MamasMamas

10:30_AM TCT832:RestingHeartRateAtDischargePredictsAdverseCardiovascularOutcomesinPatientsWithLeftMainCoronaryArteryDiseaseRevascularized

WithPCIandCABG:InsightsFromtheEXCELTrial Lecturers:LeonGustavoMacedo

10:37_AM Discussion

10:42_AM TCT833:DoesanOccludedRCAAffectPrognosisinPatientsUndergoingPCIorCABGforLeftMainCoronaryArteryDiseaseAnalysisFromtheEXCELTrial Lecturers:ShmuelChen

10:49_AM Discussion

10:54_AM TCT834:RiskStratificationUsingtheACEFScoreinPatientsUndergoingPercutaneousorSurgicalLeftMainRevascularization:InsightsFromtheEXCEL

Trial Lecturers:BimmerClaessen

11:01_AM Discussion

11:06_AM TCT835:ValidationofPARISRiskScoresinPatientsTreatedWithEverolimusElutingStentsforLeftMainCoronaryArteryDisease:AnalysisFromthe

EXCELTrial Lecturers:SabatoSorrentino

11:13_AM Discussion

11:18_AM TCT836:UniqueCalcificationPatternsintheLeftMainBifurcationinPatientsAfterCoronaryArteryBypassGrafting Lecturers:RafalWolny

11:25_AM Discussion

Page 247: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:247

MODERATEDPOSTERSESSION:PCIINHIGHBLEEDINGRISK(HBR)PATIENTSIII

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters6,ExhibitHall,GroundLevel

10:30AM-11:30AM

PCIinHighBleedingRisk(HBR)PatientsIII

Moderators:JohnA.Bittl,MichaelMaeng

Discussants:EricA.Cohen,GertRichardt,Jean-FrançoisTanguay

10:30_AM TCT841:BaselineCharacteristicsand3MonthOutcomesoftheEVOLVEShortDAPTTrialAProspectiveinvestigationofAbbreviatedAntiplatelet

TherapyinHighBleedingRiskPatientsTreatedWithAThinStrutBioabsorbablePolymerCoatedEverolimusEluti Lecturers:AjayJ.Kirtane

10:37_AM Discussion

10:42_AM TCT842:PatternsofProtonPumpInhibitorUseinPatientsPostCoronaryRevascularizationImpactofBleedingRiskonPrescriptionPatterns Lecturers:KiranSarathy

10:49_AM Discussion

10:54_AM TCT843:EvaluationofSafetyandEfficacyofLeftandRightHeartCatheterizationFromTransradialandAntecubitalAccessinPatientsonAnticoagulation Lecturers:FelipeMarques

11:01_AM Discussion

11:06_AM TCT844:LongTermRiskforMajorBleedingandIschemicEventsAfterPCIWithImplantationofEverolimusElutingStents:APooledLevelAnalysisof

8020Patients Lecturers:SabatoSorrentino

11:13_AM Discussion

11:18_AM TCT845:ClinicalImpactofLowPlateletCountinPatientsWithCoronaryArterialDiseaseAfterPercutaneousCoronaryIntervention Lecturers:SangwooPark

11:25_AM Discussion

MODERATEDPOSTERSESSION:TAVRRISKSTRATIFICATIONANDOUTCOMESIV

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters5,ExhibitHall,GroundLevel

10:30AM-11:30AM

TAVRRiskStratificationandOutcomesIV

Moderators:Marie-ClaudeMorice,ChristianM.Spaulding

Discussants:DavidJ.Cohen,BernhardReimers

10:30_AM TCT837:TranscatheterAorticValveReplacementOutcomesByProcedureLocationCatheterizationLaboratoryvsOperatingRoom Lecturers:TomNguyen

10:37_AM Discussion

10:42_AM TCT838:TheChangingLandscapeofAorticValveReplacementintheUnitedStatesInsightsFromaNationalDatabase Lecturers:TanushGupta

10:49_AM Discussion

10:54_AM TCT839:TranscatheterAorticValveReplacementforSevereAorticStenosisIsMoreLikelytoImproveThanWorsenCkdStage:AnalysisofthePartner1

2AandS3Trials Lecturers:RobertoJ.Cubeddu

11:01_AM Discussion

11:06_AM TCT840:TheImpactofTranscatheterAorticValveReplacementonShortandLongTermOutcomesinHighGradientvsLowFlowLowGradientvs

ParadoxicalLowFlowLowGradientSevereAorticStenosis:ANetworkMetaAnalysisofRandomizedControlledTrial Lecturers:AbdulahAlrifai

11:13_AM Discussion

11:18_AM TCT721:TranscatheterAorticValveReplacementinPatientsWithChronicPulmonaryHypertension Lecturers:ObaiAbdullah

Page 248: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:248

11:25_AM Discussion

MODERATEDPOSTERSESSION:THROMBUSANDTHROMBUSASPIRATIONDURINGSTEMIINTERVENTION

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters8,ExhibitHall,GroundLevel

10:30AM-11:18AM

ThrombusandThrombusAspirationDuringSTEMIIntervention

Moderators:SameerMehta,RobertS.Schwartz

Discussants:JoseL.Leiva-Pons,ChaimS.Lotan,VergheseMathew,SundeepMishra,AnandMRao

10:30_AM TCT851:HistopathologicalandScanningElectronMicroscopyThrombusFindingsinPatientsUndergoingPrimaryvsRescuePercutaneousCoronary

Intervention Lecturers:StellaMarinelliPedrini

10:37_AM Discussion

10:42_AM TCT853:ThrombusAspirationinPatientsWithSTElevationMyocardialInfarctionPresentingLateAfterSymptomOnsetLongTermClinicalOutcomeof

ARandomizedTrial Lecturers:AnneFreund

10:49_AM Discussion

10:54_AM TCT854:ThePreciseDAPTScoreRelationshipWithClinicalOutcomesAfterDrugElutingStentsImplantationandWithThromboticIschemicScores Lecturers:JoseM.delaTorreHernandez

11:01_AM Discussion

11:06_AM TCT855:OpticalCoherenceTomographyAppraisalofResidualThrombusBurdeninPatientsWithSTSegmentElevationMyocardialInfarction

UndergoingHighvsLowBivalirudinInfusionTheMATRIXMinimizingAdverseHaemorrhagicEventsByTransradialAccess Lecturers:HectorM.Garcia-Garcia

11:13_AM Discussion

MODERATEDPOSTERSESSION:VASCULARACCESSDURINGPCIIII

MONDAY,SEPTEMBER24,2018

10:30AM-11:30AM

ModeratedPosters7,ExhibitHall,GroundLevel

10:30AM-11:18AM

VascularAccessDuringPCIIII

Moderators:SamirB.Pancholy,StephenR.Ramee

Discussants:BruceBowers,MinaMadan,NishPatel,RahulSakhuja,Wei-HsianYin

10:30_AM TCT846:MulticenterStudyoftheEfficacyandSafetyofDistalRadialApproachinCoronaryAngiographyandIntervention Lecturers:YukioMizuguchi

10:37_AM Discussion

10:42_AM TCT848:ComparisonBetweenConventionalAccessSiteApproachandFullyTransWristApproachforChronicTotalOcclusionPercutaneousCoronary

Intervention:theMinimalisticHybridApproach Lecturers:LorenzoAzzalini

10:49_AM Discussion

10:54_AM TCT849:SafetyofTransradialAccessComparedtoTransfemoralAccessWithHemostaticDevicesVesselPlugsSutureDevicesandVascularClipsAfter

PercutaneousCoronaryInterventionASystematicReviewandMetaAnalysis Lecturers:YashasviChugh

11:01_AM Discussion

11:06_AM TCT850:EarlyExperienceWithUltrasoundGuidedDistalTransRadialAccessintheAnatomicalSnuffboxinCoronaryAngiographyandIntervention Lecturers:JangWhanBae

11:13_AM Discussion

MODERATEDPOSTERSESSION:CORONARYPHYSIOLOGYINAMIPATIENTS

Page 249: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:249

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

ModeratedPosters7,ExhibitHall,GroundLevel

11:30AM-12:30PM

CoronaryPhysiologyinAMIPatients

Moderators:DariuszDudek,AlanC.Yeung

Discussants:JozefBartunek,NickCurzen,MaurizioMenichelli,ErickSchampaert

11:30_AM TCT870:DoWeNeedWedgePressureforCalculationoftheIndexofMicrocirculatoryResistanceIMRPostPrimaryPercutaneousCoronaryIntervention

PPCIinPatientsWithSTSegmentElevationMyocardialInfarctionSTEMI Lecturers:GrigorisKaramasis

11:37_AM Discussion

11:42_AM TCT871:StratificationoftheCoronaryFlowImpairmentinNonInfarctedRelatedArteriesAccordingtotheCoronaryFlowCapacityCFC Lecturers:HernanMejia-Renteria

11:49_AM Discussion

11:54_AM TCT872:QuantitativeFlowRatioinMyocardialInfarctionfortheEvaluationofNonInfartRelatedArteriesTheQIMERAPilotStudy Lecturers:CarlosCortes

12:01_PM Discussion

12:06_PM TCT873:AttenuatedCoronaryPostOcclusiveFlowIncreasedInflammatoryEnvironmentandLargerInfarctSizeinSTEMIPatientsWithAcutePeripheral

VascularDysfunction Lecturers:NinaVanDerHoeven

12:13_PM Discussion

12:18_PM TCT874:CoronaryMicrovascularFunctionDuringSTEMI:RealTimeAbsoluteDynamicMicrovascularResistanceinAnExperimentalPorcineModelUsing

ControlledFlowInfusion Lecturers:RobertS.Schwartz

12:25_PM Discussion

MODERATEDPOSTERSESSION:PCIINTHEELDERLYII

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

ModeratedPosters6,ExhibitHall,GroundLevel

11:30AM-12:30PM

PCIintheElderlyII

Moderators:MatthiasLutz,MohamedAhmedSobhy

Discussants:KhaledAlmerri,ShiroUemura

11:30_AM TCT865:TemporalTrendsandOutcomesofFibrinolyticTherapyforSTElevationMyocardialInfarctionAmongPatients80YearsorOlderTransferredfor

PercutaneousCoronaryIntervention Lecturers:GbolahanOgunbayo

11:37_AM Discussion

11:42_AM TCT866:AssociationofAgeWiththeRiskofThromboticandBleedingEventAfterPercutaneousCoronaryIntervention Lecturers:HirotoshiWatanabe

11:49_AM Discussion

11:54_AM TCT867:PolymerFreeSirolimusElutingStentsinanElderlyandOctogenarianAllComerPopulation Lecturers:MarkusFlorianKrackhardt

12:01_PM Discussion

12:06_PM TCT868:DrugElutingStentsandShortDurationofDAPTinElderlyPatientsWithCoronaryArteryDiseaseResultsoftheSeniorRandomizedClinicalTrial

at2Years Lecturers:OlivierVarenne

12:13_PM Discussion

12:18_PM TCT869:TwoYearsOutcomesinElderlyPatientsPlannedforOneMonthDAPTAfterPCI:SubanalysisoftheSENIORTrial Lecturers:OlivierVarenne

12:25_PM Discussion

Page 250: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:250

MODERATEDPOSTERSESSION:TRANSCATHETERTREATMENTOFMVANDTVDISEASEII

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

ModeratedPosters5,ExhibitHall,GroundLevel

11:30AM-12:30PM

TranscatheterTreatmentofMVandTVDiseaseII

Moderators:FrancescoMaisano,RalphStephanvonBardeleben

Discussants:StamatiosLerakis,CarlosE.Ruiz,BernardVasseur

11:30_AM TCT860:LampoontoFacilitateTendyneTranscatheterMitralValveReplacementFromAnimalModeltoFirstinHuman Lecturers:JaffarMKhan

11:37_AM Discussion

11:42_AM TCT861:PredictingLeftVentricularOutflowTractObstructionFromTranscatheterMitralValveReplacementDespiteAnteriorMitralLeafletResection

TheSkirtNeoLVOT Lecturers:JaffarMKhan

11:49_AM Discussion

11:54_AM TCT862:AMoreReliableMethodforPredictingNeoLVOTObstructionAfterTMVR Lecturers:DeeDeeWang

12:01_PM Discussion

12:06_PM TCT863:SCOUT1Trial:ImpactofCenterExperienceonIntraproceduraland30DayOutcomes Lecturers:CharlesJ.Davidson

12:13_PM Discussion

12:18_PM TCT864:ShouldTricuspidValveRepairBeIndicatedforSevereSymptomaticTricuspidRegurgitationClinicalandProceduralOutcomes Lecturers:MohammadMehdiAnsari

12:25_PM Discussion

MODERATEDPOSTERSESSION:VULNERABLEPLAQUESANDVULNERABLEPATIENTSII

MONDAY,SEPTEMBER24,2018

11:30AM-12:30PM

ModeratedPosters2,ExhibitHall,GroundLevel

11:30AM-12:30PM

VulnerablePlaquesandVulnerablePatientsII

Moderators:RenuVirmani,RobertL.Wilensky

Discussants:FaroucAJaffer,TakashiKubo

11:30_AM TCT856:PeriCoronaryAdiposeTissueExpressesProInflammatoryActivityWhichMayAffectCoronaryAtherosclerosisinPatientsWithCoronaryArtery

Disease Lecturers:TomaszMazurek

11:37_AM Discussion

11:42_AM TCT857:A75StenosisCreatedTurbulentFlowRupturedBubblesCavitationPhenomenonErodedtheVulnerableCapandTriggeredAcuteMyocardial

Infarction Lecturers:HoaBui

11:49_AM Discussion

11:54_AM TCT858:ResidualInflammatoryStatusinPatientsWithStableCoronaryArteryDiseaseUndergoingPercutaneousCoronaryIntervention Lecturers:DeborahKalkman

12:01_PM Discussion

12:06_PM TCT859:CirculatingTNFSF14PredictsClinicalOutcomeinPatientsWithCoronaryArteryDiseaseUnderwentPercutaneousCoronaryIntervention Lecturers:Chien-YiHsu

12:13_PM Discussion

EVENINGPROGRAM:DAPTANDTRIPLETHERAPY:ACASE-BASEDGUIDETOOPTIMALANTIPLATELETTHERAPIES(SPONSOREDBYCRF,SUPPORTEDBY

ABBOTT,ASTRAZENECA,BOSTONSCIENTIFICCORPORATION,CELONOVABIOSCIENCES,CHIESIUSA,INC.,MEDTRONIC)

Page 251: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:251

MONDAY,SEPTEMBER24,2018

6:00PM-8:00PM

PacificBallroom14-17,LevelOne

6:00PM-6:30PM

Check-In&Reception

6:30PM-8:00PM

DAPTandTripleTherapy:ACase-basedGuidetoOptimalAntiplateletTherapies

CoChairs:AjayJ.Kirtane,RoxanaMehran

Faculty:DeepakL.Bhatt,C.MichaelGibson,JamesB.HermillerJr,SunilV.Rao

6:30_PM WelcomeIntroductionsandSessionGoals Lecturers:AjayJ.Kirtane

EVENINGPROGRAM:NEXTGENERATIONDESTECHNOLOGY:THEFUTUREISHERE!(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,BOSTONSCIENTIFIC

CORPORATION,MEDTRONIC,ANDORBUSNEICH)

MONDAY,SEPTEMBER24,2018

6:00PM-8:00PM

PacificBallroom18-19,LevelOne

6:00PM-6:30PM

Check-In&Reception

6:30PM-8:00PM

NextGenerationDESTechnology:TheFutureisHere!

CoChairs:AlexandreAbizaid,GeorgeD.Dangas,RoxanaMehran

Faculty:OriBen-Yehuda,RobertA.Byrne,DavidE.Kandzari,AjayJ.Kirtane,MitchellW.Krucoff,PatrickW.Serruys,PieterR.Stella,StephanWindecker

6:30_PM TheSciencebehindXience:FromEXCELtoSHORTDAPT Lecturers:RoxanaMehran

6:37_PM TheOnyxOnePrograms:MovingtoHighBleedingRiskPatients Lecturers:StephanWindecker

6:44_PM NovelPolyzeneFNanocoatingCOBRAPzFStent:ShortestDAPTProgram Lecturers:RobertA.Byrne

6:51_PM NovelPropertiesandResultswiththeElastomerPolymerbasedEluNIRDES Lecturers:OriBen-Yehuda

6:58_PM ModeratedDiscussionandSummary

THECASEFORBIORESORBABLEPOLYMERDES

Moderators:PatrickW.Serruys

THECASEFORBIORESORBABLEPOLYMERDES

PanelDiscussant:DavidE.Kandzari,AjayJ.Kirtane,RoxanaMehran

7:08_PM TheEvolvingSYNERGYPrograms:EVOLVEShortDAPTUpdates Lecturers:AjayJ.Kirtane

7:15_PM ORSIRO:AnUltrathinStrutMetallicDESwithBioresorbablePolymer Lecturers:DavidE.Kandzari

7:22_PM BioresorbablePolymerbasedDrugDeliverywithEndothelialProgenitorCellstoAccelerateHealing:TheCOMBOStent Lecturers:RoxanaMehran

7:29_PM ModeratedDiscussionandSummary

THECASEFORPOLYMER-FREEDES

Moderators:RoxanaMehran

THECASEFORPOLYMER-FREEDES

PanelDiscussant:MitchellW.Krucoff,PieterR.Stella

7:39_PM BIOFREEDOM:TheLEADERSFREEProgramandBeyond Lecturers:MitchellW.Krucoff

Page 252: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|MONDAY,SEPTEMBER24,2018

LastUpdated09/10/2018Page:252

7:47_PM PolymerFreeAmphilimusCRE8:ACreativeDesignforDiabetics Lecturers:PieterR.Stella

7:54_PM ModeratedDiscussionandSummary8:00_PM Adjourn

Page 253: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|TUESDAY,SEPTEMBER25,2018

LastUpdated09/10/2018Page:253

TUESDAY,SEPTEMBER25,2018-

BREAKFASTPROGRAM:GUIDEWIREDESIGNANDSELECTION:AUSER�SGUIDE(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,ASAHIINTECCUSA,INC.,BOSTONSCIENTIFICCORPORATION,ANDMEDTRONIC)

TUESDAY,SEPTEMBER25,2018

6:30AM-8:00AM

Room1,UpperLevel

6:30AM-7:00AM

Check-in&Breakfast

7:00AM-8:00AM

GuidewireDesignandSelection:AUser�sGuideCoChairs:EmmanouilS.Brilakis,GeorgeD.Dangas,AjayJ.Kirtane

Faculty:J.AaronGrantham,PaulKnaapen,RobertW.Yeh

7:00_AM WelcomeandIntroductions Lecturers:AjayJ.Kirtane

7:02_AM MatchingGuidewireDesigntoFunction:2018Updates Lecturers:RobertW.Yeh

7:12_AM AppliedUseofCoronaryGuidewires:BasicPrinciplesforWireManipulation Lecturers:EmmanouilS.Brilakis

7:24_AM UsingAllToolsatYourDisposalforWiringandTroubleshooting:CaseExamples Lecturers:J.AaronGrantham

7:36_AM CTOWires:AntegradeandRetrogradeCaseExamples Lecturers:PaulKnaapen

7:48_AM AudienceQAandDiscussion

8:00_AM Adjourn

BREAKFASTPROGRAM:INTEGRATINGPHYSIOLOGYANDIMAGINGINTOTHECATHLAB-WHATTECHNOLOGYSHOULDIUSEANDHOWANDWHEN

SHOULDIUSEIT?(SPONSOREDBYCRF,SUPPORTEDBYABBOTT,BOSTONSCIENTIFIC,ANDMEDTRONIC)

TUESDAY,SEPTEMBER25,2018

6:30AM-8:00AM

Room2,UpperLevel

6:30AM-7:00AM

Check-in&Breakfast

7:00AM-8:00AM

IntegratingPhysiologyandImagingIntotheCathLab:WhatTechnologyShouldIUseandHowandWhenShouldIUseIt?

CoChairs:GaryS.Mintz,FrancescoPrati

Faculty:JavierEscaned

7:00_AM HowDoIAssessanIntermediateLesionFFRiFRAngioFFR Lecturers:JavierEscaned

7:15_AM Discussion

7:20_AM WhatIstheStatusofVulnerablePlaqueDetection

7:30_AM Discussion

7:35_AM HowDoIOptimizeMetallicStentImplantation Lecturers:FrancescoPrati

7:55_AM QA

8:00_AM Adjourn

Page 254: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|TUESDAY,SEPTEMBER25,2018

LastUpdated09/10/2018Page:254

MAINARENAIV,TUESDAY,SEPT25

TUESDAY,SEPTEMBER25,2018

8:00AM-1:00PM

MainArena,HallF,GroundLevel

8:00AM-9:00AM

MyBestComplications(OnesThatWorkedOut)

Moderators:HowardC.Herrmann,GreggW.Stone

Discussants:KrzysztofBartus,FranciscoFdez-Aviles,GaryGershony,RobertA.Lookstein,ReginaldI.Low,FrancescoMaisano,ChristophA.Nienaber,CurtissT.Stinis,

BernhardWitzenbichler

8:00_AM MassivePerforationAfterCoronaryAtherectomy CasePresenter:GeorgeD.Dangas

8:12_AM ChordalRuptureDuringHemodynamicSupport CasePresenter:MarkReisman

8:24_AM SevereAorticDissection CasePresenter:D.ChristopherMetzger

8:36_AM SubclavianArteryRuptureandAvulsion CasePresenter:OscarA.Mendiz

8:48_AM RightHeartCatheterizationisNotAlwaysBenign CasePresenter:GiuseppeTarantini

9:00AM-10:00AM

TCTAwards:BestAbstract,BestChallengingCase,MostFascinatingLecture

AwardPresenters:AlexandreAbizaid,GaryS.Mintz,PatrickW.Serruys,GreggW.Stone

9:00_AM BestOralAbstractPresentation

9:06_AM Discussion

9:16_AM TCTAwardPresentation:BestOralAbstract AwardPresenters:PatrickW.Serruys

9:20_AM BestChallengingCasePresentation Lecturers:ShunmingZhu

9:26_AM Discussion

9:36_AM TCTAwardPresentation:BestChallengingCase AwardPresenters:AlexandreAbizaid

9:40_AM MostFascinatingLecturePresentation Lecturers:PaulRees

9:46_AM Discussion

9:56_AM TCTAwardPresentation:MostFascinatingLecture AwardPresenters:GaryS.Mintz

10:00AM-11:00AM

Late-BreakingTrials5

Moderators:FelixMahfoud,PatrickW.Serruys

Discussants:HerbertD.Aronow,BernardR.Chevalier,DavidJ.Cohen,AntonioColombo,YalingHan,TakeshiKimura,AjayJ.Kirtane,D.ChristopherMetzger,JohnA.

Ormiston,Robert-JanvanGeuns

10:00_AM ABSORBIV:ABlindedRandomizedTrialofaPolymericEverolimusElutingBioresorbableScaffoldinanExpandedPatientPopulationUsingOptimized

Technique Lecturers:GreggW.Stone

10:12_AM RoundtableDiscussion

10:20_AM COMPAREABSORB:ARandomizedTrialofaPolymericEverolimusElutingBioresorbableScaffoldinHighRiskandComplexLesions Lecturers:PieterC.Smits

10:32_AM RoundtableDiscussion

10:40_AM RADIOSOUNDHTN:AThreeArmRandomizedTrialofDifferentRenalDenervationDevicesandTechniquesinPatientsWithResistantHypertension Lecturers:PhilippLurz

10:52_AM RoundtableDiscussion

Page 255: FRIDAY, SEPTEMBER 21, 2018 · 2018-09-17 · Arteries at 24 month follow up BIOSOLVE II and BIOSOLVE III Lecturers: Michael Haude 2:40 _PM Roundtable Discussion With Audience QA 2:45

TRANSCATHETERCARDIOVASCULARTHERAPEUTICS|TUESDAY,SEPTEMBER25,2018

LastUpdated09/10/2018Page:255

11:00AM-12:00PM

Late-BreakingClinicalScience3

Moderators:JamesB.HermillerJr

CoModerator:AlainG.Cribier

Discussants:DariuszDudek,SameerGafoor,NilsJohnson,MortonJ.Kern,NealS.Kleiman,RajMakkar,GiampaoloNiccoli,SimonRedwood,JacquelineE.Tamis-Holland

11:00_AM CorMicA:ARandomizedTrialofInvasiveCoronaryFunctionTestinginPatientsWithAnginaandNonobstructiveCoronaryArteryDisease Lecturers:TomJFord

11:10_AM RoundtableDiscussion

11:15_AM RESET:SevenYearFollowupFromaRandomizedTrialofSirolimusElutingvsEverolimusElutingStentsinPatientsWithCoronaryArteryDisease Lecturers:HirokiShiomi

11:25_AM RoundtableDiscussion

11:30_AM NEOPRO:NonrandomizedComparisonofTwoTranscatheterHeartValveinPatientsWithSevereAorticStenosis Lecturers:AzeemLatib

11:40_AM RoundtableDiscussion

11:45_AM PORTICOI:OneYearOutcomesWithaSelfExpandingRepositionableTranscatheterHeartValveinPatientsWithSevereAorticStenosis Lecturers:LarsSondergaard

11:55_AM RoundtableDiscussion

12:00PM-1:00PM

MyWorstComplications(OnesThatDidn�tWorkOut)

Moderators:MartinB.Leon,BarryD.Rutherford

Discussants:EmmanouilS.Brilakis,AnthonyH.Gershlick,TakeshiKimura,UgoLimbruno,FabianNietlispach,IgorF.Palacios,DavidG.Rizik,AndrewSharp,PeterB.Sick,

PaulSorajja

12:00_PM CascadeofComplicationsDuringandAfterSingleRemainingVesselPCI CasePresenter:AzeemLatib

12:12_PM HemodynamicCollapseAfterTAVR CasePresenter:JochenWöhrle

12:24_PM TAVIwithDelayedCardiacArrest CasePresenter:MohamedAbdel-Wahab

12:36_PM ValveinValveGoneAwry CasePresenter:NiratBeohar

12:48_PM TBD